"Item Id","Item URI","Dublin Core:Title","Dublin Core:Subject","Dublin Core:Description","Dublin Core:Creator","Dublin Core:Source","Dublin Core:Publisher","Dublin Core:Date","Dublin Core:Contributor","Dublin Core:Rights","Dublin Core:Relation","Dublin Core:Format","Dublin Core:Language","Dublin Core:Type","Dublin Core:Identifier","Dublin Core:Coverage","Item Type Metadata:Bibliography","Item Type Metadata:Biographical Text","Item Type Metadata:Occupation","Item Type Metadata:Death Date","Item Type Metadata:Birthplace","Item Type Metadata:Text","Item Type Metadata:Player","Item Type Metadata:Access","Item Type Metadata:Alternate URL","Item Type Metadata:Citation","Item Type Metadata:Accessibility","Item Type Metadata:Abstract","Item Type Metadata:Read Online","Item Type Metadata:Additional Exercise","Item Type Metadata:Email Body","Item Type Metadata:Interviewer","Item Type Metadata:Interviewee","Item Type Metadata:Location","Item Type Metadata:Transcription","Item Type Metadata:Local URL","Item Type Metadata:Original Format","Item Type Metadata:Physical Dimensions","Item Type Metadata:Duration","Item Type Metadata:Compression","Item Type Metadata:Producer","Item Type Metadata:Director","Item Type Metadata:Bit Rate/Frequency","Item Type Metadata:Time Summary","Item Type Metadata:Birth Date","Item Type Metadata:Subject Line","Item Type Metadata:From","Item Type Metadata:To","Item Type Metadata:CC","Item Type Metadata:BCC","Item Type Metadata:Number of Attachments","Item Type Metadata:Standards","Item Type Metadata:Objectives","Item Type Metadata:Materials","Item Type Metadata:Lesson Plan Text","Item Type Metadata:URL","Item Type Metadata:Event Type","Item Type Metadata:Participants","PDF Text:Text",tags,file,itemType,collection,public,featured
1807,https://repository.netecweb.org/items/show/1807,"Model PPE Donning and Doffing Procedure for Suspected VHF Case without Active Bleeding, Vomiting, or Diarrhea","Emergency Medical Services","PURPOSE: This Model Guidance outlines the procedure for the proper donning and doffing of a Personal Protective Equipment (PPE) ensemble for prehospital personnel managing a patient without active bleeding, vomiting, or diarrhea who is suspected to have a Viral Hemorrhagic Fever (VHF).
SCOPE: This Model Guidance applies to all EMS personnel involved in the transport and management of a patient suspected to have a VHF, e.g., Ebola Virus Disease.
This is from the series of Model Guidance documents. Find all the resources in the series below.
- EMS Ambulance Cleaning and Disinfection
- EMS Ambulance Modification Procedure
- EMS Ambulance Operations High Consequence Infectious Disease Waste Management
- EMS Biohazard Spill
- EMS PPE Breach: High Consequence Infectious Disease Patient Transport
- EMS Provider Down Procedure
- Model PPE Donning and Doffing Procedure for Confirmed or Suspected VHF Case with Active Bleeding, Vomiting, or Diarrhea
- Model PPE Donning and Doffing Procedure for Suspected VHF Case without Active Bleeding, Vomiting, or Diarrhea
",NETEC,,,2024-02-05,,,,,,,"Emergency Medical Services",2026-02-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Doffing,Donning,Donning and Doffing,EMS,Guidance Document,Personal Protective Equipment (PPE),R-EMS,Standard Operating Procedure (SOP),Viral Hemorrhagic Fever",https://repository.netecweb.org/files/original/4c14968340abd8f2c1e18e5d5c469600.pdf,Guide,Develop,1,0
1806,https://repository.netecweb.org/items/show/1806,"Model PPE Donning and Doffing Procedure for Confirmed or Suspected VHF Case with Active Bleeding, Vomiting, or Diarrhea","Emergency Medical Services","PURPOSE: This Model Guidance outlines the procedure for the proper donning and doffing of a Personal Protective Equipment (PPE) ensemble for prehospital personnel managing a patient suspected or confirmed to have a Viral Hemorrhagic Fever (VHF) with active bleeding, vomiting, or diarrhea.
SCOPE: This Model Guidance applies to all EMS personnel involved in the transport and management of a patient suspected or confirmed to have a VHF, e.g., Ebola Virus Disease.
This is from the series of Model Guidance documents. Find all the resources in the series below.
- EMS Ambulance Cleaning and Disinfection
- EMS Ambulance Modification Procedure
- EMS Ambulance Operations High Consequence Infectious Disease Waste Management
- EMS Biohazard Spill
- EMS PPE Breach: High Consequence Infectious Disease Patient Transport
- EMS Provider Down Procedure
- Model PPE Donning and Doffing Procedure for Confirmed or Suspected VHF Case with Active Bleeding, Vomiting, or Diarrhea
- Model PPE Donning and Doffing Procedure for Suspected VHF Case without Active Bleeding, Vomiting, or Diarrhea
",NETEC,,,2024-02-05,,,,,,,"Emergency Medical Services",2026-02-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Doffing,Donning,Donning and Doffing,EMS,Guidance Document,Personal Protective Equipment (PPE),R-EMS,Standard Operating Procedure (SOP),Viral Hemorrhagic Fever",https://repository.netecweb.org/files/original/565777f92eb1b0e0fe001cbf7ccdaac8.pdf,Guide,Develop,1,0
1805,https://repository.netecweb.org/items/show/1805,"EMS Provider Down Procedure ","Emergency Medical Services","PURPOSE: This Model Guidance outlines the procedure for assessment and management of an EMS clinician who has become incapacitated while wearing a personal protective equipment ensemble.
SCOPE: This Model Guidance applies to all EMS personnel involved in the transport and management of a patient suspected or confirmed to have a high consequence infectious disease.
This is from the series of Model Guidance documents. Find all the resources in the series below.
- EMS Ambulance Cleaning and Disinfection
- EMS Ambulance Modification Procedure
- EMS Ambulance Operations High Consequence Infectious Disease Waste Management
- EMS Biohazard Spill
- EMS PPE Breach: High Consequence Infectious Disease Patient Transport
- EMS Provider Down Procedure
- Model PPE Donning and Doffing Procedure for Confirmed or Suspected VHF Case with Active Bleeding, Vomiting, or Diarrhea
- Model PPE Donning and Doffing Procedure for Suspected VHF Case without Active Bleeding, Vomiting, or Diarrhea
",NETEC,,,2024-02-05,,,,,,,"Emergency Medical Services",2026-02-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"EMS,Guidance Document,Provider Down,R-EMS,Standard Operating Procedure (SOP)",https://repository.netecweb.org/files/original/7ee744a62dbc83868def6032569cfb1c.pdf,Guide,Develop,1,0
1804,https://repository.netecweb.org/items/show/1804,"EMS PPE Breach: High Consequence Infectious Disease Patient Transport ","Emergency Medical Services","PURPOSE: This Model Guidance outlines the procedure for assessment and management of a PPE breach when caring for a patient suspected or confirmed to have a high consequence infectious disease.
SCOPE: This Model Guidance applies to all EMS personnel involved in the transport and management of a patient suspected or confirmed to have a high consequence infectious disease.
This is from the series of Model Guidance documents. Find all the resources in the series below.
- EMS Ambulance Cleaning and Disinfection
- EMS Ambulance Modification Procedure
- EMS Ambulance Operations High Consequence Infectious Disease Waste Management
- EMS Biohazard Spill
- EMS PPE Breach: High Consequence Infectious Disease Patient Transport
- EMS Provider Down Procedure
- Model PPE Donning and Doffing Procedure for Confirmed or Suspected VHF Case with Active Bleeding, Vomiting, or Diarrhea
- Model PPE Donning and Doffing Procedure for Suspected VHF Case without Active Bleeding, Vomiting, or Diarrhea
",NETEC,,,2024-02-05,,,,,,,"Emergency Medical Services",2026-02-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Breach,EMS,Guidance Document,High Consequence Infectious Disease (HCID),Patient Transport,Personal Protective Equipment (PPE),R-EMS,Standard Operating Procedure (SOP)",https://repository.netecweb.org/files/original/d5740aaad585a12f73bd899e26948524.pdf,Guide,Develop,1,0
1803,https://repository.netecweb.org/items/show/1803,"EMS Biohazard Spill","Emergency Medical Services","PURPOSE: This Model Guidance outlines the procedure for managing a biohazard spill – gross contamination with blood, vomit, or diarrhea.
SCOPE: This Model Guidance applies to all EMS personnel involved in the transport and management of a patient suspected or confirmed to have a high consequence infectious disease.
This is from the series of Model Guidance documents. Find all the resources in the series below.
- EMS Ambulance Cleaning and Disinfection
- EMS Ambulance Modification Procedure
- EMS Ambulance Operations High Consequence Infectious Disease Waste Management
- EMS Biohazard Spill
- EMS PPE Breach: High Consequence Infectious Disease Patient Transport
- EMS Provider Down Procedure
- Model PPE Donning and Doffing Procedure for Confirmed or Suspected VHF Case with Active Bleeding, Vomiting, or Diarrhea
- Model PPE Donning and Doffing Procedure for Suspected VHF Case without Active Bleeding, Vomiting, or Diarrhea
",NETEC,,,2024-02-05,,,,,,,"Emergency Medical Services",2026-02-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Biosafety,EMS,Guidance Document,R-EMS,Spills,Standard Operating Procedure (SOP)",https://repository.netecweb.org/files/original/e61df9ba2a6d73b28967c456adf6decb.pdf,Guide,Develop,1,0
1802,https://repository.netecweb.org/items/show/1802,"EMS Ambulance Operations High Consequence Infectious Disease Waste Management","Emergency Medical Services","PURPOSE: This Model Guidance outlines the procedure for management of waste resulting from transport and care of a patient suspected or confirmed to have a high consequence infectious disease.
SCOPE: This Model Guidance applies to all EMS personnel involved in the transport and management of a patient suspected or confirmed to have a high consequence infectious disease.
This is from the series of Model Guidance documents. Find all the resources in the series below.
- EMS Ambulance Cleaning and Disinfection
- EMS Ambulance Modification Procedure
- EMS Ambulance Operations High Consequence Infectious Disease Waste Management
- EMS Biohazard Spill
- EMS PPE Breach: High Consequence Infectious Disease Patient Transport
- EMS Provider Down Procedure
- Model PPE Donning and Doffing Procedure for Confirmed or Suspected VHF Case with Active Bleeding, Vomiting, or Diarrhea
- Model PPE Donning and Doffing Procedure for Suspected VHF Case without Active Bleeding, Vomiting, or Diarrhea
",NETEC,,,2024-02-05,,,,,,,"Emergency Medical Services",2026-02-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"EMS,Guidance Document,High Consequence Infectious Disease (HCID),R-EMS,Standard Operating Procedure (SOP),Waste,Waste Management",https://repository.netecweb.org/files/original/b74f66c4123a196e2884bd6e0a856ef6.pdf,Guide,Develop,1,0
1801,https://repository.netecweb.org/items/show/1801,"EMS Ambulance Modification Procedure ","Emergency Medical Services","PURPOSE: This Model Guidance outlines procedures for modification of an ambulance with the purpose of protecting environmental surfaces and EMS personnel from exposure to potentially infectious body fluids when transporting a patient confirmed to have a high consequence infectious disease.
SCOPE: This Model Guidance applies to all ground EMS personnel and ambulance operators who transport patients confirmed to have a high consequence infectious disease.
This is from the series of Model Guidance documents. Find all the resources in the series below.
- EMS Ambulance Cleaning and Disinfection
- EMS Ambulance Modification Procedure
- EMS Ambulance Operations High Consequence Infectious Disease Waste Management
- EMS Biohazard Spill
- EMS PPE Breach: High Consequence Infectious Disease Patient Transport
- EMS Provider Down Procedure
- Model PPE Donning and Doffing Procedure for Confirmed or Suspected VHF Case with Active Bleeding, Vomiting, or Diarrhea
- Model PPE Donning and Doffing Procedure for Suspected VHF Case without Active Bleeding, Vomiting, or Diarrhea
",NETEC,,,2024-02-05,,,,,,,"Emergency Medical Services",2026-02-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"EMS,Guidance Document,R-EMS,Standard Operating Procedure (SOP)",https://repository.netecweb.org/files/original/9b046da9c09e61bd64f68f6573df3c66.pdf,Guide,Develop,1,0
1800,https://repository.netecweb.org/items/show/1800,"EMS Ambulance Cleaning and Disinfection","Emergency Medical Services","PURPOSE: This Model Guidance outlines the procedure for the proper cleaning and disinfection of the ambulance after transport of a patient suspected or confirmed to have a high consequence infectious disease (HCID).
SCOPE: This Model Guidance applies to all ground EMS personnel and ambulance operators who transport patients suspected or confirmed to have a high consequence infectious disease.
This is from the series of Model Guidance documents. Find all the resources in the series below.
- EMS Ambulance Cleaning and Disinfection
- EMS Ambulance Modification Procedure
- EMS Ambulance Operations High Consequence Infectious Disease Waste Management
- EMS Biohazard Spill
- EMS PPE Breach: High Consequence Infectious Disease Patient Transport
- EMS Provider Down Procedure
- Model PPE Donning and Doffing Procedure for Confirmed or Suspected VHF Case with Active Bleeding, Vomiting, or Diarrhea
- Model PPE Donning and Doffing Procedure for Suspected VHF Case without Active Bleeding, Vomiting, or Diarrhea
",NETEC,,,2024-02-05,,,,,,,"Emergency Medical Services",2026-02-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Cleaning,Disinfection,EMS,Guidance Document,R-EMS,Standard Operating Procedure (SOP)",https://repository.netecweb.org/files/original/eb9acf78ee8d2606f46f1ac22cfe16c2.pdf,Guide,Develop,1,0
1795,https://repository.netecweb.org/items/show/1795,"Regional Ebola and Other Special Pathogen Treatment Centers COVID-19 Preparedness and Response Emergency Supplement Performance Measures",General,"Regional Ebola and Other Special Pathogen Treatment Centers COVID-19 Preparedness and Response Emergency Supplement Performance Measures by the U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response
Hospital Preparedness Program",ASPR,,,2021-03,"2024-03-27 R-Lead – never reviewed – make due in 6 months",,,,,,,2024-11-08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Intent of Evaluation and Performance Measurement for the Regional Ebola and Other Special Pathogen Treatment Center (RESPTC) COVID-19 Preparedness and Response Activities Administrative Supplement
The Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded this supplemental funding to the 10 recipients of the Hospital Preparedness Program (HPP) Ebola Preparedness and Response Activities Cooperative Agreement (CFDA #93.817) Part B in response to the COVID-19 pandemic. This emergency supplemental funding supported the launch of the National Special Pathogen System (NSPS), which builds on the Ebola-specific treatment network to create a nationwide network for special pathogen response leveraging a regional “hub-and-spoke” model. As regional hubs for special pathogen readiness, RESPTCs play a critical role in this nationwide network. The purpose of this funding is to support RESPTCs implement activities that increase the capability of health care systems to safely and effectively manage individuals with suspected and confirmed COVID-19.
The purpose of the RESPTC COVID-19 Preparedness and Response Activities Administrative Supplement Performance Measures is to demonstrate the use of funding and the outcomes achieved as a result of this funding supplement. The measures will also provide information to identify challenges and successes of activities funded. Consistent with the full scope of applicable grant regulations (45 CFR Part 75) and the purpose of this award, the recipients and sub-recipients shall provide ASPR with access to data pertinent to the award in the form of reported results for the enclosed performance measures. This funding is likely to generate positive secondary and tertiary effects for the entire health care system and to advance capabilities to respond to outbreaks of other special pathogens. As such, these measures could be used to evaluate response to outbreaks of other special pathogens, especially highly infectious pathogens.
The remainder of this document describes the performance measures ASPR will use to understand the programmatic effectiveness of the funding distributed through the RESPTC COVID-19 Preparedness and Response Activities Administrative Supplement. Where measures ask RESPTCs to respond to questions regarding ‘ASPR-funded’ activities, these activities include those 1) fully funded by this administrative supplement; 2) partially funded by this administrative supplement and by the RESPTC; and 3) supported by allowable staff positions fully- or partially-funded by this administrative supplement. Activities and supplies/materials funded by the RESPTC COVID-19 Preparedness and Response Activities Administrative Supplement include those that have been or will be retroactively compensated.1
All performance measures will be submitted by recipients to HHS ASPR within 90 days of the end of the performance period (ending on June 14). Performance measures will include (1) required quantitative measures to measure funding use and effectiveness, and (2) optional qualitative questions which will identify opportunities, needs, and challenges for RESPTCs, 3 as well as inform future funding opportunities.
1 Recipients may use a portion of the funding to retroactively compensate Regional Ebola and Other Special Pathogen Treatment Centers for any of the activities described in the notice of award that were conducted as part of COVID-19 response beginning January 20, 2020. Recipients must have requested retroactive compensation at the time of the budget submission.",,,https://www.phe.gov/Preparedness/planning/hpp/reports/COVID-19Supp-RESPTC-PM/Pages/default.aspx,,,,"Assessment Facility,CONOPS,COVID-19,Ebola,Federal,Preparedness,R-Lead,Regional Treatment Center,Special Pathogens",https://repository.netecweb.org/files/original/30d6373c1d383208e14b793651b05e10.pdf,Guide,Develop,1,0
1790,https://repository.netecweb.org/items/show/1790,"APIC Risk Assessment (example) ","Infection Control","This 2013 Infection Control Risk Assessment( Example Template) can be viewed alongside the APIC Risk Assessment Template.","The Association for Professionals in Infection Control and Epidemiology (APIC)",,,2023,,,,,,,,2024-10-16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://apic.org/Resource_/TinyMceFileManager/Academy/ASC_101_resources/Risk_Assessment/Risk_Assessment_Example_1.docx,,,,"Ambulatory Care,Infection Prevention and Control,R-IPC",,Guide,Develop,1,0
1789,https://repository.netecweb.org/items/show/1789,"APIC Risk Assessment Template ","Infection Control","This Risk Assessment tool can be used to conduct a facility risk assessment for acquiring and transmitting infections in a variety of ambulatory healthcare settings. The results of the risk assessment can then be reported using the accompanying template for a Risk Assessment Report. The findings of the risk assessment should be used to provide information about where an organization should focus its infection surveillance, prevention and control activities.","The Association for Professionals in Infection Control and Epidemiology (APIC)",,,2023,,,,,,,,2024-10-16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://apic.org/Resource_/TinyMceFileManager/Education/ASC_Intensive/Resources_Page/ASC_Risk_Assessment_Template.docx,,,,"Ambulatory Care,Infection Prevention and Control,R-IPC",,Guide,Develop,1,0
1783,https://repository.netecweb.org/items/show/1783,"Identify, Isolate, Inform Approach for High Consequence Infectious Diseases","Infection Control","As part of the CDC-funded National Infection Control Strengthening (NICS) project, experts in infection prevention and control, infectious diseases, emergency preparedness and management from NYC Health + Hospitals/Bellevue and the Massachusetts General Hospital partnered to develop practical tools to enhance infection prevention and control in healthcare facilities.
Explore this series of tools and resources.","National Infection Control Strengthening (NICS) project",,,2023-08,,,,,,,,2024-08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://mypact.us/series/identify-isolate-inform/,,,,"High Consequence Infectious Disease (HCID),Identify,Infection Prevention and Control,Inform,Isolate,R-T&C,Treatment and Care",,Hyperlink,Develop,1,0
1775,https://repository.netecweb.org/items/show/1775,"NPHL Packing & Shipping Division 6.2 & 9 Infectious Substances Training ",Laboratory,"This two-day course is appropriate for those responsible for packing, marking, labeling and documentation of shipments for the transportation of Division 6.2 infectious substance and dry ice. The procedures and practices highlighted in this training are based on the requirements of the Department of Transportation (DOT), United States Postal Services (USPS), International Civil Aviation Organization (ICAO), International Air Transportation Association (IATA), and Occupational Safety and Health Administration (OSHA). However, each facility is responsible for assuring that appropriate packing instructions are adhered to as required by federal law and air transport standards. Participants will mark, label, package and complete documentation for a variety of infectious substances shipments (Category A, Category B, Exempt Patient Specimens) through several facilitated, hands-on learning activities. An examination and practical exercises will be provided to participants to demonstrate competency.","University of Nebraska Medical Center / Nebraska Medicine",,,2021-11-24,,,"Y - D0.1Lab/D0.2Lab Qualtrics # 1020, original # 10a
Y - D0.1Lab/D0.2Lab Qualtrics # 1021, original # 10b
Y - D0.1Lab/D0.2Lab Qualtrics # 1027
Y - D0.1Lab/D0.2Lab Qualtrics # 1029, original # 21
Y - D0.1Lab/D0.2Lab Qualtrics # 1030, original # 22
Y - D0.1Lab/D0.2Lab Qualtrics # 1035, original # 24
",,,,,2024-06-01,,,,,,,,"You may need to search the ID number from Train.org: 1101336",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Attendees are encouraged to download and review all resources prior to the course date. Course resources can be downloaded in the ""Resources"" tab which will appear after registration.
At the end of this course, you will be able to:
- Recognize requirements for initial and recurrent training and certification for the transportation of Division 6.2 infectious substances and dry ice.
- Identify applicable regulations and requirements for the transportation of Division 6.2 infectious substances and dry ice.
- Determine the proper course of action for packing and shipping Division 6.2 infectious substances and dry ice.
- Summarize the potential risks associated with packing and shipping infectious substances.
- Apply the key components of Packing instruction 620, 650, and 952, and properly mark, label and document Division 6.2 infectious substances and dry ice.
",,,https://www.train.org/main/course/1101336/live-event,,,,"Category A,Laboratory,Packing and Shipping,R-Lab,Training",,"Online Course",Develop,1,0
1772,https://repository.netecweb.org/items/show/1772,"Considerations for Terminal Cleaning and Decontamination of Special Pathogen Patient Care Rooms","Infection Control","Purpose: The information in this document includes general considerations that may be incorporated into terminal cleaning plans. It is intended to serve as a planning tool and resource for risk assessments or preparedness activities.",NETEC,"The Infection Prevention and Control Work Group",,2023-04-17,,,"Y
Y - D0.1IC/D0.2IC Qualtrics # 201, original # 1
Y - D0.1IC/D0.2IC Qualtrics # 202, original # 1a
Y - D0.1IC/D0.2IC Qualtrics # 203, original # 1b
POS |
DOMAIN |
Original Question # |
Qualtrics # |
Asset Link |
45 |
2 |
1 |
201 |
Considerations for Terminal Cleaning |
46 |
2 |
1a |
202 |
Considerations for Terminal Cleaning |
47 |
2 |
1b |
203 |
Considerations for Terminal Cleaning |
56 |
2 |
6 |
211 |
Considerations for Terminal Cleaning |
58 |
2 |
6a |
212 |
Considerations for Terminal Cleaning |
61 |
2 |
8 |
215 |
Considerations for Terminal Cleaning |
62 |
2 |
8a |
216 |
Considerations for Terminal Cleaning |
64 |
2 |
9 |
218 |
Considerations for Terminal Cleaning |
66 |
2 |
9b |
220 |
Considerations for Terminal Cleaning |
67 |
2 |
9c |
221 |
Considerations for Terminal Cleaning |
68 |
2 |
10 |
222 |
Considerations for Terminal Cleaning |
69 |
2 |
11 |
223 |
Considerations for Terminal Cleaning |
72 |
2 |
13 |
226 |
Considerations for Terminal Cleaning |
73 |
2 |
14 |
227 |
Considerations for Terminal Cleaning |
74 |
2 |
15 |
228 |
Considerations for Terminal Cleaning |
75 |
2 |
16 |
229 |
Considerations for Terminal Cleaning |
76 |
2 |
17 |
230 |
Considerations for Terminal Cleaning |
",,,,,2025-04-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Cleaning,Crimean Congo Haemorrhagic Fever (CCHF),Decontamination,Disinfection,Ebola,High Consequence Infectious Disease (HCID),Identify,Infection Prevention and Control,Lassa,Marburg,Personal Protective Equipment (PPE),R-IPC,Special Pathogens,Terminal Clean,Viral Hemorrhagic Fever","https://repository.netecweb.org/files/original/be2468ba6fe788de18016ef2e6bc4445.png,https://repository.netecweb.org/files/original/c367fe2e20068bf02ac4a0471591bbff.docx",Guide,Develop,1,0
1771,https://repository.netecweb.org/items/show/1771,"EMS Biosafety Transport for Operators",Pre-Hospital,"The course aims to increase understanding about standard and transmission-based infection control practices and provides education about high consequence infectious diseases like COVID-19, Mpox, Ebola Virus Disease, Smallpox, SARS (Severe Acute Respiratory Syndrome), MERS (Middle Eastern Respiratory Syndrome), novel influenza viruses, like H5N1, and seasonal as well as pandemic influenza.
Education about these diseases, specifically the clinical course of the disease, the availability of medical countermeasures and appropriate infection control measures is essential for developing the competencies and the confidence to manage and transport patients suspected or confirmed to be infected with a high consequence infectious disease.
The course also describes operational considerations for management and transport of patients with seriohig consequence infectious diseases, to include, selection of PPE, donning and doffing of PPE, modification of the ambulance, destination considerations, decontamination and disinfection of the ambulance and durable medical equipment, waste management and post-mission medical surveillance.",NETEC,,,2023-04-13,,,,,,"Online Course",,2024-04-12,,,,,,,,"Free online with free account.",,,,,,,,,,,,,,,"The estimated time to complete this enduring material is 240 minutes. ",,,,,,,,,,,,,,"At the conclusion of this enduring material, the participants should be better able to:
- Discuss high consequence infectious diseases (smallpox, Mpox, COVID-19, SARS, MERS, Ebola, novel influenza) including standard and transmission-based infection control procedures.
- Describe the health care team’s roles and responsibilities involving implementation of a hierarchy of controls to prevent inadvertent exposure to infectious bodily fluids through the use of appropriate PPE and implementation of infection prevention guidelines for ambulances.
- Articulate processes required for safe management of wastes and post-mission health monitoring related to associated risks of exposures.
CEUs
In support of improving patient care, this activity has been planned and implemented by the University of Nebraska Medical Center and NETEC. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIANS/PHYSICIAN ASSISTANTS
The University of Nebraska Medical Center designates this enduring material for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NURSES/NURSE PRACTITIONERS
The University of Nebraska Medical Center designates this activity for 4.0 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
EMS
The University of Nebraska Medical Center, Center for Continuing Education, EMS and Trauma Division approves this educational opportunity for 4.0 hours of Emergency Medical Services Continuing Education. (Deb VonSeggern, NRP, EMSI)
",,,https://courses.netec.org/courses/ems-biosafety-transport-for-operators,,,,"CEU,CEUs,COVID-19,Ebola,EMS,Infection Prevention and Control,Influenza,MERS-CoV,Mpox,Online Course,Pre-Hospital,R-EMS,SARS,Special Pathogens",https://repository.netecweb.org/files/original/01eaeca3f4bae3401c486c883cfd57fd.png,"Online Course",Develop,1,1
1768,https://repository.netecweb.org/items/show/1768,"Packaging and Shipping Evaluation Tool",Laboratory,"APHL’s Sentinel Laboratory Partnerships and Outreach Subcommittee of the Public Health Preparedness and Response Committee developed this Packaging and Shipping Evaluation Tool to provide a standardized resource for public health laboratories (PHLs) to assess shipments received in the laboratory. The tool is primarily intended for PHLs that are reference level members of the Laboratory Response Network for Biological Threats Preparedness (LRN-B) to assess use of the proper packaging and shipping of biological threat agent rule-out samples sent from sentinel laboratories and may also be utilized for assessments of general Division 6.2 Division 6.2 (Category A and B) and other shipments received.","Association of Public Health Laboratories",,,2021,,,"Y - D0.1Lab/D0.2Lab - Qualtrics # 1020, original # 10a",,,,,2024-04-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.aphl.org/aboutAPHL/publications/Documents/PHPR-2021-Packaging-Shipping-Evaluation-Tool.pdf,,,,"Category A,Lab,Laboratory,Packing and Shipping,R-Lab",,Guide,Develop,1,0
1761,https://repository.netecweb.org/items/show/1761,"Laboratory Special Pathogen Capabilities Survey A",Laboratory,"Purpose: This survey is intended to be a high-level tool to help surveyors, NETEC or the appropriate Regional Emerging Special Pathogen Treatment Center (RESPTC), gain basic knowledge about a laboratory's capabilities for testing and handling special pathogens. This survey is designed as a basic overview of a laboratory's current status and is not intended to be a complete readiness assessment survey.",NETEC,,,2023-03-31,,,,,,,,2024-04-03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Lab,Laboratory,Laboratory Testing,R-Lab",https://repository.netecweb.org/files/original/0bc5928f5d6575f0b6d945a3278fa8ef.docx,Checklist,Develop,1,0
1748,https://repository.netecweb.org/items/show/1748,"HICS Roles and Responsibilities: Considerations for Special Pathogens Activations ","Emergency Management","The Hospital Incident Command System (HICS) purpose is an incident management system based on the Incident Command System's (ICS) principles. It assists hospitals and healthcare organizations in improving their emergency management planning, response, and recovery capabilities for planned and unplanned events, including special pathogen activations. HICS is consistent with ICS and the National Incident Management System (NIMS) principles. This module will discuss Hospital Incident Command System considerations for special pathogens activations.",NETEC,,,2023-03-01,,,"Y
Y - D0.1EM/D0.2EM Qualtrics # 503, original # 5
Y - D0.1EM/D0.2EM Qualtrics # 504, original # 7
Y - D0.1EM/D0.2EM Qualtrics # 505, original # 8
Y - D0.1EM/D0.2EM Qualtrics # 506, original # 9
Y - D0.1EM/D0.2EM Qualtrics # 512, original # 19
Y - D0.1EM/D0.2EM Qualtrics # 513, original # 20",,,"Online Course",,2025-03-01,,,,,,,,"Free online with free account.",,,,,,,,,,,,,,,Self-paced,,,,,,,,,,,,,,"EDUCATIONAL OBJECTIVES
At the conclusion of this module, the participant should be better able to:
- Define the five primary management functions of the hospital incident command system.
- Describe the roles and responsibilities of the incident commander, command staff, and general staff.
- Describe the operational considerations for various roles of the incident command staff for all-hazard and special pathogens activations.
REQUIREMENTS FOR SUCCESSFUL COMPLETION
In order to receive a certificate of completion, you must complete these steps.
- View the entire HICS learning module.
- Answer all knowledge-check questions in each lesson.
- Complete the NETEC course evaluation
- Submit the course evaluation Completion Attestation
The estimated time to complete this activity is 60 minutes.
There is a Certificate of Completion available for learners that complete the module and evaluation, but there are no continuing education credits available.
",,,https://courses.netec.org/courses/hics-roles-and-responsibilities-considerations-for-special-pathogens-activations,,,,"Emergency Management,HICS,Online Course,Preparedness,R-EM,Special Pathogens",https://repository.netecweb.org/files/original/839e1376693644cc79c6513b4761e7f4.png,"Online Course",Develop,1,0
1747,https://repository.netecweb.org/items/show/1747,"Laboratory Resources: Nipah Virus",Laboratory,"This guide, printable flyer, provides laboratory resources related to Nipah Virus. This is a part of a series of one-page resource guides for laboratorians.
Nipah virus (NiV) is a zoonotic virus that can spread between animals and people. Fruit bats, also called flying foxes, are the animal reservoir for NiV in nature. NiV can spread to people from direct contact with infected animals, such as bats or pigs, or their body fluids (such as blood, urine, or saliva), and can also occur by consuming food products that have been contaminated by body fluids of infected animals. Human transmission can occur via close contact with a person infected with NiV or their body fluids (including nasal or respiratory droplets, urine, or blood).
",NETEC,,,2023-02-21,,,,,,,,2024-02-23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Lab,Laboratorian,Laboratory,Laboratory Testing,Nipah (NiV),One Page Flyer,One-pager,Packing and Shipping,R-Lab",https://repository.netecweb.org/files/original/8a31568b3fe0474188b1ff526e2e5fd5.pdf,Guide,Develop,1,0
1741,https://repository.netecweb.org/items/show/1741,"Laboratory Resources: Yellow Fever",Laboratory,"This guide, printable flyer, provides laboratory resources related to Yellow Fever. This is a part of a series of one-page resource guides for laboratorians.
The yellow fever virus is found in tropical and subtropical areas of Africa and South America. Yellow fever virus is an RNA virus that belongs to the genus Flavivirus. It is related to West Nile, St. Louis encephalitis, and Japanese encephalitis viruses.
Yellow fever virus is transmitted to people primarily through the bite of infected Aedes or Haemagogus species mosquitoes. For people who develop symptoms, the time from infection until illness is typically 3 to 6 days. Initial symptoms can include sudden onset of fever, chills, severe headache, back pain, general body aches, nausea, vomiting, fatigue (feeling tired), and weakness. Severe symptoms include high fever, yellow skin or eyes (jaundice), bleeding, shock, and organ failure
",NETEC,,,2023-02-09,,,,,,,,2024-02-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Diagnosis,Flavivirus,Laboratory,Laboratory Testing,One Page Flyer,One-pager,R-Lab,Specimen Handling,Specimen Transport,Yellow fever",https://repository.netecweb.org/files/original/ff37fa21edfa71c50a2869eb367d7cfb.pdf,Guide,Develop,1,0
1739,https://repository.netecweb.org/items/show/1739,"Laboratory Resources: Poliovirus",Laboratory,"This guide, printable flyer, provides laboratory resources related to Poliovirus. This is a part of a series of one-page resource guides for laboratorians.
Polio, or poliomyelitis, is a disabling and life-threatening disease caused by the poliovirus. The virus can infect a person’s spinal cord, causing paralysis.
",NETEC,,,2023-01-27,,,,,,,,2024-01-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Lab,Laboratorian,Laboratory,Laboratory Testing,One Page Flyer,One-pager,Polio,R-Lab",https://repository.netecweb.org/files/original/6830f58be6736399197f0a263d63f517.pdf,Guide,Develop,1,1
1737,https://repository.netecweb.org/items/show/1737,"EMS Biosafety Transport: Viral Hemorrhagic Fevers: Ebola Virus Disease","Emergency Medical Services","This interactive module covers EMS Biosafety Transport relating to viral hemorrhagic fevers and specifically Ebola virus disease.",NETEC,"Alex Isakov, MD, MPH, FACEP, FAEMS",,2022-12-22,"2024-03-27 EMS/Pre-Hospital never reviewed – bump to next quarter",,,,,"Online Course",,2024-06-22,,,,,,,,"Free online.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"The target audience for this presentation is EMS providers of all types/levels/certifications as well as any other clinical personnel who are at risk for exposure to patients with Ebola Virus Disease. ",,,https://netec.org/2022/12/22/course-ems-biosafety-transport-viral-hemorrhagic-fevers-ebola-virus-disease/,,,,"Biosafety,Ebola,EMS,Internal Transport,Online Course,Pre-hospital Transport,R-EMS,Viral Hemorrhagic Fever",https://repository.netecweb.org/files/original/fc2d7a1ce6724c0bdbe12194cc323edc.png,"Online Course",Develop,1,0
1736,https://repository.netecweb.org/items/show/1736,"An Analysis of Organizational Trends within RESPTC Leadership Structures","Personnel Management","To support newly created State or Regional Emerging Special Pathogen Treatment Centers (RESPTCs) as they define their leadership structure, the Biocontainment (BCU) Leadership Workgroup, established by the National Emerging Special Pathogens Training and Education Center (NETEC), organized a survey and analysis of current leadership structure within the 10 established RESPTCs. Using this data, the workgroup was able to summarize common models within BCU leadership roles and respective full-time equivalent (FTE) percent commitments. The workgroup was able to breakdown the activities of these roles further into five domains. FTE support for specific domains were able determined.",NETEC,"the Biocontainment (BCU) Leadership Workgroup",,2022-12-21,"2024-03-27 R-Lead – never reviewed – make due in 6 months",,,,,,,2024-12-21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Isolation/Biocontainment,Personnel Management,R-Lead","https://repository.netecweb.org/files/original/3d4a1a89dd4bb6a9b581b519641f5930.png,https://repository.netecweb.org/files/original/1259f89a912dfb6a3b3c55b493cffa91.docx",Guide,Develop,1,0
1735,https://repository.netecweb.org/items/show/1735,"Preliminary Guidance for High-Level Containment Care of Patients Infected with Sudan Ebolavirus ","Treatment & Care","The information in this video is evolving, and updates to the content will come out in the future. Please check back for the most updated information.
Objectives:
In this video presentation, we will discuss:
- Epidemiology of Sudan Ebolavirus and the Current Outbreak Situation
- Symptoms, Presentation, and Differential Diagnosis
- Clinical Management Guidance for High-Level Containment Care
",NETEC,,,2022-12-19,"2024-03-28 by J. Mundy – Skipped 2023 (Q2) - bumping to 2024 (Q4)",,,,,,,2024-07-19,,,,,,,"
",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://youtu.be/HT90i4TNysI,,,,"Diagnosis,Ebola,Epidemiology,Isolate,Isolation/Biocontainment,R-T&C,Treatment and Care,Video,Viral Hemorrhagic Fever",https://repository.netecweb.org/files/original/8dbc0258a1b9bb2c238cef740bfbc9ed.png,Video,Develop,1,0
1734,https://repository.netecweb.org/items/show/1734,"NETEC Webinar Series (01/11/23)/Online Course: Polio Resurgence: Guidance for Health Care Workers","Treatment & Care","Polio has once again caught the attention of public health and health care officials after a case of vaccine-derived poliovirus was reported in New York this summer—the first case in the United States in 10 years.
In this webinar, experts share what you need to know about polio vaccines and CDC recommendations, patient management and post-polio syndrome, laboratory testing, and specimen handling and shipment.
SPEAKERS:
Jake Fray, MLS(ASCP)^CM Point of Care Supervisor, Denver Health
Ashlesha Kaushik, MD, FAAP Director, Pediatric Infectious Diseases and Antimicrobial Stewardship Program, Unity Point Health Clinical Assistant Professor, Department of Pediatrics, University of Iowa Carver College of Medicine
MODERATOR:
Jill Morgan, RN, BSN Site Manager, Serious Communicable Diseases Unit, Emory Healthcare
Webinar slides attached.",NETEC,,,2023-01-11,,,,,,"Webinar and Online Course",,2024-01-11,,,,,,,"
",,"CEU Online Course: https://courses.netec.org/courses/polio-resurgence-guidance-for-health-care-workers",,,,,,,,,,,,,,"Jan 11, 2023 11:00 AM in Central Time (US and Canada)",,,,,,,,,,,,,,"CONTINUING EDUCATION:
Continuing education credits will be provided for this activity. Participants will be asked to complete a post-webinar evaluation immediately following the webinar. We recommend accessing the webinar from a PC or Mac computer using the Chrome, Firefox, or Safari (Mac) web browser.",,,https://youtu.be/IsZVbqYrmI0,"Webinar, view at link below.",,,"CEU,CEUs,Online Course,Patient Care,Polio,R-T&C,Specimen Handling,Specimen Transport,Webinar","https://repository.netecweb.org/files/original/91d69bbeaef676a488887aa861096725.png,https://repository.netecweb.org/files/original/08eb668d14e916cff1ecfec7d53cf227.pdf",Webinar,Develop,1,0
1733,https://repository.netecweb.org/items/show/1733,"NETEC Webinar Series (11/22/22)/Online Course: Lab Samples and Suspect Cases",Laboratory,"Lab Samples and Suspect Cases: How to handle, package, and ship specimens from high-risk patients
This NETEC webinar will discuss frontline facility considerations for the packaging and shipping of specimens from high-risk patients. Topics include classifying specimens from persons under investigation and frontline facility shipping plans and transport options.
PANELISTS
Jill Morgan, RN, BSN
Site Manager, Serious Communicable Diseases Unit
Emory Healthcare
Robert Nickla, CBSP, RBP(ABSA), QLS, M(ASCP)
Manager, Fellowship Program
Association of Public Health Laboratories
Karen Stiles, SM(ASCP)^CM
State Training Coordinator
Nebraska Public Health Laboratory
Webinar slides attached.
Get educational credit for this webinar through Courses.netec.org.
",NETEC,,,,"2024-03-28 by J. Mundy – not yet reviewed asset – bumping first review 1 year",,,,,"Webinar and Online Course",,2024-11-22,,,,,,,"
",,"Go to CEU course: https://courses.netec.org/courses/lab-samples-and-suspect-cases",,,,,,,,,,,,,,"Nov 22, 2022 11:00 AM in Central Time (US and Canada)",,,,,,,,,,,,,,"Define the term PUI (persons under investigation).
Describe how to classify PUI specimens for shipping purposes.
Describe key considerations of a frontline facility’s shipping plan and transport options for PUI specimens.
CONTINUING EDUCATION
Continuing education credits will be provided for this activity. Participants will be asked to complete a post-webinar evaluation immediately following the webinar. We recommend accessing the webinar from a PC or Mac computer using the Chrome, Firefox, or Safari (Mac) web browser.",,,https://youtu.be/l2rgTw7929s,"Webinar, watch at link below.",,,"Frontline Facility,Laboratory,Online Course,Person Under Investigation (PUI),R-Lab,Specimen Handling,Specimen Transport,Webinar","https://repository.netecweb.org/files/original/39d6e3b08d9b4ccc3e9616509339f7fe.png,https://repository.netecweb.org/files/original/b000f05a8f420d354aa21674c2999370.pdf,https://repository.netecweb.org/files/original/9df43f2b1f9a06ff469f9df641468e57.pdf",Webinar,Develop,1,0
1732,https://repository.netecweb.org/items/show/1732,"BCU Core Competencies","Training and Exercises","Biocontainment Unit Working Group Core Competency / Competencies chart diagram.",NETEC,,,2022-10-10,"Not yet reviewed new - IPC
2024-03-28 by J. Mundy – not yet reviewed asset – bumping first review 1 year",,,,,,,2024-10-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Category A,Core Competency,Infection Prevention and Control,Internal Transport,Isolation/Biocontainment,Lab,Laboratory,Personal Protective Equipment (PPE),R-IPC,Spills,Waste Management",https://repository.netecweb.org/files/original/fd7323f6e8cbf1a7062a8d8d7128948c.pdf,Checklist,Develop,1,0
1727,https://repository.netecweb.org/items/show/1727,"NETEC Webinar Series (11/09/22)/Online Course: Influenza: 2022 Seasonal Update","Emergency Management","This NETEC webinar will discuss the current landscape of influenza in the United States and the predictions for this year’s flu season. Additional topics will include available therapeutics to treat common symptoms and co-infections and infection prevention and control measures for the detection, isolation, and management of influenza patients this season.
Webinar slides attached.
Get educational credit for this webinar through Courses.netec.org.
",NETEC,,,2022-11-09,"From Benjamin: Release Date: 12/20/2022; Expires: 12/19/2023",,,,,"Webinar and Online Course",,"No review - archived",,,,,,,"
",,"CEU online Course: https://courses.netec.org/courses/influenza-2022-seasonal-update",,,,,,,,,,,,,,"Nov 9, 2022 12:00 PM in Central Time (US and Canada)",,,,,,,,,,,,,,"Discuss the current U.S. influenza data and the potential predictors for this year’s flu season.
Articulate what therapeutics are available for patients with influenza when addressing common symptoms and co-infections.
Describe infection prevention and control measures for detection, isolation, and management of influenza patients in emergency departments and other points of entry.",,,https://youtu.be/v0gXrxj4KNE,"Webinar, watch at link below.",,,"Archived,Co-infection,Influenza,Online Course,R-EM,Therapeutics,Webinar","https://repository.netecweb.org/files/original/468b071d8ab179d7b3c810106060e0d8.png,https://repository.netecweb.org/files/original/8995c3a6b925ce1795c58e8d4b1328b9.pdf",Webinar,Develop,1,0
1726,https://repository.netecweb.org/items/show/1726,"Infection Prevention Learning Journey","Infection Control","The Infection Prevention Learning Journey will introduce learners to a special pathogen event scenario and be guide them to targeted learning modules that will enhance infection prevention and control knowledge and skills.
The Infection Prevention Learning Journey course contains an interactive scenario module and three learning modules that cover three levels of the Hierarchy of Controls: engineering, administrative, and personal protective equipment (PPE). Each of these controls is covered in a learning module comprised of several short lessons. While controls are not mutually exclusive, each module will focus on one particular control. The first module in the course, A Pathogen is Coming... is an interactive module designed to test Hierarchy of Controls knowledge in the context of a special pathogen event. The next modules, Engineering Controls, Administrative Controls, and PPE and Behavior, will reinforce the concepts introduced in the special pathogen scenarios. Each of these three learning modules can be taken for continuing education credit.
For more information, review the continuing education information found in the course.
Infection Prevention Learning Journey Course Resources
",NETEC,,,2022-11-02,"Not yet reviewed new - IPC
2024-03-28 by J. Mundy – not yet reviewed asset – bumping first review 1 year",,"Y - D0.1IPC/D0.2IPC Qualtrics # 207, original # 3
Y - D0.1IPC/D0.2IPC Qualtrics # 208, original # 4
",,,"Online Course",,2024-11-02,,,,,,,,"Available free online.",,,,,,,,,,,,,,,"Self-paced 1.5 credits
The estimated time to complete each module is 30 minutes.",,,,,,,,,,,,,,"Module 1: Engineering Controls
CID: 57762
0.5 credits/contact hours
At the conclusion of this enduring material, the participant should be better able to:
- Describe the optimal use and locations for physical barriers and visual indicators to prevent the spread of special pathogens.
- Identify methods for improving airflow and removing pathogens from the air.
- Recognize high-touch surface areas and describe techniques to clean, disinfect, and reduce contact with high-touch surfaces.
Module 2: Administrative Controls
CID: 57763
0.5 credits/contact hours
At the conclusion of this enduring material, the participant should be better able to:
- Describe the difference between cleaning and disinfecting, and how to choose, use, and monitor the cleaning and disinfection process.
- Explain who is involved in infection prevention and control, and how to break the chain of infection.
- Describe strategies the health care facilities can implement to limit exposure to a pathogen.
- Identify best practices for communication within and outside the facility.
Module 3: PPE and Behavior
CID: 57764
0.5 credits/contact hours
At the conclusion of this enduring material, the participant should be better able to:
- Select personal protective equipment (PPE) based on transmission type of a special pathogen.
- Describe best practices for donning PPE when caring for individuals with high-consequence infectious diseases.
- Describe best practices for doffing PPE when caring for individuals with high-consequence infectious diseases.
- Describe strategies and behaviors to maximize safety while wearing PPE.
- Discuss strategies for educating patients and visitors on how to help prevent the spread of a special pathogen.
- Discuss strategies for responding to coworkers who are reluctant to wear or do not wear PPE appropriately.
- Explain the process and considerations for handling contamination or a breach in PPE.
ACCREDITED CONTINUING EDUCATION
The University of Nebraska Medical Center designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University of Nebraska Medical Center designates this activity for up to 1.5 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
",,,https://courses.netec.org/courses/infection-prevention-learning-journey,,,,"Engineering Controls,Infection Prevention and Control,Personal Protective Equipment (PPE),Personnel Management,R-IPC","https://repository.netecweb.org/files/original/f86f05310af88f2ffcc53b7327352269.png,https://repository.netecweb.org/files/original/f0a38fa34a0e76309fe767cad86ceffd.pdf,https://repository.netecweb.org/files/original/756e0b71bfd3236c76e0e019725eedb6.pdf","Online Course",Develop,1,0
1725,https://repository.netecweb.org/items/show/1725,"NETEC Guidance on Breach of Personal Protective Equipment","Infection Control","This interactive educational resource discusses guidance on breach of personal protective equipment (PPE).
Health care workers rely on personal protective equipment (PPE) to provide a barrier between themselves and potentially infectious materials and other forms of contamination. Breaks in this protective layer may occur. The risk associated with these breaks will depend on many situation-specific factors, including when, where, and under what circumstances a breach occurs. Each facility should create, maintain, and exercise breach protocols based on its chosen PPE ensemble, its unique physical infrastructure, and its facility exposure plan. In this course, you will be introduced to some general guidelines to prompt the development of a PPE breach policy for your facility.",NETEC,,,2022-10-26,"2024-03-28 by J. Mundy – not yet reviewed asset – bumping first review 1 year",,"Y - for questions beginning on row 26 and include questions 26, 27, 28",,,"Online Course",,2024-10-26,,,,,,,,"Freely available through netec.org.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://netec.org/2022/10/26/course-ppe-breaches/,,,,"Occupational Exposure,Occupational Health,Personal Protective Equipment (PPE),R-PPE",https://repository.netecweb.org/files/original/31ffc72f41c64e23b267b2e5e57e976f.png,"Online Course",Develop,1,0
1724,https://repository.netecweb.org/items/show/1724,"Health Care Facility Viral Hemorrhagic Fever (VHF) Preparedness Checklist","Emergency Management","Viral Hemorrhagic Fevers (VHF) are a group of diseases caused by several families of viruses. The term VHF refers to an illness that can affect multiple organ systems and can be accompanied by fever, headache, vomiting, abdominal pain, diarrhea, and hemorrhage. VHFs addressed in this document include Crimean-Congo Hemorrhagic Fever (CCHF), Ebola Virus Disease (EVD), Lassa Fever, and Marburg Virus Disease (MVD).
All health care facilities are part of the frontline defense against the spread of disease, as patients will seek care in emergency departments, urgent care centers and clinics. Health care facility preparedness to care for patients with a VHF is essential to prevent transmission to staff, other patients, and our communities.
NETEC developed the Health Care Facility Viral Hemorrhagic Fever Preparedness Checklist to help health care facilities assess their readiness to identify, isolate, inform, and provide initial treatment for patients suspected or confirmed to have a VHF. This checklist is intended to guide facilities through a review of their immediate care capabilities and provide resources to assist in the resolution of preparedness gaps it reveals.
Subscribe to the NETEC e-newsletter highlighting courses and training events, educational resources and information, and research news. Subscribe here.
",NETEC,,,2023-04-18,"Not yet reviewed new - IPC",,,,,,,2024-04-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Checklist,Crimean Congo Haemorrhagic Fever (CCHF),Ebola,Identify,Inform,Isolate,Lassa,Marburg,Personal Protective Equipment (PPE),Preparedness,R-EM,R-IPC,South American Hemorrhagic Fever,Special Pathogens,Treatment and Care,Viral Hemorrhagic Fever,Waste Management","https://repository.netecweb.org/files/original/a193e546a23acf438c8bcb7bacb7a4cb.png,https://repository.netecweb.org/files/original/7094671700d8ca13dc461b091d64acd2.pdf,https://repository.netecweb.org/files/original/4809eb55906643bfad1ca6a90364849e.docx",Checklist,Develop,1,0
1723,https://repository.netecweb.org/items/show/1723,"NETEC Webinar Series (10/20/22): NETEC Town Hall: Preparing Frontline Healthcare Workers for Ebola","Emergency Management","This NETEC webinar series event will include a discussion about the current landscape of the Ebola outbreak, IPC and PPE considerations, lab safety precautions, transport, and training and preparedness needs for frontline workers.
Webinar slides attached.",NETEC,,,2022-10-20,"2024-03-28 by J. Mundy – not yet reviewed asset – bumping first review 1 year",,,,,"Webinar only",,2024-10-20,,,,,,,"
",,,,,,,,,,,,,,,,"Oct 20, 2022 11:00 AM in Central Time (US and Canada)",,,,,,,,,,,,,,"PANELISTS
Vicki Herrera, MS
Research Coordinator
University of Nebraska Medical Center/Nebraska Medicine
Alexander P. Isakov, MD, MPH
Executive Director and Professor of Emergency Medicine
Emory School of Medicine
Aneesh Mehta, MD, FIDSA, FAST
NETEC Co-Principal Investigator
Assistant Director of Transplant Infectious Diseases
Chief of Infectious Diseases Services
Emory University Hospital
Professor of Medicine and of Surgery
Emory University School of Medicine
Jill Morgan, RN
Emory Healthcare, Atlanta, GA
Patricia Ann Tennill RN, BSN
Associate Director of Nursing
NYC Health + Hospitals / Bellevue, New York, NY",,,https://youtu.be/Okh_Sa9cVa4,"Webinar, watch at link below",,,"Ebola,Frontline Facility,Healthcare Worker Safety,Infection Prevention and Control,Internal Transport,Laboratory,Outbreaks,Personal Protective Equipment (PPE),R-EM,Training,Viral Hemorrhagic Fever,Webinar","https://repository.netecweb.org/files/original/5465e51a135063fbc63f0a3c1a9f5290.png,https://repository.netecweb.org/files/original/eca789bac3c6f5807ec77562d70e9fc1.pdf",Webinar,Develop,1,0
1719,https://repository.netecweb.org/items/show/1719,"BCU Competency White Paper","Training and Exercises","This document serves as a training and education tool for centers who are interested in becoming or are currently a special pathogens treatment center to frame training plans. By utilizing the recommendations, curriculum can be developed to include these core competencies identified by current treatment centers as key to success. (see white paper)",NETEC,,,2022-10-10,"Not yet reviewed - IPC
2024-03-28 by J. Mundy – not yet reviewed asset – bumping first review 1 year",,,,,,,2024-10-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Category A,Core Competency,Infection Prevention and Control,Internal Transport,Isolation/Biocontainment,Lab,Laboratory,Personal Protective Equipment (PPE),R-IPC,Spills,Waste Management",https://repository.netecweb.org/files/original/fcdc1e9b43c63399c3124d9d7d454da6.pdf,Checklist,Develop,1,0
1718,https://repository.netecweb.org/items/show/1718,"Ventilation in Schools and Childcare Programs","Infection Control","How to use CDC building recommendations in your setting",CDC,,,2021-02-26,"2024-03-28 by J. Mundy – not yet reviewed asset – bumping first review 1 year",,,,,,,2024-10-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/ventilation.html,,,,"Children,COVID-19,Pediatrics,Public Health,R-SP,School",,Hyperlink,Develop,1,0
1717,https://repository.netecweb.org/items/show/1717,"Operational Guidance for K-12 Schools and Early Care and Education Programs to Support Safe In-Person Learning","Infection Control","On This Page
- Introduction
- Strategies for Everyday Operations
- COVID-19 Community Levels and Associated Prevention Strategies
- Considerations for Prioritizing Strategies
",CDC,,,2022-10-05,"2022-07 by Andi, Special Populations Treatment & Care group
2023-12-15 by Clayton Mowrer, Special Populations Treatment & Care group - note ""constantly updated""",,,,,,,2024-12-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/k-12-childcare-guidance.html,,,,"Children,COVID-19,Example,Mask,Masks,Pediatrics,Public Health,R-SP",,Hyperlink,Develop,1,0
1715,https://repository.netecweb.org/items/show/1715,"JYNNEOS Dosage Information","Treatment & Care","JYNNEOS is a vaccine indicated for prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection.
Includes: indications and usage, dosage and administration, dosage forms and strengths, and adverse reactions.",FDA,,,2022-04,"2024-03-28 by J. Mundy – not yet reviewed asset – bumping first review 1 year",,,,,,,2024-09-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.fda.gov/media/131078/download,,,,"Mpox,R-T&C,Smallpox,Treatment and Care,Vaccine Study",https://repository.netecweb.org/files/original/d6a74f7446cac0b6a24a10331769bba6.pdf,Guide,Develop,1,0
1714,https://repository.netecweb.org/items/show/1714,"Smallpox/Monkeypox Vaccine (JYNNEOS™): What You Need to Know","Treatment & Care","VACCINE INFORMATION STATEMENT",CDC,,,2022-08-23,"2024-03-28 by J. Mundy – not yet reviewed asset – bumping first review 1 year",,,,,,,2024-09-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/vaccines/hcp/vis/vis-statements/smallpox-monkeypox.pdf,,,,"Mpox,R-T&C,Smallpox,Treatment and Care,Vaccine Study",https://repository.netecweb.org/files/original/12675d97280edff3f44409936142ec7c.pdf,Guide,Develop,1,0
1710,https://repository.netecweb.org/items/show/1710,"Transmission Interrupted Podcast: Mpox Testing in Your Laboratory",Laboratory,"Join us for this episode of Transmission Interrupted as we start a new series dedicated to the laboratory community. Mpox continues to be in the news as cases rise across the country. Have you ever wondered what happens behind the laboratory curtain? How do laboratories adjust to the changing demands when a new special pathogen appears? With us today for this special episode is Karie Brouillard, Special Pathogens Laboratory Coordinator at Sacred Heart Medical Center & Children’s Hospital in Spokane, Washington. Join Karie and host Jill Morgan as they discuss hot topics and best practices for laboratorians as they navigate the challenges of monkeypox testing at their facilities.
Questions or comments for NETEC? Contact us at info@netec.org.
Visit us on the web at netec.org/podcast.
",NETEC,,,2022-08-17,"2024-03-28 by J. Mundy – not yet reviewed asset – bumping first review 1 year",,,,,Podcast,,"2024-09-06 ",,,,,,,"",,,,,,,,,,,,,,,,00:34:27,,,,,,,,,,,,,,"Guest
Karie Brouillard
Special Pathogens Laboratory Coordinator
Sacred Heart Medical Center & Children’s Hospital
Host
Jill Morgan, RN
Jill Morgan is an RN and subject matter expert in PPE for NETEC. Member APIC, ASTM, AAMI. For 35 years Jill has been an emergency department and critical care nurse, and now splits her time between education for NETEC and clinical research, most of it centering around Infection Prevention and Personal Protective Equipment.
Resources
NETEC Laboratory Resources: Monkeypox: https://repository.netecweb.org/items/show/1669
NETEC Laboratory Resources: https://repository.netecweb.org/exhibits/show/netec_guides/lab
Association of Public Health Laboratories: https://www.aphl.org/
CDC Laboratory Procedures and Biosafety Guidelines: https://www.cdc.gov/poxvirus/monkeypox/lab-personnel/lab-procedures.html
NETEC Resource Library: https://repository.netecweb.org
About NETEC
A Partnership for Preparedness
The National Emerging Special Pathogens Training and Education Center’s mission is to set the gold standard for special pathogen preparedness and response across health systems in the U.S. with the goals of driving best practices, closing knowledge gaps, and developing innovative resources.
Our vision is a sustainable infrastructure and culture of readiness for managing suspected and confirmed special pathogen incidents across the United States public health and health care delivery systems.
For more information visit NETEC on the web at www.netec.org.
NETEC Consultation Services
Assess and Advance Your Readiness for Special Pathogens with Free, Expert Consulting.
NETEC offers free virtual and onsite readiness consulting to help health care facilities and EMS agencies prepare for special pathogen events. Our targeted support services are delivered by experts selected and assigned to each inquiry based on the unique needs of your organization. Have a question? Ask a NETEC expert.
For more information visit: netec.org/consulting-services.
",,,https://netec.org/transmission-interrupted/monkeypox-testing-and-your-laboratory/,Podcast,,,"Laboratory,Laboratory Testing,Mpox,R-Lab",https://repository.netecweb.org/files/original/4550bb66213e3391ad8e528be077b5c2.png,Webinar,Develop,1,0
1709,https://repository.netecweb.org/items/show/1709,"Transmission Interrupted Podcast: Back to the Basics – Viral Hemorrhagic Fevers and PPE","Infection Control","In this episode of Transmission Interrupted, NETEC hosts Jill Morgan and Trish Tennill go back to the basics of viral hemorrhagic fevers and personal protective equipment. They discuss four of the most serious and deadly viral hemorrhagic fevers: Ebola, Marburg, Lassa, and Crimean-Congo Hemorrhagic fevers.
While cases in the U.S. are rare, recent outbreaks of Marburg in Ghana, Crimean-Congo Hemorrhagic Fever in Iraq, Lassa Fever in Nigeria, and Ebola in the Democratic Republic of Congo mean that health care workers need to know how to identify and treat these viral illnesses. Where do they get their names? What are the symptoms of viral hemorrhagic fevers? What can health care workers do to prevent transmission in health care settings? Learn the answers to these questions and more on the podcast.
Questions or comments for NETEC? Contact us at info@netec.org.
Visit us on the web at netec.org/podcast.
",NETEC,,,2022-08-31,"2023-12-04 by Jill Morgan/PPE Group",,,,,Podcast,,2024-12-04,,,,,,,"",,,,,,,,,,,,,,,,00:25:18,,,,,,,,,,,,,,"Hosts
Jill Morgan, RN
Emory Healthcare, Atlanta, GA
Jill Morgan is a registered nurse and a subject matter expert in personal protective equipment (PPE) for NETEC. For 35 years, Jill has been an emergency department and critical care nurse, and now splits her time between education for NETEC and clinical research, most of it centering around infection prevention and personal protective equipment. She is a member of the Association for Professionals in Infection Control and Epidemiology (APIC), ASTM International, and the Association for the Advancement of Medical Instrumentation (AAMI).
Patricia Ann Tennill RN, BSN
Associate Director of Nursing
NYC Health + Hospitals / Bellevue , New York, NY
Patricia Tennill is an Associate Director of Nursing in Staff Development and the nursing lead for the NYC Health + Hospitals / Bellevue Special Pathogens Program. Patricia has been involved with the Special Pathogens Program since 2014 as a nurse leader responsible for coordinating and overseeing all nursing operations on the Special Pathogens Unit, including the development of protocols concerning the movement and care of patients with special pathogens and the subsequent hands-on training for all staff involved in the Special Pathogens Program.
Resources
Transmission Interrupted, Ep 16: Back to the Basics – PPE and Mpox: https://netec.org/transmission-interrupted/back-to-basics-ppe-and-monkeypox/
NETEC PPE Resources: https://repository.netecweb.org/exhibits/show/ppe101/ppe
NETEC Viral Hemorrhagic Fever resources: https://repository.netecweb.org/items/browse?tags=Viral+Hemorrhagic+Fever
NETEC Resource Library: https://repository.netecweb.org
Transmission Interrupted on the web: https://netec.org/podcast/
About NETEC
A Partnership for Preparedness
The National Emerging Special Pathogens Training and Education Center’s mission is to set the gold standard for special pathogen preparedness and response across health systems in the U.S. with the goals of driving best practices, closing knowledge gaps, and developing innovative resources.
Our vision is a sustainable infrastructure and culture of readiness for managing suspected and confirmed special pathogen incidents across the United States public health and health care delivery systems.
For more information, visit NETEC on the web at www.netec.org.
NETEC Consultation Services
Assess and Advance Your Readiness for Special Pathogens with Free, Expert Consulting.
NETEC offers free virtual and onsite readiness consulting to help healthcare facilities and EMS agencies prepare for special pathogen events. Our targeted support services are delivered by experts selected and assigned to each inquiry based on the unique needs of your organization. Have a question? Ask a NETEC expert.
For more information, visit netec.org/consulting-services.
",,,https://netec.org/transmission-interrupted/back-to-the-basics-viral-hemorrhagic-fevers-and-ppe/,,,,"Ebola,Marburg,Personal Protective Equipment (PPE),Podcast,PPE Selection,R-PPE,Viral Hemorrhagic Fever",https://repository.netecweb.org/files/original/a28f939e96266461ac7623da2ff3a54d.png,Webinar,Develop,1,0
1708,https://repository.netecweb.org/items/show/1708,"Space Recommendations for Donning and Doffing Personal Protective Equipment (PPE) in Biocontainment Areas","Infection Control","The purpose of this document is to provide a general reference guide for safe donning and doffing spaces. Zones of contamination help guide healthcare personnel (HCP) risk assessment and risk reduction measures while working in and moving through these spaces. Donning is to be conducted in a clean space, which may be referred to as a “cold” space or zone, while the patient’s immediate environment is considered contaminated, or “hot”. The doffing space is transitional and should be as clean as possible when it is entered for doffing and is considered “warm” once doffing has occurred. Waste management and contamination mitigation measures should be established for doffing spaces.",NETEC,,,2022-08-25,"2023-12-04 by Jill Morgan/PPE Group - archive
2024-03-12 by Jill Morgan/archived in error - typo - reactivating",,"Y? - noted in review Physical infrastructure?",,,,,2024-12-26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Biosafety,Donning and Doffing,Infection Prevention and Control,Personal Protective Equipment (PPE),Physical Infrastructure,R-PPE",https://repository.netecweb.org/files/original/0db5842ee122b07a30330aa4e6ea75fb.pdf,Guide,Develop,1,0
1707,https://repository.netecweb.org/items/show/1707,"NETEC Webinar Series (08/31/22)/Online Course: Mpox Updates in Evaluation and Management","Emergency Management","This NETEC webinar series presentation will bring together health care practitioners from Massachusetts General Hospital, Cedars-Sinai, and NYC Health + Hospitals to share their first-hand experiences caring for patients with mpox. Panelists will discuss the current landscape of mpox, infection prevention in health care settings, and the role of supportive and antiviral treatments in patient care. Panelists will also answer audience questions submitted during webinar registration.
PANELISTS
Jonathan Grein, MD
Director of Hospital Epidemiology,
Cedars-Sinai Medical Center, Los Angeles
Erica S. Shenoy, MD
Associate Chief, Infection Control Unit
Medical Director, Regional Emerging Special Pathogens Treatment Center
Massachusetts General Hospital
Kevin L. Ard, MD, MPH
Director, Sexual Health Clinic,
Massachusetts General Hospital
Assistant Professor, Harvard Medical School
Webinar slides attached.
Get educational credit for this webinar through Courses.netec.org.
",NETEC,,,2022-08-31,"2024-03-28 by J. Mundy – not yet reviewed asset – bumping first review 1 year",,,,,"Webinar and Online Course",,2024-09-07,,,,,,,"
",,"CEU online course: https://courses.netec.org/courses/monkeypox-updates-in-evaluation-and-management",,,,,,,,,,,,,,"Aug 31, 2022 12:00 PM in Central Time (US and Canada)",,,,,,,,,,,,,,"OBJECTIVES
Discuss the current landscape of Mpox in the U.S and infection prevention considerations for evaluation and management in healthcare settings
Describe the clinical presentation in ambulatory and inpatient settings, as well as the role of supportive and antiviral treatments
CONTINUING EDUCATION
Continuing education credits will be provided for this activity. Participants will be asked to complete a post-webinar evaluation immediately following the webinar. We recommend accessing the webinar from a PC or Mac computer using the Chrome, Firefox, or Safari (Mac) web browser.
Online Course: Available for 1 credit of CNE and CME continuing education.",,,https://www.youtube.com/watch?v=5Gw6TnZr7lM,"Webinar, watch at link below.",,,"Emergency Management,Mpox,Online Course,R-EM","https://repository.netecweb.org/files/original/0515db76151121b782079c2e09063ddd.png,https://repository.netecweb.org/files/original/30f5506e224dbfbbea2dbe978a5f408c.pdf",Webinar,Develop,1,0
1705,https://repository.netecweb.org/items/show/1705,"Laboratory Resources: Marburg Virus Disease (MVD)",Laboratory,"This guide, printable flyer, provides laboratory resources related to Marburg Virus Disease (MVD). This is a part of a series of one-page resource guides for laboratorians.
Marburg virus disease is a rare but severe hemorrhagic fever which affects both people and non-human primates. Marburg virus is a genetically unique zoonotic (or, animal-borne) RNA virus of the filovirus family, which includes the six species of Ebola virus. The reservoir host of Marburg virus is the African fruit bat, Rousettus aegyptiacus. Fruit bats infected with Marburg virus do not show obvious signs of illness. Primates (including people) can become infected with Marburg virus and may develop serious disease with high mortality",NETEC,,,2022-08-19,"2024-03-28 by J. Mundy – not yet reviewed asset – bumping first review 1 year",,,,,,,2024-08-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Category A,Internal Transport,Laboratorian,Laboratory,Laboratory Testing,Marburg,One Page Flyer,One-pager,R-Lab,Viral Hemorrhagic Fever",https://repository.netecweb.org/files/original/613dbea8571d67a6247a77cdc4798d34.pdf,Guide,Develop,1,0
1699,https://repository.netecweb.org/items/show/1699,"Infection Prevention & Control in the Long-Term Care Setting: Cleaning and Disinfection","Infection Control","Long-term care (LTC) settings are communities where residents congregate closely in shared spaces, and equipment is used between residents, staff, visitors, and vendors who enter and leave frequently. This makes LTC an ideal environment for germs to spread and risks the lives and well-being of residents and staff.
Proper cleaning and disinfection is crucial to preventing and controlling the spread of any infection. Like many processes, cleaning and disinfection must be done correctly to be effective. This resource will provide all staff in the long-term care setting with information to help them understand and perform the steps required to clean and disinfect properly.
This printable flyer (infographic) discusses:
- Cleaning & Disinfection
- Environmental Cleaning
- Minimizing Risk
- Care of Environment
",NETEC,,,2022-07-27,"2023-08-24 - general ongoing review - IPC - Caroline/Trish - 3yr",,,,,,,2026-08-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Cleaning,Disinfection,Infection Prevention and Control,Long-term Care,Personal Protective Equipment (PPE),R-IPC,R-LTC",https://repository.netecweb.org/files/original/63fb30ebe4f56532546e833b40e75113.pdf,Guide,Develop,1,0
1698,https://repository.netecweb.org/items/show/1698,"Laboratory Resources: Crimean-Congo Hemorrhagic Fever (CCHF) ",Laboratory,"This guide, printable flyer, provides laboratory resources related to Crimean-Congo Hemorrhagic Fever (CCHF). This is a part of a series of one-page resource guides for laboratorians.
Crimean-Congo hemorrhagic fever (CCHF) is caused by infection with a tick-borne virus (Nairovirus) in the family Bunyaviridae. Crimean-Congo hemorrhagic fever is found in Eastern Europe, particularly in the former Soviet Union, throughout the Mediterranean, in northwestern China, central Asia, southern Europe, Africa, the Middle East, and the Indian subcontinent. Numerous wild and domestic animals amplify the virus's hosts, such as cattle, goats, sheep, and hares.",NETEC,,,2022-07-25,"2024-03-28 by J. Mundy – not yet reviewed asset – bumping first review 1 year",,,,,,,2024-07-25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Contact Transmission,Crimean Congo Haemorrhagic Fever (CCHF),Laboratory,Laboratory Testing,One Page Flyer,One-pager,R-Lab,Specimen Handling,Specimen Transport,Viral Hemorrhagic Fever",https://repository.netecweb.org/files/original/9bfe6d7f321ab7e544f3c9251faf1d29.pdf,Guide,Develop,1,0
1697,https://repository.netecweb.org/items/show/1697,"Mpox Specimen Collection - Interactive Resource",Laboratory,"Learn how to collect a specimen for Mpox virus diagnostic testing. This course module covers equipment considerations, specimen collection, and packaging.",NETEC,,,2022-07-22,"2024-03-28 by J. Mundy – not yet reviewed asset – bumping first review 1 year",,,,,,,2024-07-25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://netec.org/2022/07/22/course-monkeypox-specimen-collection/,,,,"Laboratory,Online Course,R-Lab,Specimen Collection,Specimen Handling",https://repository.netecweb.org/files/original/6222fb93ac347a08f7c954ef48345be9.png,Guide,Develop,1,0
1693,https://repository.netecweb.org/items/show/1693,"Viral Hemorrhagic Fevers (VHFs) Matrix","Infection Control","This group of infectious diseases is caused by several distinct viral families. The term VHF describes the conditions these pathogens can cause, which may affect many body systems, including damaging the cardiovascular system. Some of these viruses produce mild disease, while others can interfere with blood clotting, cause severe disease, and death.
This document provides information Personal Protective Equipment and Precautions, and PPE selection for Viral Hemorrhagic Fevers.",NETEC,,,2023-06-22,,,,,,,,2024-06-22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Argentine Hemorrhagic Fever,Crimean Congo Haemorrhagic Fever (CCHF),Ebola,Junín virus,Lassa,Marburg,Personal Protective Equipment (PPE),R-PPE,South American Hemorrhagic Fever,Viral Hemorrhagic Fever",https://repository.netecweb.org/files/original/51c2c26c2f346382fc8db5651c560aa1.pdf,Guide,Develop,1,0
1680,https://repository.netecweb.org/items/show/1680,"Lassa Fever: a Summary for Clinicians","Treatment & Care","On this episode of Transmission Interrupted, we welcome Dr. Jared Evans, Dr. Aneesh Mehta, and Dr. Vanessa Rabbe—members of NETEC’s Special Pathogen Research Network—to discuss their recent manuscript entitled, “Lassa Virus Infection: a Summary for Clinicians.” Developed from a clinical perspective, this manuscript provides clinicians with a condensed, accessible understanding of the current literature on Lassa virus (LASV) infection and Lassa fever disease (LF). The topics discussed in this episode will provide basic information on Lassa virus and Lassa fever, and will highlight pathogenesis, clinical features, and medical countermeasures that have demonstrated potential value for use in clinical or research environments.",NETEC,,,2022-06-29,"2024-03-28 by J. Mundy – not yet reviewed asset – bumping first review 1 year",,,,,,,2024-07-20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://netec.org/transmission-interrupted/lassa-fever-a-summary-for-clinicians/,,,,"Blog,Lassa,Podcast,Treatment and Care",https://repository.netecweb.org/files/original/4a393c9dc58620a0303e2b049704c66e.png,Hyperlink,Develop,1,0
1674,https://repository.netecweb.org/items/show/1674,"Isolation and Infection Control for Home: Mpox","Infection Control","The following resource was developed and shared during the multi-country Mpox outbreak of clade II in 2022-2023. The current outbreak of Mpox clade I requires different considerations for patient management as clade I is considered a select agent. If you have questions related to the isolation of patients and waste management, please reach out to us here or email us at info@netec.org.
People with mpox who do not require hospitalization should be isolated at home.
See this resource for information on Isolation of People with Mpox, Hand Hygiene, Source Control, and Personal Protective Equipment, and Household Disinfection.
",CDC,,,2022-08-11,"2023-12-15 by Trish and Caroline/IPC WG - updated link to mpox - added banner noting Clade I vs. II.",,,,,,,2025-12-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/poxvirus/mpox/clinicians/infection-control-home.html,,,,"Hand Hygiene,Infection Prevention and Control,Isolate,Isolation/Biocontainment,Mpox,Personal Protective Equipment (PPE)",https://repository.netecweb.org/files/original/a49f2dae5ced6412741b33ab499fbae8.png,Hyperlink,Develop,1,0
1671,https://repository.netecweb.org/items/show/1671,"Laboratory Activation Checklist",Laboratory,"This is a Word document fill-able form activation checklist for Lab.",NETEC,,,2022-05-27,,,,,,,,2024-05-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Activation,Checklist,Lab,Laboratory,R-Lab","https://repository.netecweb.org/files/original/81d9baa68bee81cbce6b0f5487119a53.png,https://repository.netecweb.org/files/original/760672f218efe45fdf61c2d96991b2c2.docx",Checklist,Develop,1,0
1669,https://repository.netecweb.org/items/show/1669,"Laboratory Resources: Mpox",Laboratory,"This guide, printable flyer, provides laboratory resources related to Mpox. This is a part of a series of one-page resource guides for laboratorians.",NETEC,,,2023-12-15,"2022-09-27 - general asset review - Treatment & Care group
2023-12-15 by Lab WG MPox review - updated name / file.",,,,,,,2025-12-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Lab,Laboratorian,Laboratory,Laboratory Testing,Mpox,One Page Flyer,One-pager,R-Lab",https://repository.netecweb.org/files/original/2857e24630356b2a3f62e5f4586e0279.pdf,Guide,Develop,1,0
1668,https://repository.netecweb.org/items/show/1668,"Laboratory Resources: Highly Pathogenic Avian Influenza (HPAI)",Laboratory,"This guide, printable flyer, provides laboratory resources related to Highly Pathogenic Avian Influenza (HPAI). This is a part of a series of one-page resource guides for laboratorians.",NETEC,,,2023-03-02,"2022-09-27 - general asset review - Treatment & Care group
2023-03-02 - updated by Laboratory group",,,,,,,2025-05-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Avian Influenza,Flu,Highly Pathogenic Avian Influenza (HPAI),Influenza,Lab,Laboratorian,Laboratory,Laboratory Testing,One Page Flyer,One-pager,R-Lab",https://repository.netecweb.org/files/original/4e9e6694d86fd75d72c6373f65110a0c.pdf,Guide,Develop,1,0
1667,https://repository.netecweb.org/items/show/1667,"Laboratory Resources: Lassa Fever",Laboratory,"This guide, printable flyer, provides laboratory resources related to Lassa Fever. This is a part of a series of one-page resource guides for laboratorians.",NETEC,,,2022-05-17,"2022-09-27 - general asset review - Treatment & Care group",,,,,,,2025-05-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Lab,Laboratorian,Laboratory,Laboratory Testing,Lassa,One Page Flyer,One-pager,R-Lab,Viral Hemorrhagic Fever",https://repository.netecweb.org/files/original/2095b71cc39b27027d11cd8ee5bbc8ca.pdf,Guide,Develop,1,0
1666,https://repository.netecweb.org/items/show/1666,"The Chain of Infection and How to Use it to Prevent the Spread of Infection in LTC","Infection Control","This printable flyer infographic describes the Chain of Infection and How to Use it to Prevent the Spread of Infection in Long-Term Care (LTC).",NETEC,,,2022-05-02,,,,,,,,2024-05-02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Chain of infection,Infection Prevention and Control,Long-term Care,R-LTC",https://repository.netecweb.org/files/original/950e75da1468a5a87a22ec88919a25f3.pdf,Guide,Develop,1,0
1665,https://repository.netecweb.org/items/show/1665,"The Trained Observer and Personal Protective Equipment","Infection Control","This printable flyer infographic discusses the Role of the Trained Observer (TO) for Personal Protective Equipment (PPE).",NETEC,,,2022-04-27,"2023-07-13 by Christa Arguinchona and Caroline Croyle (PM)",,"Y, SPORSA PPE workgroup
Y - D0.1PM/D0.2PM Qualtrics # 905, original # 4",,,,"Infection Prevention and Control; PPE",2025-07-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Donning and Doffing,Healthcare Worker Safety,Occupational Health,Personal Protective Equipment (PPE),Physical Infrastructure,R-PM,Trained Observer",https://repository.netecweb.org/files/original/9f9ce3671291efb4698ced2100d67c06.pdf,Guide,Develop,1,0
1662,https://repository.netecweb.org/items/show/1662,"Viral Hemorrhagic Fever (VHF) or Orthopox Virus ~ ED Screening","Infection Control","Viral Hemorrhagic Fever or Orthopox Virus Emergency Department Screening","University of Nebraska Medical Center / Nebraska Medicine",,,2022-03-15,"2022-03-17 by Shelly Schwedhelm (to be added)
2024-03-28 by J. Mundy – Skipped 2023 (Q2) - bumping to 2024 (Q4)",,,,,,,2024-07-24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Ebola,Emergency Department,Lassa,Marburg,Mpox,Orthopox Virus,Outbreaks,R-IIT,Screening Tool,Smallpox,Viral Hemorrhagic Fever",https://repository.netecweb.org/files/original/0960b8c92eab586586d62e37f88524ab.pdf,Guide,Develop,1,0
1660,https://repository.netecweb.org/items/show/1660,"Mind the Gap! Facemask Fit Matters","Infection Control","This printable flyer infographic ""Mind the Gap! Facemask Fit Matters"" contains information on mask and masks fit, fitting masks, as maximum mask-to-skin contact is essential.
Mind the Gap:
Mask Filtration and Fit Matter:
Mind the Gap!
No matter how well a mask tests for filtration in a lab, it offers no protection if it does not fit
properly. The purpose of your mask is to filter all the air before it reaches your airway and
lungs, and to filter what you exhale before it can be inhaled by someone else. If your mask
gaps along the sides of your face, the bridge of your nose, or under your chin it won’t provide
the best level of protection.",NETEC,,,2022-03-16,"2023-12-04 by Jill Morgan/PPE Group",,,,,,,2024-12-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Take the Course at the URL below: Mask Filtration and Fit Matter",,,https://netec.org/2022/03/11/course-mask-filtration-and-fit-matter/,,,,"2019-nCoV,Coronavirus,COVID-19,Mask,Masks,N95,Personal Protective Equipment (PPE),R-PPE,Respirator,Respiratory Pathogen,Respiratory Protection","https://repository.netecweb.org/files/original/eb690ee0e9060ac2d608d511c1a690a6.pdf,https://repository.netecweb.org/files/original/462abcc303cdd3109f4cda5831aeab66.pdf",Guide,Develop,1,0
1658,https://repository.netecweb.org/items/show/1658,"Influenza & SARS-CoV-2 (COVID-19) Testing
","Infection Control","The treatment and infection prevention recommendations for influenza and COVID-19 are VERY different. It is important to test and differentiate. This two page graphic provides guidance.",NETEC,,,2022-01-07,"2022-12-07 general asset review - IPC - mark as COVID - already tagged
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q2)",,,,,,"Infection Prevention and Control",2024-12-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Coronavirus,COVID-19,Diagnosis,Identify,Influenza,R-IPC",https://repository.netecweb.org/files/original/84e1d53150b853a509514d3ce59c39e9.pdf,Guide,Develop,1,0
1657,https://repository.netecweb.org/items/show/1657,"Your Guide to Masks","Infection Control","How to select (what to choose and what not to choose), properly wear, clean, and store masks.
Special considerations like gaiters & face shields, children, cold weather, beards, and disabilities.",CDC,,,2021-10-25,"2023-12-04 by Jill Morgan/PPE Group",,,,,,,2024-12-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/about-face-coverings.html,,,,"CDC,Example,Mask,Masks,N95,Personal Protective Equipment (PPE),R-PPE,Respirator",https://repository.netecweb.org/files/original/24bc4b6f0742e3a35818136951703cba.png,Hyperlink,Develop,1,0
1655,https://repository.netecweb.org/items/show/1655,"Strategies for Optimizing the Supply of N95 Filtering Facepiece Respirators During the Coronavirus Disease 2019 (COVID-19) Pandemic","Emergency Management","N95 respirators are personal protective equipment most often used to control exposures to infections transmitted via the airborne route. Supplies of N95 respirators can become depleted during pandemics or when otherwise in high demand. In this paper, we offer strategies for optimizing supplies of N95 respirators in health care settings while maximizing the level of protection offered to health care personnel when there is limited supply in the United States during the 2019 coronavirus disease pandemic.
","Marie A de Perio, Chad H Dowell, Lisa J Delaney, Lewis J Radonovich, David T Kuhar, Neil Gupta, Anita Patel, Satish K Pillai, Maryann D'Alessandro",,,2020-05-19,"2023-07-21 J. Mundy replaced ""Summary for Healthcare Facilities: Strategies for Optimizing the Supply of N95 Respirators during Shortages"" CDC site (archived) with this article through consultation with Brooke and Jill (PPE work group).",,"Y - PPE pos 98 qualtrics 318
Y - D0.1PPE/D0.2PPE Qualtrics # 318",,,,,2025-07-21,,,,,,,,,,"de Perio MA, Dowell CH, Delaney LJ, Radonovich LJ, Kuhar DT, Gupta N, Patel A, Pillai SK, D'Alessandro M. Strategies for Optimizing the Supply of N95 Filtering Facepiece Respirators During the Coronavirus Disease 2019 (COVID-19) Pandemic. Disaster Med Public Health Prep. 2020 Oct;14(5):658-669. doi: 10.1017/dmp.2020.160. Epub 2020 May 19. PMID: 32423515; PMCID: PMC7303467.","Free online through Pub Med Central","N95 respirators are personal protective equipment most often used to control exposures to infections transmitted via the airborne route. Supplies of N95 respirators can become depleted during pandemics or when otherwise in high demand. In this paper, we offer strategies for optimizing supplies of N95 respirators in health care settings while maximizing the level of protection offered to health care personnel when there is limited supply in the United States during the 2019 coronavirus disease pandemic. The strategies are intended for use by professionals who manage respiratory protection programs, occupational health services, and infection prevention programs in health care facilities to protect health care personnel from job-related risks of exposure to infectious respiratory illnesses. Consultation with federal, state, and local public health officials is also important. We use the framework of surge capacity and the occupational health and safety hierarchy of controls approach to discuss specific engineering control, administrative control, and personal protective equipment measures that may help in optimizing N95 respirator supplies.
Key Words: emergency preparedness, infection control, occupational health, pandemics, surge capacity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303467/,,,,,,,,,,,,,,,,,,,,,,,,,,,https://pubmed.ncbi.nlm.nih.gov/32423515/,,,,"CDC,COVID-19,Extended wear,N95,Personal Protective Equipment (PPE),R-PPE,Respirator",https://repository.netecweb.org/files/original/47c0b7dffdd10f0bd85980fa54e2aaa6.pdf,Publication,Develop,1,0
1653,https://repository.netecweb.org/items/show/1653,"Your Roles as the Trained Observer","Infection Control","
To ensure the safety of your colleagues, you must lead, protect, and guide others through the process of safely and correctly donning and doffing PPE.
As a Trained Observer, you are responsible for:
- Monitoring compliance with PPE protocols
- Guiding, correcting, and assisting during donning and doffing.
- Protecting yourself through proper PPE use during doffing, and
- Anticipating and planning for risks.
",CDC,,,2014-10-29,"2023-12-04 by Jill Morgan/PPE Group",,"Y - PPE row 44 score 0",,,,,2024-12-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/vhf/ebola/hcp/ppe-training/trained-observer/observer_02.html,,,,"Doffing,Donning,Donning and Doffing,Ebola,Example,Isolation/Biocontainment,Personal Protective Equipment (PPE),R-PPE,Trained Observer",,Hyperlink,Develop,1,0
1652,https://repository.netecweb.org/items/show/1652,"Hospital Respiratory Protection Program Toolkit","Infection Control","Resources for Respirator Program Administrators.
This document was adapted from a California-specific guide, Implementing Respiratory Protection Programs in Hospitals: A Guide for Respirator Program Administrators, May 2012, which was developed by the California Department of Public Health, Occupational Health Branch, and the Public Health Institute under contract no. 254-2010-345-11 from the National Institute for Occupational Safety and Health, National Personal Protective Technology Laboratory (NIOSH-NPPTL). The guide was adapted under contract no. 254-2011-M-40839 from NIOSH-NPPTL to produce this toolkit.",OSHA,,,2015-05,"2023-12-04 by Jill Morgan/PPE Group",,"Y - PPE pos 92 qualtrics 313
Y - D0.1PPE/D0.2PPE Qualtrics # 313",,,,,2024-12-04,,,,,,,,,,,"Free online on OSHA.gov. This document is in the public domain and may be freely copied or reprinted.",,https://www.osha.gov/sites/default/files/publications/OSHA3767.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.osha.gov/publications/publication-products?publication_title=Respiratory+Protection+Program+Toolkit,,,,"Example,Fit Testing,N95,Occupational Exposure,Personal Protective Equipment (PPE),R-PPE,Respirator",https://repository.netecweb.org/files/original/dd1c77fb00da5ebafcbbee297769b0de.pdf,Publication,Develop,1,0
1642,https://repository.netecweb.org/items/show/1642,"Mpox: RESPTC Perils and Pearls Zoomcast: Episode 22","Infection Control","Region VII Regional Emerging Special Pathogen Treatment Center (RESPTC) Perils and Pearls Zoomcast: Episode 22: Mpox.
Please join Infectious Disease experts, Dr. Agam Rao and Dr. David Brett-Major as they provide up-to-date information on Mpox and how we can prevent spread!
","University of Nebraska Medical Center / Nebraska Medicine",,,2021-10-28,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q2)",,,,,,"Infection Prevention and Control",2024-12-10,,,,,,,"
",,,,,,,,,,,,,,,,"00:24:42 min",,,,,,,,,,,,,,,,,https://youtu.be/HPOBnI5gVjY,,,,"Droplet Transmission,Infection Prevention and Control,Mpox,R-IPC",https://repository.netecweb.org/files/original/cc1c37c4b2260fdf038b92564a24a9c5.png,Webinar,Develop,1,0
1632,https://repository.netecweb.org/items/show/1632,"Transmission Interrupted Podcast: Kids Coping With COVID-19","Emergency Management","The COVID-19 pandemic continues to affect the pediatric community. With the return to school and the surge in pediatric COVID-19 cases, young children face challenges they’ve never met before, both at school and home. Join host Vanessa Raabe and special guest Abby Hollis, a Certified Child Life Specialist at Children’s Healthcare of Atlanta, as they discuss the challenges facing young children today and highlight various strategies and resources that parents, teachers, and healthcare workers can use to help kids cope with COVID-19 during the pandemic.
Questions or comments for NETEC? Contact us: info@netec.org
Find us on the web: netec.org
Host
Vanessa N. Raabe, MD
Adult and Pediatric Infectious Disease Physician at NYU Grossman School of Medicine
Guest
Abby Hollis
Certified Child Life Specialist at Children’s Healthcare of Atlanta
Resources
Association of Child Life Professionals: https://www.childlife.org
Coronavirus, a Book for Children, written by Elizabeth Jenner, Kate Wilson and Nia Roberts. FREE DOWNLOAD at https://stayhome.candlewick.com
NETEC COVID-19 Novel Coronavirus Resources: https://repository.netecweb.org/exhibits/show/ncov/ncov
NETEC COVID-19 Webinar Series Playlist: https://www.youtube.com/playlist?list=PL5JyGXQ8MP0TZXU2Ldy-jzjLuUNfFX8JZ
NETEC Resource Repository: https://repository.netecweb.org
",NETEC,,,2021-09-29,"2022-07 by Kari, Special Populations Treatment & Care group
2023-12-15 by Clayton Mowrer, Special Populations Treatment & Care group (3 yr)",,,,,Podcast,,2026-09-31,,,,,,,"
",,https://netec.org/podcast/,,,,,,,,,,,,,,00:15:21,,,,,,,,,,,,,,,,,https://player.captivate.fm/episode/b310f16d-ef25-4a2f-b139-f472d2b6ca17,,,,"2019-nCoV,Children,Coronavirus,COVID-19,Mental Health,Pediatrics,R-SP",https://repository.netecweb.org/files/original/d8535b5528c22f8f20bc2c253e24a12a.png,Webinar,Develop,1,0
1629,https://repository.netecweb.org/items/show/1629,"Pediatric COVID-19 Resources","Treatment & Care","This page contains links to: Pediatric COVID-19 JIT Resources, Clinical Pathways and Guidance, and Crisis Standards of Care.","National Pediatric Disaster Coalition",,,2021,"2022-07 by Kari, Special Populations Treatment & Care group
2023-12-15 by Clayton Mowrer, Special Populations Treatment & Care group - note ""Constantly updated Excellent resource""",,Y,,,,,2024-12-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.npdcoalition.org/resources/,,,,"2019-nCoV,Children,Coronavirus,COVID-19,Example,Just in Time training (JIT),Pediatrics,R-SP",https://repository.netecweb.org/files/original/53ccd7128a832e51075e02372ce5913f.png,Hyperlink,Develop,1,0
1628,https://repository.netecweb.org/items/show/1628,"PPE, Calculators & Essential Skills","Emergency Management","This page gathers a collection of tools related to PPE, Calculators & Essential Skills for clinicians.","Emergency Medical Services for Children Innovation and Improvement Center (EIIC)",,,2021,"2022-07 by Kari, Special Populations Treatment & Care group
2023-12-15 by Clayton Mowrer, Special Populations Treatment & Care group - note ""Constantly updated Excellent resource""",,,,,,,2024-12-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://emscimprovement.center/education-and-resources/toolkits/pediatric-disaster-preparedness-toolbox/covid-19-coronavirus/domainspreparednesscoronavirus-covid-19ppe/,,,,"2019-nCoV,Children,Coronavirus,COVID-19,Example,Pediatrics,Personal Protective Equipment (PPE),R-SP",https://repository.netecweb.org/files/original/2d10f7950e919d98a260c1fb3bee7fa7.png,Hyperlink,Develop,1,0
1627,https://repository.netecweb.org/items/show/1627,"Crisis Standards of Care Resources","Treatment & Care","A site including several resources for consideration in your crisis standards of care planning, and links to recent Crisis Standards of Care Open discussions hosted by the Eastern Great Lakes Pediatric Consortium for Disaster Response and WRAP-EM.","Western Regional Alliance for Pediatric Emergency Management (WRAP-EM)",,,2021,"2022-07 by Kari, Special Populations Treatment & Care group
2023-12-15 by Clayton Mowrer, Special Populations Treatment & Care group - note ""Constantly updated Excellent resource""",,,,,,,2024-12-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://wrap-em.org/,,,,"Children,Crisis Standards of Care,Example,Pediatrics,R-SP,Standard of Care,Treatment and Care",https://repository.netecweb.org/files/original/3dac18a07e51233294db7e37cd306c75.png,Hyperlink,Develop,1,0
1617,https://repository.netecweb.org/items/show/1617,"Long-Term Care: Personal Protective Equipment (PPE) Education","Infection Control","Welcome to NETEC education on Personal Protective Equipment (PPE) that has been developed specifically for Long-term Care (LTC) Facilities.
The content in this education has been grouped into sections that will allow you to learn or refresh your knowledge on critical concepts of PPE management and use. You have the option of reviewing all or just the part of the content depending on your interest or need.
Information in this downloadable PDF is targeted towards all professionals in LTC, from administration to the frontline workers.
Download the optimized pdf above.
Download the full size pdf here.",NETEC,,,2021-09-01,"2023-07-13 by Christa Arguinchona and Caroline Croyle (PM) - Some items are covid specific in the document for csc, worth reviewing more regularly or adding a note to the asset saying this was built during covid with considerations for contingency and crisis capacities
2023-10-17 by Darrell, T&E group",,,,,,,2026-10-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://repository.netecweb.org/files/theme_uploads/LTCPPEEducationFinalRev9.13.2021.pdf,,,,"Donning and Doffing,Face shield,Gloves,Goggles,Gown,Long-term Care,Mask,Masks,N95,Occupational Health,Personal Protective Equipment (PPE),R-T&E,Staff Support,Staffing,Training",https://repository.netecweb.org/files/original/b5c13f52031cb36625f1cf85688405fb.pdf,Guide,Develop,1,0
1604,https://repository.netecweb.org/items/show/1604,"Transmission Interrupted Podcast",General,"A podcast by NETEC, the National Emerging Special Pathogens Education and Training Center, presented in cooperation with the CDC and funded by ASPR, the Assistant Secretary for Preparedness and Response.
NETEC's podcast, covering a variety of topics. It includes the three-part debut series, with hosts Jill Morgan, RN, Emory Healthcare, and Patricia Ann Tennill, RN, BSN, Associate Director of Nursing, Bellevue Health & Hospitals, called Viruses, Mutations, and Variants. Oh My!
Topics Covered:
- Kids Coping With COVID-19: Adolescents and Young Adults
- Kids Coping with COVID-19
- COVID-19 Vaccines, Not Just For Adults
- COVID-19: Pregnancy and Vaccines
- Back to School: Securing Child Health in the Era of COVID-19 and the Delta Variant
- Viruses, Mutations, and Variations. Oh My! Episode Three: Variants Explained
- Viruses, Mutations, and Variations. Oh My! Episode Two: Viral Mutations
- Viruses, Mutations, and Variations. Oh My! Episode One: Viruses and Viral Replication
Find on:
",NETEC,,,2021-08-06,"2024-03-27 R-Lead – never reviewed – make due in 6 months",,,,,,,2024-11-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://netec.org/podcast/,,,,"2019-nCoV,Coronavirus,COVID-19,R-Lead,SARS-CoV-2,Virology",https://repository.netecweb.org/files/original/6d003b96e1a11464030375e44241ac1a.png,Hyperlink,Develop,1,1
1603,https://repository.netecweb.org/items/show/1603,"NETEC Resources for Wearing Masks","Infection Control","On July 27, the Centers for Disease Control and Prevention (CDC) updated guidance for fully vaccinated people given new evidence on the B.1.617.2 (Delta) variant of COVID-19 currently circulating in the United States. Updated mask guidelines (at the time of writing) recommend that fully vaccinated people wear a face mask in public indoor settings in areas of substantial or high transmission.
",NETEC,,,2021-07-29,,,,,,,,"Do not review - archived.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://netec.org/2021/07/29/netec-resources-for-wearing-masks/,,,,"2019-nCoV,Archived,Blog,Coronavirus,COVID-19,Mask,Masks,N95,Personal Protective Equipment (PPE),R-PPE,SARS-CoV-2",https://repository.netecweb.org/files/original/eeebefea02d5333602550e607162caa9.png,Guide,Develop,1,0
1592,https://repository.netecweb.org/items/show/1592,"Mpox Outbreak Toolbox","Emergency Management","WHO toolbox for Mpox with Key references documents, Case definitions, Data collections tools, Laboratory confirmation, Response tools and resources, Training, and Other resources.",WHO,,,2023-01,"2023-10-17 by Darrell Ruby, T & E group, updated for 2022 outbreak",,,,,,,2025-10-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.who.int/emergencies/outbreak-toolkit/disease-outbreak-toolboxes/mpox-outbreak-toolbox,,,,"Lab,Laboratory,Mpox,R-T&E",https://repository.netecweb.org/files/original/0042e655d8b55d4512c5dbe9064ecaf5.png,Hyperlink,Develop,1,0
1589,https://repository.netecweb.org/items/show/1589,"Acute, Generalized Vesicular or Pustular Rash Illness Testing Protocol in the United States",Laboratory,"This protocol has been developed to guide the sequence and type of laboratory testing to be undertaken in situations involving specimens from patients with acute, generalized vesicular or pustular rash illness, or suspected smallpox vaccine (vaccinia virus) adverse event",CDC,,,2016-12-01,"2023-12-18 by Lab (Vicki and Kim), recommended 1 yr / Example",,,,,Publication,,2024-12-18,,,,,,,,,,,"Free CDC guidance document",,,,,,,,,,,,,,,,,,,,,,,,,,"Introduction
This protocol has been developed to guide the sequence and type of laboratory testing to be undertaken in situations involving specimens from patients with acute, generalized vesicular or pustular rash illness, or suspected smallpox vaccine (vaccinia virus) adverse event. This protocol may also be followed to test environmental specimens which may contain an Orthopoxvirus. The testing protocol includes four flowchart diagrams, each illustrating a different testing circumstance. The protocol has been designed for use alongside the Centers for Disease Control and Prevention’s clinical assessment tool, Evaluating Patients for Smallpox: Acute, Generalized Vesicular or Pustular Rash Illness Protocol. The laboratory testing protocol is designed to address testing needs in a pre-event setting, when no poxvirus emergency has been detected or declared. In the event of a smallpox (variola virus) outbreak, critical updates will be announced by the Laboratory Response Network (LRN).",,,https://www.cdc.gov/smallpox/lab-personnel/laboratory-procedures/rash-testing.html,,,,"Diagnosis,Example,Laboratory Testing,Mpox,Protocol,R-Lab,R-Res&Pub,Smallpox,Special Pathogens",https://repository.netecweb.org/files/original/81a40a91cbdb605360f506c4df5e9a3c.pdf,Protocol,Develop,1,0
1584,https://repository.netecweb.org/items/show/1584,"Preferred Product Characteristics for Personal Protective Equipment for the Health Worker on the Frontline Responding to Viral Hemorrhagic Fevers*in Tropical Climates","Infection Control","*Ebola, Marburg and other hemorrhagic fevers that share similar human-to-human transmission characteristics
Guidance document.
WHO Team
Access to Assistive Technology and Medical Devices, Access to Medicines and Health Products, Health Product Policy and Standards, Medical Devices and Diagnostics
Copyright
CC BY-NC-SA 3.0 IGO
",WHO,,,2018-09-26,"2022-01-19 by Beth Beam",,,,,,,2025-01-19,,,,,,,,,,"Preferred product characteristics for personal protective equipment for the health worker on the frontline responding to viral hemorrhagic fevers in tropical climates. Geneva: World Health Organization; 2018.Licence: CCBY-NC-SA3.0IGO.",,,,,,,,,,,,,,,,,,,,,,,,,,,"- To provide a review and summary of current evidence on protective effects of PPE and applicable standards, and to identify the knowledge gaps related to safety, usability, comfort and disposal of PPE.
- To stimulate stakeholders to innovate, collaborate, design, engineer and plan for a PPE system that will increase safety and reduce the heat stress. This can be modified from current PPE already on the market or be a part of a re-imagined PPE system.
- To serve as a guide to develop a PPE system whose parts are intentionally designed with consideration of ergonomics and human factors to fit and allow for harmonized procedures on donning and doffing PPE processes. This should result in a standardized system that will remove confusion and mistakes at the user level.
",,,https://www.who.int/publications/i/item/9789241514156,,,,"Donning and Doffing,Ebola,Healthcare Worker Safety,Marburg,Personal Protective Equipment (PPE),R-PPE,Viral Hemorrhagic Fever",https://repository.netecweb.org/files/original/675be2c02f64dc68bfb3738cc7eb9d70.png,Guide,Develop,1,0
1581,https://repository.netecweb.org/items/show/1581,"PPE: Evaluating what’s in your supply","Emergency Management","Facilities need to continually reevaluate usage of personal protective equipment approved under Emergency Use Authorization.
Throughout the COVID-19 pandemic there have been supply chain issues for all organizations regarding access to appropriately approved personal protective equipment (PPE). Due to these supply shortages, several emergency use authorizations (EUA) were initially granted that allowed for the usage of various PPE outside of their intended purposes, usage beyond their stated shelf-life, usage of international but not U.S. certified/approved versions, etc.
These EUA were never intended to be long-term solutions or static, however, and have been continually changing. Many EUAs have now been repealed for a variety of reasons or have been allowed to expire.
Those who have purchased/are purchasing PPE under EUA should continually evaluate their stock to make sure that the items they have previously purchased and are using remain under their EUA and are in compliance with their respiratory protection program and/or other occupational health and safety requirements.
Some Websites with EUA approved PPE:
",NETEC,,,2021-06-30,"2024-01-08 by J. Mundy - a link is dead - tagged archived",,,,,,,"Do not review - old blog post - tagged archived",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://netec.org/2021/06/30/ppe-evaluating-whats-in-your-supply/,,,,"2019-nCoV,Archived,Blog,Coronavirus,COVID-19,Personal Protective Equipment (PPE),R-EM,R-PPE",https://repository.netecweb.org/files/original/ce504e646f407de1b84afbfa3d9c4de0.png,Guide,Develop,1,0
1564,https://repository.netecweb.org/items/show/1564,"Vaccines and maternal health Q&A: Dr. Denise Jamieson","Treatment & Care","Are vaccines safe for women who are pregnant? Hope to be pregnant? Join Emory infectious diseases and OB-GYN expert Dr. Denise Jamieson for a live discussion with Emory public health expert Dr. Jodie Guest",Emory,,,2021-05-12,"2022-09-27 - general asset review - Treatment & Care group
2022-07 by Kari, Special Populations Treatment & Care group (both 1 yr)
2023-12-15 by Clayton Mowrer, Special Populations Treatment & Care group",,,,,,,2024-09-27,,,,,,,"
",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.facebook.com/EmoryUniversity/videos/283185166802377,,,,"2019-nCoV,Coronavirus,COVID-19,Labor and Delivery,Neonates,Not updated,Pregnancy,R-SP,R-T&C,Vaccine Study",https://repository.netecweb.org/files/original/64c50f01f5416aac379037dbc4ea7d66.png,Video,Develop,1,0
1558,https://repository.netecweb.org/items/show/1558,"Procedure Title: Terminal Cleaning in the SCDU","Infection Control","SCOPE:
The SCDU follows a defined set of protocols for activation of the Unit. Because the SCDU must be prepared for a wide range of infectious agents, plans exist to respond as appropriate based on the agent and clinical presentation of the patient. Consideration must be given to appropriate safe transport into the Unit, as well as the safe delivery of care for patients while in the Unit.
PURPOSE:
To establish a process to eliminate infectious pathogens from a room previously occupied by a patient with a serious communicable disease.",Emory,,,2021-05-21,"2022-12-07 general asset review - IPC - check with Britton - ""needs reviewing/updating""
2023-01-18 - Joanna - got new version from Sharon - updated.
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q2)",,"Y
Y - D0.1IC/D0.2IC Qualtrics # 217, original # 8a
Y - D0.1IC/D0.2IC Qualtrics # 218, original # 9",,,,"Infection Prevention and Control",2024-12-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Infection Prevention and Control,Procedure,Protocol,R-IPC,Standard Operating Procedure (SOP),Terminal Clean,Waste,Waste Management",https://repository.netecweb.org/files/original/18ca4e51cf87772e23b6306a5e5658fb.pdf,Protocol,Develop,1,0
1557,https://repository.netecweb.org/items/show/1557,"Procedures for Safe Handling and Management of Ebola-Associated Waste","Waste Management","Who this if for: Hospital infection control, occupational health systems, and facility medical waste managers and personnel
What this is for: To provide detailed step by step procedures for use with the CDC guidance on Ebola-Associated Waste Management.
",CDC,,,2022-10-20,"2022-12-07 general asset review - IPC - marked needs review - checked CDC - page is updated
2024-03-27 Waste never returned – bump to next review",,"Y
Y - D0.1PI/D0.2PI Qualtrics # 123, original # 11
Y - D0.1IC/D0.2IC Qualtrics # 209, original # 4a
Y - D0.1WM/D0.2WM Qualtrics # 1106
",,,,,2024-08-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/vhf/ebola/clinicians/cleaning/handling-waste.html,,,,"Ebola,Infection Prevention and Control,Physical Infrastructure,R-WM,Standard Operating Procedure (SOP),Viral Hemorrhagic Fever,Waste,Waste Management",https://repository.netecweb.org/files/original/c71b8bc8c516b6e42a01d9d22fda28db.png,Hyperlink,Develop,1,0
1553,https://repository.netecweb.org/items/show/1553,"Interim Guidance for Preparing Ebola Treatment Centers","Physical Infrastructure","",CDC,,,2015-01-28,"2022-11-14 by IPC general asset review, marked for archive ""designations no longer in place, last updated in 2015""
2023-03-03 remarked active - in SPORSA",,"Y - D0.1PI/D0.2PI Qualtrics # 101, original # 1
Y - D0.1PI/D0.2PI Qualtrics # 116, original # 5
Y - D0.1PI/D0.2PI Qualtrics # 117, original # 6a
Y - D0.1PI/D0.2PI Qualtrics # 118, original # 6b
Y - D0.1PI/D0.2PI Qualtrics # 122, original # 10
Y - D0.1PI/D0.2PI Qualtrics # 124, original # 12",,,,,2024-03-03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/vhf/ebola/healthcare-us/preparing/treatment-centers.html,,,,"Ebola,Infection Prevention and Control,Person Under Investigation (PUI),Physical Infrastructure,R-PhIn,Treatment Facility,Viral Hemorrhagic Fever",https://repository.netecweb.org/files/original/16e048df0771ad50cb921787059ba705.png,Hyperlink,Develop,1,0
1552,https://repository.netecweb.org/items/show/1552,"Interim Guidance for Preparing Ebola Assessment Hospitals","Physical Infrastructure","
",CDC,,,2018-08-30,"2022-11-14 by IPC general asset review, marked for archive ""designations no longer in place, last updated in 2015""
2023-03-03 remarked active - in SPORSA",,"Y - D0.1PI/D0.2PI Qualtrics # 122, original # 10
Y - D0.1PI/D0.2PI Qualtrics # 124, original # 12",,,,,2024-03-03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/vhf/ebola/healthcare-us/preparing/assessment-hospitals.html,,,,"Assessment Facility,Ebola,Infection Prevention and Control,Person Under Investigation (PUI),Physical Infrastructure,R-PhIn,Viral Hemorrhagic Fever",https://repository.netecweb.org/files/original/7cba8461d5fe83f42cb172fca034537d.png,Hyperlink,Develop,1,0
1551,https://repository.netecweb.org/items/show/1551,"Interim Guidance for Preparing Frontline Healthcare Facilities for Patients Under Investigation (PUIs) for Ebola Virus Disease (EVD)","Physical Infrastructure","",CDC,,,2015-08-28,"2022-11-14 by IPC general asset review, marked for archive ""designations no longer in place, last updated in 2015""
2023-03-03 remarked active - in SPORSA",,"Y - D0.1PI/D0.2PI Qualtrics # 122, original # 10
Y - D0.1PI/D0.2PI Qualtrics # 124, original # 12
Y - D0.1EM/D0.2EM Qualtrics # 503",,,,,2024-03-03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/vhf/ebola/healthcare-us/preparing/frontline-healthcare-facilities.html,,,,"Ebola,Frontline Facility,Infection Prevention and Control,Person Under Investigation (PUI),Physical Infrastructure,R-PhIn,Viral Hemorrhagic Fever",https://repository.netecweb.org/files/original/b9080714229d5a58675a78fc0c44d7f6.png,Hyperlink,Develop,1,0
1539,https://repository.netecweb.org/items/show/1539,"Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia","Treatment & Care","Coronavirus disease 2019 (Covid-19) is associated with immune dysregulation and hyperinflammation, including elevated interleukin-6 levels. The use of tocilizumab, a monoclonal antibody against the interleukin-6 receptor, has resulted in better outcomes in patients with severe Covid-19 pneumonia in case reports and retrospective observational cohort studies. Data are needed from randomized, placebo-controlled trials.","Rosas, Ivan O., Norbert Bräu, Michael Waters, Ronaldo C. Go, Bradley D. Hunter, Sanjay Bhagani, Daniel Skiest, Mariam S. Aziz, Nichola Cooper, Ivor S. Douglas, Sinisa Savic, Taryn Youngstein, Lorenzo Del Sorbo, Antonio Cubillo Gracian, David J. De La Zerda, Andrew Ustianowski, Min Bao, Sophie Dimonaco, Emily Graham, Balpreet Matharu, Helen Spotswood, Larry Tsai, and Atul Malhotra. ",,,2021-04-22,"2022-09-27 - general asset review - Treatment & Care group
2023-03-03 - remarked active - in SPORSA",,"Y - D0.1Res/D0.2Res Qualtrics # 1301, original # 2",,,Publication,,2024-03-03,,,,,,,,,,"Rosas, Ivan O., Norbert Bräu, Michael Waters, Ronaldo C. Go, Bradley D. Hunter, Sanjay Bhagani, Daniel Skiest, Mariam S. Aziz, Nichola Cooper, Ivor S. Douglas, Sinisa Savic, Taryn Youngstein, Lorenzo Del Sorbo, Antonio Cubillo Gracian, David J. De La Zerda, Andrew Ustianowski, Min Bao, Sophie Dimonaco, Emily Graham, Balpreet Matharu, Helen Spotswood, Larry Tsai, and Atul Malhotra. 2021. ""Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia."" New England Journal of Medicine 384 (16):1503-16.
","Free online on NEJM.","Background
Coronavirus disease 2019 (Covid-19) is associated with immune dysregulation and hyperinflammation, including elevated interleukin-6 levels. The use of tocilizumab, a monoclonal antibody against the interleukin-6 receptor, has resulted in better outcomes in patients with severe Covid-19 pneumonia in case reports and retrospective observational cohort studies. Data are needed from randomized, placebo-controlled trials.
Methods
In this phase 3 trial, we randomly assigned patients who were hospitalized with severe Covid-19 pneumonia in a 2:1 ratio receive a single intravenous infusion of tocilizumab (at a dose of 8 mg per kilogram of body weight) or placebo. Approximately one quarter of the participants received a second dose of tocilizumab or placebo 8 to 24 hours after the first dose. The primary outcome was clinical status at day 28 on an ordinal scale ranging from 1 (discharged or ready for discharge) to 7 (death) in the modified intention-to-treat population, which included all the patients who had received at least one dose of tocilizumab or placebo.
Results
Of the 452 patients who underwent randomization, 438 (294 in the tocilizumab group and 144 in the placebo group) were included in the primary and secondary analyses. The median value for clinical status on the ordinal scale at day 28 was 1.0 (95% confidence interval [CI], 1.0 to 1.0) in the tocilizumab group and 2.0 (non-ICU hospitalization without supplemental oxygen) (95% CI, 1.0 to 4.0) in the placebo group (between-group difference, −1.0; 95% CI, −2.5 to 0; P=0.31 by the van Elteren test). In the safety population, serious adverse events occurred in 103 of 295 patients (34.9%) in the tocilizumab group and in 55 of 143 patients (38.5%) in the placebo group. Mortality at day 28 was 19.7% in the tocilizumab group and 19.4% in the placebo group (weighted difference, 0.3 percentage points; 95% CI, –7.6 to 8.2; nominal P=0.94).
Conclusions
In this randomized trial involving hospitalized patients with severe Covid-19 pneumonia, the use of tocilizumab did not result in significantly better clinical status or lower mortality than placebo at 28 days. (Funded by F. Hoffmann–La Roche and the Department of Health and Human Services; COVACTA ClinicalTrials.gov number, NCT04320615. opens in new tab.)
",https://www.nejm.org/doi/full/10.1056/NEJMoa2028700,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.nejm.org/doi/full/10.1056/NEJMoa2028700,,,,"2019-nCoV,Coronavirus,COVID-19,Outcomes,R-Res&Pub,Research,Therapeutics,Treatment and Care",,Publication,Develop,1,0
1505,https://repository.netecweb.org/items/show/1505,"Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020","Treatment & Care","This report summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of the rVSVΔG-ZEBOV-GP Ebola vaccine (Ervebo) in the United States. The vaccine contains rice-derived recombinant human serum albumin and live attenuated recombinant vesicular stomatitis virus (VSV) in which the gene encoding the glycoprotein of VSV was replaced with the gene encoding the glycoprotein of Ebola virus species Zaire ebolavirus. Persons with a history of severe allergic reaction (e.g., anaphylaxis) to rice protein should not receive Ervebo. This is the first and only vaccine currently licensed by the Food and Drug Administration for the prevention of Ebola virus disease (EVD). These guidelines will be updated based on availability of new data or as new vaccines are licensed to protect against EVD.
ACIP recommends preexposure vaccination with Ervebo for adults aged ≥18 years in the U.S. population who are at highest risk for potential occupational exposure to Ebola virus species Zaire ebolavirus because they are responding to an outbreak of EVD, work as health care personnel at federally designated Ebola treatment centers in the United States, or work as laboratorians or other staff at biosafety level 4 facilities in the United States. Recommendations for use of Ervebo in additional populations at risk for exposure and other settings will be considered and discussed by ACIP in the future.
",CDC,"Mary J. Choi; Caitlin M. Cossaboom; Amy N. Whitesell; Jonathan W. Dyal; Allison Joyce; Rebecca L. Morgan; Doug Campos-Outcalt; Marissa Person; Elizabeth Ervin; Yon C. Yu; Pierre E. Rollin; Brian H. Harcourt; Robert L. Atmar; Beth P. Bell; Rita Helfand; Inger K. Damon; Sharon E. Frey.",,2021-01-08,"2022-09-27 - general asset review - Treatment & Care group
2024-03-28 by J. Mundy – Treatment & Care group review 2023 (Q2) skipped – bumping to 2024 (Q2)",,,,,Publication,"Adult Care",2024-11-27,,,,,,,,,,"Choi MJ, Cossaboom CM, Whitesell AN, et al. Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recomm Rep 2021;70(No. RR-1):1–12. DOI: http://dx.doi.org/10.15585/mmwr.rr7001a1external icon","Open Access at CDC.",,https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7001a1-H.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/mmwr/volumes/70/rr/rr7001a1.htm,,,,"CDC,Ebola,Guidance Document,Immunology,R-Res&Pub,R-T&C,Vaccine Study,Viral Hemorrhagic Fever",https://repository.netecweb.org/files/original/8fed828e4910e3a46e06c89faa3896dd.pdf,Publication,Develop,1,0
1472,https://repository.netecweb.org/items/show/1472,"NETEC COVID-19 Webinar Series (02/12/21)/Online Course: SARS-CoV-2: Mutations and Variants and Strains (Oh My!)",Research,"In this webinar, we will define mutation and variant as they relate to SARS-CoV-2, discuss the importance of the current variants and mutations including future predictions surrounding the epidemiology of spread and modeling and describe what is known about SARS-CoV-2 variants’ susceptibility to vaccines and therapeutic antibodies. Continuing education credits available for attending.
Webinar slides attached.
Get educational credit for this webinar through Courses.netec.org.
",NETEC,,,2021-02-12,"2024-03-27 R-Lead – never reviewed – make due in 6 months",,,,,"Webinar and Online Course",,2024-11-27,,,,,,,"
",,"CEU online course: https://courses.netec.org/courses/21-web-021221",,,,,,,,,,,,,,"Friday, February 12, 2021 | 1:00 PM EST",,,,,,,,,,,,,,,,,https://youtu.be/DNPo2FJf75A,"Webinar, watch at link below.",,,"2019-nCoV,CEU,CEUs,Coronavirus,COVID-19,Online Course,R-Lead,SARS-CoV-2,Virology",https://repository.netecweb.org/files/original/e803d9a9ec19d2d86789c3852d41aa2a.pdf,Webinar,Develop,1,0
1448,https://repository.netecweb.org/items/show/1448,"Transport of a Proned/Intubated Patient",Pre-hospital,"This printable flyer infographic discusses the process for transporting a proned / intubated patient.
View this flyer in spanish.",NETEC,,,2020-12-04,"2024-03-27 IIT - haven't gotten back first review - bump to next quarter",,,,,,,2024-06-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Coronavirus,COVID-19,Emergency Department,EMS,Internal Transport,Pre-Hospital,Pre-hospital Transport,Proning,R-IIT,Treatment and Care",https://repository.netecweb.org/files/original/9cae22baec5d27a79ed96b5efd0c9f43.pdf,Guide,Develop,1,0
1447,https://repository.netecweb.org/items/show/1447,"Protect Your Skin this Winter","Personnel Management","This printable flyer infographic provides information for occupational health related to skin care during the winter months of the COVID-19 pandemic. The best offense is a good defense, especially when protecting your skin this winter. While frequent hand hygiene prevents infection, the dry, cracked skin it may leave behind makes it easy for bacteria to enter. Good skin care provides a strong offense when wearing a mask and practicing frequent hand hygiene.
View this flyer in Spanish.",NETEC,,,2020-12-16,"2023-07-13 by Christa Arguinchona and Caroline Croyle (PM) - specific to frequent mask wearing during pandemic. Still could be a useful asset in flu season where frequent masking occurs",,,,,,,2026-07-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Cleaning,Coronavirus,COVID-19,Gloves,Mask,Masks,N95,Occupational Health,R-Lead,R-PM",https://repository.netecweb.org/files/original/769be1088f7877832d0bc040c7672120.pdf,Guide,Develop,1,0
1446,https://repository.netecweb.org/items/show/1446,"COVID-19 Surgical Safety Best Practices and Innovations","Infection Control","This printable flyer infographic and interactive resource discusses best practices and innovations for surgical safety during the COVID-19 pandemic. Learn about best practices during surgical procedures to help prevent cross contamination in an operating room. Click the hotspots to see PPE strategies based on a patient's COVID-19 status and innovations that improve safety.",NETEC,,,2021-01-04,"2023-07-13 by Christa Arguinchona and Caroline Croyle (PM) - covid specific resource, relevancy for non covid environment",,,,,,,2024-07-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Coronavirus,COVID-19,Gloves,Gown,Hood,Infection Prevention and Control,Mask,Masks,N95,Occupational Health,Personal Protective Equipment (PPE),Physical Infrastructure,R-PM,R-PPE,Treatment and Care",https://repository.netecweb.org/files/original/29e42076c0bfde1363a6cf0c3bd12533.pdf,Guide,Develop,1,0
1445,https://repository.netecweb.org/items/show/1445,"Minimizing Surgical Room Contamination","Infection Control","This printable flyer infographic discusses methods for minimizing surgical room contamination from COVID-19. Patients may be contagious prior to symptoms or be asymptomatic. Keep personnel and patients safer by using strategies for minimizing contamination in surgical suites that reduce potential exposure. Consider physical spaces and how they are used before, during and after surgery. ",NETEC,,,2021-01-04,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q2)",,"Y
Y - D0.1IC/D0.2IC Qualtrics # 230, original # 17
Y - D0.1IC/D0.2IC Qualtrics # 231, original # 17a",,,,"Infection Prevention and Control",2024-12-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Coronavirus,COVID-19,Environmental Services,Infection Prevention and Control,Physical Infrastructure,R-IPC,Treatment and Care",https://repository.netecweb.org/files/original/810c54befb550674ee886c0da2b50c06.pdf,Guide,Develop,1,0
1444,https://repository.netecweb.org/items/show/1444,"Monoclonal Antibody Therapy","Treatment & Care","This printable flyer infographic discusses mAb for COVID-19. Monoclonal antibody therapeutics (mAb) are one of the first available medical countermeasure therapeutics for mild-to-moderate COVID-19 cases. This handout discusses what they are, the criteria for allocation and prioritization, and logistics of outpatient care.",NETEC,,,2020-12-10,"2022-09-27 - general asset review - Treatment & Care group
2024-03-28 by J. Mundy – Treatment & Care group review 2023 (Q2) skipped – bumping to 2024 (Q2)",,,,,,"Adult Care",2024-11-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Coronavirus,COVID-19,Not updated,R-T&C,Therapeutics,Treatment and Care",https://repository.netecweb.org/files/original/c9c1563923621c3e258cc0d93fe9e63b.pdf,Guide,Develop,1,0
1443,https://repository.netecweb.org/items/show/1443,"Code Blue for a Pandemic Situation","Treatment & Care","This printable flyer infographic discusses safety and plans for CPR and Code Blue in a pandemic. CPR during the COVID-19 pandemic requires extra precautions. Follow the examples and tips shown here to keep everyone safe while resuscitating a patient.",NETEC,,,2020-12-11,"2022-09-27 - general asset review - Treatment & Care group
2023-03-31 - J Mundy - change to just R-T&C
2024-03-28 by J. Mundy – Treatment & Care group review 2023 (Q2) skipped – bumping to 2024 (Q2)",,,,,,"Adult Care",2024-11-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Coronavirus,COVID-19,Emergency Department,Emergency Management,EMS,Infection Prevention and Control,Not updated,R-T&C,Treatment and Care",https://repository.netecweb.org/files/original/ee6e95028a37af0201d75dc2dd30eddc.pdf,Guide,Develop,1,0
1442,https://repository.netecweb.org/items/show/1442,"Breaking the COVID-19 Chain of Infection","Infection Control","This printable flyer infographic discusses methods for breaking the chain of infection. The chain of infection shows how the coronavirus spreads from one person to another. To spread an infection, the links in the chain must remain intact. The good news is that we have the power to break the chain and stop the spread of COVID-19.",NETEC,,,2020-12-17,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q2)",,Y,,,,"Infection Prevention and Control",2024-12-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Airborne Transmission,Chain of infection,Coronavirus,COVID-19,Droplet Transmission,Infection Prevention and Control,R-IPC",https://repository.netecweb.org/files/original/7725d015e6df6469d160fba3cbc87677.pdf,Guide,Develop,1,0
1441,https://repository.netecweb.org/items/show/1441,"Managing Highly Infectious Disease Outbreaks with HICS","Emergency Management","This printable flyer infographic discusses the use of the HICS system with infectious disease outbreaks. Hospital incident command system (HICS) is a robust framework that helps hospitals prepare, mitigate, respond, and recover from threats, planned events, and emergency incidents.",NETEC,,,2020-12-16,"2024-03-27 Emergency Management skipped in review – bump to next quarter",,"Y - D0.1EM/D0.2EM Qualtrics # 503",,,,,2024-07-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Coronavirus,COVID-19,Emergency Management,HICS,Outbreaks,R-EM,Respiratory Pathogen,Special Pathogens",https://repository.netecweb.org/files/original/887f5e210eaac80c476ffa97976eca60.pdf,Guide,Develop,1,0
1440,https://repository.netecweb.org/items/show/1440,"Hospital Incident Command System (HICS) and COVID-19","Emergency Management","This printable flyer infographic discusses the use of the HICS system with COVID-19. HICS helps hospitals prepare, mitigate, respond, and recover from an event that disrupts normal operations or threatens life, property, or the environment.",NETEC,,,2020-12-09,"2024-03-27 Emergency Management skipped in review – bump to next quarter",,,,,,,2024-07-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Coronavirus,COVID-19,Emergency Management,HICS,Preparedness,R-EM",https://repository.netecweb.org/files/original/6dfb56ad7300b7a64c661ac202849f0e.pdf,Guide,Develop,1,0
1439,https://repository.netecweb.org/items/show/1439,"COVID-19 Safety for Dental Practices","Infection Control","This printable flyer infographic discusses safety for dental practices. Recovery from and response to a disaster happen at the same time - in the short, intermediate, and long term. Recovery requires collaboration between the private and public sectors.",NETEC,,,2020-12-04,"2023-07-13 by Christa Arguinchona and Caroline Croyle (PM) - covid specific resource, relevancy for non covid environment",,,,,,,2024-07-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Coronavirus,COVID-19,Infection Prevention and Control,Occupational Health,Personal Protective Equipment (PPE),R-PM,R-PPE",https://repository.netecweb.org/files/original/a774a0db971b073b9b4808ec56f4d0fc.pdf,Guide,Develop,1,0
1438,https://repository.netecweb.org/items/show/1438,"Biosafety First: Transporting COVID-19 Patients","Treatment & Care","This printable flyer infographic discusses transporting COVID-19 patients safely.
For optimal patient and health care personnel (HCP) safety during EMS transport, environmental controls, policies and procedures, clinical considerations, and usage of safety equipment should all align. These actions limit the transmission of biological agents, including SARS-CoV-2, which causes COVID-19.",NETEC,,,2020-12-04,"2022-09-27 - general asset review - Treatment & Care group
2023-03-31 - J Mundy - change to just R-EMS for next review
2024-03-27 EMS/Pre-Hospital never reviewed – bump to next quarter",,,,,,,2024-06-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Coronavirus,COVID-19,EMS,Not updated,Pre-hospital Transport,R-EMS,R-PreH,Respiratory Pathogen,SARS-CoV-2",https://repository.netecweb.org/files/original/0ae284ddf285ab9ad6828913e877dcc3.pdf,Guide,Develop,1,0
1436,https://repository.netecweb.org/items/show/1436,"Long-Term Care (LTC) and Assisted Living Facility Biosafety: Identify, Isolate and Inform","Treatment & Care","This printable flyer infographic discusses Long-Term Care (LTC) and Assisted Living Facility Biosafety: Identify, Isolate and Inform.",NETEC,,,2020-12-12,,,,,,,,2024-01-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Biosafety,Coronavirus,COVID-19,Identify,Inform,Isolate,Long-term Care,R-LTC",https://repository.netecweb.org/files/original/6d7efb7dcce87bcd1500fba67459d56c.pdf,Guide,Develop,1,0
1416,https://repository.netecweb.org/items/show/1416,"COVID-19 Rapid Resource Center","Emergency Management","The Society of Critical Care Medicine’s (SCCM) COVID-19 Rapid Resource Center gives you access to their latest education. You can also search by specific topics.","Society of Critical Care Medicine (SCCM)",,,2020-12,"2024-03-27 Emergency Management skipped in review – bump to next quarter",,,,,,,2024-07-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.sccm.org/COVID19RapidResources/Home,,,,"2019-nCoV,Coronavirus,COVID-19,Personal Protective Equipment (PPE),R-EM",,Hyperlink,Develop,1,0
1413,https://repository.netecweb.org/items/show/1413,"Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19","Treatment & Care","These are regularly updated guidelines on the treatment and management of patients with COVID-19.","Infectious Diseases Society of America (IDSA)","Adarsh Bhimraj*, Rebecca L. Morgan**, Amy Hirsch Shumaker, Valery Lavergne**, Lindsey Baden, Vincent Chi-Chung Cheng, Kathryn M. Edwards, Rajesh Gandhi, Jason Gallagher, William J. Muller, John C. O’Horo, Shmuel Shoham, M. Hassan Murad**, Reem A. Mustafa**, Shahnaz Sultan**, Yngve Falck-Ytter**
*Corresponding Author **Methodologist
",,2020-11-22,"2022-09-27 - general asset review - Treatment & Care group
2024-03-28 by J. Mundy – Treatment & Care group review 2023 (Q2) skipped – bumping to 2024 (Q2)",,,,,,"Adult Care",2024-11-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/,,,,"2019-nCoV,Clinical Care Guidelines,Coronavirus,COVID-19,Person Under Investigation (PUI),R-T&C,SARS-CoV-2,Treatment and Care",https://repository.netecweb.org/files/original/222ca283cda8bc6488b56f7954153de8.png,Guide,Develop,1,0
1387,https://repository.netecweb.org/items/show/1387,"Renal Replacement Therapy in Patients with COVID-19: Increased Need for Renal Replacement Therapy (RRT)","Treatment & Care","Printable flyer infographic about Renal Replacement Therapy in Patients with COVID-19: Increased Need for Renal Replacement Therapy (RRT).
During the COVID-19 pandemic, the need for RRT - both inside and outside the ICU - has increased. In some cases facilities are unable to keep up with the demand for RRT.",NETEC,,,2020-11-02,"2022-09-27 - general asset review - Treatment & Care group
2024-03-28 by J. Mundy – Treatment & Care group review 2023 (Q2) skipped – bumping to 2024 (Q2)",,"Y - D0.1Tx/D0.2Tx Qualtrics # 821, Additional Resource",,,,"Adult Care",2024-11-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Clinical Care,Comorbidity,Coronavirus,COVID-19,Not updated,R-T&C,Treatment and Care",https://repository.netecweb.org/files/original/870740e497230274aff1db2f08c27b53.pdf,Guide,Develop,1,0
1383,https://repository.netecweb.org/items/show/1383,"Gaining Strength and Developing Resiliency","Personnel Management","This printable flyer infographic tells you about gaining strength and developing resiliency as a health care provider, and key risk factors and signs of psychological distress.
View this flyer in Spanish ""Desarrollando fuerza y resiliencia mental.""",NETEC,,,2020-11-02,"2023-07-13 by Christa Arguinchona and Caroline Croyle (PM)",,"Y - D0.1PM/D0.2PM Qualtrics # 914, original # 10",,,,,2024-07-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Coronavirus,COVID-19,Epidemic,Occupational Health,Pandemic,Personnel Management,Post-traumatic stress disorder (PTSD),R-Lead,R-PM,Staffing",https://repository.netecweb.org/files/original/8bd46188feac6675a08f487406f93d9e.pdf,Guide,Develop,1,0
1374,https://repository.netecweb.org/items/show/1374,"Face shield decon card ","Infection Control","COVID-19: General PPE Guidance: This card was designed for Emory Healthcare workers to keep in their ID badge case. It depicts the proper steps and guidance for decontaminating face shield for reuse.
",Emory,,,2020-07-20,"2022-03-29 by Josia Mamora",,,,,,,2025-01-01,,,,,,,,,,"Emory VME",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://med.emory.edu/departments/medicine/divisions/infectious-diseases/serious-communicable-diseases-program/covid-19-resources/general-ppe-guidance.html,,,,"2019-nCoV,Coronavirus,COVID-19,Decontamination,Example,Face shield,Gloves,Hand Hygiene,Mask,Masks,Personal Protective Equipment (PPE),R-PPE",https://repository.netecweb.org/files/original/547a6a6348c42c231d7c20eea1757061.pdf,Guide,Develop,1,0
1366,https://repository.netecweb.org/items/show/1366,"Use of HICS in COVID-19 Recovery & Resilience","Emergency Management","This interactive pdf and printable flyer infographic describes the use of HICS in COVID-19 recovery and resilience.
Recovery from and response to a disaster can happen at the same time - in the short, intermediate, and long terms. Recovery requires collaboration between the private and public sectors.",NETEC,,,2020-09-24,"2023-07-13 by Christa Arguinchona and Caroline Croyle (PM) - covid specific resource, relevancy for non covid environment",,,,,,,2024-07-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Coronavirus,COVID-19,Emergency Management,HICS,Occupational Health,R-PM,Staff Support,Staffing,Staffing Model",https://repository.netecweb.org/files/original/f014ae522df0e9be6a877f636c60ac0f.pdf,Guide,Develop,1,0
1365,https://repository.netecweb.org/items/show/1365,"Pathophysiology of COVID-19",Research,"This printable flyer infographic tells you about the pathophysiology of COVID-19.
A typical presentation for COVID-19 includes cough, dyspnea, and an x-ray with diffuse opacities in the lungs. As the disease progresses, patients may develop increased respiratory failure, a hypercoagulable state, and excessive levels of pro-inflammatory and anti-inflammatory cytokines similar to Macrophage Activation Syndrome (MAS). We are learning more about what is typical every day, however.
Each of these hallmark physiological states of COVID-19 result from SARS-CoV-2 infection via binding of its spike protein to the Angiotensin Converting 2 (ACE2) receptor on a variety of cell types, primarily epithelial. ACE2 normally cleaves regulatory proteins including angiotensins-2. Binding of the virus disrupts normal cellular regulation resulting in high levels of inflammation and cell death.",NETEC,,,2020-10-20,"2024-03-27 R-Lead – never reviewed – make due in 6 months",,,,,,,2024-11-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Coronavirus,COVID-19,Outcomes,R-Lead,SARS-CoV-2",https://repository.netecweb.org/files/original/8a1e24637d02beace162757560109ec3.pdf,Guide,Develop,1,0
1286,https://repository.netecweb.org/items/show/1286,"Children's Reopening Toolkit for Youth Organizations","Emergency Management","As we reopen, children—and those who serve them—need support more than ever. Use the resources in this toolkit as a steppingstone to help protect the kids and staff within your organization.
Find this and related resources: https://www.strong4life.com/en/landing-pages/schools-reopening","Children's Healthcare of Atlanta (CHOA)",,,2020-08,"2022-07 by Nicole, Special Populations Treatment & Care group
2023-12-15 by Clayton Mowrer, Special Populations Treatment & Care group",,,,,,,2024-12-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.strong4life.com/~/media/files/Strong4Life/Programs/School-Programs/back-to-school-2020/childrens-reopening-toolkit-youth-organizations.pdf,,,,"2019-nCoV,Children,Contingency and crisis capacities,Coronavirus,COVID-19,Emergency Management,Epidemic,Example,Pandemic,Pediatrics,R-EM,R-SP",,Guide,Develop,1,0
1284,https://repository.netecweb.org/items/show/1284,"First Responder Resiliency ECHO","Personnel Management","First responders are the primary frontline professionals responding to emergencies and are the difference between life and death for patients and community members. Continually at risk for physical injury, compassion fatigue, “burn-out”, and PTSD, the COVID-19 global pandemic is impacting First Responders and Frontline Healthcare Workers in unprecedented ways.
Join your colleagues in EMS, law enforcement, and healthcare from around the nation for our first-of-its-kind program based on real cases and situations generated by COVID-19. Learn techniques to manage self-care and increase resiliency and capacity during this crisis. Share best practices and receive support from peers, physicians, and mental health experts.
","Project Echo",,,2020-09-14,"2023-07-13 by Christa Arguinchona and Caroline Croyle (PM) - covid specific resource, relevancy for non covid environment",,,,,,,2024-07-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://echo.unm.edu/covid-19/sessions/firstresponder,,,,"2019-nCoV,Anxiety,Burnout,Coping,Coronavirus,COVID-19,EMS,Epidemic,Example,First Responder,Mental Health,Nursing,Occupational Health,Pandemic,Post-traumatic stress disorder (PTSD),R-PM,Resilience,Self-Care,Staff Support,Staffing",,Hyperlink,Develop,1,0
1276,https://repository.netecweb.org/items/show/1276,"Helping Children Wear Masks","Infection Control","Wearing a mask can be difficult for all of us. How can you teach and help a child to wear a mask? ",NETEC,,,2020-08-06,"2022-07 by Clayton, Special Populations Treatment & Care group",,,,,,,2025-07-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Children,Coronavirus,COVID-19,Mask,Masks,Pediatrics,R-SP",https://repository.netecweb.org/files/original/2cc0ae08fcb655ce947e7ac33a7c5749.pdf,Guide,Develop,1,0
1275,https://repository.netecweb.org/items/show/1275,"Routine Patient Room and Nursing Station Cleaning/Disinfection Checklist","Infection Control","It's safer with a system. Checklist.",NETEC,,,2020-07-26,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q2)",,"Y
Y - D0.1IC/D0.2IC Qualtrics # 208, original # 4
Y - D0.1IC/D0.2IC Qualtrics # 209, original # 4a
Y - D0.1IC/D0.2IC Qualtrics # 210, original # 5
Y - D0.1IC/D0.2IC Qualtrics # 220, original # 9b
Y - D0.1IC/D0.2IC Qualtrics # 221, original # 9c",,,,"Infection Prevention and Control",2024-12-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Checklist,Coronavirus,COVID-19,Disinfection,Environmental Services,High Touch Surfaces,Infection Prevention and Control,Occupational Exposure,Occupational Health,R-IPC","https://repository.netecweb.org/files/original/7be11895c9e320d914038a0d11ed2003.png,https://repository.netecweb.org/files/original/b8602adbe646e3cd113ff80d59f53973.docx",Checklist,Develop,1,0
1274,https://repository.netecweb.org/items/show/1274,"Engineering Controls for Long-term Care","Physical Infrastructure","Engineering controls can be implemented to isolate people from a hazard and provide protection for long-term care residents and staff. ",NETEC,,,2020-07-24,"2022-12-07 general asset review - IPC (move to LTC - now R-T&C)
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q2)",,,,,,"Adult Care",2024-12-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Coronavirus,COVID-19,Infection Prevention and Control,Long-term Care,Physical Infrastructure,R-LTC,R-T&C",https://repository.netecweb.org/files/original/7957373e3db7cb81aa0811b1c37838f8.pdf,Guide,Develop,1,0
1273,https://repository.netecweb.org/items/show/1273,"Work Smart!","Physical Infrastructure","Understand negative pressure isolation. Reduce your exposure risk. Conserve PPE.",NETEC,,,2020-07-17,"2022-11-14 by IPC general asset review, marked for archive ""add to COVID-19 bucket, about CSC and reuse of ppe; could pull out negative pressure component for helpful tool"" - flagged CCC and not updated
2023-03-03 removed not updated and change to Physical Infrastructure review - in SPORSA",,"Y - D0.1PI/D0.2PI Qualtrics # 106, original # 3a
Y - D0.1PI/D0.2PI Qualtrics # 107, original # 3b
Y - D0.1PI/D0.2PI Qualtrics # 108, original # 3c
Y - D0.1PI/D0.2PI Qualtrics # 109, original # 3d
Y - D0.1PI/D0.2PI Qualtrics # 110, original # 3e
Y - D0.1PI/D0.2PI Qualtrics # 111, original # 13
Y - D0.1PI/D0.2PI Qualtrics # 112, original # 14
Y - D0.1PI/D0.2PI Qualtrics # 113, original # 15",,,,,2024-03-03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Airborne Transmission,Contingency and crisis capacities,Coronavirus,COVID-19,Infection Prevention and Control,Occupational Exposure,Occupational Health,Physical Infrastructure,R-PhIn",https://repository.netecweb.org/files/original/edc21e9697d6c0eab3a7e3cb7e3231de.pdf,Guide,Develop,1,0
1272,https://repository.netecweb.org/items/show/1272,"COVID-19 Self-Screening Tips for School Staff","Infection Control","If your school is practicing in-person learning this school year, it’s more important than ever to be mindful of your health and wellness to prevent the spread of germs. Use this checklist to self-screen before heading to school, daycare or other learning facilities.
Printable flyer.
See related resources:
https://www.strong4life.com/en/landing-pages/educator-and-staff-resources","Children's Healthcare of Atlanta (CHOA)",,,2020-08-07,"2022-12-07 general asset review - IPC - change to R-SP
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q2)",,,,,,"Pediatric Care",2024-12-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.strong4life.com/~/media/files/Strong4Life/Programs/School-Programs/back-to-school-2020/covid-19-self-screening-tips-for-school-staff.pdf,,,,"2019-nCoV,Checklist,Coronavirus,COVID-19,R-SP,School,Screening Tool",,Guide,Develop,1,0
1271,https://repository.netecweb.org/items/show/1271,"How to Screen Your Child for COVID-19 Symptoms","Infection Control","As parents, we’re always mindful of how our children are feeling before they go to school. But this year we’ll have to pay more attention than ever to do our part to minimize the spread of germs.
Printable flyer.
See this and related resources:
https://www.strong4life.com/en/landing-pages/parent-resources","Children's Healthcare of Atlanta (CHOA)",,,2020-08-07,"2022-12-07 general asset review - IPC (change to R-SP)
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q2)",,,,,,"Pediatric Care",2024-12-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.strong4life.com/~/media/files/Strong4Life/Programs/School-Programs/back-to-school-2020/how-to-screen-your-child-for-covid-19-symptoms-checklist.pdf,,,,"2019-nCoV,Checklist,Children,Coronavirus,COVID-19,R-SP,Screening Tool",,Guide,Develop,1,0
1270,https://repository.netecweb.org/items/show/1270,"Preventing the Spread of Germs in Your Classroom","Infection Control","It is more important than ever to keep common spaces clean and as germ-free as possible. Check out these expert tips from our illness prevention team to keep your space clean.
Printable flyer.
See related resources:
https://www.strong4life.com/en/landing-pages/educator-and-staff-resources","Children's Healthcare of Atlanta (CHOA)",,,2020-08-07,"2022-12-07 general asset review - IPC (change R-SP)
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q2)",,,,,,"Pediatric Care",2024-12-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.strong4life.com/~/media/files/Strong4Life/Programs/School-Programs/back-to-school-2020/preventing-the-spread-of-germs-in-your-classroom.pdf,,,,"2019-nCoV,Checklist,Cleaning,Coronavirus,COVID-19,Hand Hygiene,Infection Prevention and Control,R-SP,School",,Guide,Develop,1,0
1241,https://repository.netecweb.org/items/show/1241,"Schools and Childcare Programs","Emergency Management","COVID-19: Plan, Prepare, and Respond",CDC,,,2020-07-24,"2022-07 by Clayton, Special Populations Treatment & Care group
2023-12-15 by Clayton Mowrer, Special Populations Treatment & Care group",,,,,,,2024-12-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/index.html,,,,"2019-nCoV,Coronavirus,COVID-19,Pediatrics,R-EM,R-SP",https://repository.netecweb.org/files/original/086bf78f6ed711d08cc19548e110e7ed.png,Guide,Develop,1,0
1240,https://repository.netecweb.org/items/show/1240,"Guidance for Administrators of US K-12 Schools and Child Care Programs","Emergency Management","Plan, Prepare, and Respond to Coronavirus Disease 2019 (COVID-19)",CDC,,,2022-01-28,"2022-01-31 by Joanna Mundy (URL dead - updated from Interim)
2022-07 by Nicole, Special Populations Treatment & Care group
2023-12-15 by Clayton Mowrer, Special Populations Treatment & Care group",,,,,,,2024-12-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/,,,,"2019-nCoV,Coronavirus,COVID-19,Pediatrics,R-EM,R-SP",https://repository.netecweb.org/files/original/2e817c2b6b179724b6010c4fdfc148aa.png,Guide,Develop,1,0
1239,https://repository.netecweb.org/items/show/1239,"COVID-19 Communication Resources: Print Resources",General,"The following print-only materials are developed to support COVID-19 recommendations. ",CDC,,,2020-07-29,"2022-07 by Nicole, Special Populations Treatment & Care group
2023-12-15 by Clayton Mowrer, Special Populations Treatment & Care group",,,,,,,2024-12-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/coronavirus/2019-ncov/communication/print-resources.html?Sort=Date%3A%3Adesc,,,,"2019-nCoV,Communications,Coronavirus,COVID-19,Guidance Document,Infection Prevention and Control,Inform,Pediatrics,R-SP",https://repository.netecweb.org/files/original/22b829c078a83c6b6cecb59d6f061b6d.png,Guide,Develop,1,0
1228,https://repository.netecweb.org/items/show/1228,"Sammy Stays Safe","Treatment & Care","Drs. Nicole Battaglioli, Rahel Gizaw, Kathryn Yaffee, and Anna Yaffee have co-authored a children's book on COVID-19. They created their book for a contest sponsored by Emory's Global Health Institute. The contest invited interested writers and illustrators (or aspiring writers and illustrators) to write and illustrate a children’s eBook aimed at providing age-appropriate information for children ages 6-9 on the COVID-19 pandemic. ","Drs. Nicole Battaglioli, Rahel Gizaw, Kathryn Yaffee, and Anna Yaffee",,,2020,"2022-09-27 - general asset review - Treatment & Care group
2022-07 by Andi, Special Populations Treatment & Care group
2023-12-15 by Clayton Mowrer, Special Populations Treatment & Care group - skipped - bump to next review",,,,,Publication,,2024-04-27,,,,,,,,,,,"Copyright © 2020 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the copyright holder.",,https://med.emory.edu/departments/emergency-medicine/_documents/sammystayssafe-min.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,https://med.emory.edu/departments/emergency-medicine/patient-care/covid-19/index.html,,,,"2019-nCoV,Communications,Coronavirus,COVID-19,Pediatrics,R-Res&Pub,R-SP,R-T&C",,Publication,Develop,1,0
1184,https://repository.netecweb.org/items/show/1184,"COVID-19 Ambulatory PPE Resources: Aerosol Generating Procedure","Infection Control","N95 Respirator (reuse)
Face shield or goggles (reuse)
Contact gown
Single gloves
Instructions for aerosol generating procedures. Please follow reuse protocols for N95 and gowns.
Putting ON PPE, Taking OFF PPE
These instructions are useful when you are...
- ...performing an aerosol generating procedure with a symptomatic patient who has a mask off.
",Emory,,,2020-09-04,"2022-03-29 by Josia Mamora",,,,,,,2024-01-01,,,,,,,,,,"Emory VME",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://med.emory.edu/departments/medicine/divisions/infectious-diseases/serious-communicable-diseases-program/covid-19-resources/ambulatory-ppe.html,,,,"2019-nCoV,Coronavirus,COVID-19,Donning and Doffing,Example,Face shield,N95,Personal Protective Equipment (PPE),R-PPE","https://repository.netecweb.org/files/original/0f4284f44e20d5dfa7674908f3dbdcc9.pdf,https://repository.netecweb.org/files/original/b57e52efe49ab162989288a4200e2ec9.pdf",Guide,Develop,1,0
1183,https://repository.netecweb.org/items/show/1183,"COVID-19 Ambulatory PPE Resources: Throat/sinus exam ","Infection Control","Procedure mask
Face shield or goggles (reuse)
Contact gown
Single gloves
Instructions for throat/sinus exam PPE. Standard instructions for putting on and taking off Droplet Contact Precautions with Eyewear (DICE) level PPE. This is the level of PPE which is acceptable for COVID care according to CDC. Please refer to our instructions on reuse of PPE. Talk with your supervisor if you have any questions about reuse in your area.
Putting ON PPE, Taking OFF PPE
These instructions are useful when you are...
- ...performing a physical exam with a symptomatic patient who has a mask off.
- ...NOT performing aerosolizing procedures.
",Emory,,,2020-09-04,"2022-03-29 by Josia Mamora",,,,,,,2025-01-01,,,,,,,,,,"Emory VME",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://med.emory.edu/departments/medicine/divisions/infectious-diseases/serious-communicable-diseases-program/covid-19-resources/ambulatory-ppe.html,,,,"2019-nCoV,Coronavirus,COVID-19,Donning and Doffing,Example,Face shield,Gloves,Goggles,Mask,Masks,Personal Protective Equipment (PPE),R-PPE",https://repository.netecweb.org/files/original/b122e0e50b4bda8d3b1ffde5ff84981a.pdf,Guide,Develop,1,0
1145,https://repository.netecweb.org/items/show/1145,"N95 User Seal Check","Infection Control","
COVID-19 Resources: General PPE Guidance -When wearing an N95 to care for COVID patients, you need to perform a user seal check EVERYTIME you don your PPE. This flyer instructs you on how to perform your own user seal check. Your safety depends on it.
User seal checks do NOT replace initial fit testing done by your institution to ensure that your particular piece of equipment fits properly to your specific face shape.",Emory,,,2020-08-30,"2022-02-04 by Jill Morgan
2022-02-07 by Lisa Stone (needed for old blog post)",,,,,,,"Do not review - outdated - needed for old blog post.",,,,,,,,,,"Emory VME",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://med.emory.edu/departments/medicine/divisions/infectious-diseases/serious-communicable-diseases-program/covid-19-resources/general-ppe-guidance.html,,,,"2019-nCoV,Archived,Coronavirus,COVID-19,N95,Personal Protective Equipment (PPE),R-PPE",https://repository.netecweb.org/files/original/2707db7bc7fe151d51a0cc4b577bab91.pdf,Guide,Develop,1,0
1128,https://repository.netecweb.org/items/show/1128,"Guidance for Dental Settings During the COVID-19 Response","Infection Control","During this COCA call, presenters will provide an overview of the updated guidance for dental settings, including recommendations for resuming non-emergency dental care during the COVID-19 pandemic. Presenters also will discuss strategies for dental healthcare facilities to optimize personal protective equipment (PPE).",CDC,,,2020-06-03,"2023-12-04 by Jill Morgan/PPE Group",,,,,,,2025-12-04,,,,,,,"
",,https://youtu.be/CtOThtxtqvg,,,,,,,,,,,,,,"Date: Wednesday, June 3, 2020
Time: 2:00–3:00 P.M. ET
",,,,,,,,,,,,,,"Information for dentists, dentist, dentistry. ",,,https://emergency.cdc.gov/coca/calls/2020/callinfo_060320.asp,"COCA Call webinar, will be recorded.",,,"2019-nCoV,Contingency and crisis capacities,Coronavirus,COVID-19,Example,Personal Protective Equipment (PPE),R-PPE",https://repository.netecweb.org/files/original/1f0b576bedf711a4a566adfb53282c12.png,Webinar,Develop,1,0
1114,https://repository.netecweb.org/items/show/1114,"Telemedicine Flyer","Treatment & Care","Telehealth: providing support, clinical care (education, administration, public health) to the client, or program planning at a distance.
Go to the NETEC COVID-19 webinar on Telemedicine Innovations.",NETEC,,,2020-05-13,"2022-09-27 - general asset review - Treatment & Care group
2024-03-28 by J. Mundy – Treatment & Care group review 2023 (Q2) skipped – bumping to 2024 (Q2)",,,,,,"Adult Care",2024-11-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Coronavirus,COVID-19,Epidemic,Isolate,Pandemic,R-T&C,Treatment and Care",https://repository.netecweb.org/files/original/75493b04c70c06e990289e68854f85a3.pdf,Guide,Develop,1,0
1087,https://repository.netecweb.org/items/show/1087,"Non-Sterile - Airborne Contact precautions with Eyewear (ACE) Printable Instructions ","Infection Control","Operating Room (Non-Sterile) Printable PDFs
Putting ON PPE, Taking OFF PPE
These PDF's depict the the use of PPE for non-sterile OR staff for the protection against COVID-19 that is currently in use at Emory University. Created by Emory's Visual Medical Education team.",Emory,,,2020-09-04,"2022-03-29 by Josia Mamora",,,,,,,2024-01-01,,,,,,,,,,"Emory VME",,,,,,,,,,,,,,,,,,,,,,,,,,,"Donning Airborne Contact precautions with Eyewear (ACE) Printable Instructions for non-sterile OR staff.
Doffing Airborne Contact precautions with Eyewear (ACE) Printable Instructions for non-sterile OR staff.
",,,https://med.emory.edu/departments/medicine/divisions/infectious-diseases/serious-communicable-diseases-program/covid-19-resources/surgery-dept-ppe.html,,,,"2019-nCoV,ACE,Coronavirus,COVID-19,Donning and Doffing,Example,Face shield,Gloves,Gown,N95,Personal Protective Equipment (PPE),R-PPE",https://repository.netecweb.org/files/original/c195b3bb1f42215df9fa5f41327574e5.pdf,Guide,Develop,1,0
1084,https://repository.netecweb.org/items/show/1084,"COVID-19 Unit Resources: Donning and Doffing with CAPR and double gloves, PPE","Infection Control","CAPR, RE-USE GOWN, DOUBLE Gloves - ACE Printable PDFs
Putting ON PPE, Extended Wear, Taking OFF PPE",Emory,,,2020-08-13,"2022-03-29 by Josia Mamora",,,,,,,2024-01-01,,,,,,,,,,"Emory VME",,,,,,,,,,,,,,,,,,,,,,,,,,,"Use these instructions for donning, or putting on your PPE, if you are caring for a COVID-19 positive patient next and are reusing CAPR, and gown.",,,https://med.emory.edu/departments/medicine/divisions/infectious-diseases/serious-communicable-diseases-program/covid-19-resources/conserving-ppe.html,,,,"2019-nCoV,CAPR,Coronavirus,COVID-19,Example,Extended wear,Gloves,Mask,Masks,N95,Personal Protective Equipment (PPE),R-PPE",https://repository.netecweb.org/files/original/465ae324618fd07e5f392e32d9c0a86e.pdf,Guide,Develop,1,0
1080,https://repository.netecweb.org/items/show/1080,"PPE (ACE) double gloves","Infection Control","COVID-19 Unit Resources: COVID-19 Unit - COVID-19 ACE Printable PDFs (RE-USE GOWN).
RE-USE GOWN, DOUBLE Gloves - COVID-19 Unit - ACE Printable PDFs
Putting ON PPE, Extending Wear, Taking OFF PPE
These PDFs reflect the current supply shortage in which N95 masks and face shields and gowns may be conserved and reused. Created by Emory's Visual Medical Education team.",Emory,,,2020-08-28,"2022-03-29 by Josia Mamora",,,,,,,2024-01-01,,,,,,,,,,"Emory VME",,,,,,,,,,,,,,,,,,,,,,,,,,,"Use these instructions for donning, or putting on your PPE, if you are caring for a COVID-19 positive patient next and are reusing the mask, faceshield, and gown.
Post these inside and outside COVID-19 patient rooms, use to doff. Two options, one if your next patient is COVID-19 positive (pages 2 and 3 of this pdf), the other if your next patient COVID-19 status is negative or uncertain, or if you are finished seeing patients (pages 4 and 5 of this pdf).
",,,https://med.emory.edu/departments/medicine/divisions/infectious-diseases/serious-communicable-diseases-program/covid-19-resources/conserving-ppe.html,,,,"2019-nCoV,ACE,Coronavirus,COVID-19,Donning and Doffing,Example,Extended wear,Face shield,Gloves,N95,Personal Protective Equipment (PPE),R-PPE",https://repository.netecweb.org/files/original/ff7be9009a14dba23ec23460872d5f4f.pdf,Guide,Develop,1,0
1076,https://repository.netecweb.org/items/show/1076,"CAPR - Airborne – PPE","Infection Control","Contact precautions with eyewear (ACE) Printable instructions. From CAPR (ACE) Emergency Department Printable PDFs. These PDF's depict the Emergency Department use of CAPR for protection against COVID-19 that is currently in use at Emory University. This configuration may also be useful outside of the ED context. Created by Emory's Visual Medical Education team.
Putting ON PPE, Extended Wear, Taking OFF PPE",Emory,,,2020-08-17,"2022-03-29 by Josia Mamora",,,,,,,2024-01-01,,,,,,,,,,"Emory VME",,,,,,,,,,,,,,,,,,,,,,,,,,,"Donning CAPR system PPE for contact precautions.
Doffing CAPR system PPE for contact precautions, inside room, for extended wear or terminal doffing.
Doffing CAPR system PPE for contact precautions, outside room for extended wear.
Doffing CAPR system PPE for contact precautions, outside room for terminal doffing when next patient is NOT COVID-19 positive.
",,,https://med.emory.edu/departments/medicine/divisions/infectious-diseases/serious-communicable-diseases-program/covid-19-resources/emergency-dept-ppe.html,,,,"2019-nCoV,ACE,CAPR,Coronavirus,Coveralls,COVID-19,Donning and Doffing,Example,Extended wear,Gloves,Mask,Masks,Personal Protective Equipment (PPE),R-PPE",https://repository.netecweb.org/files/original/b9826859ec95cd923f67a6d34d70bf4f.pdf,Guide,Develop,1,0
1072,https://repository.netecweb.org/items/show/1072,"PAPR - Airborne – PPE","Infection Control","Contact precautions with eyewear (ACE) Printable instructions. From PAPR (ACE) Emergency Department Printable PDFs. These PDF's depict the Emergency Department use of PAPR for protection against COVID-19 that is currently in use at Emory University. This configuration may also be useful outside of the ED context. Created by Emory's Visual Medical Education team.
Putting ON PPE, Extended Wear, Taking OFF PPE",Emory,,,2020-08-17,"2022-03-29 by Josia Mamora",,,,,,,2024-01-01,,,,,,,,,,"Emory VME",,,,,,,,,,,,,,,,,,,,,,,,,,,"Donning PAPR system PPE for airborne contact.
Doffing PAPR system PPE for airborne contact in room.
Doffing PAPR system PPE for airborne contact, outside room, for extended wear.
Terminal Doffing PAPR system PPE for airborne contact when the next patient is NOT COVID-19 positive.
",,,https://med.emory.edu/departments/medicine/divisions/infectious-diseases/serious-communicable-diseases-program/covid-19-resources/emergency-dept-ppe.html,,,,"2019-nCoV,Coronavirus,Coveralls,COVID-19,Donning and Doffing,Example,Extended wear,Gloves,Personal Protective Equipment (PPE),Powered Air Purifying Respirator (PAPR),R-PPE",https://repository.netecweb.org/files/original/5170d8055a728534503f192465da2386.pdf,Guide,Develop,1,0
1054,https://repository.netecweb.org/items/show/1054,"COVID-19 Symptoms","Intake and Internal Transport","Symptom descriptions for COVID-19. Symptoms of COVID-19 may appear 2-14 days after exposure to SARS-CoV-2 and can range from mild to severe illness. (Information is based on CDC case definition 5/4/2020).",NETEC,,,2020-05-05,"2024-03-27 IIT - haven't gotten back first review - bump to next quarter",,,,,,,2024-06-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Coronavirus,COVID-19,Identify,R-IIT,R-Lead",https://repository.netecweb.org/files/original/b5315d0c133637c28c44f8e36f623725.pdf,Guide,Develop,1,0
1053,https://repository.netecweb.org/items/show/1053,"Know Your PPE","Infection Control","Guide with information about different types of PPE (Personal Protective Equipment) and COVID-19.
View the Spanish version / versión en español.",NETEC,,,2020-05-04,"2023-12-04 by Jill Morgan/PPE Group - needs updating - submitted asset review form - CDC Recomendations needs to be reviewed and updated",,"Y - PPE pos 81 qualtrics 302; PPE pos 83 qualtrics 304
Y - D0.1PPE/D0.2PPE Qualtrics # 302
Y - D0.1PPE/D0.2PPE Qualtrics # 304",,,,,2024-12-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Coronavirus,COVID-19,Gloves,Gown,Infection Prevention and Control,Mask,Masks,N95,Personal Protective Equipment (PPE),R-PPE",https://repository.netecweb.org/files/original/8a4e0ca69136f087ca297dafa15d1760.pdf,Guide,Develop,1,0
1031,https://repository.netecweb.org/items/show/1031,"Webinar Series Conquering Stress in Difficult Times","Personnel Management","Conquering Stress in Difficult Times is an 8 session Webinar series. The series focuses on helping you understand the controllable causes of stress. Yes, contrary to popular belief stress is controllable! The content is grounded in research validated theory and Dr. Lyon’s over 34 years of experience as a Clinical Nurse Specialist in diagnosing and treating stress-related illness. To keep the time commitment manageable the series is broken down into 8 sessions and covers proven techniques to both prevent and eliminate stress not just “manage” it. You will learn the two conditions that must be present for you to experience stress, strategies to address each of the conditions and how to conquer the stress emotions of dysfunctional anxiety, unjustified guilt, chronic anger and frustration. The last session of the series focuses on grief and situational depression that can accompany grief.","National Association of Clinical Nurse Specialists (NACNS)","Dr. Brenda Lyon",,2020-04,"2023-07-13 by Christa Arguinchona and Caroline Croyle (PM) - external webinar series at the very beginning of covid",,,,,,,2026-07-14,,,,,,,,,,,,,,,,,,,,,,,"Session One: The Real and Controllable Causes of your Stress – approximately 45 minutes
Session Two: Eliminating Non-Essential Demands – approximately 40 minutes
Session Three: Maximizing Your Resources – approximately 10 minutes
Session Four: Conquering Dysfunctional Anxiety and the “Work of Worry” – approximately 25 minutes
Session Five: Conquering Unjustified Guilt – approximately 11 minutes
Session Six: Conquering Chronic Anger – approximately 16 minutes",,,,,,,,,,,,,,,,,https://nacns.org/professional-resources/covid-19-resources/,"Webinar Series",,,"2019-nCoV,Coronavirus,COVID-19,Example,Nursing,Occupational Health,R-Lead,R-PM",,Webinar,Develop,1,0
1023,https://repository.netecweb.org/items/show/1023,"Make the Smart Choice - Procedure Mask vs. N95 Respirator selection flyer","Infection Control","Printable flyer infographic explaining the reasons to choose a procedure mask or n95 respirator.
Go to the NETEC COVID-19 webinar on Healthcare Workers and Masks.
Go to the Spanish Language version of this flyer.",NETEC,,,2020-05-01,"2023-12-04 by Jill Morgan/PPE Group",,,,,,,2025-12-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Airborne Transmission,Coronavirus,COVID-19,Droplet Transmission,Mask,Masks,N95,Personal Protective Equipment (PPE),R-PPE",https://repository.netecweb.org/files/original/21e5bd19e2ac9c329118341d37c85266.pdf,Guide,Develop,1,0
1003,https://repository.netecweb.org/items/show/1003,"HHS/ASPR COVID-19 CLINICAL ROUNDS","Training and Exercises","The U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR), in collaboration with the National Ebola and Special Pathogens Training and Education Centers (NETEC), and Project ECHO, launched a series of COVID-19 Clinical Rounds on March 24th. This initiative supports a series of three weekly teleECHO programs – 1) Critical Care: Lifesaving Treatment and Clinical Operations; 2) Emergency Department: Patient Care and Clinical Operations; and 3) EMS: Patient Care and Operations. The aim is to create peer-to-peer learning networks where clinicians who have more experience treating patients with COVID-19 share their challenges and successes with clinicians across the U.S. and around the world with a wide variety of experience treating COVID-19. Each Clinical Rounds session includes brief presentations from experienced expert clinicians; the presentations have included representatives from Bellevue Hospital in New York City, Emory University, University of Minnesota, University of Washington, and Nebraska Medicine, among others. Representatives from more than 15 relevant national professional organizations round out the panel of expert discussants. The majority of each session is spent in discussion related to Q&A generated by the participants. As of mid-April more than 7500 people from all 50 states and more than 30 countries have participated in the sessions. ","Project Echo",,,2020-04,"2023-10-17 by Darrell Ruby, T&E Group, updated url
2024-02-05 by J Mundy, updated url ",,,,,,,2025-10-17,,,,,,,,,,,,,,,,,,,,,,,"Many past recordings available, covering a variety of topics.",,,,,,,,,,,,,,,,,https://iecho.org/welcome,,,,"2019-nCoV,Coronavirus,COVID-19,Critical Care,Emergency Department,EMS,R-T&E,Webinar",https://repository.netecweb.org/files/original/21a02d0f91b41d2052550472692d023e.png,Webinar,Develop,1,0
1002,https://repository.netecweb.org/items/show/1002,"NETEC COVID-19 Webinar Series (5/1/20)/Online Course: The Use of Proning: Implications for your Patients and Your Team","Treatment & Care","Discuss the clinical importance and indications of proning, describe the process of proning for COVID-19 cases, focusing on strategies employed and lessons learned.
Webinar slides attached.
Get educational credit for this webinar through Courses.netec.org.
",NETEC,,,2020-05-01,"2022-09-27 - general asset review - Treatment & Care group
2024-03-28 by J. Mundy – Treatment & Care group review 2023 (Q2) skipped – bumping to 2024 (Q2)
",,,,,"Webinar and Online Course","Adult Care",2024-11-27,,,,,,,"
",,"CEU online course: https://courses.netec.org/courses/20-web-pron",,,,,,,,,,,,,," Friday, May 1, 2020 | 12:00 PM CST",,,,,,,,,,,,,,"Self-paced, 1 credit.",,,https://youtu.be/czD6-szgDdg,"Webinar, watch at link below",,,"2019-nCoV,CEU,CEUs,Coronavirus,COVID-19,Online Course,R-T&C,Treatment and Care",https://repository.netecweb.org/files/original/c822a2931774dd4dfddc539105b4e5b1.pdf,Webinar,Develop,1,0
990,https://repository.netecweb.org/items/show/990,"Elastomeric Respirators: Strategies During Conventional and Surge Demand Situations","Infection Control","Guidance document: Conventional, Contingency, and Crisis Strategies",CDC,,,2020-04-20,"2022-01-19 by Beth Beam
2024-02-05 by J Mundy, updated URL",,,,,,,2024-01-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"
Who this guidance is for: Federal, state, and local public health officials, respiratory protection program managers, occupational health service leaders, infection prevention and control program leaders, and other leaders in healthcare settings who are responsible for developing and implementing policies and procedures for preventing pathogen transmission in healthcare settings.
Purpose: This webpage offers guidance for the use of reusable elastomeric particulate respirators to provide respiratory protection to healthcare practitioners (HCP) against pathogens as a component of a formally developed and implemented written respiratory protection program.
",,,https://www.cdc.gov/niosh/npptl/respirators/elastomeric/default.html,,,,"2019-nCoV,Coronavirus,COVID-19,Mask,Masks,N95,Personal Protective Equipment (PPE),R-PPE",,Guide,Develop,1,0
964,https://repository.netecweb.org/items/show/964,"Practice PPE Safety","Infection Control","Printable flyer infographic with Do's and Don'ts of PPE Safety.
Go to the Spanish language version.",NETEC,"Emory University, created by Visual Medical Education.",,2020-04-28,"2023-12-04 by Jill Morgan/PPE Group - recommend update - submitted asset update form",,,,,,"Infection Prevention and Control; PPE",2025-12-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Coronavirus,COVID-19,Donning and Doffing,Gloves,Gown,Mask,Masks,N95,Personal Protective Equipment (PPE),R-PPE",https://repository.netecweb.org/files/original/f227e6c708549b770225b9883e686403.pdf,Guide,Develop,1,0
942,https://repository.netecweb.org/items/show/942,"High-Consequence Infectious Disease Workshop",Pre-hospital,"This webcast aims to increase awareness about standard and transmission-based infection-control practices and teaches learners how the “Identify, Isolates and Inform” strategy can improve their ability to recognize and manage an infectious disease threats like COVID-19, MERS (Middle Eastern Respiratory Syndrome) or Ebola.
","JEMS Webcast, Alexander Isakov, Michael J. Carr, Ben Tysor, and Wade Miles",,,2020-04-07,"2022-12-07 general asset review - IPC
2023-03-31 by J Mundy - change to R-EMS for next review
2024-03-27 EMS/Pre-Hospital never reviewed – bump to next quarter",,,,,,,2024-06-10,,,,,,,,,,,,,,,,,,,,,,,"A certificate of attendance will be offered. This webcast is CAPCE certified and attendees* that watch the webcast will receive 1 hour of CE credit!",,,,,,,,,,,,,,"Attendees will become familiar with the ASPR TRACIE EMS Infectious Disease Playbook and will consider operational challenges and strategies for transport and management of patients with high-consequence infectious diseases.",,,https://event.webcasts.com/starthere.jsp?ei=1295231&tp_key=f3c48f873b,Webinar,,,"2019-nCoV,Coronavirus,COVID-19,Ebola,Emergency Management,EMS,Identify,Infection Prevention and Control,Inform,Isolate,MERS-CoV,R-EMS,R-PreH,SARS,Webinar",,Webinar,Develop,1,0
936,https://repository.netecweb.org/items/show/936,"PPE by location and task","Infection Control","PPE guide grid, organized by location and task","NYC Health + Hospitals",,,2020-04-06,"2022-02-08 by Trisch - PPE group - NYC general asset review - Archive
2022-11-16 - by Jill/Britton - on SPORSA - mark active again
2024-03-28 by J. Mundy – Skipped 2023 (Q2) - bumping to 2024 (Q4)",,"Y - PPE row 7 score 1; PPE pos 101 qualtrics 321;
Y - D0.1PPE/D0.2PPE Qualtrics # 321",,,,,2024-07-16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Coronavirus,COVID-19,Gloves,Gown,Mask,Masks,N95,Personal Protective Equipment (PPE),R-PPE",https://repository.netecweb.org/files/original/5de2a11171b93b4755253783d682b9c9.pdf,Guide,Develop,1,0
926,https://repository.netecweb.org/items/show/926,"ED - Putting ON Airborne","Infection Control","COVID-19 ED Resources: COVID-19 ACE Emergency Department CONSERVE Printable PDFs.
Putting ON PPE, Donning Only
These one-page PDF's depict the Emergency Department use of PPE for protection against COVID-19 that is currently in use at Emory University. Created by Emory's Visual Medical Education team.",Emory,,,2020-04-05,"2022-03-29 by Josia Mamora",,,,,,,2024-01-01,,,,,,,,,,"Emory VME",,,,,,,,,,,,,,,,,,,,,,,,,,,"Contact precautions with eyewear (ACE) Printable instructions ",,,https://med.emory.edu/ppe,,,,"2019-nCoV,ACE,Coronavirus,Coveralls,COVID-19,Donning,Emergency Department,Example,Face shield,Gloves,N95,One Page Flyer,R-PPE",https://repository.netecweb.org/files/original/5aa8b32c6d2ab0c72e8f5e5fff76e071.pdf,Guide,Develop,1,0
923,https://repository.netecweb.org/items/show/923,"Selecting PPE - Ambulatory PPE and Cleaning Selection Protocol","Infection Control","COVID-19 Ambulatory PPE Resources: COVID-19 Ambulatory ACE / DICE Printable PDFs.
These one-page PDF's depict Emory's use of PPE for protection against COVID-19 in the ambulatory setting. Created by Emory's Visual Medical Education team.",Emory,,,2020-08-13,"2022-03-29 by Josia Mamora",,,,,,,2024-01-01,,,,,,,,,,,"Emory VME",,,,,,,,,,,,,,,,,,,,,,,,,,"Selecting the proper PPE in an Emory ambulatory / outpatient setting.",,,https://med.emory.edu/ppe,,,,"2019-nCoV,ACE,Cleaning,Coronavirus,COVID-19,DICE,Example,Face shield,Gloves,Goggles,Gown,Mask,Masks,N95,Personal Protective Equipment (PPE),PPE Selection,R-PPE,Terminal Clean",https://repository.netecweb.org/files/original/8757ca23e986f916e4579fb686cae51a.pdf,Protocol,Develop,1,0
910,https://repository.netecweb.org/items/show/910,"Putting On PPE (ACE)","Infection Control","COVID-19 Unit Resources: COVID-19 Unit - COVID-19 ACE Printable PDFs (RE-USE GOWN).
RE-USE GOWN, SINGLE Gloves - COVID-19 Unit - COVID-19 ACE Printable PDFs.
Putting ON PPE, Extended Wear, Taking OFF PPE
This combined PDF reflects the current supply shortage in which N95 masks and face shields and gowns may be conserved and reused. Created by Emory's Visual Medical Education team.",Emory,,,2020-08-28,"2022-03-29 by Josia Mamora",,,,,,,2024-01-01,,,,,,,,,,"Emory VME",,,,,,,,,,,,,,,,,,,,,,,,,,,"Use these instructions for donning, or putting on your PPE, if you are caring for a COVID-19 positive patient next and are reusing the mask, faceshield, and gown.
Print and hang ""Inside"" page up inside the COVID-19 patient rooms near the bin where reusable gowns are going. Two options (page 2 or 4 of this pdf), based on COVID-19 status of next patient.
Post ""Outside"" outside COVID-19 patient rooms, use to doff. Two options, if your next patient is COVID-19 positive (page 3 of this pdf) and if your next patient COVID-19 status is negative or uncertain (page 5 of this pdf).
",,,https://med.emory.edu/ppe,,,,"2019-nCoV,ACE,Airborne Transmission,Coronavirus,COVID-19,Donning and Doffing,Example,Extended wear,Face shield,Gloves,Gown,N95,Personal Protective Equipment (PPE),R-PPE,Reuse",https://repository.netecweb.org/files/original/1b2587b9cf1311201d5f008a41636e87.pdf,Guide,Develop,1,0
906,https://repository.netecweb.org/items/show/906,"COVID-19 Clinical Guidance Repository","Emergency Management","The AAMC COVID-19 Clinical Guidance Repository includes content from academic medical centers (AMCs) as a resource for hospitals and clinicians across the United States. The goal is to identify, summarize, and highlight areas of alignment in clinical practice during the pandemic. Here you will find up to date COVID-19 treatment and management guidance to help clinicians optimize patient care. Clinicians can view, access, and download clinical guidance that has been collected from AMCs.
This repository is meant for clinicians (and not the general public) to access clinical and patient management information regarding COVID-19 that supplements their own independent, professional judgment, and evaluation of their institution’s unique circumstances (AAMC COVID-19 Clinical Guidance Repository Disclaimer).
","American Association of Medical Colleges (AAMC)",,,2020-05-12,"2024-03-27 Emergency Management skipped in review – bump to next quarter",,,,,,,2024-07-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.aamc.org/covid-19-clinical-guidance-repository,,,,"2019-nCoV,Clinical Care Guidelines,Coronavirus,COVID-19,R-EM",,Hyperlink,Develop,1,0
852,https://repository.netecweb.org/items/show/852,"Too Many Patients…A Framework to Guide Statewide Allocation of Scarce Mechanical Ventilation During Disasters","Treatment & Care","The threat of a catastrophic public health emergency causing life-threatening illness or injury on a massive scale has prompted extensive federal, state, and local preparedness efforts. Modeling studies suggest that an influenza pandemic similar to that of 1918 would require ICU and mechanical ventilation capacity that is significantly greater than what is available. ","Daugherty Biddison, E. Lee, Ruth Faden, Howard S. Gwon, Darren P. Mareiniss, Alan C. Regenberg, Monica Schoch-Spana, Jack Schwartz, and Eric S. Toner.",,,2019-04,"2022-09-27 - general asset review - Treatment & Care group",,,,,Publication,,2025-09-27,,,,,,,,,,"Daugherty Biddison, E. Lee, Ruth Faden, Howard S. Gwon, Darren P. Mareiniss, Alan C. Regenberg, Monica Schoch-Spana, Jack Schwartz, and Eric S. Toner. 2019. ""Too Many Patients: A Framework to Guide Statewide Allocation of Scarce Mechanical Ventilation During Disasters."" CHEST 155 (4):848-54.
","Pay online through Journal Site or subscription to CHEST","
The threat of a catastrophic public health emergency causing life-threatening illness or injury on a massive scale has prompted extensive federal, state, and local preparedness efforts. Modeling studies suggest that an influenza pandemic similar to that of 1918 would require ICU and mechanical ventilation capacity that is significantly greater than what is available. Several groups have published recommendations for allocating life-support measures during a public health emergency. Because there are multiple ethically permissible approaches to allocating scarce life-sustaining resources and because the public will bear the consequences of these decisions, knowledge of public perspectives and moral points of reference on these issues is critical. Here we describe a critical care disaster resource allocation framework developed following a statewide community engagement process in Maryland. It is intended to assist hospitals and public health agencies in their independent and coordinated response to an officially declared catastrophic health emergency in which demand for mechanical ventilators exceeds the capabilities of all surge response efforts and in which there has been an executive order to implement scarce resource allocation procedures. The framework, built on a basic scoring system with modifications for specific considerations, also creates an opportunity for the legal community to review existing laws and liability protections in light of a specific disaster response process.
Key Words:
disaster, triage, ventilator",https://journal.chestnet.org/article/S0012-3692(18)32565-0/fulltext,,,,,,,,,,,,,,,,,,,,,,,,,,,https://journal.chestnet.org/article/S0012-3692(18)32565-0/fulltext,,,,"Ethics,Pandemic,R-Res&Pub,R-T&C,Treatment and Care",,Publication,Develop,1,0
851,https://repository.netecweb.org/items/show/851,"New York State Department of Health and New York State Task Force on Life and the Law Update Ventilator Allocation Guidelines","Treatment & Care","The guidelines provide direction for the distribution of ventilators in the event of a severe pandemic, when there are insufficient ventilators to treat everyone who needs them. The guidelines balance the goal of saving the most lives with important societal values, such as protecting vulnerable populations. The guidelines are non-binding and designed with sufficient flexibility to adjust to changing clinical information.","New York State Department of Health and New York State Task Force",,,2015-11-25,"2022-09-27 - general asset review - Treatment & Care group",,,,,,,2025-09-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.health.ny.gov/press/releases/2015/2015-11-25_ventilator_allocation_guidelines.htm,,,,"Ethics,Pandemic,R-T&C,Treatment and Care","https://repository.netecweb.org/files/original/1529f3cfc83612fc39618d92eebda868.pdf,https://repository.netecweb.org/files/original/d666631ccb956f320f55b86a24a4cfdf.pdf",Guide,Develop,1,0
819,https://repository.netecweb.org/items/show/819,"Doffing (Taking OFF) ACE PPE (N95) ","Infection Control","Taking off ACE airborne PPE - doffing video with conservation of resources
Watch this video on Youtube.",Emory,"Emory VME",,2020-03-23,"2022-03-29 by Josia Mamora",,,,,,,2024-01-01,,,,,,,"
",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://med.emory.edu/departments/medicine/divisions/infectious-diseases/serious-communicable-diseases-program/covid-19-resources/conserving-ppe.html#section3,,,,"2019-nCoV,ACE,Airborne Transmission,Coronavirus,COVID-19,Donning and Doffing,Example,N95,Personal Protective Equipment (PPE),R-PPE,Respiratory Pathogen",https://repository.netecweb.org/files/original/6a03ac408a49d275146775c98facac44.png,Video,Develop,1,0
809,https://repository.netecweb.org/items/show/809,"Putting ON AND Taking OFF PPE (ACE)","Infection Control","COVID-19 Resources: Putting ON AND Taking OFF Airborne – Contact precautions with eyewear (ACE) Printable instructions
",Emory,,,2020-09-04,"2022-03-29 by Josia Mamora",,,,,,,"2024-01-01 ** Specific Review Date",,,,,,,,,,"Emory VME",,,,,,,,,,,,,,,,,,,,,,,,,,,"The following documents for use in your facility are related to COVID-19. These reflect the current supply shortage in which masks and goggles and face shields may be conserved. ",,,https://med.emory.edu/departments/medicine/divisions/infectious-diseases/serious-communicable-diseases-program/resources.html,,,,"2019-nCoV,Airborne Transmission,Coronavirus,COVID-19,Donning and Doffing,Example,Face shield,Gloves,Gown,N95,Personal Protective Equipment (PPE),R-PPE",https://repository.netecweb.org/files/original/06a7f24e65f4fdec891e2a06c8bb3ba9.pdf,Guide,Develop,1,0
808,https://repository.netecweb.org/items/show/808,"Predicting the Effects of the COVID Pandemic On US Health System Capacity","Emergency Management","Predicting the Effects of the COVID-19 Pandemic On US Health System Capacity
Qventus works with leading health systems across the country to improve operations and drive more efficient patient flow. Over recent weeks, they have been helping their partners with COVID-19 planning and preparation, including adapting the CDC Flu Surge model to COVID-19 and running it for key metropolitan areas and all states.
They’re sharing the information at the link with the hope that health systems find it informative as they plan for the impact of COVID-19. This analysis is preliminary, and they will continue to refine it as they get more information.
",Qventus,,,2020-03-13,"2024-03-27 Emergency Management skipped in review – bump to next quarter",,,,,,,2024-07-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://qventus.com/blog/predicting-the-effects-of-the-covid-pandemic-on-us-health-system-capacity/#tableau-3,,,,"2019-nCoV,Coronavirus,COVID-19,Emergency Management,Epidemic,Pandemic,R-EM",https://repository.netecweb.org/files/original/6ce5f8dfdde6a4d11f15346146283e0b.png,Hyperlink,Develop,1,0
807,https://repository.netecweb.org/items/show/807,"COVID-19 Hospital Impact Model for Epidemics","Emergency Management","This tool was developed by the Predictive Healthcare team at Penn Medicine. For questions and comments please see their contact page. Code can be found on Github. You can join their Slack channel if you would like to get involved.
Discrete-time SIR modeling of infections/recovery
The model consists of individuals who are either Susceptible, Infected, or Recovered.
The epidemic proceeds via a growth and decline process. This is the core model of infectious disease spread and has been in use in epidemiology for many years.
","Predictive Healthcare team at Penn Medicine",,,2020-03-16,"2024-03-27 Emergency Management skipped in review – bump to next quarter",,,,,,,2024-07-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://penn-chime.phl.io/,,,,"2019-nCoV,Coronavirus,COVID-19,Emergency Management,Preparedness,R-EM",https://repository.netecweb.org/files/original/781723cf3645be9f2b73a606d12a0cf1.png,Hyperlink,Develop,1,0
806,https://repository.netecweb.org/items/show/806,"CDC COCA Call: Coronavirus Disease 2019 (COVID-19) Update and Infection Prevention and Control Recommendations","Infection Control","During this COCA Call, presenters will focus on current information about COVID-19 and provide clinicians with updated information on implementing infection prevention and control measures, assessing risks for exposures, and optimizing the use of personal protective equipment supplies.",CDC,,,2020-03-13,"2022-12-07 general asset review - IPC",,,,,,,"No review ""not updated""",,,,,,,,,https://emergency.cdc.gov/coca/calls/2020/callinfo_031320.asp,,,,,,,,,,,,,,"Date: Friday, March 13, 2020
Time: 2:00 P.M. – 3:00P.M. (Eastern Time)
",,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Coronavirus,COVID-19,Infection Prevention and Control,Not updated,R-IPC",https://repository.netecweb.org/files/original/f6de03f4dbaee33e71745cbbd421e242.png,Webinar,Develop,1,0
784,https://repository.netecweb.org/items/show/784,"NETEC - Online Course - Process and Documentation of Informed Consent for Subjects Involved in Research ","Intake and Internal Transport","COURSE DESCRIPTION
This course will provide information on many aspects of informed consent and focuses on the unique challenges with special pathogen research. This includes the process of informed consent, general requirements, telephone consent, child assent, consent of vulnerable populations and the documentation of that process.
TARGET AUDIENCE
This course is intended primarily for healthcare workers and teams in a biocontainment unit environment. Additional medical staff and public health professionals may also find the course to be of benefit. Those individuals may include, but are not limited to, medical and/or nursing staff involved in conducting research, administration, education/training leadership, and infection control leadership. Staff specializing in communications, specialized clinical areas, laboratory, facilities management, and environmental services are also welcome.
LEARNING OBJECTIVES
At the conclusion of this activity, the participant should be able to:
- Recognize the standard for completing informed consent
- Demonstrate how to conduct informed consent and document it appropriately
- Recognize the regulations with special circumstances when completing informed consent
",NETEC,,,2020-03,"2023-10-17 by Darrell Ruby, T&E Group",,,,,"Online Course",,2026-10-17,,,,,,,,"Free with free account",,,,,,,,,,,,,,,self-paced,,,,,,,,,,,,,,"0.75 credits (CNE/CME)",,,https://courses.netec.org/courses/20-ol-icr,,,,"Inform,Informed Consent,R-T&E,Training",https://repository.netecweb.org/files/original/09f70d854fe67e09b03fe3306e08431f.png,"Online Course",Develop,1,0
743,https://repository.netecweb.org/items/show/743,"CDC Planning and Preparedness Resources for Pandemic Flu","Emergency Management","Although pandemics occur infrequently, planning and preparing for a pandemic is important to ensure an effective response. Planning for and responding to a pandemic is complex and pandemics can affect everyone in a community. Therefore, public health officials, health care professionals, researchers and scientists in the United States and across the world are working together to plan and prepare for possible pandemics. Many resources are available to help international, national, state and local governments, public health and health care professionals, corporations, and communities develop pandemic preparedness plans and strengthen their capabilities to respond to different pandemic scenarios.
",CDC,,,2016-11-03,"2023-09-06 by J. Mundy - link https://archive.cdc.gov/#/details?url=https://www.cdc.gov/flu/pandemic-resources/pandemic-resources.html archived - linked up one level to the CDC list of resources.
2024-03-27 Emergency Management skipped in review – bump to next quarter",,,,,,,2024-09-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Resources to help hospital administrators and state and local health officials prepare for the next influenza pandemic",,,https://www.cdc.gov/flu/pandemic-resources/planning-preparedness/index.html,,,,"Flu,Influenza,Pandemic,Preparedness,R-EM",https://repository.netecweb.org/files/original/23e32e48e668fa6eda08f2ab5d809af1.png,Guide,Develop,1,0
729,https://repository.netecweb.org/items/show/729,"CLINIC CORONAVIRUS (COVID-19) SCREENING PROTOCOL","Infection Control","General travel screening and Coronavirus (COVID-19) specific screening","University of Nebraska Medical Center / Nebraska Medicine",,,2020-02-19,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q1)",,,,,,"Infection Prevention and Control",2024-09-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Coronavirus,COVID-19,Identify,Infection Prevention and Control,Isolate,Protocol,R-IPC",https://repository.netecweb.org/files/original/3cfefe8a1d979b628e55060e15e71ebd.pdf,Protocol,Develop,1,0
728,https://repository.netecweb.org/items/show/728,"ED CORONAVIRUS (COVID-19) SCREENING PROTOCOL ","Infection Control","General travel screening and Coronavirus (COVID-19) specific screening","University of Nebraska Medical Center / Nebraska Medicine",,,2020-02-19,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q1)",,,,,,"Infection Prevention and Control",2024-09-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Coronavirus,COVID-19,Identify,Infection Prevention and Control,Isolate,Protocol,R-IPC",https://repository.netecweb.org/files/original/cd4d3edb8f4f69de0779308b69306ea7.pdf,Protocol,Develop,1,0
703,https://repository.netecweb.org/items/show/703,"Lessons from Ebola: Preventing the Next Pandemic","Emergency Management","Understanding the context for the Ebola outbreak: What went right, what went wrong, and how we can all do better. Open September 3, 2018 – September 1, 2020","Harvard University",,,2018-09-03,"2023-10-17 by Darrell Ruby, T&E Group",,,,,,,2025-10-17,,,,,,,,"Free online",,,,,,,,,,,,,,,"4 weeks/3-5 hours per week",,,,,,,,,,,,,,"
What you'll learn
- What happened during the Ebola outbreak in West Africa?
- What were the local challenges faced by patients, clinicians, and national policy makers?
- Why did the international response fail to halt Ebola and prevent its spread?
- How do we prevent the next the pandemic?
",,,https://online-learning.harvard.edu/course/lessons-ebola-preventing-next-pandemic?delta=0,,,,"Ebola,Outbreaks,Pandemic,R-T&E,Training",,"Online Course",Develop,1,0
697,https://repository.netecweb.org/items/show/697,"COVID-19 PPE Guidance","Infection Control","COVID-19:
- PPE-Flyer (pdf file, printable flyer, infographic)
- PPE Competency Validation Checklist (pdf file)
- PPE Competency Validation Checklist - Instructor Guide. (pdf instructor guide)
PPE/Glove removal: For step-by-step instructions on the beak method visit Contaminated Glove Removal instructions.
Video: See the Just in Time (JIT) Training video on Personal Protective Equipment for the 2019 Novel Coronavirus (COVID-19).",NETEC,,,2020-03-16,"2023-12-04 by Jill Morgan/PPE Group",,,,,,"Infection Prevention and Control; PPE",2025-12-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Contingency and crisis capacities,Coronavirus,COVID-19,Donning and Doffing,Gloves,Gown,Infection Prevention and Control,Mask,Masks,N95,Personal Protective Equipment (PPE),R-PPE","https://repository.netecweb.org/files/original/dca73031fbbc6c342e084bc2929732ef.pdf,https://repository.netecweb.org/files/original/69c8c15ef5ad8f675d21481bde793154.pdf,https://repository.netecweb.org/files/original/b1abd8f26ee3739f72e62718691f663b.pdf",Guide,Develop,1,0
696,https://repository.netecweb.org/items/show/696,"Unique Considerations for Home Isolation Care",General,"An example workbook from the University of Washington Harborview Medical Center on the implementation of a home assessment team for novel coronavirus.","Harborview Medical Center, UW Medicine",,,2020-02,"2024-03-28 by J. Mundy – General subject – setting first review day 2025-01-01",,,,,,,2025-01-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Coronavirus,COVID-19,R-Gen",https://repository.netecweb.org/files/original/30594a6e04cb1bc5ee925b3f0cfb7cdb.docx,Protocol,Develop,1,0
691,https://repository.netecweb.org/items/show/691,"Contaminated Glove Removal","Infection Control","Poster showing the process for removing contaminated gloves.","Emory Environmental Health and Safety Office",,,2020,"2022-03-29 by Josia Mamora",,,,,,,2024-01-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.ehso.emory.edu/documents/contaminated-glove-removal-poster.pdf,,,,"Doffing,Example,Gloves,Infection Prevention and Control,Personal Protective Equipment (PPE),R-PPE",https://repository.netecweb.org/files/original/4796a8f2f7f27772b0eec4addcf5c494.pdf,Guide,Develop,1,0
690,https://repository.netecweb.org/items/show/690,"What health care providers need to know about 2019-Novel Coronavirus (Webinar on demand)",General,"“What health care providers need to know about 2019-Novel Coronavirus” will feature Sharon Vanairsdale and Bruce Ribner from NETEC as they review how to identify and isolate – and notify the proper officials – if a patient with symptoms and epidemiological risk presents at points of entry to health care staff. ","Emergency Nurses Association, NETEC",,,2020-02-18,"2024-03-28 by J. Mundy – General subject – setting first review day 2025-01-01",,,,,"Webinar only",,2025-01-01,,,,,,,,,,,,,,,,,,,,,,,"Feb 18, 2020 01:00 PM in Central Time (US and Canada). Recording duration: 00:59:00",,,,,,,,,,,,,,"Register at the URL below to view on Demand",,,https://emergencynursesassociation.zoom.us/webinar/register/WN_bnM6AJ9tQqqzp043wfKu4w,"Emergency Nurses Association Webinar.",,,"Coronavirus,COVID-19,Identify,Isolate,Nursing,R-Gen",https://repository.netecweb.org/files/original/569a7f9e16813ebb22cca9d828ae622f.png,Webinar,Develop,1,0
689,https://repository.netecweb.org/items/show/689,"Hospital Personal Protective Equipment (PPE) Planning Tool / Calculator","Infection Control","Purpose: The Hospital Personal Protective Equipment (PPE) Planning Tool is designed to help hospitals determine approximate minimum PPE needs based on special pathogen category and a number of facility specific variables. Calculators are included for Ebola Virus Disease/Viral Hemorrhagic Fever (EVD/VHF) as well as special respiratory pathogens such as Middle East Respiratory Syndrome/Severe Acute Respiratory Syndrome (MERS/SARS), and for pandemic influenza. The tool does not provide information for less virulent pathogens. It is not intended as a clinical tool and should be used as a pre-incident planning tool and NOT during an outbreak.
You can find it in Plans, Tools, and Templates.","ASPR TRACIE",,,2018,"2022-01-19 by Beth Beam",,,,,,,2025-01-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://files.asprtracie.hhs.gov/documents/aspr-tracie-hospital-ppe-planning-tool.pdf,,,,"Coronavirus,Ebola,Infection Prevention and Control,MERS-CoV,Personal Protective Equipment (PPE),R-PPE,SARS,Special Pathogens,Viral Hemorrhagic Fever","https://repository.netecweb.org/files/original/4da5a2de22ddb0c1a3cf41c61334f68a.pdf,https://repository.netecweb.org/files/original/2e6c13dc7b070e14c2f88c696b83a419.xlsx",Hyperlink,Develop,1,0
667,https://repository.netecweb.org/items/show/667,"How to Properly Put on and Take off a Disposable Respirator","Infection Control","WASH YOUR HANDS THOROUGHLY BEFORE PUTTING ON AND TAKING OFF THE RESPIRATOR.
- If you have used a respirator before that fit you, use the same make, model and size.
- Inspect the respirator for damage.
- If your respirator appears damaged, DO NOT USE IT. Replace it with a new one.
- Do not allow facial hair, hair, jewelry, glasses, clothing, or anything else to prevent proper placement or come between your face and the respirator.
- Follow the instructions that come with your respirator.
NOTE: If you cannot achieve a proper seal due to air leakage, and you need to try a different size or model - you will need to restart the process and go through fit testing again!
",CDC,,,2010,"2022-01-19 by Beth Beam",,,,,,,2025-01-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Directions on how to properly put on and take off a disposable respirator (mask/masks).",,,https://www.cdc.gov/niosh/docs/2010-133/pdfs/2010-133.pdf,,,,"Airborne Transmission,Coronavirus,Donning,Donning and Doffing,N95,Personal Protective Equipment (PPE),R-PPE",https://repository.netecweb.org/files/original/5d1ec343f3bc2b035a3aef8af33f773d.pdf,Guide,Develop,1,0
665,https://repository.netecweb.org/items/show/665,"Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19)",Laboratory,"Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Patients Under Investigation (PUIs) for 2019 Novel Coronavirus (2019-nCoV)",CDC,,,2021-10-25,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q1)",,,,,,"Infection Prevention and Control",2024-09-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html,,,,"Coronavirus,COVID-19,Infection Prevention and Control,Lab,Laboratory,Person Under Investigation (PUI),R-IPC,R-Lab",https://repository.netecweb.org/files/original/dcd1d4b5cbe67483ec52ce1df90b9add.png,Hyperlink,Develop,1,0
663,https://repository.netecweb.org/items/show/663,"Criteria to Guide Evaluation of Patients Under Investigation (PUI) for 2019-nCoV","Infection Control","Interim Guidance for Healthcare Professionals
Limited information is available to characterize the spectrum of clinical illness associated with 2019-nCoV. No vaccine or specific treatment for 2019-nCoV infection is available; care is supportive.
The CDC clinical criteria for a 2019-nCoV patient under investigation (PUI) have been developed based on what is known about MERS-CoV and SARS-CoV and are subject to change as additional information becomes available.
Health care providers should obtain a detailed travel history for patients being evaluated with fever and acute respiratory illness. CDC guidance for evaluating and reporting a PUI for MERS-CoV remains unchanged.",CDC,,,2020-02-27,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q1)",,,,,,"Infection Prevention and Control",2024-09-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://stacks.cdc.gov/view/cdc/85453,,,,"Coronavirus,COVID-19,Infection Prevention and Control,Person Under Investigation (PUI),R-IPC",https://repository.netecweb.org/files/original/38bce9fbae01d5b3f2fef1c6ceb3c97a.png,Hyperlink,Develop,1,0
654,https://repository.netecweb.org/items/show/654,"Bio Isolation Transfer Card (BIT) - Kings County Hospital Example","Intake and Internal Transport","FDNY Transport to Hospital, Receiving Hospital Transfer to Treatment Hospital","Kings County Hospital",,,2019,"2024-03-27 IIT - haven't gotten back first review - bump to next quarter",,,,,,,2024-06-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Emergency Management,EMS,Ground Transport,Isolate,Isolation/Biocontainment,Patient Transport,R-IIT",https://repository.netecweb.org/files/original/ae752dc3510f6b0804fe746a752a6f58.pdf,Checklist,Develop,1,0
653,https://repository.netecweb.org/items/show/653,"Bio Isolation Transfer Card (BIT) - Bellevue Hospital Center Example","Intake and Internal Transport","FDNY Transport to Hospital, Receiving Hospital to Treatment Hospital Transfer","Bellevue Hospital Center",,,2019,"2024-03-27 IIT - haven't gotten back first review - bump to next quarter",,,,,,,2024-06-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Emergency Management,EMS,Ground Transport,Isolate,Isolation/Biocontainment,Patient Transport,R-IIT",https://repository.netecweb.org/files/original/9fe0ad684a7659261236f10986e3b594.pdf,Checklist,Develop,1,0
652,https://repository.netecweb.org/items/show/652,"EMS Transport from Ambulatory Site Checklist","Intake and Internal Transport","Ambulatory Site Requirements, EMS Requirements (FDNY), FDNY Contacts","NYC Health + Hospitals",,,2019,"2024-03-27 IIT - haven't gotten back first review - bump to next quarter",,,,,,,2024-06-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Emergency Management,EMS,Ground Transport,Patient Transport,R-IIT",https://repository.netecweb.org/files/original/84be369c4175ce0ae783f43cc2dc7e9c.pdf,Checklist,Develop,1,0
647,https://repository.netecweb.org/items/show/647,"Bio Isolation Transfer Card (BIT) - Emory Example","Intake and Internal Transport","Emory University Hospital (EUH), Serious Communicable Diseases Unit (SCDU), Bio Isolation Transfer Card (BIT),
EMS Transport to EUH SCDU",Emory,,,2019-10-31,"2024-03-27 IIT - haven't gotten back first review - bump to next quarter",,,,,,,2024-06-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Biosafety,EMS,Internal Transport,Isolate,Isolation/Biocontainment,R-IIT,Waste Management",https://repository.netecweb.org/files/original/170c4d4d05c237ba94d558344510d9ce.pdf,Checklist,Develop,1,0
646,https://repository.netecweb.org/items/show/646,"CDC COCA Call: Update on Ebola Diagnostics at the State and Federal Levels in the United States",Laboratory,"
Overview
Due to the ongoing Ebola virus disease (Ebola) outbreak in the Democratic Republic of the Congo, subject matter experts from the Centers for Disease Control and Prevention (CDC) will discuss the current status of Ebola diagnostic testing that is available through the Laboratory Response Network (LRN) and CDC in the United States. The presenters will also discuss considerations around using OraQuick® Ebola Rapid Antigen Test (RDT), the first Ebola RDT that FDA has allowed for marketing in the United States.
During this COCA Call, clinicians will learn about options for testing for suspected Ebola virus infection in coordination with state and local public health authorities and CDC, as well as the benefits and limitations of existing diagnostic tools.
",CDC,,,2019-12-19,"2023-12-18 by Lab (Vicki and Kim), 1 yr / Example",,,,,,,2024-12-18,,,,,,,,,"
A few minutes before the webinar begins on Thursday, December 19, 2019, please click the link below to join the webinar:
https://zoom.us/j/804256797external icon
Or iPhone one-tap:
US: +16468769923,,779319056# or +16699006833,,779319056#
Or Telephone:
Dial(for higher quality, dial a number based on your current location):
US: +1 646 876 9923 or +1 669 900 6833
Webinar ID: 804 256 797
International numbers available: https://zoom.us/u/anixAVglVexternal icon
",,,,,,,,,,,,,,"1 hr: Time: 2:00pm-3:00pm (Eastern Time)",,,,,,,,,,,,,,"
At the conclusion of the session, the participant will be able to accomplish the following:
- Cite background information on the topic covered during the presentation.
- Discuss CDC’s role in the topic covered during the presentation.
- Describe the topic’s implications for clinicians.
- Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
- Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of health care providers.
Activity Specific Objectives
- Discuss procedures for assessing ill travelers returning from the outbreak area, including consultation with relevant public health authorities.
- Describe CDC’s role in providing technical support and testing approval for persons under investigation (PUI) for Ebola virus infection.
- Review the procedure for reporting and consulting on a suspected case of Ebola in the United States.
- Discuss considerations and limitations for domestic use of novel rapid diagnostic tests for Ebola.
- Discuss how to coordinate between clinicians, state health departments, and CDC as it pertains to domestic Ebola preparedness and diagnostics.
",,,https://emergency.cdc.gov/coca/calls/2019/callinfo_121919.asp,"COCA Call",,,"Diagnosis,Example,Lab,Laboratory,Laboratory Testing,R-Lab",https://repository.netecweb.org/files/original/34b2c2d397c48f8751c0aaea3f03a7e9.png,Webinar,Develop,1,0
645,https://repository.netecweb.org/items/show/645,"Collection Checklist: Partner Method",Laboratory,"Collection & Transport of Specimens Suspected To Contain Special Pathogens",NETEC,,,2019-11-08,"2023-10-03 from Trisch - this badly needs updating - is going on the list
2023-12-18 by Lab (Vicki and Kim), 1 yr ",,"Y - D0.1Lab/D0.2Lab Qualtrics # 1018, original # 9
Y - D0.1Lab/D0.2Lab Qualtrics # 1019, original # 10",,,,,2024-01-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Frontline Facilities Tools,Lab,Laboratory,R-Lab,Specimen Collection,Specimen Handling,Specimen Transport",https://repository.netecweb.org/files/original/9a42c07cccf849a374b33a5ad7645d9b.pdf,Checklist,Develop,1,0
643,https://repository.netecweb.org/items/show/643,"Special Pathogen L2 Donning and Doffing Checklist","Infection Control","Level 2 Donning and Doffing Checklists. The word doc can be downloaded and edited as a template.","NYC Health + Hospitals",,,2019-07-28,"2022-02-08 by PPE group NYCHH (EB)",,"Y - PPE pos 102 qualtrics 322; PPE pos 103 qualtrics 323; PPE pos 104 qualtrics 324; PPE pos 105 qualtrics 325
Y - D0.1PPE/D0.2PPE Qualtrics # 322
Y - D0.1PPE/D0.2PPE Qualtrics # 323
Y - D0.1PPE/D0.2PPE Qualtrics # 324
Y - D0.1PPE/D0.2PPE Qualtrics # 325",,,,,2025-02-08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Checklist,Donning and Doffing,Example,Frontline Facilities Tools,Isolate,Level 2 PPE,Patient Care,Personal Protective Equipment (PPE),R-PPE,Trained Observer",https://repository.netecweb.org/files/original/27ae3d08823bebbc0d36598e3073516e.docx,Checklist,Develop,1,0
642,https://repository.netecweb.org/items/show/642,"Healthcare Facility Preparedness Checklist","Intake and Internal Transport","All U.S. healthcare facilities need to be prepared for new and emerging infectious disease threats such as Middle East Respiratory Syndrome Coronavirus (MERS-CoV). All hospitals should be equipped and ready to
- care for a limited number of infected patients as part of routine operations
- potentially care for a larger number of patients in the context of escalating transmission
- outline plans for administrative, environmental, and communication measures
- define the individual work practices that will be required to detect the introduction of MERS-CoV or other emerging infectious diseases
- prevent spread of MERS-CoV
- manage the impact on patients, the facility, and staff
The following checklist highlights some key areas for healthcare facilities to review in preparation for MERS-CoV. The checklist format is not intended to set forth mandatory requirements or establish national standards.
",CDC,,,2019-08-02,"2024-03-27 IIT - haven't gotten back first review - bump to next quarter",,,,,,,2024-06-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/coronavirus/mers/preparedness/checklist-facility-preparedness.html,,,,"Frontline Facility,Intake,MERS-CoV,Preparedness,R-IIT,R-Lead",https://repository.netecweb.org/files/original/54fa7d645eb1ca679a344d144caa376e.pdf,Checklist,Develop,1,0
641,https://repository.netecweb.org/items/show/641,"Healthcare Provider Preparedness Checklist for MERS-CoV","Intake and Internal Transport","Front-line healthcare providers in the United States should be prepared to evaluate patients for new and emerging infectious diseases such as Middle East Respiratory Syndrome Coronavirus (MERS-CoV). The following checklist highlights key steps for healthcare providers to take in preparation for transport and arrival of patients potentially infected with MERS-CoV.",CDC,,,2019-08-02,"2024-03-27 IIT - haven't gotten back first review - bump to next quarter",,"Y - D0.1IIT/D0.2IIT - Qualtrics # 714",,,,,2024-06-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/coronavirus/mers/preparedness/checklist-provider-preparedness.html,,,,"Checklist,Frontline Facility,Intake,MERS-CoV,R-IIT,R-Lead",https://repository.netecweb.org/files/original/502d76aaae559c53c9715f3fa560616f.pdf,Checklist,Develop,1,0
640,https://repository.netecweb.org/items/show/640,"APHL Biosafety Checklist",Laboratory,"APHL A Biosafety Checklist: Developing A Culture of Biosafety","Association of Public Health Laboratories (APHL)",,,2015-04,"2023-12-18 by Lab (Vicki and Kim), 1 yr / Example",,,,,,,2024-12-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.aphl.org/AboutAPHL/publications/Documents/ID_BiosafetyChecklist_42015.pdf,,,,"Checklist,Ebola,Example,Lab,Laboratory,R-Lab",https://repository.netecweb.org/files/original/c99fae4067ff336c0a98aee7b2ac380f.png,Checklist,Develop,1,0
638,https://repository.netecweb.org/items/show/638,"APHL Laboratory Risk Assessment Best Practices Templates",Laboratory,"APHL Laboratory Risk Assessment Best Practices Templates","Association of Public Health Laboratories (APHL)",,,2016-05-05,"2023-12-18 by Lab (Vicki and Kim), 1 year / Example, This is from 2016 and contacts may be out of date but overall info is good.",,"Y - D0.1Lab/D0.2Lab Qualtrics # 1014, original # 5
Y - D0.1Lab/D0.2Lab Qualtrics # 1015, original # 5a",,,,,2024-12-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.aphl.org/programs/preparedness/Documents/APHL%20Risk%20Assessment%20Best%20Practices%20and%20Examples.pdf,,,,"Example,Lab,Laboratory,R-Lab,Templates",https://repository.netecweb.org/files/original/c8c4f41d62fcfbf605355ed564b5f874.png,Guide,Develop,1,0
635,https://repository.netecweb.org/items/show/635,"Are you preparing suspected Ebola contaminated waste for transportation?","Waste Management","Ebola Contaminated Waste for Transportation Poster","United States Department of Transportation (DOT): Pipeline and Hazardous Materials Safety Administration (PHMSA)",,,2022-10-13,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q1)",,,,,,"Infection Prevention and Control",2024-09-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.phmsa.dot.gov/transporting-infectious-substances/ebola-contaminated-waste-transportation-poster,,,,"Category A,Ebola,Infection Prevention and Control,R-IPC,Waste,Waste Management",https://repository.netecweb.org/files/original/29a6370a36005cd3f6f5fea1f7197316.pdf,Guide,Develop,1,0
631,https://repository.netecweb.org/items/show/631,"1910.134 App B-1 - User Seal Check Procedures (Mandatory).","Infection Control","Available in spanish (Español) on the linked page.
User Seal Check Procedures (Mandatory)
- Part Number: 1910
- Part Number Title: Occupational Safety and Health Standards
- Subpart: 1910 Subpart I
- Subpart Title: Personal Protective Equipment
- Standard Number: 1910.134 App B-1
- Title: User Seal Check Procedures (Mandatory).
- GPO Source: e-CFR
","Occupational Safety and Health Administration (OSHA)",,,1998-01-08,"2022-01-19 by Beth Beam",,,,,,,2025-01-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.134AppB1,,,,"Donning,N95,Occupational Health,Personal Protective Equipment (PPE),R-PM,R-PPE",https://repository.netecweb.org/files/original/50b56f827f2b42e04c0cafcd50f687b9.png,Hyperlink,Develop,1,0
629,https://repository.netecweb.org/items/show/629,"PPE Training Videos","Infection Control","Guidance for Donning and Doffing Personal Protective Equipment (PPE) During Management of Patients with Ebola Virus Disease in U.S. Hospitals - Step by Step Videos",CDC,,,2019-07-25,"2023-12-04 by Jill Morgan/PPE Group",,,,,,,2026-12-04,,,,,,,,"Free online",,,,,,,,,,,,,,,"Training videos for each step of the donning and doffing process:
",,,,,,,,,,,,,,"
Guidance on Personal Protective Equipment
The following informational materials demonstrate the procedures described in CDC guidance for donning and doffing (i.e., putting on and removing) personal protective equipment (PPE) for all healthcare providers entering the room of a patient hospitalized with known or suspected Ebola virus disease (Ebola). These informational materials are intended to promote patient safety and increase the safety of the healthcare provider.
Prior to working with Ebola patients, all healthcare providers involved in the care of Ebola patients must receive training and demonstrate competency in performing all Ebola-related infection control practices and procedures, specifically in donning and doffing proper PPE.
",,,https://www.cdc.gov/vhf/ebola/hcp/ppe-training/index.html,,,,"CDC,Donning and Doffing,Ebola,Example,Gloves,Gown,Infection Prevention and Control,Mask,Masks,N95,Powered Air Purifying Respirator (PAPR),R-PPE",https://repository.netecweb.org/files/original/100dd3e01959ec4b0c5aeeaf759fcc0c.png,"Online Course",Develop,1,0
628,https://repository.netecweb.org/items/show/628,"Doffing PPE: Your PPE Video PAPR and Coverall","Infection Control","Guidance for Donning and Doffing Personal Protective Equipment (PPE) During Management of Patients with Ebola Virus Disease in U.S. Hospitals",CDC,,,2014-10-30,"2023-12-04 by Jill Morgan/PPE Group",,,,,,,2026-12-04,,,,,,,"
",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/vhf/ebola/hcp/ppe-training/videos/DOFF_PAPR_COVER-01.MP4,,,,"Donning and Doffing,Ebola,Example,Personal Protective Equipment (PPE),Powered Air Purifying Respirator (PAPR),R-PPE",https://repository.netecweb.org/files/original/0b8d0ac6ab822a26d1841c5a492ee478.png,Video,Develop,1,0
627,https://repository.netecweb.org/items/show/627,"Doffing PPE: Doff Your PPE Video PAPR and Gown","Infection Control","Guidance for Donning and Doffing Personal Protective Equipment (PPE) During Management of Patients with Ebola Virus Disease in U.S. Hospitals",CDC,,,2014-10-30,"2023-12-04 by Jill Morgan/PPE Group",,,,,,,2026-12-04,,,,,,,"
",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/vhf/ebola/hcp/ppe-training/videos/DOFF_PAPR_GOWN-01.MP4,,,,"Donning and Doffing,Ebola,Example,Gown,Personal Protective Equipment (PPE),Powered Air Purifying Respirator (PAPR),R-PPE",https://repository.netecweb.org/files/original/8f54476985640be03a3a32161d8c120c.png,Video,Develop,1,0
626,https://repository.netecweb.org/items/show/626,"Doffing PPE: Doff your PPE Video Respirator and Coverall","Infection Control","Guidance for Donning and Doffing Personal Protective Equipment (PPE) During Management of Patients with Ebola Virus Disease in U.S. Hospitals",CDC,,,2014-10-30,"2023-12-04 by Jill Morgan/PPE Group",,,,,,,2026-12-04,,,,,,,"
",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/vhf/ebola/hcp/ppe-training/videos/DOFF_N95_COVER-01.MP4,,,,"Donning and Doffing,Ebola,Example,Mask,Masks,N95,Personal Protective Equipment (PPE),R-PPE",https://repository.netecweb.org/files/original/c1fbc99a57071adbbe803b4980e1164d.png,Video,Develop,1,0
625,https://repository.netecweb.org/items/show/625,"Doffing PPE: Doff Your PPE Video Respirator and Gown","Infection Control","Guidance for Donning and Doffing Personal Protective Equipment (PPE) During Management of Patients with Ebola Virus Disease in U.S. Hospitals",CDC,,,2014-10-30,"2022-01-19 by Beth Beam",,,,,,,2025-01-19,,,,,,,"
",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/vhf/ebola/hcp/ppe-training/videos/DOFF_N95_GOWN-01.MP4,,,,"Donning and Doffing,Ebola,Gown,Mask,Masks,N95,Personal Protective Equipment (PPE),R-PPE",https://repository.netecweb.org/files/original/e1ce33606b3f6ae4f8de9e81124f9821.png,Video,Develop,1,0
624,https://repository.netecweb.org/items/show/624,"Trained Observer for All PPE","Infection Control","This training module discusses the roles and responsibilities of Trained Donning and Doffing Observers (called Trained Observers or TO). in Guidance for Donning and Doffing Personal Protective Equipment (PPE) During Management of Patients with Ebola Virus Disease in U.S. Hospitals",CDC,,,2019-07-25,"2022-01-19 by Beth Beam",,,,,,,2025-01-19,,,,,,,,"Free online on CDC website.",https://www.cdc.gov/vhf/ebola/hcp/ppe-training/index.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,"When you work with a health care provider and doffing assistant you will not physically assist at all. You are there to monitor, protect, and guide health care providers through the protocols of donning and doffing PPE. Remember, an effective Trained Observer:
- is vigilant in spotting defects in equipment;
- is proactive in identifying upcoming risks;
- follows the provided checklist, but focuses on the big picture;
- is informative, supportive and well-paced in issuing instructions or advice;
- always practices hand hygiene immediately after providing assistance.
",,,https://www.cdc.gov/vhf/ebola/hcp/ppe-training/trained-observer/observer_01.html,,,,"Donning and Doffing,Ebola,Occupational Health,Personal Protective Equipment (PPE),R-PM,R-PPE,Trained Observer",https://repository.netecweb.org/files/original/ca6874a3f6a906e6128f5ba5b2e940d6.png,"Online Course",Develop,1,0
623,https://repository.netecweb.org/items/show/623,"Donning PPE: Introduction Video Respirator and Coverall","Infection Control","Guidance for Donning and Doffing Personal Protective Equipment (PPE) During Management of Patients with Ebola Virus Disease in U.S. Hospitals",CDC,,,2014-10-30,"2023-12-04 by Jill Morgan/PPE Group",,,,,,,2026-12-04,,,,,,,"
",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/vhf/ebola/hcp/ppe-training/videos/DON_N95_COVER-00.MP4,,,,"Donning and Doffing,Ebola,Example,Mask,Masks,N95,Personal Protective Equipment (PPE),R-PPE",https://repository.netecweb.org/files/original/941563737f44bea1ac6b141b22402ef7.png,Video,Develop,1,0
622,https://repository.netecweb.org/items/show/622,"Donning PPE: Introduction Video PAPR Coverall","Infection Control","Guidance for Donning and Doffing Personal Protective Equipment (PPE) During Management of Patients with Ebola Virus Disease in U.S. Hospitals",CDC,,,2014-10-30,"2023-12-04 by Jill Morgan/PPE Group",,,,,,,2026-12-04,,,,,,,"
",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/vhf/ebola/hcp/ppe-training/videos/DON_PAPR_COVER-00.MP4,,,,"Donning and Doffing,Ebola,Example,Personal Protective Equipment (PPE),Powered Air Purifying Respirator (PAPR),R-PPE",https://repository.netecweb.org/files/original/fc0692d2bd2d0157e5a16b779c7519f3.png,Video,Develop,1,0
621,https://repository.netecweb.org/items/show/621,"Donning PPE: Introduction Video PAPR and Gown","Infection Control","Guidance for Donning and Doffing Personal Protective Equipment (PPE) During Management of Patients with Ebola Virus Disease in U.S. Hospitals",CDC,,,2014-10-30,"2023-12-04 by Jill Morgan/PPE Group",,,,,,,2026-12-04,,,,,,,"
",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/vhf/ebola/hcp/ppe-training/videos/DON_PAPR_GOWN-00.MP4,,,,"Donning and Doffing,Ebola,Example,Gown,Personal Protective Equipment (PPE),Powered Air Purifying Respirator (PAPR),R-PPE",https://repository.netecweb.org/files/original/7c0d72e5fc9e1b99213fd30bd10ce2fc.png,Video,Develop,1,0
620,https://repository.netecweb.org/items/show/620,"Donning PPE: Introduction Video Respirator and Gown","Infection Control","Guidance for Donning and Doffing Personal Protective Equipment (PPE) During Management of Patients with Ebola Virus Disease in U.S. Hospitals",CDC,,,2014-10-30,"2022-01-19 by Beth Beam",,,,,,,2025-01-19,,,,,,,"
",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/vhf/ebola/hcp/ppe-training/videos/DON_N95_GOWN-00.MP4,,,,"Donning,Ebola,Gown,N95,Personal Protective Equipment (PPE),R-PPE",https://repository.netecweb.org/files/original/fd23bedd1baf8e9dbd81bce84d009a98.png,Video,Develop,1,0
612,https://repository.netecweb.org/items/show/612,"NYC Health + Hospitals Special Pathogens Response Matrix","Emergency Management","Matrix with response to different special pathogens. ","NYC Health + Hospitals",,,2023-12-15,"2023-12-15 by Darrell Ruby and Amy Mead/EM WG - recommended update MPox section. Syra Madad submitted updated version.",,"Y - D0.1EM/D0.2EM - Qualtrics # 505",,,,,2025-12-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Coronavirus,Crimean Congo Haemorrhagic Fever (CCHF),Ebola,Flu,Influenza,Lassa,Marburg,MERS-CoV,Mpox,Plague,Protocol,R-EM,SARS,Special Pathogens,Viral Hemorrhagic Fever",https://repository.netecweb.org/files/original/2d96838a144eb3974e7dc8ea2e26ec3a.pdf,Guide,Develop,1,0
611,https://repository.netecweb.org/items/show/611,"Preparing for Transfer – Sending Facility","Intake and Internal Transport","Questions to prepare for transfer.",NETEC,,,2019,"2024-03-27 IIT - haven't gotten back first review - bump to next quarter",,,,,,,2024-06-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Exercises and Drills,Frontline Facilities Tools,Internal Transport,R-IIT,R-Lead",https://repository.netecweb.org/files/original/a9ee64403adcd4a8dbf3eec526256e3f.docx,Checklist,Develop,1,0
610,https://repository.netecweb.org/items/show/610,"Patient Movement Checklist","Intake and Internal Transport","The Movement Team is the group of personnel responsible for moving the PUI from the hospital bed to the transport vehicle. The team typically consists of at least two EMS paramedics and two hospital clinicians; however, factors such as patient size, clinical acuity, and need for ongoing clinical interventions (e.g., manual ventilation) may require additional staffing. The Movement Team Leader will be the EMS officer/paramedic supervisor. The Movement Team Leader will confer with the clinical staff and develop a plan for the move, including (but not limited to) patient management needs and interventions required en route;movement device;adjunctive equipment needed (e.g., patient lift; slider board; linen);egress route/movement path;destination and arrival plan/coordination;and accompanying staff, equipment, and documentation. The Movement Team Leader will also be responsible for the directing the actual lifting, packaging, and moving activities to minimize contamination risk and avoid risks or injuries to the patient or staff.","NYC Health + Hospitals",,,2019,"2024-03-27 IIT - haven't gotten back first review - bump to next quarter",,,,,,,2024-06-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"EMS,Frontline Facilities Tools,Internal Transport,Person Under Investigation (PUI),R-IIT",https://repository.netecweb.org/files/original/3715945ca697316064b75afadc451fde.docx,Checklist,Develop,1,0
609,https://repository.netecweb.org/items/show/609,Laboratory,Laboratory,"All states are strongly encouraged to consider identifying Ebola assessment hospitals; however, in geographic areas where state and local public health authorities have elected not to identify or designate Ebola assessment hospitals, all hospitals should plan, in coordination with state and local authorities, for adequate staff training and PPE supplies if a PUI has to be managed. In this instance, frontline healthcare facilities should have plans in place to safely collect, package, and transport laboratory specimens for PUIs, if needed. If frontline healthcare facilities cannot immediately transfer the patient to another facility, they should also have plans in place to ensure that routine laboratory tests needed to determine alternative diagnoses are performed while the patient is evaluated for EVD.",NETEC,,,2019,"2023-12-18 by Lab (Vicki and Kim), 1 yr",,,,,,,2024-12-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Assessment Facility,Frontline Facilities Tools,Frontline Facility,Lab,Laboratory,Laboratory Testing,Person Under Investigation (PUI),Personal Protective Equipment (PPE),R-Lab,R-PPE","https://repository.netecweb.org/files/original/464349b58ac0059a95dcb2d2e33c634a.pdf,https://repository.netecweb.org/files/original/43761f094e5d1363affdad530148f0ed.docx",Checklist,Develop,1,0
608,https://repository.netecweb.org/items/show/608,"Frontline Facility Preparedness Questions: Transport and Testing","Intake and Internal Transport","These questions should serve as a guide for examining your plans and processes and applying what you learn in the Biopreparedness: Identify, Isolate, Inform Course to your own facility.",NETEC,,,2019-11-03,"2023-12-18 by Lab (Vicki and Kim), 1 yr. This should be reviewed to see if protocols have changed.",,"Y - D0.1Lab/D0.2Lab Qualtrics # 1011, original # 3c",,,,,2024-12-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Transportation and Testing worksheet",,,,,,,"Frontline Facilities Tools,Internal Transport,Laboratory Testing,R-Lab",https://repository.netecweb.org/files/original/44dfbf6191fadf1137bfb196714a2bf3.pdf,Exercise,Develop,1,0
607,https://repository.netecweb.org/items/show/607,"Frontline Facility Preparedness Questions: Treatment and Care","Treatment & Care","These questions should serve as a guide for examining your plans and processes and applying what you learn in the Biopreparedness: Identify, Isolate, Inform Course to your own facility.",NETEC,,,2019-11-15,"2022-09-27 - general asset review - Treatment & Care group",,"Y - D0.1Tx/D0.2Tx Qualtrics # 806, original # 2
Y - D0.1Tx/D0.2Tx Qualtrics # 808, original # 2b
Y - D0.1Tx/D0.2Tx Qualtrics # 809, original # 3
Y - D0.1Tx/D0.2Tx Qualtrics # 811, original # 3b
Y - D0.1Tx/D0.2Tx Qualtrics # 812, original # 4
Y - D0.1Tx/D0.2Tx Qualtrics # 813, original # 5
Y - D0.1Tx/D0.2Tx Qualtrics # 816, original # 8
Y - D0.1Tx/D0.2Tx Qualtrics # 817, original # 9
Y - D0.1Tx/D0.2Tx Qualtrics # 818, original # 10
Y - D0.1Tx/D0.2Tx Qualtrics # 821, Additional Resource",,,,,2025-09-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Treatment and Care worksheet",,,,,,,"Frontline Facilities Tools,R-T&C,Treatment and Care",https://repository.netecweb.org/files/original/71028eadfb30cd38c0ba31e01a5fa28a.pdf,Exercise,Develop,1,0
606,https://repository.netecweb.org/items/show/606,"Frontline Facility Preparedness Questions: Inform","Treatment & Care","These questions should serve as a guide for examining your plans and processes and applying what you learn in the Biopreparedness: Identify, Isolate, Inform Course to your own facility.",NETEC,,,2019-10-18,"2022-09-27 - general asset review - Treatment & Care group",,"Y - D0.1Tx/D0.2Tx Qualtrics # 806, original # 2",,,,,2025-09-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Inform worksheet",,,,,,,"Communications,Frontline Facilities Tools,Inform,R-T&C",https://repository.netecweb.org/files/original/a537618495fdb8be570540cb604ca035.pdf,Exercise,Develop,1,0
605,https://repository.netecweb.org/items/show/605,"Frontline Facility Preparedness Questions: Isolate","Infection Control","These questions should serve as a guide for examining your plans and processes and applying what you learn in the Biopreparedness: Identify, Isolate, Inform Course to your own facility. ",NETEC,,,2019-10-18,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q1)",,Y,,,,"Infection Prevention and Control",2024-09-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Isolation worksheet",,,,,,,"Exercises and Drills,Frontline Facilities Tools,Isolate,R-IPC",https://repository.netecweb.org/files/original/77003e56292b75db4d90bccdea9120ca.pdf,Exercise,Develop,1,0
604,https://repository.netecweb.org/items/show/604,"Frontline Facility Preparedness Questions: Identify","Intake and Internal Transport","These questions should serve as a guide for examining your plans and processes and applying what you learn in the Biopreparedness: Identify, Isolate, Inform Course to your own facility.",NETEC,,,2019-10-18,"2024-03-27 IIT - haven't gotten back first review - bump to next quarter",,,,,,,2024-06-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Identify worksheet",,,,,,,"Exercises and Drills,Frontline Facilities Tools,Identify,R-IIT,R-Lead","https://repository.netecweb.org/files/original/c1c81476c9626fd1d8f8be5fa75f9ad3.pdf,https://repository.netecweb.org/files/original/9136c8837485e81ed26ffe581eb9a2f0.png",Exercise,Develop,1,0
603,https://repository.netecweb.org/items/show/603,"Lab Chain of Custody Form",Laboratory,"Chain of Custody Form",NETEC,,,2019,"2022-12-07 general asset review - IPC (change to R-Lab)
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q1)",,,,,,Laboratory,2024-09-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Frontline Facilities Tools,Infection Prevention and Control,Lab,Laboratory,R-Lab","https://repository.netecweb.org/files/original/2525e1922862992c6385d947a9a6177f.pdf,https://repository.netecweb.org/files/original/381cfa7272385b03df05a1eb66706386.doc",Protocol,Develop,1,0
602,https://repository.netecweb.org/items/show/602,"Lab Scenarios","Training and Exercises","Laboratory Scenarios for mitigating risk in Frontline Facilities",NETEC,,,2019,"2023-10-17 by Darrell Ruby, T&E group
2023-12-18 by Lab (Vicki and Kim), This should be updated or archived.",,,,,,,2024-12-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Frontline Facilities Tools,Lab,Laboratorian,Laboratory,Occupational Exposure,Occupational Health,Personnel Management,R-Lab,Staffing",https://repository.netecweb.org/files/original/72d8ee2c937f3b01e936ec44f1218982.docx,Exercise,Develop,1,0
601,https://repository.netecweb.org/items/show/601,"Person Under Investigation: Job Action Sheets","Treatment & Care","The Job Action Sheets are to be used as an example of the different roles and responsibilities. Please adapt and edit these to meet the needs of your department.","Emory Medicine, University of Nebraska Medical Center / Nebraska Medicine, NYC Health + Hospitals, Funded by ASPR and CDC ",,,2019-09-19,"2022-09-27 - general asset review - Treatment & Care group",,"Y - D0.1Tx/D0.2Tx Qualtrics # 806, original # 2
Y - D0.1PM/D0.2PM Qualtrics # 904, original # 3
Y - D0.1PM/D0.2PM Qualtrics # 905, original # 4",,,,,2025-09-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Example,Frontline Facilities Tools,Occupational Health,Personnel Management,R-PM,R-T&C,Staff Rotations,Staffing","https://repository.netecweb.org/files/original/6eb58f6089556df0997d19368648b7fc.pdf,https://repository.netecweb.org/files/original/20f3c4cd7eeae30ccc4c277d55d12909.docx",Guide,Develop,1,0
600,https://repository.netecweb.org/items/show/600,"Daily Schedule with 12-hour Shifts","Treatment & Care","Daily Schedule with 12-hour Shifts Example: ***Please adapt for patient and staffing needs***","Emory Medicine, University of Nebraska Medical Center / Nebraska Medicine, NYC Health + Hospitals, Funded by ASPR and CDC ",,,2019,"2022-09-27 - general asset review - Treatment & Care group",,"Y - D0.1PM/D0.2PM Qualtrics # 908, original # 6",,,,,2025-09-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Example,Frontline Facilities Tools,Occupational Health,Personnel Management,R-PM,R-T&C,Staff Rotation Schedules,Staffing","https://repository.netecweb.org/files/original/53ce6055a19e4c9ecb81598e5fca02cc.pdf,https://repository.netecweb.org/files/original/d29c8df913e738de84e23f8c92934951.docx",Guide,Develop,1,0
599,https://repository.netecweb.org/items/show/599,"Standard Operating Procedure - Transfer Center Ebola Virus Disease (EVD) Call Tree","Intake and Internal Transport","Transfer Center and Admission Criteria - Transfer Center Ebola Virus Disease (EVD) Call Tree - Example",NETEC,,,2019-05-15,"2023-07-13 by Christa Arguinchona and Caroline Croyle (PM)",,,,,,,2024-07-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Communications,Frontline Facilities Tools,Inform,Internal Transport,Personnel Management,R-PM,Staffing",https://repository.netecweb.org/files/original/2a915b965407eb26e8aaab05262b19f9.pdf,Protocol,Develop,1,0
598,https://repository.netecweb.org/items/show/598,"Stop Sign","Infection Control","Attention all Staff - Stop - Poster",NETEC,,,2019,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q1)",,"Y
Y - D0.1IC/D0.2IC Qualtrics # 231, original # 17a (additional resources)",,,,"Infection Prevention and Control",2024-09-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Communications,Frontline Facilities Tools,Isolate,Personnel Management,R-IPC,R-PM,Staffing","https://repository.netecweb.org/files/original/29ef7cce838d6be0c49712ae040a93c1.pdf,https://repository.netecweb.org/files/original/a0cb40b14d814ce880f0af9389bbc066.pptx",Guide,Develop,1,0
597,https://repository.netecweb.org/items/show/597,"Special Pathogens Precautions","Infection Control","Special Pathogens Precautions list - HCWs & Visitors: SEE NURSE BEFORE ENTERING",NETEC,,,2019-08-30,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q1)",,Y,,,,"Infection Prevention and Control",2024-09-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Communications,Frontline Facilities Tools,Isolate,Personnel Management,R-IPC,R-PM,Staffing",https://repository.netecweb.org/files/original/f63b78cbefaa77bc4f7389fbbb2087a4.docx,Guide,Develop,1,0
596,https://repository.netecweb.org/items/show/596,"Special Pathogen L1 Personal Protective Equipment: Donning and Doffing Checklist","Infection Control","Donning and Doffing Checklists. The word doc can be downloaded and edited as a template. This is a Level 1 PPE Checklist.","NYC Health + Hospitals",,,2019-02-13,"2022-02-08 by PPE group NYCHH (EB)",,"Y - PPE pos 102 qualtrics 322
Y - D0.1PPE/D0.2PPE Qualtrics # 322",,,,,2025-02-08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Checklist,Donning and Doffing,Example,Frontline Facilities Tools,Isolate,Level 1 PPE,Patient Care,Personal Protective Equipment (PPE),R-PPE,Trained Observer","https://repository.netecweb.org/files/original/83bdbe1b588410fa388769ef05cb49b6.pdf,https://repository.netecweb.org/files/original/ff9449b2fdb9e0c2c792ab72b91e19b8.docx",Checklist,Develop,1,0
595,https://repository.netecweb.org/items/show/595,"Special Pathogens Cart Weekly Checklist","Infection Control","Weekly Checklist",NETEC,,,2019-09,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q1)",,Y,,,,"Infection Prevention and Control",2024-09-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Frontline Facilities Tools,Isolate,R-IPC","https://repository.netecweb.org/files/original/402cc16da4df6c51cf103e73fa533afa.pdf,https://repository.netecweb.org/files/original/520a9f7904b7906ab8badcaf2de36fed.docx",Checklist,Develop,1,0
594,https://repository.netecweb.org/items/show/594,"NETEC In Room Log Sheet","Infection Control","In Room Log Sheet for Isolation rooms: Staff members entering the isolation room will sign in and out. All possible breaches should also be documented.",NETEC,,,2019-09,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,"Y
Y - D0.1IC/D0.2IC Qualtrics # 227, original # 14
Y - D0.1PM/D0.2PM Qualtrics # 911, original # 7a",,,,,2024-06-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Frontline Facilities Tools,Isolate,Isolation/Biocontainment,Personnel Management,R-IPC,R-PM,Staffing","https://repository.netecweb.org/files/original/78157aefeb472e0d99e0300509f72a1a.pdf,https://repository.netecweb.org/files/original/86e023d7c650544e09bacc2cf142e37d.docx",Protocol,Develop,1,0
593,https://repository.netecweb.org/items/show/593,"Equipment removal list","Infection Control","Equipment removal checklist",NETEC,,,2019-08-30,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,"Y
Y - D0.1IC/D0.2IC Qualtrics # 227, original # 14",,,,,2024-06-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Frontline Facilities Tools,Isolate,R-IPC","https://repository.netecweb.org/files/original/78753695c59d9e4999f115fcd6496cbc.pdf,https://repository.netecweb.org/files/original/6c252766e42e3a3f0f87ecc9cf74219d.docx",Checklist,Develop,1,0
592,https://repository.netecweb.org/items/show/592,"Room Preparation Checklist","Infection Control","Checklist for preparing room",NETEC,,,2019-08-30,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,"Y
Y - D0.1IC/D0.2IC Qualtrics # 227, original # 14",,,,,2024-06-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Checklist,Frontline Facilities Tools,Isolate,R-IPC","https://repository.netecweb.org/files/original/add811bd240b8d2439e041ee74673cc5.pdf,https://repository.netecweb.org/files/original/f68d8e9aea6a6714bac807452acbd892.docx",Checklist,Develop,1,0
591,https://repository.netecweb.org/items/show/591,"""Do you have a fever?"" Screening Signs","Intake and Internal Transport","Screening Signage Example from Emory Healthcare","Emory Healthcare",,,2019,"2024-03-27 IIT - haven't gotten back first review - bump to next quarter",,"Y - D0.1IIT/D0.2IIT Qualtrics # 702",,,,,2024-06-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Communications,Frontline Facilities Tools,Identify,Intake,Public Relations,R-IIT,R-Lead",https://repository.netecweb.org/files/original/c63b9dab9691d0d39bfdd4731e180cdd.pdf,Guide,Develop,1,0
590,https://repository.netecweb.org/items/show/590,"Screening Pictograms","Intake and Internal Transport","Pictograms of symptoms",,,,2019,"2024-03-27 IIT - haven't gotten back first review - bump to next quarter",,"Y - D0.1IIT/D0.2IIT Qualtrics # 702",,,,,2024-06-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Frontline Facilities Tools,Identify,Intake,R-IIT,R-Lead","https://repository.netecweb.org/files/original/8a7baf2941570fb6ee760995feaf2c63.pdf,https://repository.netecweb.org/files/original/9387a533f5d0b6a8900556a22305595c.pdf,https://repository.netecweb.org/files/original/f89b0f57001ceeaa5ac98debddb2c29b.pdf,https://repository.netecweb.org/files/original/8e70ecd55f456d8690fce2bc66ca5bdd.pdf,https://repository.netecweb.org/files/original/41dfd27cb3f18fe2c58e5b3f81ed94ec.pdf,https://repository.netecweb.org/files/original/22105254e7a113b7187df69fa412b593.pdf,https://repository.netecweb.org/files/original/976e764f973003db3161c944e7e62551.pdf",Guide,Develop,1,0
589,https://repository.netecweb.org/items/show/589,"Initial Patient Screening Algorithm for Infectious Diseases for EDs","Intake and Internal Transport","Screening Algorithm, example from NYC Health + Hospitals","NYC Health + Hospitals",,,2019,"2024-03-27 IIT - haven't gotten back first review - bump to next quarter",,,,,,,2024-06-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Frontline Facilities Tools,Identify,Intake,R-IIT,R-Lead",https://repository.netecweb.org/files/original/50db5f67b0bb707a20fe06dfd113c8bd.pdf,Guide,Develop,1,0
587,https://repository.netecweb.org/items/show/587,"Sample Daily Screening and Triage Process - No Significant Risk of a Special Pathogens Patient Presenting.","Intake and Internal Transport","This is a general screening algorithm and should be modified during an epidemic and/or with current community cases. Algorithms are helpful, but do not replace good clinical judgment.","NYC Health + Hospitals",,,2019,"2024-03-27 IIT - haven't gotten back first review - bump to next quarter",,"Y - D0.1IIT/D0.2IIT - Qualtrics # 707",,,,,2024-06-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"General screening algorithm ",,,,,,,"Frontline Facilities Tools,Identify,Intake,R-IIT,R-Lead",https://repository.netecweb.org/files/original/d5c7d088d8401e3bc8a7a834307cafb2.pdf,Guide,Develop,1,0
585,https://repository.netecweb.org/items/show/585,"Interim Guidance for Healthcare Professionals (MERS-CoV)","Treatment & Care","Healthcare providers should maintain awareness of the need to detect patients who should be evaluated for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection; this requires clinical judgment as information on modes of transmission of MERS-CoV and clinical presentation of MERS continues to evolve.",CDC,,,2019-08-02,"2022-09-27 - general asset review - Treatment & Care group (3 yr - went with T&C)
2022-12-07 general asset review - IPC ('III of HCID for respiratory' 1 yr)",,"Y - D0.1IC/D0.2IC Qualtrics # 231, original # 17a (additional resources)",,,,,2025-09-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"",,,https://www.cdc.gov/coronavirus/mers/interim-guidance.html,,,,"Identify,Infection Prevention and Control,Laboratory Testing,MERS-CoV,Person Under Investigation (PUI),R-IPC,R-T&C",https://repository.netecweb.org/files/original/dcfa8b40eaaf9bef3980ffe7a041377a.png,Guide,Develop,1,0
555,https://repository.netecweb.org/items/show/555,"Surface Sampling of MERS-CoV in Health Care Settings: A Practical “How to” Protocol for Health Care and Public Health Professionals","Infection Control","WHO Draft MERS-CoV Surface sampling of MERS-CoV in health care settings:A practical “how to” protocol for health care and public health professionals, June 2019",WHO,"This document was conceived at a meeting on the Environmental Contamination Studies of MERS-CoV in Health Care Settings co-hosted by WHO and The University of Hong Kong on 13-14 March 2017.The participants of this meeting are listed at the end of the document. This protocol was developed by Reina Sikkema, Chantal Reusken, Pieter Fraaij, Bart Haagmans and Marion Koopmans from Erasmus Medical Center, Rotterdam, the Netherlands, with input and reviews provided by WHO and a large number of respiratory disease experts (see acknowledgements at the end). This work was supported by the European Commission's H2020 program under contract number 643476 and US Agency for International Development (USAID).",,2019-06,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,Y,,,,"Infection Prevention and Control",2024-06-10,,,,,,,,,,,"Available online",,,,,,,,,,,,,,,,,,,,,,,,,,"The protocol provides health care and public health professionals guidance on how to investigate the role of environmental contamination during outbreaks of MERS-CoV in a health care setting where a patient infected with MERS-CoV is currently being treated. The results from such studies will be used in risk assessment and risk management of MERS-CoV hospital-acquired infections, but also for guiding the implementation and monitoring of effectiveness of infection prevention and control measures.",,,https://www.who.int/publications/m/item/surface-sampling-of-mers-cov-in-health-care-settings,,,,"Coronavirus,Infection Prevention and Control,Lab,Laboratory,Laboratory Testing,MERS-CoV,Occupational Exposure,Public Health,R-IPC",,Protocol,Develop,1,0
554,https://repository.netecweb.org/items/show/554,"NETEC - Online Course - Elements of Discussion-Based and Operations- Based Exercises Related to Ebola or Other Special Pathogens ","Training and Exercises","
COURSE DESCRIPTION
This course will provide information about conducting exercises for the care of a patient with Ebola or other special pathogen. It will also introduce the Homeland Security Exercise and Evaluation Program and provide an overview of different types of exercises. The course will outline how to develop, conduct, and evaluate discussion and operation-based exercises, and review the After Action Report and Improvement Plan process.
INTENDED AUDIENCE
This course is intended primarily for healthcare workers and teams in a biocontainment unit environment. Additional medical staff and public health professionals may also find the course to be of benefit. Those individuals may include, but are not limited to, medical and/or nursing staff, administration, education/training leadership, and infection control leadership. Staff specializing in communications, specialized clinical areas, laboratory, facilities management and environmental services are also welcome.
",NETEC,,,2019-09-19,"2023-10-17 by Darrell Ruby, T&E group",,"Y - D0.1TE/D0.2TE Qualtrics # 405, original # 301",,,"Online Course",,2026-10-17,,,,,,,,"Free with account",,,,,,,,,,,,,,,Self-paced,,,,,,,,,,,,,,"CONTINUING EDUCATION UNITS AVAILABLE
",,,https://courses.netec.org/courses/19-ol-em,,,,"Ebola,Exercises and Drills,R-Lead,R-T&E,Training",https://repository.netecweb.org/files/original/3a194fa4b3ec0f14691f8a9ada735a79.png,"Online Course",Develop,1,0
552,https://repository.netecweb.org/items/show/552,"Managing Solid Waste Contaminated with a Category A Infectious Substance: Summary of Key Points and Significant Changes","Waste Management","
- This document summarizes a full guide., which has been updated on June 10, 2022. The full guide supersedes an interim version, previously published on January 19, 2017 and that on August, 2019.
- This document does not create new requirements, nor does it remove the obligation to comply with all applicable federal, state, local, tribal, and territorial laws and regulations.
- See the full guide, which has been updated on June 10, 2022.
","U.S. Department of Transportation
U.S. Environmental Protection Agency
U.S. Department of Labor
Centers for Disease Control and Prevention (CDC)
Assistant Secretary for Preparedness and Response (ASPR)",,,2019-09-26,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,"Y
Y - D0.1IC/D0.2IC Qualtrics # 209, original # 4a (additional resources)",,,,"Infection Prevention and Control",2024-06-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Category A,Guidance Document,R-IPC,Waste,Waste Management",https://repository.netecweb.org/files/original/01a0d83bed6d724e89456c3975050d7f.pdf,Guide,Develop,1,0
540,https://repository.netecweb.org/items/show/540,"Managing Solid Waste Contaminated with a Category A Infectious Substance","Waste Management","Key Points:
- This documents supersedes earlier versions from January 2017 and August 2019.
- This document does not create new requirements, nor does it remove the obligation to comply with all applicable federal, state, local, tribal, and territorial laws and regulations.
- See the Summary of Key Points and Significant Changes
This replaces: Domestic Resilience Group. (2017). Interim – Planning Guidance for the Handling of Solid Waste Contaminated with a Category A Infectious Substance. from 2017-01-19.
And a previous version from 2019-08.
What this is for: This Guidance is for safe handling of solid waste contaminated with a Category A infectious substance (henceforth, ""contaminated waste"") and the proper management of inactivated Category A waste materials in the United States.* An infectious substance meets Category A criteria if it is in a form capable of causing permanent disability or life-threatening or fatal disease in otherwise healthy humans or animals upon exposure to the substance.
Who this is for: Local emergency medical services (EMS); hospital or healthcare facility personnel; public health officials; environmental officials; individuals and organizations involved in healthcare waste management and solid waste management operations; and Federal, State (or, in some jurisdictions, tribal or territorial), or local officials who have to handle, transport, or dispose of waste from a person with a suspected or known exposure to a Category A infectious substance. NOTE: Parts of this guidance may not apply to every State or hospital, depending on individual State or hospital plans in place.
How to use: Use these recommendations to: 1)identify handling considerations for contaminated waste for your locality; 2) develop a contaminated waste protocol or evaluate an existing protocol; 3) guide protection of worker health and safety; and 4) support the development of Category A waste management and response plans for contaminated and inactivated waste materials. This guidance does not address wastewater streams or provide instruction on decontamination measures, nor does it remove the obligation to comply with all applicable Federal, State,and local laws and regulations.
*NOTE: Wastewater treatment is regulated by the Environmental Protection Agency and State agencies and is outside the scope of this document. This document is also not intended to describe environmental cleaning and decontamination","U.S. Department of Transportation
U.S. Environmental Protection Agency
U.S. Department of Labor
Centers for Disease Control and Prevention (CDC)
Assistant Secretary for Preparedness and Response (ASPR)",,"This document was approved for publication by the National Security Council (NSC)-led Homeland and Critical Infrastructure Resilience (HCIR) and Countering Biological Threats (CBT) Interagency Policy Committees on June 3, 2022.
",2022-06-10,"2022-01-19 by Beth Beam (Item 452)
2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,"Y
Y - D0.1IC/D0.2IC Qualtrics # 209, original # 4a (additional resources)",,,,"Infection Prevention and Control",2024-06-10,,,,,,,,,,"Domestic Resilience Group. (2022). Managing Solid Waste Contaminated with a Category A Infectious Substance.",,,,,,,,,,,,,,,,,,,,,,,,,,,"This guidance focuses on managing waste contaminated with the Category A infectious substances that affect humans.4 These substances are identified by the United Nations (UN) identification number 2814 under an international system for identifying hazardous materials. Appendix B – Infectious Agent Categorization provides a non-exhaustive list identifying, among other categorizations, common agents classified as UN 2814 Category A infectious substances affecting humans. Medical care of a person suspected of or confirmed as having a disease caused by a Category A pathogen (i.e., germ) typically generates used healthcare products or linens that are classified as Category A waste. While this document chiefly addresses Category A waste associated with hospital care of infectious patients, it also recognizes that infected people may contaminate their homes, vehicles in which they travel, and other environments before they are hospitalized. Category A waste may also come from laboratories that work with UN 2814 Category A pathogens, including when they intentionally cultivate certain pathogens (a process known as “culturing”) that are not considered Category A (i.e., UN 2814 infectious substances) in other forms (e.g., in body fluids or tissues of an infected person).5 Where appropriate, this document addresses these additional, non-healthcare scenarios and settings from which Category A waste may arise.
Information in this guidance serves several purposes. As a whole, the document offers readers an overview of Category A waste management in the United States. The main component of this guidance addresses planning for Category A waste management activities, including considerations for developing, evaluating, and revising organizational (e.g., hospital) or jurisdictional (e.g., state, territorial, or local) plans. It is presented in sections that break down waste management activities according to responsibilities as waste is moved from its point of generation to its place of disposal. Several accompanying appendices provide users with information about pathogens classified as Category A infectious substances, decision making for waste treatment and disposal activities, communicating effectively about safe waste management and associated issues, and additional related resources. The included listing of acronyms and glossary of terms applies to the entire document. Unless otherwise noted, references to a particular appendix or section refer to parts of this document (and, in the electronic version, can be clicked to navigate to that information directly).
Note that this document intentionally repeats some information, particularly when waste management requires actions from multiple parties (e.g., overlapping responsibilities between waste generators and waste transporters). Information presented in the planning guidance is also intentionally repeated in the appendices to make it as accessible as possible for a wide variety of readers. (Page 4.)
4. This document is not intended to cover Category B infectious substances (UN 3373) nor Category A Infectious substances that affect animals only (UN 2900). Category A infectious substances that affect humans and animals are categorized as Category A Infectious substances, affecting humans (UN 2814).
5. Appendix B – Infectious Agent Categorization distinguishes these “cultures only” pathogens from other Category A pathogens. (See page 37.)
",,,https://www.phmsa.dot.gov/transporting-infectious-substances/planning-guidance-handling-category-solid-waste,,,,"Autoclave,Category A,Ebola,Federal,Guidance Document,Infection Prevention and Control,Personal Protective Equipment (PPE),R-WM,Regulations,Sterilizer,Training,Viral Hemorrhagic Fever,Waste,Waste Management",https://repository.netecweb.org/files/original/a2ab8b2de877a48cb039d0c39bc36bfc.pdf,Guide,Develop,1,0
536,https://repository.netecweb.org/items/show/536,"Guidance for Screening and Caring for Pregnant Women with Ebola Virus Disease for Healthcare Providers in U.S. Hospitals","Treatment & Care","Key Points
- Healthcare providers caring for pregnant women in U.S. hospitals should be prepared to screen patients for EVD and have a plan in place to triage these patients.
- Obstetric management of pregnant women with EVD, particularly decisions about mode of delivery for women in labor, needs to consider risks to the woman, risks of exposure for healthcare providers, and potential benefits to the neonate.
- Healthcare workers who are pregnant should not care for patients with EVD.
- Pregnant PUIs or patients with confirmed EVD should be hospitalized, and CDC guidance for hospitalized PUIs or patients with confirmed EVD should be followed.
",CDC,,,2018-05-30,"2022-09-27 - general asset review - Treatment & Care group",,Y,,,,,2025-09-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"
Who this is for: Healthcare providers working in emergency departments and labor and delivery units in U.S. hospitals.
What this is for: Guidance on how to screen pregnant women for Ebola virus disease (EVD) and how to care for pregnant women as patients under investigation (PUIs) for or with confirmed EVD, including considerations for pregnant healthcare workers.
How to use: This guidance is intended to help U.S. hospitals develop a plan for screening and treating pregnant PUIs or patients with confirmed EVD.
",,,https://www.cdc.gov/vhf/ebola/clinicians/evd/pregnant-women.html,,,,"Ebola,Labor and Delivery,R-SP,R-T&C",https://repository.netecweb.org/files/original/84ca03c4be00e1f9e6cdfcf23a699a76.png,Guide,Develop,1,0
528,https://repository.netecweb.org/items/show/528,"Care of a Neonate Born to a Mother who is Confirmed to have Ebola, is a Person under Investigation, or has been Exposed to Ebola","Treatment & Care","Interim Guidance for U.S. Hospitals on the Care of a Neonate Born to a Mother who is Confirmed to have Ebola, is a Person under Investigation (PUI), or has been Exposed to Ebola",CDC,,,2018-05-30,"2022-09-27 - general asset review - Treatment & Care group",,Y,,,,,2025-09-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Who this is for: Healthcare professionals working with neonates in labor and delivery, neonatal intensive care units, newborn nurseries, and other settings in U.S. hospitals.
What this is for: Guidance on how to care for neonates born to mothers exposed to Ebola virus, PUIs, or with confirmed Ebola.
",,,https://www.cdc.gov/vhf/ebola/clinicians/evd/neonatal-care.html,,,,"Neonates,Patient Care,Pediatrics,R-SP,R-T&C",https://repository.netecweb.org/files/original/23c98e81421bb74f3306a11445fb3b3d.png,Guide,Develop,1,0
512,https://repository.netecweb.org/items/show/512,"“Let’s talk Trash”","Waste Management","Slides on waste from a NETEC Year 4- Year 5 course.",NETEC,,,2019-08-07,"2022-11-14 by IPC general asset review, marked for archive with note: ""powerpoint""
2023-01-04 Lisa noted broken link in blog post - do not Archive.
2023-12-04 - Joanna added to 2024-01-01 review for updating
2024-03-08 - Joanna added thumbnail",,"Y - D0.1WM/D0.2WM Qualtrics # 1101, original #
Y - D0.1WM/D0.2WM Qualtrics # 1105, original #
Y - D0.1WM/D0.2WM Qualtrics # 1109, original # 2
Y - D0.1WM/D0.2WM Qualtrics # 1111, original # 3
Y - D0.1WM/D0.2WM Qualtrics # 1112, original # 4
Y - D0.1WM/D0.2WM Qualtrics # 1115, original #
Y - D0.1WM/D0.2WM Qualtrics # 1116, original # 5
Y - D0.1WM/D0.2WM Qualtrics # 1121, original # 9
Y - D0.1WM/D0.2WM Qualtrics # 1122, original # 9a
Y - D0.1WM/D0.2WM Qualtrics # 1133, original # ",,,,,"2024-01-01 No review ""not updated"" - needs updating for SPORSA",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Waste Management education",,,,,,,"Autoclave,Category A,Ebola,MERS-CoV,Not updated,R-WM,Waste,Waste Management","https://repository.netecweb.org/files/original/8487cfbb259e200542a50db950c8e305.png,https://repository.netecweb.org/files/original/90cd1ef105d9f95d38fa68dde74ea5a6.pptx","In Person Course",Develop,1,0
505,https://repository.netecweb.org/items/show/505," Corporate Report: Secure Specimen Transfer from Ebola Biobank to the UK (United Kingdom) ",Research,"This report summarizes the establishment of the Ebola Biobank, its governance, and how materials were safely transported in 2015 from West Africa to the United Kingdom for curation by Public Health England. The Biobank is a secure but accessible resource of biological samples that are essential for understanding human disease and the development of vaccines, diagnostics, and treatments.","United Kingdom Department of Health (DH)",,,2019-07-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"This information has been published in response to a request (FOI) made under the Freedom of Information Act 2000.",,,https://www.gov.uk/government/publications/ebola-biobank-2015-specimen-transfer,,,,"Ebola,R-Res&Pub,Specimen Transport,Therapeutics,Vaccine Study",,Guide,Develop,1,0
504,https://repository.netecweb.org/items/show/504,"Preparing for a Pandemic: An Emergency Response Benchbook and Operational Guidebook for State Court Judges and Administrators","Emergency Management","This document was prepared with support from a State Justice Institute grant.","National Center for State Courts",,"National Center for State Courts",2016,"2024-03-27 Emergency Management skipped in review – bump to next quarter",,,,,,,2024-07-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://ncsc.contentdm.oclc.org/digital/collection/facilities/id/194,,,,"Emergency Management,Legal,Pandemic,R-EM",,Guide,Develop,1,0
499,https://repository.netecweb.org/items/show/499,"Frontline Hospital Planning Guide: Special Pathogens","Emergency Management","With the increasing demand for preparedness for and responses to the world’s emerging public health threats, this planning guide breaks new ground and leads the way as a distinctive domestic resource for healthcare delivery systems to customize their plans specific to their unique clinical, operational, and financial needs. (2)","NYC Health + Hospitals",,,2019-06-30,"2024-03-27 Emergency Management skipped in review – bump to next quarter",,"Y - D0.1EM/D0.2EM Qualtrics # 511",,,,,2024-07-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Purpose and Audience:
All hospitals must be prepared to identify and isolate a patient presenting with a suspected special pathogen infection (i.e., one that is particularly virulent and requires care processes and personal protective equipment beyond daily infection control practices) and inform internal and external stakeholders. This document provides high level planning guidance for a frontline hospital multidisciplinary team (e.g., emergency management, infection prevention and control, emergency department, inpatient care, safety, public relations, and infectious disease, depending on the resources and role of the facility in the community) to support planning and training for the provision of initial care to such patients while determining whether and when the patient will be transferred to another facility for further assessment and treatment. Though the target audience is frontline hospitals, other facilities may fnd information that is applicable to their planning. The information in this planning guide is neither presented as a complete and stand-alone resource for special pathogen management nor is it intended as a universal document for all staff within an entire hospital. It aims to serve as a high level “jumping-off point” to be supplemented by the most current pathogen-specific guidance and customized to meet facility needs.
Scope:
This document is NOT intended for facilities managing patients confirmed to have a viral hemorrhagic fever or special respiratory pathogen. Rather, this planning guide is designed to assist frontline hospitals to develop systems and provide training to screen for special pathogen infectious diseases and effectively identify, isolate, and inform when a case is suspected, and safely manage patients until diagnosis, transfer, or release. In certain circumstances, patients may require further intervention or invasive procedures based on clinical status or may be at frontline hospitals longer than 24 hours. Hospitals should always consult with public health officials to ascertain risk and to obtain the most current information available including their state and local health departments, the Centers for Disease Control and Prevention (CDC), and other sources to assure their practices and knowledge are current.
The planning guide format provides an overview of the issues that should be addressed as well as planning considerations for specific topics, particularly when such information is not easily accessible from other sources. Much more detailed guidance on infection control for specific pathogens as well as personal protective equipment and other topics is available and is referenced and linked throughout the document for use in planning by those personnel who need more specific information. Frontline facilities are varied, from critical access hospitals to major metropolitan medical centers, and depending on the regional resources and systems the frontline facility may have to simply recognize a suspect case and transfer them, or provide patient care for days at a time awaiting confirmatory testing prior to patient movement. This planning guide attempts to provide high level resources for the full spectrum of care and must be tailored to the specifics of the facility.
Notes and Caveats:
This document was created by subject matter experts using official or best practice information taken from multiple organizations that was vetted and assembled by NYC Health + Hospitals. This document does not constitute official policies or viewpoints of any government agency, including NYC Health + Hospitals.
The information contained in this planning guide is intended as a planning resource and should be incorporated in plans and procedures developed by frontline hospitals.
The authors take no responsibility and bear no liability for any clinical care outcomes, provider injury/illness, or inaccuracies in or resulting from this document. All content was current at the time of publication and vetted to the best of our ability.
Inclusion of specific references and resources is offered as an acknowledgement of their contribution of material and to identify sources of additional information, but it does not constitute endorsement or vouch for the accuracy or applicability of the referenced documents.",,,https://www.nychealthandhospitals.org/center-for-global-healthcare-preparedness-for-special-pathogens/tools-and-resources/#infocus,,,,"Checklist,Emergency Management,Exercises and Drills,Frontline Facility,R-EM,Respiratory Pathogen,Special Pathogens,Viral Hemorrhagic Fever",https://repository.netecweb.org/files/original/88c19ab57d7a694097be49a4a729b8d5.pdf,Guide,Develop,1,0
489,https://repository.netecweb.org/items/show/489,"Preliminary results on the efficacy of rVSV-ZEBOV-GP Ebola vaccine using the ring vaccination strategy in the control of an Ebola outbreak in the Democratic Republic of the Congo: an example of integration of research into epidemic response.","Infection Control","ABOUT THIS ANALYSIS: DRC’s national research institute, the Institut National pour la Recherche Biomedicale (INRB) and WHO have conducted a preliminary analysis of the data being collected from the ring vaccination protocol. The analysis summarized here includes data between May 1, 2018 and March 25, 2019.This preliminary analysis was completed with the aim to better understand whether or not the rVSV-ZEBOV-GP candidate vaccine is effective and is contributing to prevent cases when delivered using the ring vaccination strategy.A more detailed analysis is being prepared and will be available in a peer-reviewed journal.",WHO,,,2019-04-12,"2022-12-07 general asset review - IPC (move to R-T&C)
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,,,,Publication,"Adult Care",2024-06-10,,,,,,,,,,"WHO. 2019. Preliminary results on the efficacy of rVSV-ZEBOV-GP Ebola vaccine using the ring vaccination strategy in the control of an Ebola outbreak in the Democratic Republic of the Congo: an example of integration of research into epidemic response. https://www.who.int/csr/resources/publications/ebola/vaccines/en/","Free online, copyright WHO.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.who.int/publications/m/item/preliminary-results-on-the-efficacy-of-rvsv-zebov-gp-ebola-vaccine-using-the-strategy-in-the-control-of-an-ebola-outbreak,,,,"Clinical Trial,Ebola,Epidemic,Outbreaks,R-Res&Pub,R-T&C,Research,Research Design,Therapeutics,Vaccine Study",,Publication,Develop,1,0
488,https://repository.netecweb.org/items/show/488,"Ebola Recommendations for Organizations","Personnel Management","Recommendations for organizations sending US-based health care or emergency response workers to areas with Ebola outbreaks and predeparture assessment of any workers traveling from Ebola outbreak areas to the United States.",CDC,,,2019-04-16,"2022-01-19 by Beth Beam",,"Y - D0.1PM/D0.2PM Qualtrics # 911, original # 7a
Y - D0.1PM/D0.2PM Qualtrics # 912, original # 8",,,,,2025-01-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://wwwnc.cdc.gov/travel/page/recs-organizations-sending-workers-ebola,,,,"Clinical Trial,Ebola,Outbreaks,Personal Protective Equipment (PPE),R-PM,R-PPE,Travel Screening,Vaccine Study",,Guide,Develop,1,0
481,https://repository.netecweb.org/items/show/481,"Special Pathogens of Concern: Middle East Respiratory Syndrome ","Infection Control","COURSE DESCRIPTION
It is critical that healthcare personnel have knowledge of Middle East Respiratory Syndrome (MERS) and the implications for healthcare delivery in a biocontainment unit (BCU) or special pathogen isolation area. In this course, learners will be able to describe pathogen-related factors that may warrant treatment in a BCU or special pathogen isolation area. Learners will also be able to describe the clinical presentation, management, and treatment of MERS.
TARGET AUDIENCE
This course is intended primarily for healthcare workers and teams in a biocontainment unit or special pathogen isolation area environment. Additional medical staff and public health professionals may also find the course to be of benefit. Those individuals may include but are not limited to, medical and nursing staff, administration, education/training leadership, and infection control leadership. Staff specializing in emergency management, communications, specialized clinical areas, laboratory, facilities management, and environmental services are also welcome.
",NETEC,,,2019-05-31,"2022-12-07 Note from Benjamin - ON Air Force online course list - DO NOT ARCHIVE
2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,"Y
Y - D0.1IC/D0.2IC Qualtrics # 231, original # 17a (additional resources)",,,"Online Course","Infection Prevention and Control",2024-06-10,,,,,,,,"Free online with account",,,,,,,,,,,,,,,Self-paced,,,,,,,,,,,,,,"CONTINUING EDUCATION UNITS AVAILABLE
CME .25",,,https://courses.netec.org/courses/spoc-middle-east-respiratory-syndrome,,,,"Identify,Isolation/Biocontainment,MERS-CoV,R-IPC,Special Pathogens",https://repository.netecweb.org/files/original/53856aba0d4644c1609303ccbd7b40ba.png,"Online Course",Develop,1,0
480,https://repository.netecweb.org/items/show/480,"High Consequence Infectious Disease (HCID) Toolbox for Frontline Health Care Facilities","Infection Control","This toolbox contains
- Planning Tools
- Training Tools
- Exercise Templates
- Readiness binder
- References
How to use the toolbox
- Use sample multi-year planning, training and exercise plan templates to lay out preparedness activities over multiple years.
- Incorporate readymade slides and personal protective equipment (PPE) videos into facility infection prevention and emergency preparedness training.
- Use or modify sample exercises (seminar, workshop, table top, mini-exercise, game) and templates (Planning Tool, After Action Report).
- Use components to make a binder for staff to use at point of care.
","Minnesota Department of Health",,,2019-06-11,"2023-12-04 by Jill Morgan/PPE Group",,,,,,,2026-12-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Purpose of toolbox
- Provides ready-to-use tools for frontline facilities to prepare and respond to patients who may have a high consequence infectious disease (HCID).
- Helps facilities meet CMS emergency preparedness regulatory requirements for training and testing programs.
- Helps facilities develop a multi-year plan for HCID education and exercises.
- Incorporates standard infection prevention concepts into training and exercises.
",,,https://www.health.state.mn.us/diseases/hcid/,,,,"Donning and Doffing,Example,Frontline Facility,High Consequence Infectious Disease (HCID),Infection Prevention and Control,R-PPE,Special Pathogens",,Guide,Develop,1,0
479,https://repository.netecweb.org/items/show/479,"Module 9: Transfer of Patient Care for Patients with Ebola and Highly Infectious Diseases and Introduction to Biocontainment Units","Emergency Medical Services","EID 4 EMT Free Video Training Series -
Emerging Infectious Diseases Videos for Prehospital Providers -
Transfer of Patient Care for Patients with Ebola and Highly Infectious Diseases and Introduction to Biocontainment Units","University of Maryland, Baltimore County (UMBC)",,,2018-05-15,"2022-12-07 general asset review - IPC
2023-03-31 by J Mundy - changed to R-PreH for next review
2024-03-27 EMS/Pre-Hospital never reviewed – bump to next quarter",,,,,,,2024-06-10,,,,,,,"
",,,,,,,,,,,,,,,,00:17:24,,,,,,,,,,,,,," This instructional series was created by the University of Maryland Baltimore County (UMBC), Department of Emergency Health Services, with assistance from the Maryland Department of Health, and funding from the U.S. Centers for Disease Control and Prevention.
This program is designed to meet the needs of first responders who are expected to deal with the health needs of people who find themselves in health emergencies they cannot manage on their own. These first responders are typically emergency medical services personnel, such as EMTs and paramedics, but can also be first-aid trained fire fighters, law enforcement personnel, and volunteers such as Red Cross disaster workers. Health officers in summer camps, youth clubs, and other organizations that work with groups of people who may have some vulnerability may also benefit from this program. ",,,https://eid4emt.umbc.edu/courses/index.php?courseNum=10,"Instructional series",,,"Ebola,Isolation/Biocontainment,Patient Care,Patient Transport,Pre-Hospital,Pre-hospital Transport,R-EMS,R-PreH,Special Pathogens",https://repository.netecweb.org/files/original/e13ea06750135dd47b62c8062f170d31.png,Webinar,Develop,1,0
478,https://repository.netecweb.org/items/show/478,"Module 8: Transport during Highly Infectious Disease Investigations & Operational Considerations for Portable Isolation Units","Emergency Medical Services","EID 4 EMT Free Video Training Series -
Emerging Infectious Diseases Videos for Prehospital Providers -
Transport during Highly Infectious Disease Investigations & Operational Considerations for Portable Isolation Units","University of Maryland, Baltimore County (UMBC)",,,2018-05-15,"2022-12-07 general asset review - IPC
2023-03-31 by J Mundy - changed to R-PreH for next review
2024-03-27 EMS/Pre-Hospital never reviewed – bump to next quarter",,,,,,,2024-06-10,,,,,,,"
",,,,,,,,,,,,,,,,00:20:14,,,,,,,,,,,,,," This instructional series was created by the University of Maryland Baltimore County (UMBC), Department of Emergency Health Services, with assistance from the Maryland Department of Health, and funding from the U.S. Centers for Disease Control and Prevention.
This program is designed to meet the needs of first responders who are expected to deal with the health needs of people who find themselves in health emergencies they cannot manage on their own. These first responders are typically emergency medical services personnel, such as EMTs and paramedics, but can also be first-aid trained fire fighters, law enforcement personnel, and volunteers such as Red Cross disaster workers. Health officers in summer camps, youth clubs, and other organizations that work with groups of people who may have some vulnerability may also benefit from this program.",,,https://eid4emt.umbc.edu/courses/index.php?courseNum=9,"Instructional series",,,"Identify,Isolate,Isolation/Biocontainment,Isopod,Person Under Investigation (PUI),Portable Isolation Unit,Pre-Hospital,Pre-hospital Transport,R-EMS,R-PreH,Special Pathogens",https://repository.netecweb.org/files/original/1feaaffcbf46f5e0e9471774049df025.png,Webinar,Develop,1,0
477,https://repository.netecweb.org/items/show/477,"Module 7: Infectious Waste Disposal and Equipment Decontamination","Infection Control","EID 4 EMT Free Video Training Series -
Emerging Infectious Diseases Videos for Prehospital Providers -
Infectious Waste Disposal and Equipment Decontamination","University of Maryland, Baltimore County (UMBC)",,,2018-05-15,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,"Y
Y - D0.1IC/D0.2IC Qualtrics # 217, original # 8a
Y - D0.1IC/D0.2IC Qualtrics # 218, original # 9
Y - D0.1IC/D0.2IC Qualtrics # 222, original # 10
Y - D0.1IC/D0.2IC Qualtrics # 223, original # 11
Y - D0.1IC/D0.2IC Qualtrics # 225, original # 12
Y - D0.1IC/D0.2IC Qualtrics # 229, original # 16",,,,"Infection Prevention and Control",2024-06-10,,,,,,,"
",,,,,,,,,,,,,,,,00:27:08,,,,,,,,,,,,,," This instructional series was created by the University of Maryland Baltimore County (UMBC), Department of Emergency Health Services, with assistance from the Maryland Department of Health, and funding from the U.S. Centers for Disease Control and Prevention.
This program is designed to meet the needs of first responders who are expected to deal with the health needs of people who find themselves in health emergencies they cannot manage on their own. These first responders are typically emergency medical services personnel, such as EMTs and paramedics, but can also be first-aid trained fire fighters, law enforcement personnel, and volunteers such as Red Cross disaster workers. Health officers in summer camps, youth clubs, and other organizations that work with groups of people who may have some vulnerability may also benefit from this program.",,,https://eid4emt.umbc.edu/courses/index.php?courseNum=8,"Instructional series",,,"Decontamination,Equipment and Supplies,Pre-Hospital,R-IPC,Waste,Waste Management",https://repository.netecweb.org/files/original/392d87f792e5d921c1a6fa77ce6e53b7.png,Webinar,Develop,1,0
476,https://repository.netecweb.org/items/show/476,"Module 6: Decontamination of Personnel and Provider Care","Emergency Medical Services","EID 4 EMT Free Video Training Series -
Emerging Infectious Diseases Videos for Prehospital Providers -
Decontamination of Personnel and Provider Care","University of Maryland, Baltimore County (UMBC)",,,2018-05-15,"2022-12-07 general asset review - IPC
2023-03-31 by J Mundy - changed to R-PreH for next review
2024-03-27 EMS/Pre-Hospital never reviewed – bump to next quarter",,,,,,,2024-06-10,,,,,,,"
",,,,,,,,,,,,,,,,00:13:00,,,,,,,,,,,,,," This instructional series was created by the University of Maryland Baltimore County (UMBC), Department of Emergency Health Services, with assistance from the Maryland Department of Health, and funding from the U.S. Centers for Disease Control and Prevention.
This program is designed to meet the needs of first responders who are expected to deal with the health needs of people who find themselves in health emergencies they cannot manage on their own. These first responders are typically emergency medical services personnel, such as EMTs and paramedics, but can also be first-aid trained fire fighters, law enforcement personnel, and volunteers such as Red Cross disaster workers. Health officers in summer camps, youth clubs, and other organizations that work with groups of people who may have some vulnerability may also benefit from this program.",,,https://eid4emt.umbc.edu/courses/index.php?courseNum=7,"Instructional series",,,"Decontamination,Occupational Exposure,Occupational Health,Patient Care,Pre-Hospital,R-EMS,R-PreH",https://repository.netecweb.org/files/original/7482283fda309aff82ca03e122cf97e6.png,Webinar,Develop,1,0
475,https://repository.netecweb.org/items/show/475,"Module 5: Part 2: Donning and Doffing PPE for Wet Ebola Precautions","Infection Control","EID 4 EMT Free Video Training Series -
Emerging Infectious Diseases Videos for Prehospital Providers -
Donning and Doffing PPE for Wet Ebola Precautions","University of Maryland, Baltimore County (UMBC)",,,2018-05-15,"2024-03-27 EMS/Pre-Hospital never reviewed – bump to next quarter",,,,,,,2024-06-27,,,,,,,"
",,,,,,,,,,,,,,,,00:21:14,,,,,,,,,,,,,," This instructional series was created by the University of Maryland Baltimore County (UMBC), Department of Emergency Health Services, with assistance from the Maryland Department of Health, and funding from the U.S. Centers for Disease Control and Prevention.
This program is designed to meet the needs of first responders who are expected to deal with the health needs of people who find themselves in health emergencies they cannot manage on their own. These first responders are typically emergency medical services personnel, such as EMTs and paramedics, but can also be first-aid trained fire fighters, law enforcement personnel, and volunteers such as Red Cross disaster workers. Health officers in summer camps, youth clubs, and other organizations that work with groups of people who may have some vulnerability may also benefit from this program.",,,https://eid4emt.umbc.edu/courses/index.php?courseNum=6,"Instructional series",,,"Donning and Doffing,Droplet Transmission,Ebola,Personal Protective Equipment (PPE),Pre-Hospital,R-EMS,R-PPE,R-PreH",https://repository.netecweb.org/files/original/f5fd708413132f91d8f2cc87fb69a9db.png,Webinar,Develop,1,0
474,https://repository.netecweb.org/items/show/474,"Module 5: Part 1: Donning and Doffing PPE for Special Respiratory Precautions, Dry EVD, and Other Highly Infectious Diseases","Infection Control","EID 4 EMT Free Video Training Series -
Emerging Infectious Diseases Videos for Prehospital Providers -
Donning and Doffing PPE for Special Respiratory Precautions, Dry EVD, and Other Highly Infectious Diseases","University of Maryland, Baltimore County (UMBC)",,,2018-04-03,"2024-03-27 EMS/Pre-Hospital never reviewed – bump to next quarter",,,,,,,2024-06-27,,,,,,,"
",,,,,,,,,,,,,,,,00:23:04,,,,,,,,,,,,,," This instructional series was created by the University of Maryland Baltimore County (UMBC), Department of Emergency Health Services, with assistance from the Maryland Department of Health, and funding from the U.S. Centers for Disease Control and Prevention.
This program is designed to meet the needs of first responders who are expected to deal with the health needs of people who find themselves in health emergencies they cannot manage on their own. These first responders are typically emergency medical services personnel, such as EMTs and paramedics, but can also be first-aid trained fire fighters, law enforcement personnel, and volunteers such as Red Cross disaster workers. Health officers in summer camps, youth clubs, and other organizations that work with groups of people who may have some vulnerability may also benefit from this program. ",,,https://eid4emt.umbc.edu/courses/index.php?courseNum=5,"Instructional series",,,"Donning and Doffing,Ebola,Personal Protective Equipment (PPE),Pre-Hospital,R-EMS,R-PPE,R-PreH,Respiratory Pathogen,Special Pathogens",https://repository.netecweb.org/files/original/def1fa03779e86fb9ab8bc2686f73c86.png,Webinar,Develop,1,0
473,https://repository.netecweb.org/items/show/473,"Module 4: Donning & Doffing PPE for Contact, Droplet, and Airborne Precautions","Infection Control","EID 4 EMT Free Video Training Series -
Emerging Infectious Diseases Videos for Prehospital Providers -
Donning & Doffing PPE for Contact, Droplet, and Airborne Precautions","University of Maryland, Baltimore County (UMBC)",,,2018-05-15,"2024-03-27 EMS/Pre-Hospital never reviewed – bump to next quarter",,,,,,,2024-06-27,,,,,,,"
",,,,,,,,,,,,,,,,00:34:57,,,,,,,,,,,,,," This instructional series was created by the University of Maryland Baltimore County (UMBC), Department of Emergency Health Services, with assistance from the Maryland Department of Health, and funding from the U.S. Centers for Disease Control and Prevention.
This program is designed to meet the needs of first responders who are expected to deal with the health needs of people who find themselves in health emergencies they cannot manage on their own. These first responders are typically emergency medical services personnel, such as EMTs and paramedics, but can also be first-aid trained fire fighters, law enforcement personnel, and volunteers such as Red Cross disaster workers. Health officers in summer camps, youth clubs, and other organizations that work with groups of people who may have some vulnerability may also benefit from this program. ",,,https://eid4emt.umbc.edu/courses/index.php?courseNum=4,"Instructional series",,,"Airborne Transmission,Contact Transmission,Donning and Doffing,Droplet Transmission,Personal Protective Equipment (PPE),Pre-Hospital,R-EMS,R-PPE,R-PreH",https://repository.netecweb.org/files/original/0f8ce2531e96282078b37df2ffdaa82f.png,Webinar,Develop,1,0
472,https://repository.netecweb.org/items/show/472,"Module 3: PPE Considerations for Prehospital Providers: Using the Multi-Pathogen Approach","Infection Control","EID 4 EMT Free Video Training Series -
Emerging Infectious Diseases Videos for Prehospital Providers -
PPE Considerations for Prehospital Providers: Using the Multi-Pathogen Approach","University of Maryland, Baltimore County (UMBC)",,,2018-05-15,"2024-03-27 EMS/Pre-Hospital never reviewed – bump to next quarter",,,,,,,2024-06-27,,,,,,,"
",,,,,,,,,,,,,,,,00:22:33,,,,,,,,,,,,,," This instructional series was created by the University of Maryland Baltimore County (UMBC), Department of Emergency Health Services, with assistance from the Maryland Department of Health, and funding from the U.S. Centers for Disease Control and Prevention.
This program is designed to meet the needs of first responders who are expected to deal with the health needs of people who find themselves in health emergencies they cannot manage on their own. These first responders are typically emergency medical services personnel, such as EMTs and paramedics, but can also be first-aid trained fire fighters, law enforcement personnel, and volunteers such as Red Cross disaster workers. Health officers in summer camps, youth clubs, and other organizations that work with groups of people who may have some vulnerability may also benefit from this program. ",,,https://eid4emt.umbc.edu/courses/index.php?courseNum=3,"Instructional series",,,"Personal Protective Equipment (PPE),Pre-Hospital,R-EMS,R-PPE,R-PreH,Special Pathogens",https://repository.netecweb.org/files/original/73aad92d1657764b32dec7a8013a0345.png,Webinar,Develop,1,0
471,https://repository.netecweb.org/items/show/471,"Module 2: Basic Infection Control Concepts and Recognition of Infectious Patients","Infection Control","EID 4 EMT Free Video Training Series -
Emerging Infectious Diseases Videos for Prehospital Providers -
Basic Infection Control Concepts and Recognition of Infectious Patients","University of Maryland, Baltimore County (UMBC)",,,2018-05-15,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,"Y
Y - D0.1IC/D0.2IC Qualtrics # 207, original # 3
Y - D0.1IC/D0.2IC Qualtrics # 222, original # 10
Y - D0.1IC/D0.2IC Qualtrics # 223, original # 11",,,,"Infection Prevention and Control",2024-06-10,,,,,,,"
",,,,,,,,,,,,,,,,00:20:31,,,,,,,,,,,,,," This instructional series was created by the University of Maryland Baltimore County (UMBC), Department of Emergency Health Services, with assistance from the Maryland Department of Health, and funding from the U.S. Centers for Disease Control and Prevention.
This program is designed to meet the needs of first responders who are expected to deal with the health needs of people who find themselves in health emergencies they cannot manage on their own. These first responders are typically emergency medical services personnel, such as EMTs and paramedics, but can also be first-aid trained fire fighters, law enforcement personnel, and volunteers such as Red Cross disaster workers. Health officers in summer camps, youth clubs, and other organizations that work with groups of people who may have some vulnerability may also benefit from this program.",,,https://eid4emt.umbc.edu/courses/index.php?courseNum=2,"Instructional series",,,"Identify,Infection Prevention and Control,Pre-Hospital,R-IPC",https://repository.netecweb.org/files/original/286dfe57be4697e585438358f1b58a54.png,Webinar,Develop,1,0
470,https://repository.netecweb.org/items/show/470,"Module 1: Introduction to Infectious Diseases","Infection Control","EID 4 EMT Free Video Training Series -
Emerging Infectious Diseases Videos for Prehospital Providers -
Introduction to Infectious Diseases","University of Maryland, Baltimore County (UMBC)",,,2018-05-18,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,"Y
Y - D0.1IC/D0.2IC Qualtrics # 207, original # 3
Y - D0.1IC/D0.2IC Qualtrics # 222, original # 10
Y - D0.1IC/D0.2IC Qualtrics # 223, original # 11",,,,"Infection Prevention and Control",2024-06-10,,,,,,,"
",,,,,,,,,,,,,,,,00:17:22,,,,,,,,,,,,,," This instructional series was created by the University of Maryland Baltimore County (UMBC), Department of Emergency Health Services, with assistance from the Maryland Department of Health, and funding from the U.S. Centers for Disease Control and Prevention.
This program is designed to meet the needs of first responders who are expected to deal with the health needs of people who find themselves in health emergencies they cannot manage on their own. These first responders are typically emergency medical services personnel, such as EMTs and paramedics, but can also be first-aid trained fire fighters, law enforcement personnel, and volunteers such as Red Cross disaster workers. Health officers in summer camps, youth clubs, and other organizations that work with groups of people who may have some vulnerability may also benefit from this program. ",,,https://eid4emt.umbc.edu/courses/index.php?courseNum=1,"Instructional series",,,"Pre-Hospital,R-IPC,Special Pathogens",https://repository.netecweb.org/files/original/f65b8659e2f001f35b094ddf527562b9.png,Webinar,Develop,1,0
458,https://repository.netecweb.org/items/show/458,"Viral Hemorrhagic Fever (VHF) or Orthopox Virus ~ ED Screening Protocol","Intake and Internal Transport","This Viral Hemorrhagic Fever (VHF) or Orthopox Virus ~ ED Screening Protocol is the updated version of the Nebraska - Ebola Virus Disease (EVD) Resources - Ebola Viral Disease ED Screening Protocol-Main Campus","University of Nebraska Medical Center / Nebraska Medicine",,,2021-09,"2024-03-27 IIT - haven't gotten back first review - bump to next quarter",,,,,,,2024-06-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Ebola,Emergency Department,Identify,Inform,Isolate,Orthopox Virus,Procedure,Process,Protocol,R-IIT,R-Lead,Viral Hemorrhagic Fever",https://repository.netecweb.org/files/original/3211f8defa09702d57ea2e2d462c2f9f.pdf,Protocol,Develop,1,0
457,https://repository.netecweb.org/items/show/457,"MERS-CoV ED Screening Algorithm","Intake and Internal Transport","Leadership Toolbox, Mitigation: MERS Co-V ED Screening Protocol, Nebraska Medical Center","University of Nebraska Medical Center / Nebraska Medicine",,,2019-05-08,"2024-03-27 IIT - haven't gotten back first review - bump to next quarter",,,,,,,2024-06-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Emergency Department,Identify,Inform,Isolate,Leadership Toolbox,MERS-CoV,Mitigation Tools,Procedure,Process,Protocol,R-IIT,R-Lead",https://repository.netecweb.org/files/original/795599742a973fe90b1ab0500cc410e1.PDF,Protocol,Develop,1,0
456,https://repository.netecweb.org/items/show/456,"Procedural Guidance on the Proper Packaging of Ebola Suspected Waste: DOT Guidance for Preparing Packages of Ebola Contaminated Waste for Transportation and Disposal","Waste Management","This guidance is intended for persons who prepare packages containing waste contaminated or suspected of being contaminated with Ebola, for transportation to off-site treatment and disposal. It provides guidance on DOT regulations regarding the transportation of a Category A infectious substance only and highlights some of the requirements of the HMR, which can affect transportation safety. This document should not be used as a substitute for the HMR to determine compliance.","U.S. Department of Transportation (DOT)",,,2014,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,"Y
Y - D0.1IC/D0.2IC Qualtrics # 209, original # 4a (additional resources)",,,,"Infection Prevention and Control",2024-06-10,,,,,,,,,,"U.S. Department of Transportation, Pipeline and Hazardous Materials Safety Administration. (2014). Procedural Guidance on the Proper Packaging of Ebola Suspected Waste.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/docs/suspected_ebola_patient_packaging_guidance_final.pdf,,,,"Ebola,Guidance Document,R-IPC,Viral Hemorrhagic Fever,Waste,Waste Management",https://repository.netecweb.org/files/original/180695c4e547c60466cb50f5fc4efcb6.pdf,Guide,Develop,1,0
454,https://repository.netecweb.org/items/show/454,"Safe Handling, Treatment, Transport and Disposal of Ebola-Contaminated Waste","Waste Management","Ebola-Contaminated Waste safe handling Fact Sheet","U.S. Department of Labor, Occupational Safety and Health Administration
Centers for Disease Control and Prevention (CDC)
National Institute for Occupational Safety and Health (NIOSH)
Environmental Protection Agency (EPA)",,,2016-03,"2022-01-19 by Beth Beam",,"Y - D0.1WM/D0.2WM Qualtrics # 1110, original # 14
",,,Publication,,2025-01-19,,,,,,,,,,"U.S. Department of Labor, Occupational Safety and Health Administration, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, and Environmental Protection Agency. (2016). Safe Handling, Treatment, Transport and Disposal of Ebola-Contaminated Waste.","Free online",,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.osha.gov/Publications/OSHA_FS-3766.pdf,,,,"Category A,Ebola,Guidance Document,Infection Prevention and Control,Personal Protective Equipment (PPE),R-WM,Sterilizer,Waste,Waste Management",https://repository.netecweb.org/files/original/bb85272eb8f4d2088fb9de3f85c33810.pdf,Publication,Develop,1,0
451,https://repository.netecweb.org/items/show/451,"Ebola-Associated Waste Management","Waste Management","
Who this is for: Hospitals and healthcare providers that care for patients under investigation (PUIs) for Ebola virus disease (EVD) or with confirmed cases of EVD.
What this is for: To help hospitals and healthcare providers safely handle, transport, and dispose of waste generated by the care of patients under investigation (PUIs) for or with confirmed Ebola virus disease (EVD).
How to use: This guidance is intended to provide key information about procedures and regulations regarding waste associated with the care of patients under investigation (PUIs) for or with confirmed Ebola virus disease (EVD).
",CDC,,,2019-04-03,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,"Y
Y - D0.1IC/D0.2IC Qualtrics # 209, original # 4a (additional resources)",,,,"Infection Prevention and Control",2024-06-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/vhf/ebola/clinicians/cleaning/waste-management.html,,,,"Category A,Ebola,Federal,Guidance Document,Infection Prevention and Control,R-IPC,Regulations,Sterilizer,Viral Hemorrhagic Fever,Waste,Waste Management",https://repository.netecweb.org/files/original/ca42e4ae60b148b047c670fce6db3795.png,Hyperlink,Develop,1,0
450,https://repository.netecweb.org/items/show/450," Ebola Waste Management ","Waste Management","This ASPR TRACIE TA response includes links to best practices related to the Ebola and other Category A agent medical waste management. The information can also be used by facilities without autoclaves or incinerators.
Related resources:
- ASPR TRACIE VHF/Ebola Topic Collection, section on Waste Management.
- ASPR TRACIE EMS Infectious Disease Playbook.
- Ebola-Associated Waste Management
- Interim – Planning Guidance for the Handling of Solid Waste Contaminated with a Category A Infectious Substance
- Nebraska Biocontainment Unit perspective on disposal of Ebola medical waste
- Safe Handling, Treatment, Transport and Disposal of Ebola-Contaminated Waste
- Procedural Guidance on the Proper Packaging of Ebola Suspected Waste: DOT Guidance for Preparing Packages of Ebola Contaminated Waste for Transportation and Disposal
","ASPR TRACIE",,,2019-01-31,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,"Y
Y - D0.1IC/D0.2IC Qualtrics # 209, original # 4a (additional resources)",,,,"Infection Prevention and Control",2024-06-10,,,,,,,,,,"ASPR TRACIE. (2019). Ebola Waste Management. ",,,,,,,,,,,,,,,,,,,,,,,,,,,"The requestor asked ASPR TRACIE for assistance in identifying best practices related to Ebola medical waste management, especially for hospitals that do not have an autoclave or incinerator. She is particularly interested in how other facilities move waste from the red zone to the green zone and what vendors others are using for Category A waste removal. ",,,https://files.asprtracie.hhs.gov/documents/aspr-tracie-ta-ebola-waste-management-redacted-1-31-19.pdf,,,,"Ebola,R-IPC,Viral Hemorrhagic Fever,Waste,Waste Management",https://repository.netecweb.org/files/original/b196bf3165239a1886f84a82b46061d7.pdf,Guide,Develop,1,0
427,https://repository.netecweb.org/items/show/427,"NETEC - Online Course - Infection Control for Special Pathogen Isolation ","Infection Control","This course will provide information on the importance of having robust infection control procedures in place to care for a patient with Ebola or other special pathogen. Some topics that will be discussed include patient placement, patient care, donning and doffing personal protective equipment and how to transfer and dispose of waste from care of the patient.
This course is intended primarily for healthcare workers and teams in a biocontainment unit or special pathogen isolation area. Additional medical staff and public health professionals may also find the course to be of benefit. Those individuals may include but are not limited to, medical and nursing staff, administration, education/training leadership, and infection control leadership. Staff specializing in emergency management, communications, specialized clinical areas, laboratory, facilities management and environmental services are also welcome.",NETEC,,,2019-02-22,"2022-12-07 Note from Benjamin - ON Air Force online courses list - DO NOT ARCHIVE
2023-10-17 by Darrell Ruby, T&E group",,"Y - PPE pos 83 qualtrics 304
Y - D0.1PPE/D0.2PPE Qualtrics # 304",,,"Online Course",,2026-10-17,,,,,,,,"Free with free account",,,,,,,,,,,,,,,"Self-paced ",,,,,,,,,,,,,,"Continuing Education Units Available
CNE .72
CME .75",,,"https://courses.netec.org/courses/infection-control-for-special-pathogen-isolation ",,,,"Donning and Doffing,Infection Prevention and Control,Intake,Internal Transport,Patient Care,Patient Placement,Personal Protective Equipment (PPE),R-T&E,Special Pathogens,Training,Waste,Waste Management",https://repository.netecweb.org/files/original/8e1c5658576d9a00af2162ce47809675.png,"Online Course",Develop,1,0
409,https://repository.netecweb.org/items/show/409,"How to Remove Gloves Safely","Infection Control","CDC Communication Resources, Poster on how to remove gloves safely: To protect yourself, use the following steps to take off gloves.",CDC,,,2018-08-27,"2022-01-19 by Beth Beam",,,,,,,2025-01-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/vhf/ebola/resources/posters.html,,,,"Doffing,Gloves,Infection Prevention and Control,Personal Protective Equipment (PPE),R-PPE",https://repository.netecweb.org/files/original/851535e52c508d4104cebdc6c95bd715.pdf,Guide,Develop,1,0
359,https://repository.netecweb.org/items/show/359,"Community Engagement in Ethics and Ebola",General,"A learning module for students to discuss, identify, and consider issues related to community engagement in public health emergency planning and response.","Presidential Commission for the Study of Bioethical Issues",,,2016-07-13,"2024-03-28 by J. Mundy – General subject – setting first review day 2025-01-01",,,,,,,2025-01-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://bioethicsarchive.georgetown.edu/pcsbi/node/5834.html,,,,"Communications,Ebola,Epidemic,Ethics,Legal,Outbreaks,Patient Care,Public Health,Quarantine,R-Gen,Research",,"Online Course",Develop,1,0
357,https://repository.netecweb.org/items/show/357,"Lessons Learned in Developing an Effective Regional Ebola CONOPS (Concept of Operations)","Emergency Management","This recorded webinar with slides aims to share lessons learned to assist regions in the development of their Ebola concept of operations (CONOPS) (ASPR).",ASPR,,,2016-08-10,"2024-03-27 Emergency Management skipped in review – bump to next quarter",,,,,,,2024-07-27,,,,,,,,,https://attendee.gotowebinar.com/recording/7535609970138234881,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://files.asprtracie.hhs.gov/documents/aspr-tracie-ebola-conops-webinar-slides.pdf,,,,"Communications,CONOPS,Ebola,Emergency Management,Epidemic,Identify,Inform,Isolate,Outbreaks,Pre-Hospital,Public Health,Quarantine,R-EM,R-EMS,R-PreH",https://repository.netecweb.org/files/original/33fc46a2ef0427131874445e95642a86.pdf,Webinar,Develop,1,0
356,https://repository.netecweb.org/items/show/356,"Ethically Sound",General,"Episode of the 'Ethically Sound' podcast, discussing ethics and ebola.","Presidential Commission for the Study of Bioethical Issues",,,2016-09-19,"2024-03-28 by J. Mundy – General subject – setting first review day 2025-01-01",,,,,,,2025-01-01,,,,,,,"",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://bioethicsarchive.georgetown.edu/pcsbi/node/5891.html,,,,"Ebola,Epidemic,Ethics,Legal,Outbreaks,Patient Care,Public Health,Quarantine,R-Gen,Research,Special Pathogens,Survivors",,Webinar,Develop,1,0
355,https://repository.netecweb.org/items/show/355,"Guidance For Managing Ethical Issues In Infectious Disease Outbreaks",General,"Infectious disease outbreaks are frequently characterized by scientific uncertainty, social and institutional disruption, and an overall climate of fear and distrust. Policy makers and public health professionals may be forced to weigh and prioritize potentially competing ethical values in the face of severe time and resource constraints. This document seeks to assist policy-makers, health care providers, researchers, and others prepare for outbreak situations by anticipating and preparing for the critical ethical issues likely to arise. (WHO)","World Health Organization (WHO)",,,2016-10-18,"2024-03-28 by J. Mundy – General subject – setting first review day 2025-01-01",,,,,Publication,,2025-01-01,,,,,,,,,,"WHO. 2016. Guidance for Managing Ethical Issues in Infectious Disease Outbreaks. ",,,http://apps.who.int/iris/bitstream/10665/250580/1/9789241549837-eng.pdf?ua=1,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.who.int/publications/i/item/9789241549837,,,,"Ebola,Epidemic,Ethics,Legal,Outbreaks,Patient Care,Public Health,Quarantine,R-Gen,R-Res&Pub,Research,Special Pathogens,Survivors",,Publication,Develop,1,0
354,https://repository.netecweb.org/items/show/354,"Patient Isolation and Transportation - ISO-POD Update: AirBoss Defense Advantage",Pre-Hospital,"An ISOPOD is a device used in the transportation of a potentially infectious patient, either internally at a facility, or from one facility to another.
In this video Brittany Nordby, RN, BSN, EMT, Project Coordinator for HEROES, provides an explanation of the new features found on the latest generation of ISO-POD manufactured by AirBoss Defense.","University of Nebraska Medical Center / Nebraska Medicine / Heroes",,,2017-11-27,"2022-12-07 general asset review - IPC (change to R-IIT, R-PreH)
2024-03-27 EMS/Pre-Hospital never reviewed – bump to next quarter",,,,,,,2024-06-10,,,,,,,"",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.youtube.com/watch?v=m-_MFBdxYt4,,,,"Infection Prevention and Control,Isopod,Patient Transport,Portable Isolation Unit,Protocol,R-IIT,R-PreH,Standard Operating Procedure (SOP)",,Video,Develop,1,0
353,https://repository.netecweb.org/items/show/353,"Activation Checklist","Personnel Management","Checklist for when the NBU is being activated.","University of Nebraska Medical Center / Nebraska Medicine",,,2018-06-01,"2023-07-13 by Christa Arguinchona and Caroline Croyle (PM)",,,,,,,2024-07-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Activation,Inform,Personnel Management,R-Lead,R-PM,Staffing,Standard Operating Procedure (SOP)",https://repository.netecweb.org/files/original/11a347cfbc7fbd5b97d6d9a230483643.pdf,Checklist,Develop,1,0
352,https://repository.netecweb.org/items/show/352,"Activation Staff Roles","Personnel Management","Policies and Procedures Manual: To provide guidance for staffing and operating the NBU during periods of activation. ","University of Nebraska Medical Center / Nebraska Medicine",,,2018-06-01,"2023-07-13 by Christa Arguinchona and Caroline Croyle (PM)",,"Y - D0.1PM/D0.2PM Qualtrics # 905, original # 4",,,,,2024-07-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Activation,Inform,Personnel Management,R-Lead,R-PM,Staff Rotations,Staffing,Staffing Model,Standard Operating Procedure (SOP)",https://repository.netecweb.org/files/original/b9fc09f1d00dad841849d099dd647d98.pdf,Protocol,Develop,1,0
351,https://repository.netecweb.org/items/show/351,"Waste Removal Process (Categories A and B)","Waste Management","Policies and Procedures Manual: To provide guidance for removing waste items from the NBU. ","University of Nebraska Medical Center / Nebraska Medicine",,,2017-12-01,"2022-12-07 general asset review - IPC
2024-03-27 Waste never returned – bump to next review",,"Y - D0.1WM/D0.2WM Qualtrics # 1101, original #
Y - D0.1IC/D0.2IC Qualtrics # 209, original # 4a (additional resources)",,,,,2024-08-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Autoclave,Infection Prevention and Control,Protocol,R-WM,Standard Operating Procedure (SOP),Waste Management",https://repository.netecweb.org/files/original/a709da8bb0b1340277e89c318e445cc7.pdf,Protocol,Develop,1,0
350,https://repository.netecweb.org/items/show/350,"Laundry Policy (VHF)","Infection Control","Policies and Procedures Manual: To prevent the potential transmission of highly hazardous communicable diseases through contaminated laundry. ","University of Nebraska Medical Center / Nebraska Medicine",,,2018-06-01,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,,,,,"Infection Prevention and Control",2024-06-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Decontamination,Infection Prevention and Control,Protocol,R-IPC,Standard Operating Procedure (SOP),Viral Hemorrhagic Fever",https://repository.netecweb.org/files/original/088f4257f07d32d3fe3842a3b3b7626c.pdf,Protocol,Develop,1,0
349,https://repository.netecweb.org/items/show/349,"Isopod Setup",Pre-Hospital,"Policies and Procedures Manual: Instructions on how to set-up the Isopod to allow for the safe transportation of a patient with a highly hazardous communicable disease.","University of Nebraska Medical Center / Nebraska Medicine",,,2018-07-01,"2022-12-07 general asset review - IPC (change R-PreH)
2024-03-27 EMS/Pre-Hospital never reviewed – bump to next quarter",,,,,,,2024-06-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Infection Prevention and Control,Isopod,Patient Transport,Portable Isolation Unit,Protocol,R-EMS,R-PreH,Standard Operating Procedure (SOP)",https://repository.netecweb.org/files/original/96bcc35f787443417084de21b33acb0a.pdf,Protocol,Develop,1,0
348,https://repository.netecweb.org/items/show/348,"Isopod Cleaning and Storage","Infection Control","Policies and Procedures Manual: To insure the Isopod is charged and ready for use when needed and to safely dispose of the Isopod after use. ","University of Nebraska Medical Center / Nebraska Medicine",,,2018-04-01,"2022-12-07 general asset review - IPC (change to R-IIT)
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,,,,,IIT,2024-06-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Decontamination,Infection Prevention and Control,Isopod,Portable Isolation Unit,Protocol,R-IIT,Standard Operating Procedure (SOP)",https://repository.netecweb.org/files/original/5a49149e53c019c125e3e52047f80a1c.pdf,Protocol,Develop,1,0
347,https://repository.netecweb.org/items/show/347,"Obtaining and Processing Laboratory Specimens",Laboratory,"Policies and Procedures Manual: To obtain and process laboratory specimens while maintaining infection control practices. ","University of Nebraska Medical Center / Nebraska Medicine",,,2018-05-01,"2022-12-07 general asset review - IPC (change to R-Lab)
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,,,,,Laboratory,2024-06-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Infection Prevention and Control,Lab,Laboratory,Protocol,R-Lab,Specimen Collection,Specimen Handling,Specimen Transport,Standard Operating Procedure (SOP)",https://repository.netecweb.org/files/original/319de4d429f263b40f89ea97e22096ca.pdf,Protocol,Develop,1,0
346,https://repository.netecweb.org/items/show/346,"Containment Wrap Guidelines","Intake and Internal Transport","Policies and Procedures Manual: To provide guidelines for the use of a containment wrap during intra-facility transport; or direct admission from the emergency department to the Nebraska Biocontainment Unit (NBU). ","University of Nebraska Medical Center / Nebraska Medicine",,,2018-08-01,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,"Y
Y - D0.1IC/D0.2IC Qualtrics # 213, original # 7
Y - D0.1IIT/D0.2IIT - Qualtrics # 715",,,,"Infection Prevention and Control",2024-06-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Infection Prevention and Control,Internal Transport,Patient Transport,Pre-Hospital,Protocol,R-IPC,Standard Operating Procedure (SOP)",https://repository.netecweb.org/files/original/b68363bffb7eec4a6189ada3a480317f.pdf,Protocol,Develop,1,0
345,https://repository.netecweb.org/items/show/345,"Autoclave Policy/Procedure","Waste Management","Policies and Procedures Manual: To prevent patients and healthcare workers from becoming contaminated by any materials used in the NBU. ","University of Nebraska Medical Center / Nebraska Medicine",,,2021-12,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,Y,,,,"Infection Prevention and Control",2024-06-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Autoclave,Infection Prevention and Control,Protocol,R-IPC,Standard Operating Procedure (SOP),Waste Management",https://repository.netecweb.org/files/original/c7c4a0214b5d91d8d3180384d467609a.pdf,Protocol,Develop,1,0
344,https://repository.netecweb.org/items/show/344,"Handling Infectious Human Remains (BioSeal System)","Decedent Management","Policies and Procedures Manual: To provide a safe method for the removal of infectious human remains from the Nebraska Biocontainment Unit (NBU). ","University of Nebraska Medical Center / Nebraska Medicine",,,2021-03,"2022-04-27 by Kate Boulter - file updated
2022-12-07 general asset review - IPC
2024-03-27 Decedent Management never returned – bump to next review",,"Y
Y - D0.1IC/D0.2IC Qualtrics # 213, original # 7 (additional resources)",,,,,2024-08-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Decedent Management,Decontamination,Equipment and Supplies,Infection Prevention and Control,Protocol,Public Health,R-DM,Standard Operating Procedure (SOP)",https://repository.netecweb.org/files/original/c97d0df20340e6de1e0b78ec231aa93f.pdf,Protocol,Develop,1,0
343,https://repository.netecweb.org/items/show/343,"Bodily Fluid / Other Liquid Spills / Sharps Cleanup","Infection Control","Policies and Procedures Manual: To define a process for clean-up, disinfection and disposal of bodily fluid and other fluid spills, including those that contain sharps. ","University of Nebraska Medical Center / Nebraska Medicine",,,2018-03-01,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,"Y
Y - D0.1IC/D0.2IC Qualtrics # 213, original # 7",,,,"Infection Prevention and Control",2024-06-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Infection Prevention and Control,Protocol,R-IPC,Spills,Standard Operating Procedure (SOP)",https://repository.netecweb.org/files/original/038464633df922287eae748185e97474.pdf,Protocol,Develop,1,0
337,https://repository.netecweb.org/items/show/337,"Kansas Highly Infectious Disease and Pandemic Plan","Emergency Management","The Kansas Department of Health and Environment (KDHE) developed a preparedness and response plan following the 2014 Ebola outbreak in West Africa in response to the possibility of cases affecting Kansas. This ""Kansas Ebola Virus Preparedness and Response Plan"" has been updated to the ""Kansas Highly Infectious Disease and Pandemic Plan.""
https://www.kdhe.ks.gov/1505/Ebola-Virus-Disease","Kansas Department of Health and Environment",,,2023-01,,,,,,,,2024-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"See Resources under the ""For Health Care Providers"" section of the page. Requires login.",,,https://www.kdhe.ks.gov/1505/Ebola-Virus-Disease,,,,"Communications,CONOPS,Decontamination,Ebola,Emergency Management,EMS,Epidemic,Federal,Identify,Infection Prevention and Control,Inform,Isolate,Lab,Laboratory,Laboratory Testing,Medical Surveillance,Outbreaks,Patient Transport,Person Under Investigation (PUI),Personal Protective Equipment (PPE),Public Health,Quarantine,R-EM,Region 7,Specimen Collection,Specimen Handling,Specimen Transport,Temperature Monitoring,Waste Management",,Guide,Develop,1,0
336,https://repository.netecweb.org/items/show/336,"Recommendations for Assessment of Blood Donor Eligibility, Donor Deferral and Blood Product Management in Response to Ebola Virus","Treatment & Care","This guidance represents the current thinking of the Food and Drug Administration (FDA or Agency) on this topic. It does not establish any rights for any person and is not binding on FDA or the public. You can use an alternative approach if it satisfies the requirements of the applicable statutes and regulations. To discuss an alternative approach, contact the FDA staff responsible for this guidance as listed on the title page (FDA, page 1).","U.S. Food and Drug Administration",,,2017-01-01,"2022-09-27 - general asset review - Treatment & Care group",,,,,,,2025-09-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM475072.pdf,,,,"Ebola,Example,Lab,Laboratory,Public Health,R-T&C,Specimen Collection,Specimen Handling,Therapeutics",,Guide,Develop,1,0
335,https://repository.netecweb.org/items/show/335,"Completing the Development of Ebola Vaccines: CURRENT STATUS, REMAINING CHALLENGES, AND RECOMMENDATIONS","Treatment & Care","In the third major report from the Wellcome Trust–CIDRAP Ebola Vaccine Team B reflects on progress to date and the remaining challenges faced.","University of Minnesota, Center for Infectious Disease Research and Policy",,,2017-01-17,"2022-09-27 - general asset review - Treatment & Care group",,,,,Publication,,2025-09-27,,,,,,,,,,,"Available online. © 2017 Regents of the University of Minnesota. All rights reserved.",,https://www.cidrap.umn.edu/sites/default/files/downloads/ebola_team_b_report_3-011717-final_0.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cidrap.umn.edu/sites/default/files/downloads/ebola_team_b_report_3-011717-final_0.pdf,,,,"Clinical Trial,Ebola,Ethics,Federal Research Partners,Prophylaxis,Public Health,R-Res&Pub,R-T&C,Research Design,Vaccine Study",,Publication,Develop,1,0
334,https://repository.netecweb.org/items/show/334,"Planning Guidance for Handling Category A Solid Waste","Waste Management","What this is for: This Guidance is for safe handling of solid waste contaminated with a Category A infectious substance (henceforth, “contaminated waste”) and the proper management of inactivated Category A waste materials in the United States.* An infectious substance meets Category A criteria if it is in a form capable of causing permanent disability or life-threatening or fatal disease in otherwise healthy humans or animals upon exposure to the substance.
","U.S. Department of Transportation",,,2022-06-10,"2022-12-07 general asset review IPC - updated from Interim-Planning Guidance for the Handling of Solid Waste Contaminated with a Category A Infectious Substance from 2017-01-19",,"Y - D0.1WM/D0.2WM Qualtrics # 1101, original #
Y - D0.1WM/D0.2WM Qualtrics # 1102
Y - D0.1WM/D0.2WM Qualtrics # 1103
Y - D0.1WM/D0.2WM Qualtrics # 1104
Y - D0.1WM/D0.2WM Qualtrics # 1108, original # 1
Y - D0.1IC/D0.2IC Qualtrics # 209, original # 4a (additional resources)
",,,,,2024-12-07,,,,,,,,,,https://www.phmsa.dot.gov/transporting-infectious-substances/planning-guidance-handling-category-solid-waste,,,,,,,,,,,,,,,,,,,,,,,,,,,"Information in this guidance serves several purposes. As a whole, the document offers readers an overview of Category A waste management in the United States. The main component of this guidance addresses planning for Category A waste management activities, including considerations for developing, evaluating, and revising organizational (e.g., hospital) or jurisdictional (e.g., state, territorial, or local) plans. It is presented in sections that break down waste management activities according to responsibilities as waste is moved from its point of generation to its place of disposal. Several accompanying appendices provide users with information about pathogens classified as Category A infectious substances, decision making for waste treatment and disposal activities, communicating effectively about safe waste management and associated issues, and additional related resources. The included listing of acronyms and glossary of terms applies to the entire document. Unless otherwise noted, references to a particular appendix or section refer to parts of this document (and, in the electronic version, can be clicked to navigate to that information directly).
",,,https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/2022-06/Cat%20A%20Waste%20Planning%20Guidance_Final_2022_06.pdf,,,,"Category A,R-WM,Special Pathogens,Waste Management",https://repository.netecweb.org/files/original/1079f8b32bbc30c6d77973694d85ab5c.pdf,Guide,Develop,1,0
333,https://repository.netecweb.org/items/show/333,"Care and Protection of Children in the West African Ebola Virus Disease Epidemic: Lessons learned for future public health emergencies","Treatment & Care","Report and webinar about child protection response with Ebola.","Alliance for Child Protection in Humanitarian Action, UNICEF",,,2017-01-23,"2022-09-27 - general asset review - Treatment & Care group (3 yr)
2022-07 by Clayton, Special Populations Treatment & Care group (1 yr - went with T&C)",,,,,,,2025-09-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://resourcecentre.savethechildren.net/library/care-and-protection-children-west-african-ebola-virus-disease-epidemic-lessons-learned,,,,"Ebola,Pediatrics,Public Health,R-SP,R-T&C,Treatment and Care",,Guide,Develop,1,0
331,https://repository.netecweb.org/items/show/331,"Integrating Clinical Research into Epidemic Response",Research,"
Table of Contents
|
|
Front Matter
|
i-xxvi
|
Summary
|
1-18
|
1 Introduction
|
19-36
|
2 Conducting Clinical Research During an Epidemic
|
37-82
|
3 Assessment of Therapeutic Trials
|
83-112
|
4 Assessment of Vaccine Trials
|
113-154
|
5 Strengthening Capacity for Response and Research
|
155-198
|
6 Engaging Communities in Research and Response
|
199-222
|
7 Facilitating International Coordination and Collaboration
|
223-250
|
Appendix A: Study Approach and Methods
|
251-286
|
Appendix B: Clinical Trial Designs
|
287-296
|
Appendix C: Ethical Principles for Research with Human Subjects
|
297-300
|
Appendix D: Biographical Sketches of Committee Members and Staff
|
301-316
|
","National Academies Press",,,2017-04-12,,,,,,,,,,,,,,,,,,"National Academies of Sciences, Engineering, and Medicine. 2017. Integrating Clinical Research into Epidemic Response: The Ebola Experience. Washington, DC: The National Academies Press. https://doi.org/10.17226/24739.","Free online or pdf download.","Contributors
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Global Health; Board on Health Sciences Policy; Committee on Clinical Trials During the 2014-2015 Ebola Outbreak; Gerald Keusch, Keith McAdam, Patricia A. Cuff, Michelle Mancher, and Emily R. Busta, Editors
Description
The 2014–2015 Ebola epidemic in western Africa was the longest and most deadly Ebola epidemic in history, resulting in 28,616 cases and 11,310 deaths in Guinea, Liberia, and Sierra Leone. The Ebola virus has been known since 1976, when two separate outbreaks were identified in the Democratic Republic of Congo (then Zaire) and South Sudan (then Sudan). However, because all Ebola outbreaks prior to that in West Africa in 2014–2015 were relatively isolated and of short duration, little was known about how to best manage patients to improve survival, and there were no approved therapeutics or vaccines. When the World Heath Organization declared the 2014-2015 epidemic a public health emergency of international concern in August 2014, several teams began conducting formal clinical trials in the Ebola affected countries during the outbreak.
",https://www.nap.edu/read/24739,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.nap.edu/catalog/24739/integrating-clinical-research-into-epidemic-response-the-ebola-experience,,,,"Clinical Trial,Ebola,Ethics,Master Protocol,Prophylaxis,R-Res&Pub,Research Design,Special Pathogens,Therapeutics",,Publication,Develop,1,0
329,https://repository.netecweb.org/items/show/329,"Health Sector Resilience Checklist for High-Consequence Infectious Diseases",General,"Using lessons learned from treating Ebola patients in the US during the 2014-2016 Ebola epidemic in West Africa, this paper works to develop an evidence-informed checklist that outlines action steps.","Johns Hopkins Center for Health Security","Eric Toner, MD; Matthew P. Shearer, MPH; Tara Kirk Sell, PhD; Diane Meyer, RN, MPH; Hannah Chandler; Monica Schoch-Spana, PhD; Erin Thomas Echols, PhD; Dale Rose, PhD; Eric Carbone, MBA, PhD",,2017-05-24,"2022-12-07 general asset review - IPC (change R-EM)
2023-05-15 JCM - updated URL to PDF
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,,,,,"Emergency Management",2024-06-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://centerforhealthsecurity.org/sites/default/files/2023-02/hcidfinalreport05232017.pdf,,,,"Communications,Decontamination,Ebola,Emergency Management,EMS,Epidemic,High Consequence Infectious Disease (HCID),Identify,Infection Prevention and Control,Inform,Isolate,Lab,Laboratory,Medical Surveillance,Outbreaks,Patient Transport,Person Under Investigation (PUI),Public Health,Quarantine,R-EM,Special Pathogens,Temperature Monitoring",,Checklist,Develop,1,0
327,https://repository.netecweb.org/items/show/327,"Flexible Clinical Trial Design Suitable for Emerging Disease Outbreaks ",Research,"FDA CDER statisticians are designing trials with adaptive features to make clinical evaluation of new drug treatments more efficient and informative. (FDA)
More information on the subject can be read here.","U.S. Food and Drug Administration (FDA)",,,2018-08-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.fda.gov/media/115957/download,,,,"Clinical Trial,Ebola,Master Protocol,Prophylaxis,R-Res&Pub,Research Design,Special Pathogens,Therapeutics",,Guide,Develop,1,0
326,https://repository.netecweb.org/items/show/326,"Consultation on Monitored Emergency Use of Unregistered and Investigational Interventions (MEURI) for Ebola Virus Disease (EVD) ","Treatment & Care","A group of independent scientific experts were convened by the WHO for the purpose of updating the May 2018 statement on MEURI for Ebola virus disease (EVD) during the current outbreak, 27 August 2018. (1)",WHO,,,2018-08-27,"2022-09-27 - general asset review - Treatment & Care group",,,,,,,2025-09-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.medbox.org/document/notes-for-the-record-consultation-on-monitored-emergency-use-of-unregistered-and-investigational-interventions-meuri-for-ebola-virus-disease-evd#GO,,,,"Ebola,Prophylaxis,R-T&C,Therapeutics",,Guide,Develop,1,0
324,https://repository.netecweb.org/items/show/324,"Working with People and Communities in Urban Humanitarian Crises","Emergency Management","This Working Paper explores the topic of working with urban populations and communities.","Active Learning Network for Accountability and Performance in Humanitarian Action","Leah Campbell, author.",,2017-06-01,"2024-02-26 by J. Mundy - updated the URL from ALNAP to ResearchGate, publication appears gone from ALNAP website.
2024-03-27 Emergency Management skipped in review – bump to next quarter",,,,,Publication,,2024-07-27,,,,,,,,,,"Campbell, L. (2017) ‘Working with people and communities in urban humanitarian crises’ ALNAP Working Paper. London: ODI/ALNAP.","Free Online","This Working Paper explores the topic of working with urban populations and communities. It draws on practical challenges and approaches in relation to targeting and communication with urban populations, and in the mobilisation of urban communities. The paper was informed by a literature review, as well as ALNAP’s ongoing urban webinar series and Community of Practice discussions, which have consistently raised these issues over the past few years. (4)",,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.researchgate.net/publication/322664589_Working_with_people_and_communities_in_urban_humanitarian_crises,,,,"Communications,Ebola,Emergency Management,Epidemic,Epidemiology,Outbreaks,Public Health,Quarantine,R-EM,R-Res&Pub,Special Pathogens",,Publication,Develop,1,0
322,https://repository.netecweb.org/items/show/322,"Emerging Diseases and Implementation of Emergency Use Authorizations",Laboratory,"Emerging Infections and Implementation of Emergency Use Authorizations content was developed by Susanne Norris Zanto of Laboratory SolutionZ. The narrator is Tracy Hoke, the BT Coordinator at the North Dakota Department of Health, Division of Laboratory Services.","North Dakota Department of Health",,,2017-06-23,"2023-12-18 by Lab (Vicki and Kim), 3 yr / Example",,,,,,,2026-12-18,,,,,,,,,,,,,,,,,,,,,,,"77 minutes 46 seconds.",,,,,,,,,,,,,,,,,http://www.ndhealth.gov/microlab/BTWorkshop/Emerging_Diseases_2017/index.htm,,,,"Diagnosis,Ebola,Epidemic,Example,Lab,Laboratory,Laboratory Testing,Public Health,R-Lab,Special Pathogens,Specimen Collection,Specimen Handling",,Webinar,Develop,1,0
321,https://repository.netecweb.org/items/show/321,"Ebola Response in Cities","Emergency Management","In November 2014, ALNAP launched a sub-group of the Urban Response Community of Practice (CoP) to gather learning from the urban aspects of the Ebola Virus Disease (EVD) response in West Africa.","Active Learning Network for Accountability and Performance in Humanitarian Action",,,2017-06-26,"2024-02-26 by J. Mundy - updated url from ALNAP to ResearchGate, publication appears gone from ALNAP website.
2024-03-27 Emergency Management skipped in review – bump to next quarter",,,,,Publication,,2024-07-27,,,,,,,,,,"Campbell, L. (2017) Ebola Response in cities: Learning for future public health crises. ALNAP Working Paper. London: ALNAP/ODI.","Free online.","Summary:
In November 2014, ALNAP launched a sub-group of the Urban Response Community of Practice (CoP) to gather learning from the urban aspects of the Ebola Virus Disease (EVD) response in West Africa. Informed by CoP discussions, interviews and review of literature and media articles, ALNAP has produced four brief learning reports. Three of these cover issues around population movement ; working in a context of quarantine ; and communication and engagement . This paper explores a variety of issues by looking at the case of one urban informal settlement, West Point, Monrovia, Liberia, and its experience of the EVD outbreak and response.
The EVD outbreak in West Africa was the first time EVD had infiltrated an urban area. The unprecedented scale of the outbreak combined with the dynamic urban contexts within the affected region challenged responders considerably.
The three most affected countries were Guinea, Liberia and Sierra Leone. All three have seen unprecedented urban growth in recent years. All three have a legacy of conflict and unplanned development, and they all struggle with health care and other related infrastructure, including water, sanitation and electricity.
West Point, Monrovia, is an informal settlement in Liberia that, despite being an official township of the capital city, has experienced decades of unplanned growth and expansion, particularly since internally displaced persons from the Liberian civil war began to arrive. It has significant water, sanitation, hygiene, electricity, access, land tenure, erosion and protection issues, which have been persistently present and unresolved pretty much since the settlement was established. Despite these challenges, West Point has been described as fairly cohesive, and its proximity both to the coast and to economic activity in Monrovia means many residents do have an income. At the time of the EVD outbreak, West Point was home to approximately 70,000 residents.
EVD reached Monrovia in June 2014, having arrived in the country in March. Few cases were reported in April and May, which led officials to believe the outbreak had been contained. However, over the summer, it became clear that failed messaging combined with denial, mistrust and scepticism had driven the outbreak underground, with illness and death occurring without being reported. In August, after an official visiting West Point discovered several cases of EVD deaths, the government enacted a swift plan to transform a school in the settlement into an Ebola holding centre. Within a matter of days the holding centre was opened, the community rioted, the entire settlement was put under quarantine and it was released, following long-overdue consultations between government and community leaders.
From September 2014, the response to EVD in West Point was largely community-led. While there was support from and programming by both the government and international actors, it was West Point community volunteers who tackled the denial, got cases reported and ultimately ended the crisis in the settlement, which reported its last case of EVD in December 2014. Leaders from West Point were later asked to help other parts of Monrovia still tackling the disease.
Today, though Ebola-free, West Point remains an informal settlement with great water, sanitation and hygiene, environmental, social and political challenges. The handful of upgrades and improvements it received during the response has not tackled issues that have persisted since long prior to the outbreak. And mistrust between the community and the government is likely to continue, as the future of West Point and its residents has yet to be determined.
West Point’s experience of EVD sheds light on many of the issues discussed throughout this series, including the challenges posed when quarantine is enacted in a dense informal settlement; the importance of community mobilisation, particularly in an urban environment; the critical role of population movement in informing the makeup of the community and also in illustrating behaviour throughout the outbreak; and why it took so long to apply an urban response to this largely urban crisis.",,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.researchgate.net/publication/322664653_Ebola_Response_in_cities_Learning_for_future_public_health_crises,,,,"Communications,Ebola,Emergency Management,Epidemic,Epidemiology,Outbreaks,Public Health,Quarantine,R-EM,R-Res&Pub",,Publication,Develop,1,0
311,https://repository.netecweb.org/items/show/311,"Online Audiocasts From the SHEA/CDC ORTP (Society for Healthcare Epidemiology of America/Centers for Disease Control and Prevention Outbreak Response Training Program) Regional Training Workshop",General,"These audiocasts, recorded at the SHEA/CDC ORTP Regional Training Workshop, discuss successes and failures of past infectious disease outbreaks and offer insights into the key steps involved in preparing your facility for the next high-consequence pathogen infection, communicating during hospital crises, defining leadership roles during responses, and identifying actions that can and should be taken to care for patients, staff, and public.","Centers for Disease Control and Prevention",,,2023-10-18,"2022-01-31 by Joanna Mundy and Shelly Schwedhelm (url updated)
2023-02-01 by Joanna Mundy waiting for re-review until I receive first reviews from T&E.
2023-10-17 by Darrell, T&E group.",,,,,,,2024-10-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Click the ""Register/Enroll"" tab to get to the webinars, simulations, audiocasts, and guidance.",,,https://learningce.shea-online.org/content/audiocasts,,,,"Behavioral Health,Biosafety,Clinical Care Guidelines,Communications,CONOPS,Diagnosis,Ebola,Emergency Management,Epidemic,Exercises and Drills,MERS-CoV,Person Under Investigation (PUI),Preparedness,Public Health,R-T&E,Special Pathogens,Therapeutics,Training,Treatment and Care,Viral Hemorrhagic Fever",,"In Person Course",Develop,1,0
310,https://repository.netecweb.org/items/show/310,"Products Approved for Other Bioterrorism Emergencies","Treatment & Care","This site lists products for Botulism due to Clostridium botulinum toxin; Ebola Virus Disease (EVD); Glanders and Melioidosis due to Burkholderia mallei and B. pseudomallei, respectively; Plague due to Yersinia pestis; Smallpox due to Variola major and Variola minor; Tularemia due to Francisella tularensis; and Zika Virus Disease.","U.S. Food and Drug Administration",,,2017-09-08,"2022-09-27 - general asset review - Treatment & Care group",,,,,,,2025-09-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.fda.gov/Drugs/EmergencyPreparedness/BioterrorismandDrugPreparedness/ucm063804.htm,,,,"Coronavirus,Ebola,Experimental Drugs,MERS-CoV,Orthopox Virus,Plague,Prophylaxis,R-T&C,Respiratory Pathogen,Smallpox,Special Pathogens,Therapeutics,Viral Hemorrhagic Fever",,Guide,Develop,1,0
300,https://repository.netecweb.org/items/show/300,"Public health interventions in pandemics and epidemics ","Emergency Management","The 21st century has witnessed changes - travel and trade, urbanization, environmental degradation and other trends that increase the risk of disease outbreaks, their spread and amplification into epidemics and pandemics. At the same time, the science and knowledge around infectious hazards are constantly evolving. This introductory level online course will guide you through the new landscape by providing information and tools you need to better manage disease outbreaks and health emergencies. (WHO)",WHO,,,2018-07-05,"2024-03-27 Emergency Management skipped in review – bump to next quarter",,,,,,,2024-07-27,,,,,,,,"Free with free OpenWHO account.",,,,,,,,,,,,,,,"Approximately 3 hours.",,,,,,,,,,,,,,,,,https://openwho.org/courses/public-health-interventions,,,,"Emergency Management,Epidemic,Flu,Influenza,Pandemic,Public Health,R-EM",,"Online Course",Develop,1,0
252,https://repository.netecweb.org/items/show/252,"Enacting high reliability principles while caring for people with Ebola Virus Disease","Infection Control","Fear surrounds Ebola Virus Disease (EVD) because it is highly infectious. Yet members of the Serious Communicable Diseases Unit (SCDU) at Emory University Hospital (EUH) had to overcome that fear when caring for patients with EVD.","Jennings B. M., Yeager K. A., Feistritzer N. R., Gullatte M. M., Martyn K. K.",,,2018-05-18,"2022-01-10 by PPE group Shawn Gibbs",,"Y - D0.1Tx/D0.2Tx Qualtrics # 822, original #
Y - D0.1PM/D0.2PM Qualtrics # 910, original # 7",,,Publication,,2025-01-10,,,,,,,,,,"Jennings, B. M., K. A. Yeager, N. R. Feistritzer, M. M. Gullatte and K. K. Martyn (2018). ""Enacting high reliability principles while caring for people with Ebola Virus Disease."" Am J Infect Control.","pay online - or through clinicalkey, or elsevier subscription","
BACKGROUND:
Fear surrounds Ebola Virus Disease (EVD) because it is highly infectious. Yet members of the Serious Communicable Diseases Unit (SCDU) at Emory University Hospital (EUH) had to overcome that fear when caring for patients with EVD.
PURPOSE:
The analysis reported here illustrates how the members of EUH's SCDU tacitly enacted high reliability (HR) principles while caring for patients with EVD.
METHODS:
A qualitative study was conducted to describe the experience of members of the EUH SCDU who worked with EVD patients in 2014. We completed 17 semi-structured interviews involving registered nurses, physicians, and support personnel (eg, laboratory technicians). Interview recordings were transcribed and analyzed using conventional content analysis. Exploring HR principles was not among the questions guiding this exploration, but the participants repeatedly described concepts related to HR.
RESULTS:
The goal of the SCDU team was to save patients' lives while protecting their own lives. Rigorous training and meeting high standards were required to make the team. The fear surrounding EVD set in motion the enactment of HR principles. HR principles served to alleviate failures or breakdowns in infection prevention and control, thus keeping patients and staff safe.
CONCLUSIONS:
These findings illustrate that it is possible to move HR principles from theory to practice in high-risk situations. HR principles were essential to safety and to infection prevention and control.
",https://www.ajicjournal.org/article/S0196-6553(18)30461-9/fulltext,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/29784444,,,,"Fitness for Duty,Infection Prevention and Control,Nursing,Occupational Health,Personal Protective Equipment (PPE),Personnel Management,R-PM,R-PPE,R-Res&Pub,Site Managers,Staff Retention,Staff Rotation Schedules,Staff Support,Staffing,Staffing Model,Trained Observer,Treatment and Care,Waste",,Publication,Develop,1,0
248,https://repository.netecweb.org/items/show/248,"Public Health Resilience Checklist for High-Consequence Infectious Diseases-Informed by the Domestic Ebola Response in the United States","Infection Control","The experiences of communities that responded to confirmed cases of Ebola virus disease in the United States provide a rare opportunity for collective learning to improve resilience to future high-consequence infectious disease events.","Sell, T. K., M. P. Shearer, D. Meyer, H. Chandler, M. Schoch-Spana, E. Thomas, D. A. Rose, E. G. Carbone and E. Toner.",,,2018-03-27,"2022-12-07 general asset review - IPC (change to R-Res)
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,"Y - D0.1Tx/D0.2Tx Qualtrics # 821, original # ",,,Publication,,2024-06-10,,,,,,,,,,"Sell, T. K., M. P. Shearer, D. Meyer, H. Chandler, M. Schoch-Spana, E. Thomas, D. A. Rose, E. G. Carbone and E. Toner (2018). ""Public Health Resilience Checklist for High-Consequence Infectious Diseases-Informed by the Domestic Ebola Response in the United States."" Journal of public health management and practice.","pay online - or through Ovid","
CONTEXT:
The experiences of communities that responded to confirmed cases of Ebola virus disease in the United States provide a rare opportunity for collective learning to improve resilience to future high-consequence infectious disease events.
DESIGN:
Key informant interviews (n = 73) were conducted between February and November 2016 with individuals who participated in Ebola virus disease planning or response in Atlanta, Georgia; Dallas, Texas; New York, New York; or Omaha, Nebraska; or had direct knowledge of response activities. Participants represented health care; local, state, and federal public health; law; local and state emergency management; academia; local and national media; individuals affected by the response; and local and state governments. Two focus groups were then conducted in New York and Dallas, and study results were vetted with an expert advisory group.
RESULTS:
Participants focused on a number of important areas to improve public health resilience to high-consequence infectious disease events, including governance and leadership, communication and public trust, quarantine and the law, monitoring programs, environmental decontamination, and waste management.
CONCLUSIONS:
Findings provided the basis for an evidence-informed checklist outlining specific actions for public health authorities to take to strengthen public health resilience to future high-consequence infectious disease events.
",https://insights.ovid.com/pubmed?pmid=29595573,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/29595573,,,,"Checklist,Public Health,R-Res&Pub,R-T&C",,Publication,Develop,1,0
242,https://repository.netecweb.org/items/show/242,"PPE 201","Training and Exercises","Past in Person Course Presentation - Identify and select the PPE components needed in the care and management of wet patients with potentially hazardous and communicable diseases such as Ebola and other special pathogens. Develop SOP for wet PPE donning and doffing, using appropriate equipment. Assess strengths and weakness of PPE SOP.",NETEC,,,2018,"2023-10-30 by Darrell Ruby/Amy Mead - submit asset update - Consider adding in context on difference between a trained observer and a doffing assistant. ",,,,,,,2025-10-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Donning and Doffing,Personal Protective Equipment (PPE),R-PPE,R-T&E",https://repository.netecweb.org/pdfs/PPE201.pdf,"In Person Course",Develop,1,0
241,https://repository.netecweb.org/items/show/241,"Leadership: Mitigation, Preparation, Response, and Recovery","Training and Exercises","Past in Person Course Presentation - Determine methods and tools to consider when developing staffing models. Identify training and competency tools and demonstrate how to apply them to sustain readiness. Define fun and interactive strategies to engage team members and encourage team building.",NETEC,,,2018,"2023-07-13 by Christa Arguinchona and Caroline Croyle (PM) - no longer a course offered in person, may be worth revisiting for a lms module (can't archive - SPORSA)",,"Y - PPE pos 82 qualtrics 303
Y - D0.1PPE/D0.2PPE Qualtrics # 303
Y - D0.1PM/D0.2PM Qualtrics # 907, original # 5
Y - D0.1PM/D0.2PM Qualtrics # 910, original # 7",,,,,2024-07-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://repository.netecweb.org/exhibits/show/leadership,,,,"R-PPE,Staff Support,Staffing,Staffing Model",,"In Person Course",Develop,1,0
240,https://repository.netecweb.org/items/show/240,"Laboratory Considerations for Ebola Virus and other Special Pathogens","Training and Exercises","Past in Person Course Presentation.
Objectives:
Pertaining to the care of a PUI or patient infected with a high-risk pathogen.
- Describe components of a biological risk assessment.
- Identify critical elements to collect, package, and ship a diagnostic specimen.
- List elements of a response plan to provide clinical laboratory services.
- Discover lessons learned to identify and correct potential gaps in clinical laboratory practices.
Zip file contains presentation slide deck and Laboratory Resources folder.
Laboratory Resources in Folder: APHL Template for Public Health Laboratory Risk Assessment for Ebola Virus Disease (EVD) Testing.pdf; Respiratory Pathogens Laboratory Testing Menu - Adult and Pediatric.pdf; VHF Laboratory Testing Menu - Adult.pdf; VHF Laboratory Testing Menu - Pediatric.pdf; Glossary of Laboratory Acronyms.pdf; Two-Center Evaluation of Disinfectant Efficacy against Ebola Virus in Clinical and Laboratory Matrices.pdf.
Download the zip file from the URL below.",NETEC,,,2018,"2023-10-17 by Darrell Ruby, T & E group, needs review by Lab.",,"Y - D0.1TE/D0.2TE Qualtrics # 403, original # 003",,,,,2024-10-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://repository.netecweb.org/pdfs/Laboratory.zip,,,,"Identify,Isolate,Lab,Laboratory,Person Under Investigation (PUI),R-Lab",,"In Person Course",Develop,1,0
239,https://repository.netecweb.org/items/show/239,"PPE Training the Trainer","Training and Exercises","Past In Person Course Presentation.
Objectives:
- Review key concepts of personal protective equipment (PPE).
- Clarify competency: Theory, Practice and Use.
- Discuss strategies for developing PPE courses.
- Discuss ways of maintaining ongoing PPE competency.
",NETEC,,,2017,"2023-10-30 by Darrell Ruby/Amy Mead - submit asset update - Outdated information on NETEC resources available, old tiered structure verbiage. ",,"Y - D0.1TE/D0.2TE Qualtrics # 407",,,,,2026-10-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Personal Protective Equipment (PPE),R-PPE,R-T&E,Staff Support,Staffing",http://repository.netecweb.org/pdfs/PPE_Training_the_Trainer.pdf,"In Person Course",Develop,1,0
238,https://repository.netecweb.org/items/show/238,"Person Under Investigation Case Studies","Training and Exercises","Past In Person Course Presentation:
Session Outline:
- Go over case presentation of potential PUIs.
- Work through discussion questions in small groups and share thoughts with the larger group.
- Your group may come up with additional questions for discussion - this is good!
",NETEC,,,2017,"2023-10-17 by Darrell Ruby, T & E group",,,,,,,2025-10-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Identify,Isolate,Person Under Investigation (PUI),R-Lead,R-T&E",http://repository.netecweb.org/pdfs/Person_Under_Investigation-Case_Studies.pdf,"In Person Course",Develop,1,0
237,https://repository.netecweb.org/items/show/237,"Pathogen Specific Strategies","Training and Exercises","Past In Person Course Presentation.
After completion of this session, participants will be able to:
- Describe strategies for screening patients to identify highly infectious diseases.
- Differentiate various administrative, environmental and physical strategies to prevent transmission of various highly infectious pathogens.
- Determine how to integrate newly obtained knowledge into one's work place to prevent transmission of various highly infectious pathogens.
",NETEC,,,2023-11-02,"2023-10-17 by Darrell Ruby, needs updated links. Updated by Jill Morgan and Jason.",,"Y - D0.1TE/D0.2TE Qualtrics # 407",,,,,2025-10-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Identify,Inform,Isolate,Person Under Investigation (PUI),R-T&E,Special Pathogens",https://repository.netecweb.org/files/original/0e68d743ea93bce605f76955db97be9a.pdf,"In Person Course",Develop,1,0
232,https://repository.netecweb.org/items/show/232,"PAPR Level PPE - Doffing full Checklist","Infection Control","PPE Checklist",Emory,,,2018-05-17,"2022-03-29 by Josia Mamora",,,,,,,2024-01-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Checklist,Donning and Doffing,Example,Personal Protective Equipment (PPE),Powered Air Purifying Respirator (PAPR),R-PPE",https://repository.netecweb.org/pdfs/PAPRLevelPPE-DoffingfullChecklist.doc,Checklist,Develop,1,0
229,https://repository.netecweb.org/items/show/229,"HIGH Level PPE - Doffing Full Checklist","Infection Control","PPE Checklist",Emory,,,2018-05-17,"2022-03-29 by Josia Mamora",,,,,,,2024-01-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Checklist,Donning and Doffing,Example,Personal Protective Equipment (PPE),R-PPE",https://repository.netecweb.org/pdfs/HIGHLevelPPE-DoffingFullChecklist.doc,Checklist,Develop,1,0
129,https://repository.netecweb.org/items/show/129,"Ebola surgical protocols enhance safety of patients and personnel","Treatment & Care","In the months since Ebola patients were first treated in US hospitals, much progress has been made in establishing protocols to protect patients and healthcare workers from harm.","Mathias, J. M.",,,2015-04-30,"2022-09-27 - general asset review - Treatment & Care group
2022-12-07 general asset review - IPC (both 1 yr)
2023-08-24 general ongoing review - IPC - Caroline/Trish (pub.)",,"Y
Y - D0.1Tx/D0.2Tx Qualtrics # 821, Additional Resource
Y - D0.1IC/D0.2IC Qualtrics # 222, original # 10, Additional Resource",,,Publication,,2026-08-24,,,,,,,,,,"Mathias, J. M. (2015). ""Ebola surgical protocols enhance safety of patients and personnel."" OR Manager 31(4): 1, 7-11.","free online journal website - Copyright © 2015. Access Intelligence. All rights reserved. 888/707-5814. www.ormanager.com","In the months since Ebola patients were first treated in US hospitals, much progress has been made in establishing protocols to protect patients and healthcare workers from harm.",https://www.ormanager.com/wp-content/uploads/2015/03/0415_ORM_01_Patient-safety.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/25951684,,,,"Clinical Care Guidelines,Ebola,Infection Prevention and Control,Occupational Health,Patient Care,Patient Transport,R-IPC,R-PM,R-Res&Pub,R-T&C,Surgery",,Publication,Develop,1,0
127,https://repository.netecweb.org/items/show/127,"Effectiveness of Four Disinfectants against Ebola Virus on Different Materials","Infection Control","The West Africa Ebola virus (EBOV) outbreak has highlighted the need for effective disinfectants capable of reducing viral load in a range of sample types, equipment and settings.
This article was corrected in Erratum on August 4, 2016.","Smither, S., Phelps, A., Eastaugh, L., Ngugi, S., O’Brien, L., Dutch, A., & Lever, M. S. ",,,2016-08-04,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,"Y - D0.1PI/D0.2PI Qualtrics # 128, original # 17",,,Publication,"Infection Prevention and Control",2024-06-10,,,,,,,,,,"Smither S, Phelps A, Eastaugh L, et al. Effectiveness of Four Disinfectants against Ebola Virus on Different Materials. Kuhn JH, ed. Viruses. 2016;8(7):185. doi:10.3390/v8070185","free online - Pubmed","The West Africa Ebola virus (EBOV) outbreak has highlighted the need for effective disinfectants capable of reducing viral load in a range of sample types, equipment and settings. Although chlorine-based products are widely used, they can also be damaging to equipment or apparatus that needs continuous use such as aircraft use for transportation of infected people. Two aircraft cleaning solutions were assessed alongside two common laboratory disinfectants in a contact kill assay with EBOV on two aircraft relevant materials representative of a porous and non-porous surface. A decimal log reduction of viral titre of 4 is required for a disinfectant to be deemed effective and two of the disinfectants fulfilled this criteria under the conditions tested. One product, Ardrox 6092, was found to perform similarly to sodium hypochlorite, but as it does not have the corrosive properties of sodium hypochlorite, it could be an alternative disinfectant solution to be used for decontamination of EBOV on sensitive apparatus.",,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974520/,,,,"Decontamination,Ebola,Infection Prevention and Control,Physical Infrastructure,R-PhIn,R-Res&Pub,Terminal Clean",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974520/pdf/viruses-08-00185.pdf,Publication,Develop,1,0
126,https://repository.netecweb.org/items/show/126,"Two-Center Evaluation of Disinfectant Efficacy against Ebola Virus in Clinical and Laboratory Matrices","Infection Control","Ebola virus (EBOV) in body fluids poses risk for virus transmission.","Sophie J. Smither, Lin Eastaugh, Claire Marie Filone, Denise Freeburger, Artemas Herzog, M. Stephen Lever, David M. Miller, Dana Mitzel, James W. Noah, Mary S. Reddick-Elick, Amy Reese, Michael Schuit, Carly B. Wlazlowski, Michael Hevey, and Victoria Wahl-Jensen",,,2018-01-01,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,"Y - D0.1PI/D0.2PI Qualtrics # 128, original # 17",,,Publication,"Infection Prevention and Control",2024-06-10,,,,,,,,,,"Smither, Sophie J., Lin Eastaugh, Claire Marie Filone, Denise Freeburger, Artemas Herzog, M. Stephen Lever, David M. Miller, Dana Mitzel, James W. Noah, Mary S. Reddick-Elick, Amy Reese, Michael Schuit, Carly B. Wlazlowski, Michael Hevey, and Victoria Wahl-Jensen (2018). ""Two-Center Evaluation of Disinfectant Efficacy against Ebola Virus in Clinical and Laboratory Matrices."" Emerging Infectious Diseases, 24(1):135-139.","free online","Ebola virus (EBOV) in body fluids poses risk for virus transmission. However, there are limited experimental data for such matrices on the disinfectant efficacy against EBOV. We evaluated the effectiveness of disinfectants against EBOV in blood on surfaces. Only 5% peracetic acid consistently reduced EBOV titers in dried blood to the assay limit of quantification.",,,,,,,,,,,,,,,,,,,,,,,,,,,,https://wwwnc.cdc.gov/eid/article/24/1/17-0504_article,,,,"Decontamination,Ebola,Infection Prevention and Control,Lab,Laboratory,Physical Infrastructure,R-PhIn,R-Res&Pub,Terminal Clean","http://repository.netecweb.org/pdfs/Smither_EID_Jan2018_Ebola Disinfect.pdf",Publication,Develop,1,0
125,https://repository.netecweb.org/items/show/125,"Use of Postexposure Prophylaxis After Occupational Exposure to Zaire ebolavirus",Research,"From September 2014 to April 2015, 6 persons who had occupational exposures to Zaire ebolavirus in West Africa received investigational agent rVSV-ZEBOV or TKM-100802 for postexposure prophylaxis and were monitored in the United States.","Wong, K. K., R. T. Davey, Jr., A. L. Hewlett, C. S. Kraft, A. K. Mehta, M. J. Mulligan, A. Beck, W. Dorman, C. J. Kratochvil, L. Lai, T. N. Palmore, S. Rogers, P. W. Smith, A. F. Suffredini, M. Wolcott, U. Stroher and T. M. Uyeki ",,,2016-08-01,"2023-07-13 by Christa Arguinchona and Caroline Croyle (PM)",,"Y - D0.1PM/D0.2PM Qualtrics # 912, original # 8",,,Publication,,2026-07-14,,,,,,,,,,"Wong, K. K., R. T. Davey, Jr., A. L. Hewlett, C. S. Kraft, A. K. Mehta, M. J. Mulligan, A. Beck, W. Dorman, C. J. Kratochvil, L. Lai, T. N. Palmore, S. Rogers, P. W. Smith, A. F. Suffredini, M. Wolcott, U. Stroher and T. M. Uyeki (2016). ""Use of Postexposure Prophylaxis After Occupational Exposure to Zaire ebolavirus."" Clin Infect Dis 63(3): 376-379.","free online - Pubmed Central","From September 2014 to April 2015, 6 persons who had occupational exposures to Zaire ebolavirus in West Africa received investigational agent rVSV-ZEBOV or TKM-100802 for postexposure prophylaxis and were monitored in the United States. All patients experienced self-limited symptoms after postexposure prophylaxis; none developed Ebola virus disease.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946014/pdf/ciw256.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/27118786,,,,"Ebola,Example,Occupational Exposure,Occupational Health,Prophylaxis,R-PM,R-Res&Pub",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946014/pdf/ciw256.pdf,Publication,Develop,1,0
124,https://repository.netecweb.org/items/show/124,"Emergency Department Processes for the Evaluation and Management of Persons Under Investigation for Ebola Virus Disease","Intake and Internal Transport","Due to the recent Ebola virus outbreak in West Africa, patients with epidemiologic risk for Ebola virus disease and symptoms consistent with Ebola virus disease are presenting to emergency departments (EDs) and clinics in the United States.","Wadman, M. C., S. S. Schwedhelm, S. Watson, J. Swanhorst, S. G. Gibbs, J. J. Lowe, P. C. Iwen, A. K. Hayes, S. Needham, D. W. Johnson, D. J. Kalin, W. G. Zeger and R. L. Muelleman",,,2015-09-01,"2022-01-10 by PPE group Shawn Gibbs",,,,,Publication,,2025-01-10,,,,,,,,,,"Wadman, M. C., S. S. Schwedhelm, S. Watson, J. Swanhorst, S. G. Gibbs, J. J. Lowe, P. C. Iwen, A. K. Hayes, S. Needham, D. W. Johnson, D. J. Kalin, W. G. Zeger and R. L. Muelleman (2015). ""Emergency Department Processes for the Evaluation and Management of Persons Under Investigation for Ebola Virus Disease."" Ann Emerg Med 66(3): 306-314.","pay online - or through clinicalkey, or elsevier subscription","INTRODUCTION: Due to the recent Ebola virus outbreak in West Africa, patients with epidemiologic risk for Ebola virus disease and symptoms consistent with Ebola virus disease are presenting to emergency departments (EDs) and clinics in the United States. These individuals, identified as a person under investigation for Ebola virus disease, are initially screened using a molecular assay for Ebola virus. If this initial test is negative and the person under investigation has been symptomatic for < 3 days, a repeat test is required after 3 days of symptoms to verify the negative result. In the time interval before the second test result is available, manifestations of the underlying disease process for the person under investigation, whether due to Ebola virus disease or some other etiology, may require further investigation to direct appropriate therapy. MATERIALS AND METHODS: ED administrators, physicians, and nurses proposed processes to provide care that is consistent with other ED patients. Biocontainment unit administrators, industrial hygienists, laboratory directors, physicians, and other medical personnel examined the ED processes and offered biocontainment unit personal protective equipment and process strategies designed to ensure safety for providers and patients. CONCLUSION: ED processes for the safe and timely evaluation and management of the person under investigation for Ebola virus disease are presented with the ultimate goals of protecting providers and ensuring a consistent level of care while confirmatory testing is pending.",,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/26003001,,,,"Clinical Care Guidelines,Diagnosis,Ebola,Emergency Department,Identify,Infection Prevention and Control,Inform,Isolate,Person Under Investigation (PUI),Personal Protective Equipment (PPE),R-IIT,R-PPE,R-Res&Pub,Travel Screening,Viral Hemorrhagic Fever",,Publication,Develop,1,0
123,https://repository.netecweb.org/items/show/123,"Advancing Preparedness for Highly Hazardous Contagious Diseases: Admitting 10 Simulated Patients with MERS-CoV","Training and Exercises","The Ebola outbreak of 2014-2016 highlighted the need for the development of a more robust healthcare infrastructure in the United States to provide isolation care for patients infected with a highly hazardous contagious disease. ","Vasa, A., P. W. Smith, M. Schwedhelm, T. J. Cieslak, J. Lowe, C. J. Kratochvil, E. L. Beam, K. Boulter and A. Hewlett",,,2017-08-01,"2022-01-10 by PPE group Shawn Gibbs",,"Y - D0.1TE/D0.2TE Qualtrics # 423, original # 308",,,Publication,,2025-01-10,,,,,,,,,,"Vasa, A., P. W. Smith, M. Schwedhelm, T. J. Cieslak, J. Lowe, C. J. Kratochvil, E. L. Beam, K. Boulter and A. Hewlett (2017). ""Advancing Preparedness for Highly Hazardous Contagious Diseases: Admitting 10 Simulated Patients with MERS-CoV."" Health Secur 15(4): 432-439.","pay online - or through Liebert connect","The Ebola outbreak of 2014-2016 highlighted the need for the development of a more robust healthcare infrastructure in the United States to provide isolation care for patients infected with a highly hazardous contagious disease. Routine exercises and skills practice are required to effectively and safely prepare care teams to confidently treat this special population of patients. The Nebraska Biocontainment Unit (NBU) at Nebraska Medicine in Omaha has been conducting exercises since 2005 when the unit was opened. Previous activities and exercises conducted by the Nebraska Biocontainment Unit have focused on transporting and caring for up to 3 patients with Ebola virus disease or other special pathogens. Changes in regional and national mandates, as well as the increased potential for receiving multiple patients at once, at a single location, have resulted in a greater demand to exercise protocols for the treatment of multiple patients. This article discusses in detail the planning, execution, and outcomes of a full-scale exercise involving 10 simulated patients with a highly infectious pathogen transmitted by the airborne route.",http://online.liebertpub.com/doi/abs/10.1089/hs.2017.0003?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/28805464,,,,"Exercises and Drills,Intake,MERS-CoV,Patient Care,Personal Protective Equipment (PPE),Public Health,R-T&E,Respiratory Pathogen,Special Pathogens,Staffing,Staffing Model,Surge,Viral Hemorrhagic Fever",,Publication,Develop,1,0
122,https://repository.netecweb.org/items/show/122,"Persistence of Ebola Virus in Ocular Fluid during Convalescence",Research,"Among the survivors of Ebola virus disease (EVD), complications that include uveitis can develop during convalescence, although the incidence and pathogenesis of EVD-associated uveitis are unknown.
This article was corrected in volume 372 on page 2469.","Varkey, J. B., J. G. Shantha, I. Crozier, C. S. Kraft, G. M. Lyon, A. K. Mehta, G. Kumar, J. R. Smith, M. H. Kainulainen, S. Whitmer, U. Stroher, T. M. Uyeki, B. S. Ribner and S. Yeh",,,2015-06-18,"2022-01-10 by PPE group Shawn Gibbs",,,,,Publication,,2025-01-10,,,,,,,,,,"Varkey, J. B., J. G. Shantha, I. Crozier, C. S. Kraft, G. M. Lyon, A. K. Mehta, G. Kumar, J. R. Smith, M. H. Kainulainen, S. Whitmer, U. Stroher, T. M. Uyeki, B. S. Ribner and S. Yeh (2015). ""Persistence of Ebola Virus in Ocular Fluid during Convalescence."" N Engl J Med 372(25): 2423-2427.","free online - Pubmed Central","Among the survivors of Ebola virus disease (EVD), complications that include uveitis can develop during convalescence, although the incidence and pathogenesis of EVD-associated uveitis are unknown. We describe a patient who recovered from EVD and was subsequently found to have severe unilateral uveitis during convalescence. Viable Zaire ebolavirus (EBOV) was detected in aqueous humor 14 weeks after the onset of EVD and 9 weeks after the clearance of viremia.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547451/,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/25950269,,,,"Ebola,Eye/Ocular Health,Follow up,Infection Prevention and Control,Laboratory Testing,Patient Care,Personal Protective Equipment (PPE),R-PPE,R-Res&Pub,Specimen Collection,Specimen Handling,Survivors",http://repository.netecweb.org/pdfs/nihms711769.pdf,Publication,Develop,1,0
121,https://repository.netecweb.org/items/show/121,"Ebola Virus Persistence in Semen of Male Survivors",Research,"We investigated the duration of Ebola virus (EBOV) RNA and infectious EBOV in semen specimens of 5 Ebola virus disease (EVD) survivors.","Uyeki, T. M., B. R. Erickson, S. Brown, A. K. McElroy, D. Cannon, A. Gibbons, T. Sealy, M. H. Kainulainen, A. J. Schuh, C. S. Kraft, A. K. Mehta, G. M. Lyon, 3rd, J. B. Varkey, B. S. Ribner, R. T. Ellison, 3rd, E. Carmody, G. J. Nau, C. Spiropoulou, S. T. Nichol and U. Stroher",,,2016-06-15,,,,,,Publication,,,,,,,,,,,,"Uyeki, T. M., B. R. Erickson, S. Brown, A. K. McElroy, D. Cannon, A. Gibbons, T. Sealy, M. H. Kainulainen, A. J. Schuh, C. S. Kraft, A. K. Mehta, G. M. Lyon, 3rd, J. B. Varkey, B. S. Ribner, R. T. Ellison, 3rd, E. Carmody, G. J. Nau, C. Spiropoulou, S. T. Nichol and U. Stroher (2016). ""Ebola Virus Persistence in Semen of Male Survivors."" Clin Infect Dis 62(12): 1552-1555.","free online - Oxford Academic","We investigated the duration of Ebola virus (EBOV) RNA and infectious EBOV in semen specimens of 5 Ebola virus disease (EVD) survivors. EBOV RNA and infectious EBOV was detected by real-time RT-PCR and virus culture out to 290 days and 70 days, respectively, after EVD onset.",https://academic.oup.com/cid/article/62/12/1552/1745446,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/27045122,,,,"Ebola,Follow up,Laboratory Testing,Public Health,R-Res&Pub,Specimen Collection,Specimen Handling,Survivors,Viral Hemorrhagic Fever",http://repository.netecweb.org/pdfs/ciw202.pdf,Publication,Develop,1,0
120,https://repository.netecweb.org/items/show/120,"Comparison of FilmArray and Quantitative Real-Time Reverse Transcriptase PCR for Detection of Zaire Ebolavirus from Contrived and Clinical Specimens",Research,"Rapid, reliable, and easy-to-use diagnostic assays for detection of Zaire ebolavirus (ZEBOV) are urgently needed.","Southern, T. R., L. D. Racsa, C. G. Albarino, P. D. Fey, S. H. Hinrichs, C. N. Murphy, V. L. Herrera, A. R. Sambol, C. E. Hill, E. L. Ryan, C. S. Kraft, S. Campbell, T. K. Sealy, A. Schuh, J. C. Ritchie, G. M. Lyon, 3rd, A. K. Mehta, J. B. Varkey, B. S. Ribner, K. P. Brantly, U. Stroher, P. C. Iwen and E. M. Burd",,,2015-09-01,,,,,,Publication,,,,,,,,,,,,"Southern, T. R., L. D. Racsa, C. G. Albarino, P. D. Fey, S. H. Hinrichs, C. N. Murphy, V. L. Herrera, A. R. Sambol, C. E. Hill, E. L. Ryan, C. S. Kraft, S. Campbell, T. K. Sealy, A. Schuh, J. C. Ritchie, G. M. Lyon, 3rd, A. K. Mehta, J. B. Varkey, B. S. Ribner, K. P. Brantly, U. Stroher, P. C. Iwen and E. M. Burd (2015). ""Comparison of FilmArray and Quantitative Real-Time Reverse Transcriptase PCR for Detection of Zaire Ebolavirus from Contrived and Clinical Specimens."" J Clin Microbiol 53(9): 2956-2960.","free online - Pubmed Central","Rapid, reliable, and easy-to-use diagnostic assays for detection of Zaire ebolavirus (ZEBOV) are urgently needed. The goal of this study was to examine the agreement among emergency use authorization (EUA) tests for the detection of ZEBOV nucleic acids, including the BioFire FilmArray BioThreat (BT) panel, the FilmArray BT-E panel, and the NP2 and VP40 quantitative real-time reverse transcriptase (qRT) PCR assays from the Centers for Disease Control and Prevention (CDC). Specimens used in this study included whole blood spiked with inactivated ZEBOV at known titers and whole-blood, plasma, and urine clinical specimens collected from persons diagnosed with Ebola virus disease (EVD). The agreement for FilmArray and qRT-PCR results using contrived whole-blood specimens was 100% (6/6 specimens) for each ZEBOV dilution from 4 x 10(7) to 4 x 10(2) 50% tissue culture infective dose (TCID50)/ml, as well as the no-virus negative-control sample. The limit of detection for FilmArray and qRT-PCR assays with inactivated ZEBOV, based on duplicate positive results, was determined to be 4 x 10(2) TCID50/ml. Rates of agreement between FilmArray and qRT-PCR results for clinical specimens from patients with EVD were 85% (23/27 specimens) for whole-blood specimens, 90% (18/20 specimens) for whole-blood specimens tested by FilmArray testing and matched plasma specimens tested by qRT-PCR testing, and 85% (11/13 specimens) for urine specimens. Among 60 specimens, eight discordant results were noted, with ZEBOV nucleic acids being detected only by FilmArray testing in four specimens and only by qRT-PCR testing in the remaining four specimens. These findings demonstrate that the rapid and easy-to-use FilmArray panels are effective tests for evaluating patients with EVD.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540924/,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/26157148,,,,"Diagnosis,Ebola,Immunology,Lab,Laboratory,Laboratory Testing,R-Res&Pub,Specimen Handling",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540924/pdf/zjm2956.pdf,Publication,Develop,1,0
119,https://repository.netecweb.org/items/show/119,"The Psychosocial Challenges of Caring for Patients with Ebola Virus Disease","Personnel Management","Caring for highly infectious patients in biocontainment units is a new phenomenon, and little is known about the behavioral health of workers in this setting. ","Smith, M. W., P. W. Smith, C. J. Kratochvil and S. Schwedhelm",,,2017-02-01,"2023-07-13 by Christa Arguinchona and Caroline Croyle (PM)",,"Y - D0.1PM/D0.2PM Qualtrics # 914, original # 10",,,Publication,,2026-07-14,,,,,,,,,,"Smith, M. W., P. W. Smith, C. J. Kratochvil and S. Schwedhelm (2017). ""The Psychosocial Challenges of Caring for Patients with Ebola Virus Disease."" Health Secur 15(1): 104-109.","pay online - or through Liebert connect","Caring for highly infectious patients in biocontainment units is a new phenomenon, and little is known about the behavioral health of workers in this setting. This is a qualitative study exploring the unique experiences of workers involved in the care of patients with Ebola virus disease (EVD) at Nebraska Medicine during the 2014 Ebola outbreak. Twenty-one in-depth interviews were conducted focused on topics of personal memories, interpersonal experiences, stress response, and patient management. Five themes were identified: (1) positive experiences were emotional while challenges were technical; (2) a significant percentage of workers encountered interpersonal stressors, with 29% of respondents having feelings of isolation, 33% having alterations in home life, and 25% experiencing at least 1 episode of discrimination; (3) physicians and nurses had stressors primarily related to patient care; (4) mental health was an important supportive service, with 45% of respondents using behavioral health counseling; and (5) working in the biocontainment unit during activation was more stressful than everyday work for 60% of respondents. Differences were also noted based on employee occupation and leadership level: nurses, physicians, and members of the leadership team tended to focus on emotional experiences and were more likely to utilize behavioral health counseling services than support staff and nonleadership personnel. These findings provide a framework for thinking about the unique aspects of caring for highly infectious patients, and understanding these issues will improve training, enable management to better support staff, and provide insights to those establishing biocontainment units.",http://online.liebertpub.com/doi/abs/10.1089/hs.2016.0068?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/28192056,,,,"Behavioral Health,Ebola,Example,Family Support,Nursing,Occupational Health,Patient Care,Patient Support,R-Lead,R-PM,R-Res&Pub,Staff Support,Staffing",,Publication,Develop,1,0
118,https://repository.netecweb.org/items/show/118,"Long-term Management of Panuveitis and Iris Heterochromia in an Ebola Survivor","Treatment & Care","The 2013-2016 West African Ebola virus disease (EVD) outbreak has been the largest in history with 28,616 cases and 11,310 deaths in the highest transmission countries of Sierra Leone, Guinea, and Liberia. ","Shantha, J. G., I. Crozier, J. B. Varkey, C. S. Kraft, G. M. Lyon, 3rd, A. K. Mehta, R. D. Carlson, C. E. Hill, G. Kumar, M. R. Debiec, P. S. Patel, T. W. Olsen, R. B. Nussenblatt, D. F. Martin, U. Stroher, T. M. Uyeki, B. S. Ribner, J. R. Smith and S. Yeh",,,2016-12-01,"2022-09-27 - general asset review - Treatment & Care group",,,,,Publication,,2024-09-27,,,,,,,,,,"Shantha, J. G., I. Crozier, J. B. Varkey, C. S. Kraft, G. M. Lyon, 3rd, A. K. Mehta, R. D. Carlson, C. E. Hill, G. Kumar, M. R. Debiec, P. S. Patel, T. W. Olsen, R. B. Nussenblatt, D. F. Martin, U. Stroher, T. M. Uyeki, B. S. Ribner, J. R. Smith and S. Yeh (2016). ""Long-term Management of Panuveitis and Iris Heterochromia in an Ebola Survivor."" Ophthalmology 123(12): 2626-2628 e2622.","free online - Pubmed Central","The 2013-2016 West African Ebola virus disease (EVD) outbreak has been the largest in history with 28,616 cases and 11,310 deaths in the highest transmission countries of Sierra Leone, Guinea, and Liberia. Reports of uveitis have emerged in EVD survivors. Herein we discuss clinical features, multimodality imaging, and long-term management of aggressive, sight-threatening panuveitis, in an EVD survivor, providing insight into the pathogenesis of this condition.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121070/,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/27594198,,,,"Ebola,Example,Eye/Ocular Health,Follow up,Public Health,R-Res&Pub,R-T&C,Specimen Collection,Survivors",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121070/pdf/nihms-804549.pdf,Publication,Develop,1,0
117,https://repository.netecweb.org/items/show/117,"Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever","Treatment & Care","Two patients with Lassa fever are described who are the first human cases treated with a combination of ribavirin and favipiravir.","Raabe, V. N., G. Kann, B. S. Ribner, A. Morales, J. B. Varkey, A. K. Mehta, G. M. Lyon, S. Vanairsdale, K. Faber, S. Becker, M. Eickmann, T. Strecker, S. Brown, K. Patel, P. De Leuw, G. Schuettfort, C. Stephan, H. Rabenau, J. D. Klena, P. E. Rollin, A. McElroy, U. Stroher, S. Nichol, C. S. Kraft, T. Wolf and U. Emory Serious Communicable Diseases",,,2017-09-01,"2022-09-27 - general asset review - Treatment & Care group",,,,,Publication,,2024-09-27,,,,,,,,,,"Raabe, V. N., G. Kann, B. S. Ribner, A. Morales, J. B. Varkey, A. K. Mehta, G. M. Lyon, S. Vanairsdale, K. Faber, S. Becker, M. Eickmann, T. Strecker, S. Brown, K. Patel, P. De Leuw, G. Schuettfort, C. Stephan, H. Rabenau, J. D. Klena, P. E. Rollin, A. McElroy, U. Stroher, S. Nichol, C. S. Kraft, T. Wolf and U. Emory Serious Communicable Diseases (2017). ""Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever."" Clin Infect Dis 65(5): 855-859.","free online - Pubmed Central","Two patients with Lassa fever are described who are the first human cases treated with a combination of ribavirin and favipiravir. Both patients survived but developed transaminitis and had prolonged detectable virus RNA in blood and semen, suggesting that the possibility of sexual transmission of Lassa virus should be considered.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682919/,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/29017278,,,,"Example,Lassa,Patient Care,R-Res&Pub,R-T&C,Therapeutics",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682919/pdf/nihms904566.pdf,Publication,Develop,1,0
116,https://repository.netecweb.org/items/show/116,"Performance of bedside diagnostic ultrasound in an Ebola isolation unit: the Emory University Hospital experience","Treatment & Care","Individuals with Ebola virus disease, a contagious and potentially lethal infection, are now being treated in specialized units in the United States. ","Moreno, C. C., C. S. Kraft, S. Vanairsdale, P. Kandiah, M. A. Klopman, B. S. Ribner and S. Tridandapani",,,2015-06-01,"2022-09-27 - general asset review - Treatment & Care group
2022-12-07 general asset review - IPC (change to R-T&C)",,"Y - D0.1Tx/D0.2Tx Qualtrics # 821, Additional Resource",,,Publication,,2025-09-27,,,,,,,,,,"Moreno, C. C., C. S. Kraft, S. Vanairsdale, P. Kandiah, M. A. Klopman, B. S. Ribner and S. Tridandapani (2015). ""Performance of bedside diagnostic ultrasound in an Ebola isolation unit: the Emory University Hospital experience."" AJR Am J Roentgenol 204(6): 1157-1159.","free online - Pubmed Central","OBJECTIVE: Individuals with Ebola virus disease, a contagious and potentially lethal infection, are now being treated in specialized units in the United States. We describe Emory University's initial experience, current operating procedures, and ongoing planning with diagnostic ultrasound in the isolation unit. CONCLUSION: Ultrasound use has been limited to date. Future planning considerations include deciding what types of ultrasound studies will be performed, which personnel will acquire the images, and which ultrasound machine will be used.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502572/,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/25730332,,,,"Diagnosis,Ebola,Equipment and Supplies,Infection Prevention and Control,Patient Care,R-Res&Pub,R-T&C",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502572/pdf/nihms-704742.pdf,Publication,Develop,1,0
115,https://repository.netecweb.org/items/show/115,"Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease",Research,"Ebola virus (EBOV) infection causes a severe and often fatal disease.
An updated was made in Erratum on 2017 July 5.","McElroy, A. K., J. R. Harmon, T. D. Flietstra, S. Campbell, A. K. Mehta, C. S. Kraft, M. G. Lyon, J. B. Varkey, B. S. Ribner, C. J. Kratochvil, P. C. Iwen, P. W. Smith, R. Ahmed, S. T. Nichol and C. F. Spiropoulou",,,2016-08-15,,,,,,Publication,,,,,,,,,,,,"McElroy, A. K., J. R. Harmon, T. D. Flietstra, S. Campbell, A. K. Mehta, C. S. Kraft, M. G. Lyon, J. B. Varkey, B. S. Ribner, C. J. Kratochvil, P. C. Iwen, P. W. Smith, R. Ahmed, S. T. Nichol and C. F. Spiropoulou (2016). ""Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease."" Clin Infect Dis 63(4): 460-467.","free online - Pubmed Central","BACKGROUND: Ebola virus (EBOV) infection causes a severe and often fatal disease. Despite the fact that more than 30 000 individuals have acquired Ebola virus disease (EVD), the medical and scientific community still does not have a clear understanding of the mechanisms by which EBOV causes such severe disease. METHODS: In this study, 54 biomarkers in plasma samples serially collected from 7 patients with EVD were analyzed in an attempt to define the kinetics of inflammatory modulators. Two clinical disease groups were defined (moderate and severe) based on the need for clinical support. Biomarkers were evaluated for correlation with viremia and clinical disease in an effort to identify pathways that could be useful targets of therapeutic intervention. RESULTS: Patients with severe disease had higher viremia than those with moderate disease. Several biomarkers of immune activation and control were significantly elevated in patients with moderate disease. A series of pro-inflammatory cytokines and chemokines were significantly elevated in patients with severe disease. CONCLUSIONS: Biomarkers that were associated with severe EVD were proinflammatory and indicative of endothelial or coagulation cascade dysfunction, as has been seen historically in patients with fatal outcomes. In contrast, biomarkers that were associated with moderate EVD were suggestive of a strong interferon response and control of both innate and adaptive responses. Therefore, clinical interventions that modulate the phenotype and magnitude of immune activation may be beneficial in treating EVD.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967605/,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/27353663,,,,"Antibodies,Ebola,Immunology,Patient Care,R-Res&Pub,Therapeutics",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967605/pdf/ciw334.pdf,Publication,Develop,1,0
114,https://repository.netecweb.org/items/show/114,"A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses",Research,"A nurse who acquired Lassa virus infection in Togo in the spring of 2016 was repatriated to the United States for care at Emory University Hospital. ","McElroy, A. K., R. S. Akondy, J. R. Harmon, A. H. Ellebedy, D. Cannon, J. D. Klena, J. Sidney, A. Sette, A. K. Mehta, C. S. Kraft, M. G. Lyon, J. B. Varkey, B. S. Ribner, S. T. Nichol and C. F. Spiropoulou",,,2017-06-15,,,,,,Publication,,,,,,,,,,,,"McElroy, A. K., R. S. Akondy, J. R. Harmon, A. H. Ellebedy, D. Cannon, J. D. Klena, J. Sidney, A. Sette, A. K. Mehta, C. S. Kraft, M. G. Lyon, J. B. Varkey, B. S. Ribner, S. T. Nichol and C. F. Spiropoulou (2017). ""A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses."" J Infect Dis 215(12): 1862-1872.","free online - Oxford Academic","A nurse who acquired Lassa virus infection in Togo in the spring of 2016 was repatriated to the United States for care at Emory University Hospital. Serial sampling from this patient permitted the characterization of several aspects of the innate and cellular immune responses to Lassa virus. Although most of the immune responses correlated with the kinetics of viremia resolution, the CD8 T-cell response was of surprisingly high magnitude and prolonged duration, implying prolonged presentation of viral antigens. Indeed, long after viremia resolution, there was persistent viral RNA detected in the semen of the patient, accompanied by epididymitis, suggesting the male reproductive tract as 1 site of antigen persistence. Consistent with the magnitude of acute T-cell responses, the patient ultimately developed long-term, polyfunctional memory T-cell responses to Lassa virus.",https://academic.oup.com/jid/article/215/12/1862/3871090,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/28863472,,,,"Antibodies,Immunology,Lassa,Patient Care,R-Res&Pub,Therapeutics",http://repository.netecweb.org/pdfs/jix201.pdf,Publication,Develop,1,0
113,https://repository.netecweb.org/items/show/113,"Human Ebola virus infection results in substantial immune activation",Research,"Four Ebola patients received care at Emory University Hospital, presenting a unique opportunity to examine the cellular immune responses during acute Ebola virus infection. ","McElroy, A. K., R. S. Akondy, C. W. Davis, A. H. Ellebedy, A. K. Mehta, C. S. Kraft, G. M. Lyon, B. S. Ribner, J. Varkey, J. Sidney, A. Sette, S. Campbell, U. Stroher, I. Damon, S. T. Nichol, C. F. Spiropoulou and R. Ahmed",,,2015-04-14,,,,,,Publication,,,,,,,,,,,,"McElroy, A. K., R. S. Akondy, C. W. Davis, A. H. Ellebedy, A. K. Mehta, C. S. Kraft, G. M. Lyon, B. S. Ribner, J. Varkey, J. Sidney, A. Sette, S. Campbell, U. Stroher, I. Damon, S. T. Nichol, C. F. Spiropoulou and R. Ahmed (2015). ""Human Ebola virus infection results in substantial immune activation."" Proc Natl Acad Sci U S A 112(15): 4719-4724.","free online - Pubmed Central","Four Ebola patients received care at Emory University Hospital, presenting a unique opportunity to examine the cellular immune responses during acute Ebola virus infection. We found striking activation of both B and T cells in all four patients. Plasmablast frequencies were 10-50% of B cells, compared with less than 1% in healthy individuals. Many of these proliferating plasmablasts were IgG-positive, and this finding coincided with the presence of Ebola virus-specific IgG in the serum. Activated CD4 T cells ranged from 5 to 30%, compared with 1-2% in healthy controls. The most pronounced responses were seen in CD8 T cells, with over 50% of the CD8 T cells expressing markers of activation and proliferation. Taken together, these results suggest that all four patients developed robust immune responses during the acute phase of Ebola virus infection, a finding that would not have been predicted based on our current assumptions about the highly immunosuppressive nature of Ebola virus. Also, quite surprisingly, we found sustained immune activation after the virus was cleared from the plasma, observed most strikingly in the persistence of activated CD8 T cells, even 1 mo after the patients' discharge from the hospital. These results suggest continued antigen stimulation after resolution of the disease. From these convalescent time points, we identified CD4 and CD8 T-cell responses to several Ebola virus proteins, most notably the viral nucleoprotein. Knowledge of the viral proteins targeted by T cells during natural infection should be useful in designing vaccines against Ebola virus.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403189/,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/25775592,,,,"Antibodies,Ebola,Immunology,R-Res&Pub",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403189/pdf/pnas.201502619.pdf,Publication,Develop,1,0
112,https://repository.netecweb.org/items/show/112,"Surrogate Testing Suggests That Chlorine Dioxide Gas Exposure Would Not Inactivate Ebola Virus Contained in Environmental Blood Contamination","Infection Control","The ability to decontaminate a room potentially containing the Ebola virus is important to healthcare facilities in the United States.","Lowe, J. J., A. L. Hewlett, P. C. Iwen, P. W. Smith and S. G. Gibbs",,,2015-05-08,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,,,,Publication,"Infection Prevention and Control",2024-06-10,,,,,,,,,,"Lowe, J. J., A. L. Hewlett, P. C. Iwen, P. W. Smith and S. G. Gibbs (2015). ""Surrogate Testing Suggests That Chlorine Dioxide Gas Exposure Would Not Inactivate Ebola Virus Contained in Environmental Blood Contamination."" Journal of Occupational and Environmental Hygiene 12(9): D211-D215.","pay online - or through Taylor and Francis subscription","The ability to decontaminate a room potentially containing the Ebola virus is important to healthcare facilities in the United States. The Ebola virus remains viable in body fluids, a room that has housed a patient with Ebola virus disease must have all surfaces manually wiped with an approved disinfectant, which increases occupational exposure risk. This study evaluated the efficacy of gaseous chlorine dioxide inactivation of bacterial organisms in blood as the Ebola virus surrogates and as the organisms used by the Nebraska Biocontainment Unit to provide the margin of safety for decontamination. Bacillus anthracis, Escherichia coli, Enterococcus faecalis, and Mycobacterium smegmatis blood suspensions that were exposed to ClO2 gas concentrations and exposure limits. The log reduction in Colony Forming Units (CFU) was determined for each bacterial blood suspension. Exposure parameters approximating industry practices for ClO2 environmental decontamination (360 ppm concentration to 780 ppm-hr exposure, 65% relative humidity) as well as parameters exceeding current practice (1116 ppm concentration to 1400 ppm-hr exposure; 1342 ppm concentration to 1487 ppm-hr exposure) were evaluated. Complete inactivation was not achieved for any of the bacterial blood suspensions tested. Reductions were observed in concentrations of B. anthracis spores (1.3?3.76 log) and E. faecalis vegetative cells (1.3 log) whereas significant reductions in vegetative cell concentrations for E. coli and M. smegmatis blood suspensions were not achieved. Our results showed that bacteria in the presence of blood were not inactivated using gaseous ClO2 decontamination. ClO2 decontamination alone should not be used for the Ebola virus, but decontamination processes should first include manual wiping of potentially contaminated blood; especially for microorganisms as infectious as the Ebola virus.",http://www.tandfonline.com/doi/full/10.1080/15459624.2015.1043058,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/25955403,,,,"Biosafety,Ebola,Lab,Laboratory,Laboratory Testing,R-IPC,R-Res&Pub,Specimen Handling",,Publication,Develop,1,0
111,https://repository.netecweb.org/items/show/111,"Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States","Treatment & Care","More than 26,000 cases of Ebola virus disease (EVD) have been reported in western Africa, with high mortality. Several patients have been medically evacuated to hospitals in the United States and Europe.","Liddell, A. M., R. T. Davey, Jr., A. K. Mehta, J. B. Varkey, C. S. Kraft, G. K. Tseggay, O. Badidi, A. C. Faust, K. V. Brown, A. F. Suffredini, K. Barrett, M. J. Wolcott, V. C. Marconi, G. M. Lyon, 3rd, G. L. Weinstein, K. Weinmeister, S. Sutton, M. Hazbun, C. G. Albarino, Z. Reed, D. Cannon, U. Stroher, M. Feldman, B. S. Ribner, H. C. Lane, A. S. Fauci and T. M. Uyeki ",,,2015-07-21,"2022-09-27 - general asset review - Treatment & Care group",,,,,Publication,,2025-09-27,,,,,,,,,,"Liddell, A. M., R. T. Davey, Jr., A. K. Mehta, J. B. Varkey, C. S. Kraft, G. K. Tseggay, O. Badidi, A. C. Faust, K. V. Brown, A. F. Suffredini, K. Barrett, M. J. Wolcott, V. C. Marconi, G. M. Lyon, 3rd, G. L. Weinstein, K. Weinmeister, S. Sutton, M. Hazbun, C. G. Albarino, Z. Reed, D. Cannon, U. Stroher, M. Feldman, B. S. Ribner, H. C. Lane, A. S. Fauci and T. M. Uyeki (2015). ""Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States."" Ann Intern Med 163(2): 81-90.","free online - Pubmed Central","BACKGROUND: More than 26,000 cases of Ebola virus disease (EVD) have been reported in western Africa, with high mortality. Several patients have been medically evacuated to hospitals in the United States and Europe. Detailed clinical data are limited on the clinical course and management of patients with EVD outside western Africa. OBJECTIVE: To describe the clinical characteristics and management of a cluster of patients with EVD, including the first cases of Ebola virus (EBOV) infection acquired in the United States. DESIGN: Retrospective clinical case series. SETTING: Three U.S. hospitals in September and October 2014. PATIENTS: First imported EVD case identified in the United States and 2 secondary EVD cases acquired in the United States in critical care nurses who cared for the index case patient. MEASUREMENTS: Clinical recovery, EBOV RNA level, resolution of Ebola viremia, survival with discharge from hospital, or death. RESULTS: The index patient had high EBOV RNA levels, developed respiratory and renal failure requiring critical care support, and died. Both patients with secondary EBOV infection had nonspecific signs and symptoms and developed moderate illness; EBOV RNA levels were moderate, and both patients recovered. LIMITATION: Both surviving patients received uncontrolled treatment with multiple investigational agents, including convalescent plasma, which limits generalizability of the results. CONCLUSION: Early diagnosis, prompt initiation of supportive medical care, and moderate clinical illness likely contributed to successful outcomes in both survivors. The inability to determine the potential benefit of investigational therapies and the effect of patient-specific factors that may have contributed to less severe illness highlight the need for controlled clinical studies of these interventions, especially in the setting of a high level of supportive medical care. PRIMARY FUNDING SOURCE: None.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724427/,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/25961438,,,,"Critical Care,Diagnosis,Ebola,Example,Immunology,Occupational Exposure,Occupational Health,Patient Care,R-PM,R-Res&Pub,R-T&C,Therapeutics",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724427/pdf/nihms743262.pdf,Publication,Develop,1,0
110,https://repository.netecweb.org/items/show/110,"A gap analysis of the United States death care sector to determine training and education needs pertaining to highly infectious disease mitigation and management","Decedent Management","A United States industry-specific gap analysis survey of the death care sector-which comprises organizations and businesses affiliated with the funeral industry and the handling of human remains- was developed, the results analyzed, and training and education needs in relation to highly infectious disease mitigation and management were explored in an effort to identify where occupational health and safety can be enhanced in this worker population.","Le, A. B., L. Witter, J. J. Herstein, K. C. Jelden, E. L. Beam, S. G. Gibbs and J. J. Lowe",,,2017-09-01,"2022-01-10 by PPE group Shawn Gibbs",,,,,Publication,,2024-01-10,,,,,,,,,,"Le, A. B., L. Witter, J. J. Herstein, K. C. Jelden, E. L. Beam, S. G. Gibbs and J. J. Lowe (2017). ""A gap analysis of the United States death care sector to determine training and education needs pertaining to highly infectious disease mitigation and management."" J Occup Environ Hyg 14(9): 674-680.","pay online - or through Taylor and Francis subscription","PURPOSE: A United States industry-specific gap analysis survey of the death care sector-which comprises organizations and businesses affiliated with the funeral industry and the handling of human remains- was developed, the results analyzed, and training and education needs in relation to highly infectious disease mitigation and management were explored in an effort to identify where occupational health and safety can be enhanced in this worker population. METHODS: Collaborating national death care organizations distributed the 47-question electronic survey. N = 424 surveys were initiated and results recorded. The survey collected death care sector-specific information pertaining to the comfortability and willingness to handle highly infectious remains; perceptions of readiness, current policies and procedures in place to address highly infectious diseases; current highly infectious disease training levels, available resources, and personal protective equipment. RESULTS: One-third of respondents have been trained on how to manage highly infectious remains. There was a discrepancy between Supervisor/Management and Employee/Worker perceptions on employees' willingness and comfortability to manage potentially highly infectious remains. More than 40% of respondents did not know the correct routes of transmission for viral hemorrhagic fevers. CONCLUSIONS: Results suggest death care workers could benefit from increasing up-to-date industry-specific training and education on highly infectious disease risk mitigation and management. Professional death care sector organizations are positioned to disseminate information, training, and best practices.",,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/28609169,,,,"Decedent Management,Ebola,Infection Prevention and Control,Personal Protective Equipment (PPE),Public Health,R-DM,Special Pathogens,Training,Waste",,Publication,Develop,1,0
109,https://repository.netecweb.org/items/show/109,"A pilot survey of the U.S. medical waste industry to determine training needs for safely handling highly infectious waste","Waste Management","The recent Ebola outbreak led to the development of Ebola virus disease (EVD) best practices in clinical settings. However, after the care of EVD patients, proper medical waste management and disposal was identified as a crucial component to containing the virus.","Le, A. B., S. Hoboy, A. Germain, H. Miller, R. Thompson, J. J. Herstein, K. C. Jelden, E. L. Beam, S. G. Gibbs and J. J. Lowe",,,2018-01-17,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,"Y
Y - D0.1IC/D0.2IC Qualtrics # 209, original # 4a (additional resources)
",,,Publication,"Infection Prevention and Control",2024-06-10,,,,,,,,,,"Le, A. B., S. Hoboy, A. Germain, H. Miller, R. Thompson, J. J. Herstein, K. C. Jelden, E. L. Beam, S. G. Gibbs and J. J. Lowe (2017). ""A pilot survey of the U.S. medical waste industry to determine training needs for safely handling highly infectious waste."" American Journal of Infection Control.","pay online - or through clinicalkey, or elsevier subscription","The recent Ebola outbreak led to the development of Ebola virus disease (EVD) best practices in clinical settings. However, after the care of EVD patients, proper medical waste management and disposal was identified as a crucial component to containing the virus. Category A waste—contaminated with EVD and other highly infectious pathogens—is strictly regulated by governmental agencies, and led to only several facilities willing to accept the waste. A pilot survey was administered to determine if U.S. medical waste facilities are prepared to handle or transport category A waste, and to determine waste workers' current extent of training to handle highly infectious waste. Sixty-eight percent of survey respondents indicated they had not determined if their facility would accept category A waste. Of those that had acquired a special permit, 67% had yet to modify their permit since the EVD outbreak. This pilot survey underscores gaps in the medical waste industry to handle and respond to category A waste. Furthermore, this study affirms reports a limited number of processing facilities are capable or willing to accept category A waste. Developing the proper management of infectious disease materials is essential to close the gaps identified so that states and governmental entities can act accordingly based on the regulations and guidance developed, and to ensure public safety.",,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.sciencedirect.com/science/article/pii/S0196655317309975,,,,"Autoclave,Category A,Ebola,Infection Prevention and Control,R-WM,Special Pathogens,Training,Waste",https://repository.netecweb.org/files/original/8c7f028995127765b991d83b313ba36a.png,Publication,Develop,1,0
108,https://repository.netecweb.org/items/show/108,"The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States",Research,"The current West Africa Ebola virus disease (EVD) outbreak has resulted in multiple individuals being medically evacuated to other countries for clinical management.","Kraft, C. S., A. L. Hewlett, S. Koepsell, A. M. Winkler, C. J. Kratochvil, L. Larson, J. B. Varkey, A. K. Mehta, G. M. Lyon, 3rd, R. J. Friedman-Moraco, V. C. Marconi, C. E. Hill, J. N. Sullivan, D. W. Johnson, S. J. Lisco, M. J. Mulligan, T. M. Uyeki, A. K. McElroy, T. Sealy, S. Campbell, C. Spiropoulou, U. Stroher, I. Crozier, R. Sacra, M. J. Connor, Jr., V. Sueblinvong, H. A. Franch, P. W. Smith, B. S. Ribner, U. Nebraska Biocontainment and U. the Emory Serious Communicable Diseases",,,2015-08-15,,,,,,Publication,,,,,,,,,,,,"Kraft, C. S., A. L. Hewlett, S. Koepsell, A. M. Winkler, C. J. Kratochvil, L. Larson, J. B. Varkey, A. K. Mehta, G. M. Lyon, 3rd, R. J. Friedman-Moraco, V. C. Marconi, C. E. Hill, J. N. Sullivan, D. W. Johnson, S. J. Lisco, M. J. Mulligan, T. M. Uyeki, A. K. McElroy, T. Sealy, S. Campbell, C. Spiropoulou, U. Stroher, I. Crozier, R. Sacra, M. J. Connor, Jr., V. Sueblinvong, H. A. Franch, P. W. Smith, B. S. Ribner, U. Nebraska Biocontainment and U. the Emory Serious Communicable Diseases (2015). ""The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States."" Clin Infect Dis 61(4): 496-502.","free online - Pubmed Central","BACKGROUND: The current West Africa Ebola virus disease (EVD) outbreak has resulted in multiple individuals being medically evacuated to other countries for clinical management. METHODS: We report two patients who were transported from West Africa to the United States for treatment of EVD. Both patients received aggressive supportive care measures, as well as an investigational therapeutic (TKM-100802) and convalescent plasma. RESULTS: While one patient experienced critical illness with multi-organ failure requiring mechanical ventilation and renal replacement therapy, both patients recovered without serious long-term sequelae to date. CONCLUSIONS: It is unclear what role the experimental drug and convalescent plasma had in the recovery of these patients. Prospective clinical trials are needed to delineate the role of investigational therapies in the care of patients with EVD.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542597/,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/25904375,,,,"Critical Care,Ebola,Experimental Drugs,Patient Care,R-Res&Pub,Therapeutics",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542597/pdf/civ334.pdf,Publication,Develop,1,0
107,https://repository.netecweb.org/items/show/107,"Editorial Commentary: Considerations of Favipiravir as a Medical Countermeasure in Future Randomized Controlled Trials Against Ebola Virus Disease",Research,"Since the discovery of Ebola virus in the Democratic Republic of Congo in 1976, outbreaks of EVD had been mainly confined to rural areas (http://www.cdc.gov/vhf/ebola/outbreaks/history/chronology.html)...","Kraft, C. S.",,,2016-11-15,,,,,,Publication,,,,,,,,,,,,"Kraft, C. S. (2016). ""Editorial Commentary: Considerations of Favipiravir as a Medical Countermeasure in Future Randomized Controlled Trials Against Ebola Virus Disease."" Clin Infect Dis 63(10): 1295-1296.","free online - Oxford Academic",,https://academic.oup.com/cid/article/63/10/1295/2450073,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/27553374,,,,"Clinical Trial,Ebola,Experimental Drugs,Patient Care,R-Res&Pub,Therapeutics",http://repository.netecweb.org/pdfs/ciw575.pdf,Publication,Develop,1,0
106,https://repository.netecweb.org/items/show/106,"Lessons learned: critical care management of patients with Ebola in the United States","Treatment & Care","This report will describe the preparations for and the provision of care of two patients with Ebola virus disease in the biocontainment unit at the University of Nebraska Medical Center. ","Johnson, D. W., J. N. Sullivan, C. A. Piquette, A. L. Hewlett, K. L. Bailey, P. W. Smith, A. C. Kalil and S. J. Lisco",,,2015-06-01,"2022-09-27 - general asset review - Treatment & Care group
2022-01-10 by PPE group Shawn Gibbs (both 3 years)",,,,,Publication,,2025-09-27,,,,,,,,,,"Johnson, D. W., J. N. Sullivan, C. A. Piquette, A. L. Hewlett, K. L. Bailey, P. W. Smith, A. C. Kalil and S. J. Lisco (2015). ""Lessons learned: critical care management of patients with Ebola in the United States."" Crit Care Med 43(6): 1157-1164.","pay online - or through ovid subscription","OBJECTIVE: This report will describe the preparations for and the provision of care of two patients with Ebola virus disease in the biocontainment unit at the University of Nebraska Medical Center. DATA SOURCES: Patient medical records. STUDY SELECTION: Not applicable. DATA EXTRACTION: Not applicable. DATA SYNTHESIS: Not applicable. CONCLUSIONS: Safe and effective care of patients with Ebola virus disease requires significant communication and planning. Adherence to a predetermined isolation protocol is essential, including proper donning and doffing of personal protective equipment. Location of the patient care area and the logistics of laboratory testing, diagnostic imaging, and the removal of waste must be considered. Patients with Ebola virus disease are often dehydrated and need adequate vascular access for fluid resuscitation, nutrition, and phlebotomy for laboratory sampling. Advanced planning for acute life-threatening events and code status must be considered. Intensivist scheduling should account for the significant amount of time required for the care of patients with Ebola virus disease. With appropriate precautions and resources, designated hospitals in the United States can safely provide care for patients with Ebola virus disease.",,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/25756410,,,,"Clinical Care Guidelines,Critical Care,Ebola,Example,Infection Prevention and Control,Patient Care,Personal Protective Equipment (PPE),Phlebotomy,R-PPE,R-Res&Pub,R-T&C,Therapeutics",,Publication,Develop,1,0
105,https://repository.netecweb.org/items/show/105,"Learning from Ebola: Interprofessional practice in the Nebraska Biocontainment Unit","Treatment & Care","Caring for patients with Ebola virus disease (EVD) in the Nebraska Biocontainment Unit (NBU) has necessitated and enabled extensive interprofessional relationships and the creation of a collaborative care model.","Jelden, K. C., P. W. Smith, M. M. Schwedhelm, S. G. Gibbs, J. J. Lowe, E. L. Beam, C. J. Kratochvil, K. C. Boulter and A. L. Hewlett",,,2015-12-01,"2022-09-27 - general asset review - Treatment & Care group",,"Y - D0.1PM/D0.2PM Qualtrics # 906, original # 4a
Y - D0.1PM/D0.2PM Qualtrics # 907, original # 5",,,Publication,,2025-09-27,,,,,,,,,,"Jelden, K. C., P. W. Smith, M. M. Schwedhelm, S. G. Gibbs, J. J. Lowe, E. L. Beam, C. J. Kratochvil, K. C. Boulter and A. L. Hewlett (2015). ""Learning from Ebola: Interprofessional practice in the Nebraska Biocontainment Unit."" Journal of Interprofessional Education & Practice 1(3): 97-99.","Free online through Pub Med Central.","
Caring for patients with Ebola virus disease (EVD) in the Nebraska Biocontainment Unit (NBU) has necessitated and enabled extensive interprofessional relationships and the creation of a collaborative care model. Critical aspects of NBU functionality include a constructive leadership environment, staff inclusion and consideration during protocol development, and a culture of partnership and communication.
Copyright © 2015 Elsevier Inc. All rights reserved.
",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104021/,,,,,,,,,,,,,,,,,,,,,,,,,,,https://pubmed.ncbi.nlm.nih.gov/32289082/,,,,"Ebola,Example,Isolation/Biocontainment,Nursing,R-PM,R-Res&Pub,Staffing,Staffing Model",,Publication,Develop,1,0
104,https://repository.netecweb.org/items/show/104,"Nebraska Biocontainment Unit patient discharge and environmental decontamination after Ebola care","Infection Control","The Nebraska Biocontainment Unit (NBUacrnm1), which operates through collaboration of Nebraska Medicine, the University of Nebraska Medical Center, and the Nebraska Department of Health and Human Services, recently treated patients with Ebola viru...","Jelden, K. C., S. G. Gibbs, P. W. Smith, M. M. Schwedhelm, P. C. Iwen, E. L. Beam, A. K. Hayes, N. Marion, C. J. Kratochvil, K. C. Boulter, A. L. Hewlett and J. J. Lowe ",,,2015-03-01,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,Y,,,Publication,"Infection Prevention and Control",2024-06-10,,,,,,,,,,"Jelden, K. C., S. G. Gibbs, P. W. Smith, M. M. Schwedhelm, P. C. Iwen, E. L. Beam, A. K. Hayes, N. Marion, C. J. Kratochvil, K. C. Boulter, A. L. Hewlett and J. J. Lowe (2015). ""Nebraska Biocontainment Unit patient discharge and environmental decontamination after Ebola care."" Am J Infect Control 43(3): 203-205.","pay online - or through clinicalkey, or elsevier subscription",,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/25637433,,,,"Decontamination,Discharge,Ebola,Infection Prevention and Control,R-IPC,R-Res&Pub",,Publication,Develop,1,0
103,https://repository.netecweb.org/items/show/103,"Safety considerations in the laboratory testing of specimens suspected or known to contain Ebola virus",Laboratory,"Reference to the Ebola virus causes concern among all individuals, whether from the public or within the medical community.","Iwen, P. C., P. W. Smith, A. L. Hewlett, C. J. Kratochvil, S. J. Lisco, J. N. Sullivan, S. G. Gibbs, J. J. Lowe, P. D. Fey, V. L. Herrera, A. R. Sambol, J. L. Wisecarver and S. H. Hinrichs",,,2015-01-01,"2022-01-10 by PPE group Shawn Gibbs",,,,,Publication,,2025-01-10,,,,,,,,,,"Iwen, P. C., P. W. Smith, A. L. Hewlett, C. J. Kratochvil, S. J. Lisco, J. N. Sullivan, S. G. Gibbs, J. J. Lowe, P. D. Fey, V. L. Herrera, A. R. Sambol, J. L. Wisecarver and S. H. Hinrichs (2015). ""Safety considerations in the laboratory testing of specimens suspected or known to contain Ebola virus."" Am J Clin Pathol 143(1): 4-5.","free online - Oxford Academic",,https://academic.oup.com/ajcp/article/143/1/4/1760657,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/25511134,,,,"Biosafety,Ebola,Infection Prevention and Control,Lab,Laboratory,Laboratory Testing,Personal Protective Equipment (PPE),R-Lab,R-PPE,R-Res&Pub,Specimen Handling",http://repository.netecweb.org/pdfs/ajcpath143-0004.pdf,Publication,Develop,1,0
102,https://repository.netecweb.org/items/show/102,"Parental presence at the bedside of a child with suspected Ebola: an expert discussion","Treatment & Care","This clinical report offers guidance to health care providers and hospitals on options to consider regarding parental presence at the bedside while caring for a child with suspected or proven Ebola virus disease (Ebola) or other highly consequential infection.","Hinton, C. F., H. D. Davies, S. N. Hocevar, S. E. Krug, A. M. Milstone, L. Ortmann, C. H. Cassell, G. Peacock and S. E. Griese",,,2016-03-01,"2022-09-27 - general asset review - Treatment & Care group
2022-07 by Clayton, Special Populations Treatment & Care group (both agree 3 years)",,"Y
Y - D0.1Tx/D0.2Tx Qualtrics # 811, original # 3b",,,Publication,,2025-09-27,,,,,,,,,,"Hinton, C. F., H. D. Davies, S. N. Hocevar, S. E. Krug, A. M. Milstone, L. Ortmann, C. H. Cassell, G. Peacock and S. E. Griese (2016). ""Parental presence at the bedside of a child with suspected Ebola: an expert discussion."" Clinical Pediatric Emergency Medicine 17(1): 81-86.","free online - Nebraska site","
This clinical report offers guidance to health care providers and hospitals on options to consider regarding parental presence at the bedside while caring for a child with suspected or proven Ebola virus disease (Ebola) or other highly consequential infection. Options are presented to help meet the needs of the patient and the family while also posing the least risk to providers and health care organizations. The optimal way to minimize risk is to limit contact between the person under investigation or treatment and family members/caregivers whenever possible while working to meet the emotional support needs of both patient and family. At times, caregiver presence may be deemed to be in the best interest of the patient, and in such situations, a strong effort should be made to limit potential risks of exposure to the caregiver, health care providers, and the community. The decision to allow parental/caregiver presence should be made in consultation with a team including an infectious diseases expert and state and/or local public health authorities and should involve consideration of many factors, depending on the stage of investigation and management, including (1) a careful history, physical examination, and investigations to elucidate the likelihood of the diagnosis of Ebola or other highly consequential infection; (2) ability of the facility to offer appropriate isolation for the person under investigation and family members and to manage Ebola; (3) ability to recognize and exclude people at increased risk of worse outcomes (eg, pregnant women); and (4) ability of parent/caregiver to follow instructions, including appropriate donning and doffing of personal protective equipment.
Copyright © 2016 by the American Academy of Pediatrics.
",https://digitalcommons.unl.edu/cgi/viewcontent.cgi?article=1513&context=publichealthresources,,,,,,,,,,,,,,,,,,,,,,,,,,,https://pubmed.ncbi.nlm.nih.gov/27550981/,,,,"Ebola,Example,Family Support,Patient Care,Patient Support,Pediatrics,R-Res&Pub,R-SP,R-T&C","http://repository.netecweb.org/pdfs/Parental Presence at the Bedside of a Child withSuspected Ebola.pdf",Publication,Develop,1,0
101,https://repository.netecweb.org/items/show/101,"Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease",Research,"From 2014 to May 2015, >26 000 Ebola virus disease (EVD) cases were reported from West Africa.","Florescu, D. F., A. C. Kalil, A. L. Hewlett, A. J. Schuh, U. Stroher, T. M. Uyeki and P. W. Smith",,,2015-09-15,,,,,,Publication,,,,,,,,,,,,"Florescu, D. F., A. C. Kalil, A. L. Hewlett, A. J. Schuh, U. Stroher, T. M. Uyeki and P. W. Smith (2015). ""Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease."" Clin Infect Dis 61(6): 969-973.","free online - Oxford Academic","From 2014 to May 2015, >26 000 Ebola virus disease (EVD) cases were reported from West Africa. We present a patient with EVD who received brincidofovir and convalescent plasma. The relative contributions of supportive care, investigational therapies, and patient's immune-response on survival could not be determined. Randomized trials are needed.",https://academic.oup.com/cid/article/61/6/969/450746,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/25991468,,,,"Antibodies,Ebola,Immunology,Patient Care,R-Res&Pub,Therapeutics",http://repository.netecweb.org/pdfs/civ395.pdf,Publication,Develop,1,0
100,https://repository.netecweb.org/items/show/100,"Successful delivery of RRT in Ebola virus disease.","Treatment & Care","AKI has been observed in cases of Ebola virus disease. ","Connor, M. J., Jr., C. Kraft, A. K. Mehta, J. B. Varkey, G. M. Lyon, I. Crozier, U. Stroher, B. S. Ribner and H. A. Franch",,,2015-01-01,"2022-09-27 - general asset review - Treatment & Care group
2022-12-07 general asset review - IPC (change to R-T&C)",,"Y - D0.1Tx/D0.2Tx Qualtrics # 822",,,Publication,,2025-09-27,,,,,,,,,,"Connor, M. J., Jr., C. Kraft, A. K. Mehta, J. B. Varkey, G. M. Lyon, I. Crozier, U. Stroher, B. S. Ribner and H. A. Franch (2015). ""Successful delivery of RRT in Ebola virus disease."" J Am Soc Nephrol 26(1): 31-37.","free online - Pubmed Central","AKI has been observed in cases of Ebola virus disease. We describe the protocol for the first known successful delivery of RRT with subsequent renal recovery in a patient with Ebola virus disease treated at Emory University Hospital, in Atlanta, Georgia. Providing RRT in Ebola virus disease is complex and requires meticulous attention to safety for the patient, healthcare workers, and the community. We specifically describe measures to decrease the risk of transmission of Ebola virus disease and report pilot data demonstrating no detectable Ebola virus genetic material in the spent RRT effluent waste. This article also proposes clinical practice guidelines for acute RRT in Ebola virus disease.",,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/25398785,,,,"Clinical Care Guidelines,Complications,Ebola,Example,Infection Prevention and Control,Patient Care,R-Res&Pub,R-T&C,Therapeutics",http://jasn.asnjournals.org/content/26/1/31.full.pdf,Publication,Develop,1,0
99,https://repository.netecweb.org/items/show/99,"Are We There Yet? Laboratory Preparedness for Emerging Infectious Diseases.",Laboratory,"We have asked 4 experts in this field to share their thoughts on contemporary challenges in laboratory preparedness for emerging infectious diseases.","Burnham, C. D., J. H. Kwon, E. M. Burd, S. Campbell, P. C. Iwen and M. B. Miller",,,2016-11-10,"2022-01-10 by PPE group Shawn Gibbs",,,,,Publication,,2024-01-10,,,,,,,,,,"Burnham, C. D., J. H. Kwon, E. M. Burd, S. Campbell, P. C. Iwen and M. B. Miller (2017). ""Are We There Yet? Laboratory Preparedness for Emerging Infectious Diseases."" Clin Chem 63(4): 807-811.","free online","The West African Ebola virus epidemic of 2013–2016 was the most widespread epidemic of this disease in his- tory; it is estimated that this occurrence contributed to more than 11000 deaths. During the epidemic, health- care workers (HCW)8 (including laboratorians) were mobilized to care for individuals with suspected or con- firmed Ebola virus disease (EVD). However, at the height of the epidemic, guidance on appropriate safety measures for laboratory workers manipulating specimens from EVD patients was sparse. This highlighted the need for data and guidelines for laboratories testing specimens not only for patients with EVD, but for any emerging infectious disease. During the Ebola epidemic, questions were raised about the roles and responsibilities of laborato- ries in responding to highly infectious diseases, and the bur- den of ongoing readiness for rare events. As the outbreak decelerates, laboratorians must regroup, gather data, and prepare for future outbreaks. We have asked 4 experts in this field to share their thoughts on contemporary challenges in laboratory preparedness for emerging infectious diseases.",,,,,,,,,,,,,,,,,,,,,,,,,,,,http://clinchem.aaccjnls.org/content/clinchem/63/4/807.full.pdf,,,,"Diagnosis,Infection Prevention and Control,Lab,Laboratory,Personal Protective Equipment (PPE),R-Lab,R-PPE,R-Res&Pub,Special Pathogens",http://clinchem.aaccjnls.org/content/clinchem/63/4/807.full.pdf,Publication,Develop,1,0
98,https://repository.netecweb.org/items/show/98,"Personal protective equipment processes and rationale for the Nebraska Biocontainment Unit during the 2014 activations for Ebola virus disease.","Infection Control","In response to the Ebola virus disease outbreak of 2014, specific procedures for personal protective equipment use were developed in the Nebraska Biocontainment Unit for the isolation care of patients with the illness. ","Beam, E. L., S. Schwedhelm, K. Boulter, C. Kratochvil, J. Lowe, A. Hewlett, S. G. Gibbs and P. W. Smith",,,2016-03-01,"2022-01-10 by PPE group Shawn Gibbs",,,,,Publication,,2025-01-10,,,,,,,,,,"Beam, E. L., S. Schwedhelm, K. Boulter, C. Kratochvil, J. Lowe, A. Hewlett, S. G. Gibbs and P. W. Smith (2016). ""Personal protective equipment processes and rationale for the Nebraska Biocontainment Unit during the 2014 activations for Ebola virus disease."" Am J Infect Control 44(3): 340-342.","pay online - or through clinicalkey, or elsevier subscription","In response to the Ebola virus disease outbreak of 2014, specific procedures for personal protective equipment use were developed in the Nebraska Biocontainment Unit for the isolation care of patients with the illness. This brief report describes the 2 different levels used for patient care and presents the rationales for the specialized processes.",,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/26559735,,,,"Contact Transmission,Donning and Doffing,Droplet Transmission,Ebola,Infection Prevention and Control,Patient Care,Personal Protective Equipment (PPE),R-PPE,R-Res&Pub",,Publication,Develop,1,0
97,https://repository.netecweb.org/items/show/97,"Radiographic imaging for patients with contagious infectious diseases: how to acquire chest radiographs of patients infected with the Ebola virus","Treatment & Care","Contagious infectious diseases add a new dimension to radiology and pose many unanswered questions. ","Auffermann, W. F., C. S. Kraft, S. Vanairsdale, G. M. Lyon, 3rd and S. Tridandapani",,,2015-01-01,"2022-09-27 - general asset review - Treatment & Care group
2022-12-07 general asset review - IPC (change to R-T&C)",,"Y
Y - D0.1IC/D0.2IC Qualtrics # 226, original # 13
Y - D0.1Tx/D0.2Tx Qualtrics # 821, Additional Resource",,,Publication,,2025-09-27,,,,,,,,,,"Auffermann, W. F., C. S. Kraft, S. Vanairsdale, G. M. Lyon, 3rd and S. Tridandapani (2015). ""Radiographic imaging for patients with contagious infectious diseases: how to acquire chest radiographs of patients infected with the Ebola virus."" AJR Am J Roentgenol 204(1): 44-48.","free online from journal website","OBJECTIVE: Contagious infectious diseases add a new dimension to radiology and pose many unanswered questions. In particular, what is the safest way to image patients with contagious and potentially lethal infectious diseases? Here, we describe protocols used by Emory University to successfully acquire chest radiographs of patients with Ebola virus disease. CONCLUSION: Radiology departments need to develop new protocols for various modalities used in imaging patients with contagious and potentially lethal infectious diseases.",https://www.ajronline.org/doi/full/10.2214/AJR.14.14041,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/25402496,,,,"Clinical Care Guidelines,Ebola,Infection Prevention and Control,Patient Care,R-Res&Pub,R-T&C",,Publication,Develop,1,0
61,https://repository.netecweb.org/items/show/61,"Emory University Coursera Course – Ebola Virus Disease: An Evolving Epidemic",General,"Ebola Virus Disease: An Evolving Epidemic - Emory University | Coursera",Emory,,,2018-01-08,"2022-03-29 by Josia Mamora",,,,,,,2024-01-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.coursera.org/course/ebola,,,,"Communications,Diagnosis,Donning and Doffing,Ebola,Epidemic,Epidemiology,Ethics,Example,Immunology,Infection Prevention and Control,Lab,Laboratory,Laboratory Testing,Nursing,Outbreaks,Outcomes,Patient Care,Personal Protective Equipment (PPE),Prophylaxis,Public Health,Public Relations,Quarantine,R-PPE,Therapeutics,Virology",,"Online Course",Develop,1,0
50,https://repository.netecweb.org/items/show/50,"PAPR Assembly and Testing – Level C: ILC Dover Sentinel XL","Infection Control","The Nebraska Biocontainment Unit Videos - National Ebola Training and Education Center (NETEC)","University of Nebraska Medical Center / Nebraska Medicine / Heroes",,,2012-03-03,"2022-03-08 by PPE group UNMC (JC)",,,,,,,"2025-08-22 ** Specific Review Date",,,,,,,"",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Aerosols,Airborne Transmission,Example,Personal Protective Equipment (PPE),Powered Air Purifying Respirator (PAPR),R-PPE",https://repository.netecweb.org/files/original/abbaa723ded5b55c7aa69f67242c291e.png,Video,Develop,1,0
48,https://repository.netecweb.org/items/show/48,"ISOPOD Basics: TVI Model",Pre-Hospital,"The Nebraska Biocontainment Unit Videos - National Ebola Training and Education Center (NETEC)","University of Nebraska Medical Center / Nebraska Medicine / Heroes",,,2013-02-19,"2022-03-08 by PPE group UNMC (JC, BH)",,,,,,,"2025-08-22 ** Specific Review Date",,,,,,,"",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"EMS,Example,Intake,Isopod,Patient Transport,Personal Protective Equipment (PPE),Portable Isolation Unit,Pre-hospital Transport,R-EMS,R-IIT,R-PPE,R-PreH",https://repository.netecweb.org/files/original/706da07956c9e1fdb2ba27eb95064f43.png,Video,Develop,1,0
47,https://repository.netecweb.org/items/show/47,"ISOPOD Basics: IRT Model",Pre-Hospital,"The Nebraska Biocontainment Unit Videos - National Ebola Training and Education Center (NETEC)","University of Nebraska Medical Center / Nebraska Medicine / Heroes",,,2013-02-28,"2022-03-08 by PPE group UNMC (JC, BH)",,,,,,,"2025-08-22 ** Specific Review Date",,,,,,,"",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"EMS,Example,Intake,Isopod,Patient Transport,Personal Protective Equipment (PPE),Portable Isolation Unit,Pre-hospital Transport,R-EMS,R-IIT,R-PPE,R-PreH",https://repository.netecweb.org/files/original/fc471999030600150990c225411ac029.png,Video,Develop,1,0
46,https://repository.netecweb.org/items/show/46,"ISOPOD Basics: Patient Care",Pre-Hospital,"The Nebraska Biocontainment Unit Videos - National Ebola Training and Education Center (NETEC)","University of Nebraska Medical Center / Nebraska Medicine / Heroes",,,2013-03-06,"2022-03-08 by PPE group UNMC (JC, BH)",,,,,,,"2025-08-22 ** Specific Review Date",,,,,,,"",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"EMS,Example,Intake,Isopod,Patient Care,Patient Transport,Personal Protective Equipment (PPE),Portable Isolation Unit,Pre-hospital Transport,R-EMS,R-IIT,R-PPE,R-PreH",https://repository.netecweb.org/files/original/eb6c8c11d942dfbf847fda2453ad9528.png,Video,Develop,1,0
45,https://repository.netecweb.org/items/show/45,"Doffing PAPR Level PPE","Infection Control","The Nebraska Biocontainment Unit Videos - National Ebola Training and Education Center (NETEC)","University of Nebraska Medical Center / Nebraska Medicine / Heroes",,,2015-10-31,"2022-03-08 by PPE group UNMC (JC)
2024-03-28 by J. Mundy – Skipped 2023 (Q2) - bumping to 2024 (Q1)",,,,,,,"2024-08-22 ** Specific Review Date",,,,,,,"",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Doffing,Emergency Management,Infection Prevention and Control,Personal Protective Equipment (PPE),Powered Air Purifying Respirator (PAPR),R-PPE",https://repository.netecweb.org/files/original/7ec63b43f98bd8d3539f26f449d8cf63.png,Video,Develop,1,0
44,https://repository.netecweb.org/items/show/44,"Donning PAPR Level PPE","Infection Control","The Nebraska Biocontainment Unit Videos - National Ebola Training and Education Center (NETEC)","University of Nebraska Medical Center / Nebraska Medicine / Heroes",,,2015-10-31,"2022-03-08 by PPE group UNMC (JC)
2024-03-28 by J. Mundy – Skipped 2023 (Q2) - bumping to 2024 (Q1)",,,,,,,"2024-08-22 ** Specific Review Date",,,,,,,"",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Donning,Emergency Management,Infection Prevention and Control,Personal Protective Equipment (PPE),Powered Air Purifying Respirator (PAPR),R-PPE",https://repository.netecweb.org/files/original/52c87b179cd89b020289130a7e759f88.png,Video,Develop,1,0
39,https://repository.netecweb.org/items/show/39,"Cleaning Up Spills","Infection Control","Emory University Videos - National Ebola Training and Education Center (NETEC)",Emory,"Emory Healthcare YouTube: https://www.youtube.com/channel/UCdznuDWlX476PqxNJdoubjg",,2014-12-03,"2022-02-07 by Joanna Mundy (video now private)
2022-12-07 general asset review - IPC (needs updating)
2024-03-28 by J. Mundy – Skipped 2023 (Q2) - bumping to 2024 (Q4)",,"Y
Y - D0.1IC/D0.2IC Qualtrics # 213, original # 7 (additional resources)",,,,,"2024-07-10 - needs updating",,,,,,,"
",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.youtube.com/watch?v=rGk8s8tySew&list=PLrAuA0-_XmsP0AGyLUknA9pW9b7PBQ1t7&index=7,,,,"Decontamination,Infection Prevention and Control,Not updated,R-IPC,Spills,Waste",https://repository.netecweb.org/files/original/9cbdb4075ded38785ecff3d35eb0178b.png,Video,Develop,1,0
32,https://repository.netecweb.org/items/show/32,"Validation of Autoclave Protocols for Successful Decontamination of Category A Medical Waste Generated from Care of Patients with Serious Communicable Diseases.","Waste Management","General Resources | Ebola Hemorrhagic Fever Resources: In response to the Ebola outbreak in 2014, many hospitals designated specific areas to care for patients with Ebola and other highly infectious diseases. The safe handling of category A infectious substances is a unique challenge in this environment.","Johns Hopkins","Garibaldi BT, Reimers M, Ernst N, Bova G, Nowakowski E, Bukowski J, Ellis BC, Smith C, Sauer L, Dionne K, Carroll KC, Maragakis LL, Parrish NM.",,2017-02-01,"2022-12-07 general asset review - IPC",,"Y
Y - D0.1IC/D0.2IC Qualtrics # 209, original # 4a (additional resources)",,,Publication,,2025-12-10,,,,,,,,,,"Garibaldi, Brian T., Mallory Reimers, Neysa Ernst, Gregory Bova, Elaine Nowakowski, James Bukowski, Brandon C. Ellis, Chris Smith, Lauren Sauer, Kim Dionne, Karen C. Carroll, Lisa L. Maragakis, and Nicole M. Parrish. 2016. ""Validation of autoclave protocols for the successful decontamination of Category A medical waste generated from the care of patients with serious communicable diseases."" Journal of Clinical Microbiology. doi: 10.1128/jcm.02161-16.
","Free online","In response to the Ebola outbreak in 2014, many hospitals designated specific areas to care for patients with Ebola and other highly infectious diseases. The safe handling of Category A infectious substances is a unique challenge in this environment. One solution is onsite waste treatment with a steam sterilizer or autoclave. The Johns Hopkins Hospital (JHH) installed two pass-through autoclaves in its Biocontainment Unit (BCU). The JHH BCU and The Johns Hopkins Biosafety Level 3 Clinical Microbiology Laboratory designed and validated waste handling protocols with simulated patient trash to ensure adequate sterilization. The results of the validation process revealed that autoclave factory default settings are potentially ineffective for certain types of medical waste, and highlighted the critical role of waste packaging in successful sterilization. The lessons learned from the JHH validation process can inform the design of waste management protocols to ensure effective treatment of highly infectious medical waste.",https://journals.asm.org/doi/10.1128/JCM.02161-16,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/27927920,,,,"Autoclave,Category A,Decontamination,Ebola,Infection Prevention and Control,R-IPC,R-Res&Pub,Waste",https://repository.netecweb.org/files/original/900d8badf43b6443015d034d49e56e01.pdf,Publication,Develop,1,0
31,https://repository.netecweb.org/items/show/31,"MERS-CoV ED Lab Protocol - Main Campus",Laboratory,"Nebraska - MERS CoV Resources","University of Nebraska Medical Center / Nebraska Medicine",,,2017-03-15,"2023-12-18 by Lab (Vicki and Kim), 1 yr, Review to make sure practices are current",,,,,,,2024-12-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Emergency Department,Lab,Laboratory,Laboratory Testing,MERS-CoV,R-Lab,Respiratory Pathogen,Specimen Collection,Specimen Handling,Specimen Transport",http://repository.netecweb.org/pdfs/MERS-Co-V-Lab-Protocol-main-campus-11-2-15.pdf,Protocol,Develop,1,0
30,https://repository.netecweb.org/items/show/30,"MERS-CoV ED Screening Protocol","Intake and Internal Transport","Nebraska - MERS CoV Resources","University of Nebraska Medical Center / Nebraska Medicine",,,2017-03-01,"2024-03-27 IIT - haven't gotten back first review - bump to next quarter",,,,,,,2024-06-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Emergency Department,Identify,Inform,Isolate,MERS-CoV,R-IIT,R-Lead,Respiratory Pathogen",http://repository.netecweb.org/pdfs/9450-MERS-Flow-Chart_NMC.pdf,Protocol,Develop,1,0
28,https://repository.netecweb.org/items/show/28,"Emory University Protocols",General,"Resources - National Ebola Training and Education Center",Emory,,,2018-01-08,"2022-03-29 by Josia Mamora",,,,,,,2024-01-01,,,,,,,,,,,"Must provide contact info and sign user agreement. Lots of clicking to get to end protocols.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.emoryhealthcare.org/ebola-protocol/ehc-message.html,,,,"Autoclave,Donning and Doffing,Ebola,Emergency Department,Emergency Management,EMS,Example,Identify,Infection Prevention and Control,Inform,Isolate,Isolation/Biocontainment,Occupational Health,Patient Care,Personal Protective Equipment (PPE),Physical Infrastructure,R-PPE,Regional Treatment Center,Special Pathogens,Staffing,Staffing Model,Waste",,Protocol,Develop,1,0
19,https://repository.netecweb.org/items/show/19,"PPE Calculator","Infection Control","Estimated Personal Protective Equipment (PPE) Needed for Healthcare Facilities | Ebola Hemorrhagic Fever | CDC Go to the PPE Calculator at the URL below.
Directly download from the CDC here.",CDC,,,2018-01-08,"2023-07-13 by Christa Arguinchona and Caroline Croyle (PM)",,"Y - PPE pos 86 qualtrics 307
Y - D0.1PPE/D0.2PPE Qualtrics # 307",,,,,2026-07-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.cdc.gov/vhf/ebola/healthcare-us/ppe/calculator.html,,,,"Ebola,Example,Federal,Personal Protective Equipment (PPE),R-PM,R-PPE,Staffing,Staffing Model",https://repository.netecweb.org/files/original/a6782cf618e22d25290b255edbe8fbcf.png,Hyperlink,Develop,1,0